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Abstract 
 
Background 
Stroke is the third most common cause of death in the world and is projected to be the second 
leading cause by the year 2020. Although rates of stroke mortality have decreased in high 
income countries (HICs) in recent decades, the burden of stroke may be increasing in low and 
middle income countries (LMICs) but information is scarce. To address this critical lack of 
data for Viet Nam, five studies of stroke occurrence, costs of treatment and short-term 
outcomes were conducted. 
Methods 
The first study involved surveillance of 5,017 admissions of stroke patients over 12 months at 
a tertiary public teaching hospital in Ho Chi Minh City. To obtain information on outcomes at 
three months, 450 consecutive patients with first-ever stroke were followed-up. The 
remaining four studies of this thesis present findings from this follow-up study. 
Results 
Principal surveillance findings were that the median age of patients was 65.0 years, ischaemic 
stroke was the dominant type, the majority of admissions were for first-ever events, and the 
signs and symptoms of stroke were similar in Viet Nam as elsewhere. Around one-half of 
patients had scores on the modified Rankin Scale (mRS) corresponding to most severe 
disability (mRS=4/5). The estimated incidence of hospital-admitted stroke was 105.6 per 
100,000 person-years, and the confirmed case-fatality at 28 days was 12.2%. 
Case-fatality and functional outcomes at 3 months after stroke were assessed in the second 
study. With minimal loss to follow-up, case-fatality at 3 months was 10.4% and one-third of 
survivors had most severe disability (mRS=4/5). Over three months, one-half of patients had 
improved functional status and one-quarter had worsened, with male patients having greater 
improvement.  
In the third study, information for 437 patients in the cohort was used to estimate the costs of 
stroke treatment. Average total costs per stroke admission were USD 963 comprising USD 
560 for direct medical cost, USD 171 for direct non-medical cost, and USD 240 for indirect 
costs. Health insurance halved out-of-pocket direct medical costs. Severity of stroke, length of 
stay and household wealth were the major predictors of cost.  
The reliability and validity of the Duke Health Profile (DHP) for assessing the Health Related 
Quality of Life (HRQoL) of stroke patients was examined in the fourth study of 108 patients 
and 94 caregivers of patients. They completed the DHP questionnaire and a comparison 
instrument, the EQ-5D. Each was re-administered after 1 week. Intra-class correlations ranged 
from 0.60 to 0.86 (patient test-retest) and from 0.55 to 0.98 (patient-proxy agreement). 
Correlations between DHP and EQ-5D dimensions were strongest for similar constructs 
(r=0.53–0.66).  
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The HRQoL of 373 stroke survivors at 3 months was assessed in the fifth study. Their 
average DHP overall score (58.7) and EQ-5D utility score (0.67) were lower than those from 
comparable general population samples. Female sex, increasing age, lower SES, severe stroke 
at admission time and poor functional status at 3 months were predictors of poorer HRQoL.  
Conclusions and implications 
Young age at stroke onset relative to patients in HICs, and the high proportion with moderate-
to-severe disability, confers a high burden of stroke in Viet Nam. The similar clinical 
presentation suggests that campaigns used in HICs to raise awareness of early signs and 
symptoms could be adopted in Viet Nam. The comparable factors associated with stroke 
occurrence and with functional outcomes prompt application of strategies for prevention and 
management of stroke that are effective in HICs. Despite relatively short average length of 
stay, the total costs of treatment amounted to 2 and 3 times the median monthly income of 
insured and non-insured patients, respectively. Broader health insurance coverage of the 
Vietnamese population would help to bridge the gap. The overload of patients in the stroke 
unit at this hospital signals the need for more stroke units to be established in other hospitals 
in HCMC and surrounds. Measurements of HRQoL with the DHP, which has moderate 
reliability and validity for use with stroke patients in Viet Nam, demonstrated that stroke 
reduces the reported psychological well-being of survivors, and particularly that of female 
patients.  
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Chapter 1: Introduction 
 
1.1. Preface 
Stroke was ranked as the second most common cause of death and the third most common 
cause of disability-adjusted life-years worldwide in 2010 [2]. This thesis explores the 
epidemiology of stroke in a hospital-based setting in Ho Chi Minh City, Viet Nam. It reports 
findings from a series of studies of the burden of stroke in Viet Nam. Those studies include 12 
months surveillance of stroke at a major teaching hospital in Ho Chi Minh City, an 
investigation of costs of treatment of stroke in hospital, and a three-month follow-up of 
survivors to elicit information on outcomes and health-related quality of life (HRQoL) at that 
time. This introductory chapter provides background information on key issues including the 
clinical manifestation of stroke, the burden of stroke in lower and middle income countries 
(LMICs) and a description of the study setting including the healthcare system in Viet Nam. 
 
1.2. Clinical manifestation of stroke 
 
1.2.1. Definition of stroke 
Stroke has been defined by the World Health Organization (WHO) as “rapidly developing 
clinical symptoms and/or signs of focal, and at times global, loss of cerebral function, with 
symptoms lasting more than 24 hours or leading to death, with no apparent cause other than 
that of vascular origin” [3]. This definition excludes transient ischemic attack (TIA, defined as 
focal neurological symptoms that last less than 24 hours), subdural haemorrhage, epidural 
haemorrhage, poisoning and symptoms caused by trauma [4]. First-ever stroke is defined as a 
stroke occurring for the first time during a patient’s lifetime [5]. 
The American Heart Association has recently developed an updated definition of stroke and 
transient ischaemic attack (TIA). The major difference in the updated definition is the 
recognition of the role of imaging in diagnosis, removing the emphasis on time in the earlier 
WHO definition. The updated definition classifies central nervous system infarction as “brain, 
spinal cord, or retinal cell death attributable to ischemia, based on either pathological, 
imaging, or other objective evidence of focal ischemic injury in a defined vascular 
distribution, or clinical evidence of focal ischemic injury based on symptoms persisting ≥  24 
hours or until death, and other aetiologies excluded” [5]. Ischaemic stroke (IS) has been 
defined as “an episode of neurological dysfunction caused by focal cerebral, spinal or retinal 
infarction”. The definition of stroke caused by intracerebral haemorrhage (ICH) is “rapidly 
developing clinical signs of neurological dysfunction attributable to a focal collection of 
blood within the brain parenchyma or ventricular system that is not caused by trauma”. A 
stroke caused by subarachnoid haemorrhage (SAH) has been defined as “rapidly developing 
signs of neurological dysfunction and/or headache because of bleeding into the subarachnoid 
space (the space between the arachnoid membrane and the pia mater of the brain or spinal 
cord), which is not caused by trauma”. Those who suffer transient sudden focal neurological 
symptoms < 24 hours of presumed vascular origin, but without demonstrable infarction or 
haemorrhage on brain imaging, are classified as having a transient ischaemic attack (TIA) [5]. 
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1.2.2. Pathological types of stroke  
 
Worldwide, IS account for 80-85% of stroke. Haemorrhagic stroke, including ICH and SAH, 
account for 15-20% of strokes [6]. 
These major stroke types are often further classified according either to the region of the brain 
they affect or their aetiology. The Oxfordshire Community Stroke Project Classification 
(OCSP) [7] is an old clinical classification, categorising strokes into four regional subtypes 
including total anterior, partial anterior, lacunar and posterior circulation infarcts. In the 
absence of advanced brain imaging techniques, this classification was based on the clinical 
presentation alone and therefore the accuracy of this system has some limitation. [8,9]. The 
most commonly-used classification system for the aetiology of stroke is that used in the Trial 
of Org 10172 in Acute Stroke Treatment (TOAST) criteria [10] that use all available clinical 
and diagnostic test information to categorise IS into 5 subtypes: 1) large-artery 
atherosclerosis, 2) cardioembolism, 3) small-vessel occlusion, 4) stroke of other determined 
aetiology, and 5) stroke of undetermined aetiology. Treatment guidelines and prognosis differ 
depending on the type of stroke.  
Table 1.1 shows the distribution of types of stroke in a number of LMICs. IS is usually the 
dominant type of stroke, ranging from 64.4% in Nigeria [11] to 80.2% in Mumbai, India [12]. 
The incidence of haemorrhagic stroke has increased in LMICs during the 20 years from 1990 
to 2010 [13]. It is notable that ICH has been found to be more prevalent in India, Nigeria and 
China [11,14,15]. 
 
Table 1.1: Distribution of types of stroke in LMICs. 
Location Source IS ICH SAH 
High income countries [16] 82.0% 11.0% 3.0% 
Low and middle income countries [16] 67.0% 22.0% 7.0% 
Mumbai, India [12] 80.2% 17.7% N.A. 
Kolkata, India [17] 68.0% 32.0% N.A. 
Izmir, Turkey [18] 77.0% 19.0% 4.0% 
Chennai, India [19] 77.0% 17.0% 3.0% 
Nigeria [11] 64.4% 31.7% 3.0% 
Fortaleza, Brazil [20] 72.9% 15.2% 6.0% 
Matao, Brazil [21] 85.2% 13.6% 1.2% 
 
In a recent review, the pooled proportions of IS and ICH in high income countries (HICs) 
were found to be 82% and 11% respectively during the period 2000-08 [18]. During the same 
period, the pooled proportional frequency of IS in LMICs (67%) was much lower than that in 
HICs (82%) and the proportional frequency of haemorrhagic stroke in LMICs was much 
higher with a doubling of primary ICH (22% in LMICs vs 11% in HICs) and SAH (7% in 
LMICs vs 3% in HICs) [16]. The increasing relative frequency of haemorrhagic strokes in 
LMICs may be due to changes in, and the increasing prevalence of, risk factors for stroke in 
those countries [16,22]. The risk factors are outlined in the next section. 
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1.2.3. Risk factors for stroke  
 
Non-modifiable risk factors 
Non-modifiable risk factors are those that cannot be directly altered by interventions. The 
major non-modifiable risk factors of stroke are advanced age and male sex. The pattern of 
increasing incidence of stroke at greater ages becomes particularly apparent after the age of 
55 years [2,23-25]. Although this pattern is found in both high income countries (HICs) and 
LMICs, there is a notable shift in the distribution towards lesser average age of initial stroke 
onset in LMICs (Table 1.2). For example, the mean age of patients with stroke in previous 
studies conducted in LMICs ranged from 54.5 years in Bangalore [26], India, to 68.0 years in 
Nigeria [11]. The average age of stroke patients from 9 surveillance sites in 5 different LMICs 
was found to be 64.2 years by Truelsen et al. [27]. In comparison, the mean age of onset is 
around 10 years greater in HICs [27]. Possible explanations of why stroke develops at lesser 
ages on average in LMICs than in HICs are discussed in the following section on modifiable 
risk factors for stroke.  
Table 1.2: Average age at stroke onset from stroke surveillance studies in LMICs. 
  Overall Male Female 
Location Source Mean (SD) Mean (SD) Mean (SD) 
HICs [2] 74.5 (0.13)   
LMICs [2] 69.4 (0.17)   
Mumbai, India [12] 66.0 (13.6) 63.4 (13.5) 68.9 (13.1) 
Ibanda,Nigeria [27] 60.5 (13.1)   
Chennai, India [19] 61.7 (13.4)   
Bangalore, India [26] 54.5 (17.0)   
Trivandrum, India [28] 65.7 (12.1)   
Isfasan, Iran [27] 68.1 (13.1)   
Maputo, Mozambique [27] 57.6 (12.6)   
Matao, Brazil [21] N.A. 65.1 (11.6) 65.3(12.1) 
Moscow 1,Russia [27] 68.4 (12.2)   
Rural Nigeria [11] 68.0 (12.0)   
Indonesia [29] 58.8 (13.3) 57.5 (12.7) 60.4 (13.8) 
Sao Paulo, Brazil [30] 68.0 (14.0)   
Izmir, Turkey [18] 62.3 (12.0)   
Fortaleza, Brazil [20] 67.7(14.4)   
 
The male/female differences in mean age of onset in three LMICs shown in the final two 
columns of Table 1.2 are consistent with general findings that whilst age-specific rates of 
stroke are higher among men than women, women survive to greater ages on average and 
accumulate greater numbers of strokes at advanced ages. In a recent review of stroke in HICs 
[24], the incidence of stroke was found to be about 25% to 30% higher among men, with a 
larger male predominance in the populations of Australia, New Zealand and the Americas 
than in the populations of Europe. The greater life expectancy of women than men, coupled 
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with the increased risk of stroke at greater ages, means that the absolute number of strokes 
occurring among women is greater than the number occurring among men.  
In Viet Nam, the percentage of the population over 60 years (the ageing index in the context 
of a developing country) has risen from 18.2% in 1989 to 24.3% in 1999 and 35.5% in 2009, 
with the expectation of further increases in the future [31]. This demographic transition 
suggests a rising burden from stroke in coming years. 
Whilst beyond the scope of this thesis, there are important questions about differences in 
treatment of men and women following stroke. For example, some studies show that women 
more often have severe strokes but conversely are less likely to receive evidence-based care 
[32-37]. Studies in HICs have investigated social and cultural factors specific to women that 
may impact on receiving stroke care, such as the fact that women more often live alone than 
men. Some authors have suggested that women may have greater delays in seeking care due 
to their neglect of stroke warning signs [32,38]. The extent to which these associations hold 
true in LMICs, which have different social and cultural structures relating to women and 
families, is uncertain. What is known is that hospitalisation for stroke is relatively more 
common for males in LMICs [24]. The male to female ratio of hospital admission was around 
1.1 in studies conducted in Indonesia (53.8% of hospitalisations were of males) [29], Brazil 
(54.7%) [30] and Turkey (55.6%) [18], and as high as 1.9 in Chennai, India (65.9%) [19]. 
 
Modifiable risk factors 
Modifiable risk factors for stroke are those that may be controlled by lifestyle or 
pharmacological intervention. The best quality and most up-to-date evidence on modifiable 
risk factors for stroke has been provided by the INTERSTROKE study, which was a multi-
centre case-control study conducted in 22 countries [39]. The major risk factors for stroke 
were identified as history of hypertension, current smoking, abdominal obesity, poor diet, 
physical inactivity, diabetes mellitus, excessive alcohol intake, psychosocial stress and 
depression, cardiac causes, and ratio of lipoproteins B and A1. These were found to be 
responsible for 90% of strokes [39]. The results of INTERSTROKE largely confirmed 
findings from earlier case-control and cohort studies of the risk factors for stroke [40-47]. 
Although there was some variation in the risk factors for IS and ICH, they were generally 
similar. In this study, high blood pressure and smoking were stronger risks for ICH than for 
IS. The INTERSTROKE study did not examine the major risk factors for SAH. Other studies 
have shown that the risk factors for SAH include oral contraceptive use and hormone 
replacement [48-50], high blood pressure [49], cigarette smoking [49-51] and heavy alcohol 
consumption [52]. 
Although INTERSTROKE included data from some LMICs – including Argentina, Brazil, 
Chile, China, Colombia, Croatia, Ecuador, India, Malaysia, Mozambique, Nigeria, Peru, 
Philippines, South Africa, Sudan, and Uganda – there is some concern that the findings of the 
study are not truly generalizable to the entire populations of these countries [53]. This is 
because participants were recruited from large hospitals, whereas many people suffering 
stroke would not be treated in such facilities. However, other studies have suggested that the 
risk factors of stroke in LMICs are relative similar to those in HICs [15,28,54-60]. For 
example, as in western countries, high blood pressure is considered to be a major modifiable 
risk factor of stroke throughout the developing world [61] including rural South Africa [62] 
and South Asia [63].  
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In recognition of these common risk factors, concerns have been raised regarding a pending 
“epidemic” [64,65] of stroke within LMICs that have experienced rapid industrialisation in 
recent decades. This industrialisation has led to improved economic conditions particularly in 
urban areas, and an accompanying reduction in the burden of infectious, nutritional, and 
perinatal diseases due to increased availability of clean water, food, shelter and medical care. 
In consequence, many more people are surviving to the ages at which non-communicable 
diseases, including stroke, become more common. Increased urbanisation has resulted in 
reductions in physical activity and significant dietary changes [66]. Diets in the developing 
world now contain much higher levels of fat, salt and sugar that are associated with increases 
in blood pressure, serum cholesterol levels and body weight [64-66].  
Additionally, the relative strength of a risk factor and the proportion of cases attributable to it 
each depends on its population prevalence relative to the prevalence of other risk factors. A 
recent meta-analysis of 22 community-based cohort studies has shown that the importance of 
risk factors for stroke differs between Western and Asian countries [67] because some risk 
factors are more prevalent in LMICs than HICs [68]. For example, the prevalence of diabetes 
is reported to be higher in the populations of some developing regions such as Martinique, 
West Indies [38], and Latin American [69] than in the populations of developed countries. 
One study from the Eastern Stroke Coronary Heart Disease Collaborative Research Group 
[70] found a stronger association between high blood pressure and stroke in Eastern Asia 
countries than is reported for developed countries [71]. Although tobacco smoking provides a 
relatively low elevation in risk of  stroke occurrence in LMICs [68,72], the burden of stroke 
related to smoking and cases attributable to it is greater due to the high prevalence of smoking 
in some of those countries [67,68,72]. In addition, the increasing prevalence of obesity, high 
blood pressure and excessive alcohol consumption in LMIC populations may contribute to 
mounting stroke incidence in those countries [72]. 
There is evidence that some aspects of the lifestyle of Vietnamese people – particularly high 
intake of fatty and salty foods [66] and high prevalence of tobacco smoking among men – 
confer elevated risk of stroke. Data from the national survey on risk factors for non-
communicable disease conducted during 2009-2010 in Viet Nam showed that 57.7% of men 
and 1.7% of women aged 25-64 years were current smokers and that 18.5% of men and 
10.2% of women had hypertension [73]. The limited data that are available suggest that the 
prevalence of smoking, excessive alcohol consumption, overweight and obesity, high blood 
pressure and diabetes have each increased in recent decades. For example, the prevalence of 
obesity among Vietnamese adults aged 25-64 years is reported to have nearly doubled from 
2000 to 2005 (increasing from 3.5% to 6.6%) [66]. If there is to be an “epidemic” of stroke in 
LMICs, Viet Nam is a potential candidate to be a victim. 
 
1.2.4. Diagnosis 
Stroke is diagnosed based on medical history, clinical examination, findings from brain CT 
scans or MRI, vascular imaging (e.g. extracranial ultrasound and angiography) and 
cardiovascular examination [74]. Signs and symptoms of stroke include the following: 1) 
motor impairments (paresis or paralysis of face or other parts of the body, on one or both 
sides); 2) sensory deficits (touch, pain, warm/cold); 3) speech difficulties or slurred speech; 4) 
hemianopia (decreased vision, blurred vision); 5) dizziness, gait disturbance, convulsion; 6) 
headache; and 7) difficulty swallowing. Those who have had a haemorrhagic stroke (ICH) are 
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more likely to have headache and convulsions, while a relatively greater proportion of 
patients with IS have speech difficulty and sensory deficits [75,76].  
The data relating to the signs and symptoms of stroke are derived largely from studies 
conducted in HICs, and it is not certain that the same patterns are evident in LMICs. In 
addition, it is important to understand the presentation of stroke in different settings and 
different population sub-groups such as men and women, because information about signs 
and symptoms are used to raise community awareness of stroke and of the need to seek 
medical attention. Currently there is no information for Viet Nam regarding the major signs 
and symptoms and, in consequence, no evidence base for determining whether awareness-
raising campaigns developed in HICs – such as the Face, Arm, Speech Test (FAST) [77] – 
can be applied in that country. 
 
1.2.5. Treatment 
The treatment of stroke is focused on achieving reperfusion for IS and limiting bleeding for 
ICH, and managing the downstream effects of the neurological injury resulting from the 
stroke [78]. In guidelines for acute stroke management by the American Heart Association, it 
is acknowledged that the first 24 hours of treatment are particularly important including 
management of airways, blood pressure, temperature, infection, blood glucose, fluid and 
electrolytes balances and controlling seizures are particularly important [79,80]. 
Each subtype of stroke requires a different treatment strategy [76]. For IS, intravenous 
recombinant tissue plasminogen activator (r-tPA) is recommended within first 3 hours to 
improve outcomes [81-84]. Combined treatment with intravenous and intra-arterial 
thrombolysis, also known as bridging therapy, has acceptable safety and efficacy for 
treatment of stroke patients [85]. For ICH, although activated recombinant factor VII (rFVIIa) 
can limit hematoma expansion, the improvements of outcomes following this treatment has 
not been proven [86]. If there is severely elevated intracranial pressure, surgery with 
craniotomy is sometimes required [87]. Anderson et al. [88] showed that patients had better 
outcomes in terms of limiting hematoma expansion when treated early with intensive blood 
pressure lowering, but the association of early blood pressure control and hematoma 
expansion became non-significant after adjustment for initial haematoma volume [88]. 
Therefore, more evidence is required before it can be accepted that blood pressure lowering 
therapy improves outcomes following ICH [89]. The recommended treatment of SAH from 
ruptured aneurysms includes strict control of blood pressure and securing the aneurysm [90]. 
The aneurysm can be clipped or intravascular coiling can be used, ideally as early as possible 
[90,91]. 
In a review of acute treatment and management of stroke in LMICs, Brainin et al. concluded 
that the quality and quantity of stroke care in those countries varied widely and depended on 
patient-level factors such as their location, socioeconomic status, education and even cultural 
beliefs [22,58]. Whether this is the case in Viet Nam is unknown, because there are limited 
data on clinical care pathways and outcomes following stroke in that country. 
 
1.3. Burden of stroke  
The WHO estimated that stroke accounted for 6.7 million deaths worldwide (11.9% of all 
deaths) in 2012. It has been projected that four out of five stroke victims in 2025 will be 
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people living in LMICs [27,92]. However, these estimates are based on projections of data 
from non-representative samples. Therefore, it is essential to obtain epidemiological data on 
occurrence of stroke in LMICs including estimates of incidence, prevalence and case-fatality. 
These data are needed to inform decisions about the allocations of resources that are needed to 
meet the increasing needs of patients with stroke and their families. These data can also be 
used to plan and evaluate intervention programmes to reduce the burden of stroke and 
improve outcomes in LMICs [27].  
There are many ways to measure the burden of stroke within a population. In this thesis, the 
author examines the burden of stroke on society, the healthcare system and patients in terms 
of occurrence of stroke, functional outcomes, economic costs and health-related quality of life 
(see Figure 1.1). 
 
 
1.3.1. Population-based measures of the occurrence of stroke 
The three population-based measures of occurrence are incidence, prevalence and mortality. 
The incidence of stroke is defined as the number of new cases of stroke occurring during a 
specified period in a population at risk of stroke. New cases of stroke include both first-ever 
stroke (a first event of stroke for an individual) and recurrent stroke (an event of stroke 
subsequent to the first event for an individual). The prevalence of stroke is defined as the 
number of people with stroke (new and old cases) in a population at a particular point in time. 
It combines measures of incidence and survival. The mortality from stroke is the number of 
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deaths recorded as being due to stroke during a specified period in a population at risk of 
stroke. This information can be sourced from routine death registrations if cause of death is 
determined and recorded. It therefore has the disadvantage of only capturing events that 
resulted in death, which may only be 17-30% of strokes in HICs and 18-30% in LMICs based 
on early case-fatality during the period 2000-08 reported in the review by Feigin et al. [16]. 
Incidence of stroke 
 
Measurement of incidence of stroke 
Measuring the incidence of any disease is difficult but the wide ranging severity of strokes 
and the disparate outcomes following treatment means that capturing all events requires 
monitoring of many layers of the healthcare system. Acknowledging this, and other issues 
related to gathering data on stroke, guidelines were developed for conducting the “ideal” 
stroke incidence study first by Malmgren et al. (1987) [93] and then updated by Sudlow and 
Warlow (1996) [94] and Coull et al. (2004) [95]. These methods were developed to ensure 
complete capture of stroke cases in the community irrespective of stroke severity by using 
multiple overlapping sources of case ascertainment. These could include records of hospital 
admissions and discharges, general and specialist practitioners, nursing homes, community-
based allied health settings and death registries where they exist. To collect all appropriate 
data, reduce selection bias and improve the accuracy of clinical data, these “’ideal” studies 
would need to be prospective over at least one year  and conducted in a well-defined 
geographic region with a stable population that provides an accurate denominator for 
incidence calculations [96]. 
Such studies have been conducted in various locations across the world (see Figure 1.2, 
which is taken from the review of Feigin et al. [16]). It is evident that most of these studies 
have been conducted in HICs including Finland, Denmark, France, Sweden, Italy, Norway, 
Portugal, UK, Russia, Ukraine, USA, Australia and New Zealand [16], with only a small 
number of studies in LMICs such as India [12] and Brazil [21].  
 
Figure 1.2: World map showing areas of population-based stroke incidence studies. 
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A major reason for the lack of stroke incidence data for LMICs is the lack of resources with 
which to conduct these studies. It is not possible, at present, for many LMICs to meet the 
requirements for an ideal stroke incidence study. Their populations are often fast growing, 
particularly in urban areas, and routine monitoring of deaths at a population level is not 
reliable or not available due to the lack of medically-certified cause-of-death data. There is 
also a lack of funding, infrastructure and suitably trained researchers required to undertake 
these types of studies. Therefore, the methodology required for an “ideal” incidence study is 
very difficult to apply in LMICs. 
To standardise the process of data collection to make data on stroke comparable between 
different LMICs and across time, the WHO – in collaboration with the World Stroke 
Organisation (formerly the International Stroke Society and the World Stroke Federation) – 
developed a standardised stepwise approach to measuring the burden of stroke. This 
standardised methodology is termed STEPS-Stroke. It is designed to allow data collection to 
be tailored to the limited resources that are available in each LMIC [97,98].  
The STEPS-Stroke method covers three 'Steps' for finding cases of stroke for a defined 
population (see Figure 1.3). Each Step has a core and expanded dataset with the different 
levels of data collection increasing in complexity, as detailed below. 
 
 
Step 1 (hospitalised events) focuses on persons who are admitted to a hospital following a 
stroke defined using the WHO definition. A hospital-based registry is required to collect core 
data on stroke admissions, severity of stroke and short-term survival. The expanded data 
requirement of Step 1, if adopted, is for information on exposure of major risk factors before 
stroke onset to be collected and for assessments of functional status at discharge to be made. 
A comprehensive implementation of Step 1 is possible if neuroimaging facilities are available 
at the hospital to validate diagnosis and determine stroke sub-type. If the catchment area of 
the hospital is well-defined and census data are available on the population of that catchment 
area, the incidence density of hospital-admitted stroke can be determined. This is an under-
estimate of all cases of stroke if very mild cases and very severe cases resulting in rapid death 
do not present to hospital.  
Step 2 (fatal events in community) involves the collection of information on fatal stroke 
events that have occurred in the same community but out of hospital. If cause-of-death 
Figure 1.3: The proposed WHO stepwise approach to stroke surveillance. 
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certification is undertaken in the community, an assessment of its validity must be undertaken 
prior to the acceptance of information from death certificates. Verbal autopsy techniques are 
recommended to verify a stroke death. The main outcomes of Step 2 are estimates of the 
specific mortality and years of life lost due to stroke in the population. 
Step 3 (non-fatal events in community) involves the collection of data on milder strokes that 
occur in the community. The main outcome of Step 3, when combined with results from Step 
1 and Step 2, is the calculation of incidence and prevalence of stroke and of mortality and 
case-fatality from stroke. This is the most challenging step of STEPS-Stroke methodology. 
The WHO has recommended that Step 1 should be conducted in most countries in order to 
obtain the minimum data needed on the burden of stroke across the world. If resources allow 
and central death registration is available and reliable, then all three steps should be attempted 
to achieve population-based stroke surveillance. Using the WHO STEPS-Stroke method, 
surveillance of stroke has been conducted in Sri Lanka [99] and India [12] (South Asia), 
Ukraine [100], Georgia [101] and Bulgaria [102] (Europe); Brazil [21] (South America), 
Mongolia [99] (Western Pacific); Nigeria [21] (West Africa) and Tanzania [103] (East 
Africa). Most studies were conducted in urban areas, while the studies in Bulgaria [102] and 
Tanzania [103] were conducted in both urban and rural areas. Only one study, based in urban 
India [12], incorporated the complete STEPS-Stroke surveillance protocol. Many of these 
studies did not adhere completely to the Step 1 protocols due to limited resources, particularly 
in respect of neuroimaging to validate diagnoses and categorise type of stroke [104]. In a 
recent review of data from 9 STEPS-Stroke study centres in five LMICs (India, Iran, 
Mozambique, Nigeria and Russia), Truelsen et al. [27] nevertheless affirmed that this method 
is feasible for stroke surveillance in LMICs.  
Viet Nam is a LMIC with very limited resources and research capacity and, in consequence, 
conducting Step 2 and Step 3 of the STEPS-Stroke methodology would be impractical at first. 
Implementing Step 1 (hospital-based register) is a reasonable starting point for examining 
stroke in Viet Nam. One of the aims of this thesis, therefore, was to undertake surveillance of 
stroke and to estimate the incidence density of hospital-admitted stroke in the largest city of 
Viet Nam using Step 1 of the WHO STEPS-Stroke methodology. 
 
Hospital-based surveillance study 
As noted earlier, hospital-based data collection (Step 1, Figure 1.3) is considered to be 
feasible in LMICs [27]. By linking admission data to the catchment population served by the 
relevant health facilities, a hospital-based register may provide information on hospital-
admitted stroke rates in the source population [27]. Hospital-based studies do have some 
limitations as they can only provide data on hospitalised cases. This is likely to result in 
under-ascertainment in HICs, but the under-ascertainment in LMICs is amplified by non-
availability of diagnostic services particularly in rural areas, socio-economic factors limiting 
hospital access, and lack of universal healthcare. For these reasons, it is likely that patients 
admitted to hospital for stroke in LMICs are not representative of the entire population of 
stroke patients. Hospital-based studies are also limited in that they tend to under-ascertain 
mild cases that are not admitted to hospital, and the most severe cases that result in early 
death before hospital admission or home palliation without hospital admission.  
The experience of population-based stroke incidence studies in HICs is that the proportion of 
first-ever stroke cases admitted to hospital ranges from 60% to 86% [105,106]. The 
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underestimation may not be uniform across all groups that suffer stroke. For example, in the 
1989-90 Perth Community Stroke Study, Anderson et al. [105] reported that they would have 
underestimated the incidence of stroke among the most elderly patients by 40% if only cases 
admitted to hospital were counted. In the 1991-92 Auckland Stroke Study, Bonita et al. [96] 
reported that the majority (63%) of cases were ascertained from hospital admission records, 
while the remaining came from death registrations (10%) and general practitioners or other 
community-based sources (27%). A higher hospital admission rate of 86% was reported in the 
North East Melbourne Stroke Incidence Study (NEMESIS) conducted between 1996 and 
1997 [106]. 
There appear to be similar differences in hospital admission rates in LMICs. For example, in 
India, Dalal et al. (2008) [12] conducted a study using all three Steps of the WHO STEPS-
Stroke methodology in Mumbai from January 2005 to December 2006. They found that two 
thirds of the first-ever cases of stroke were admitted to hospitals. The remaining one third was 
found to be dead, treated at home or living in a nursing home. The proportion of cases 
admitted to hospital in other LMICs were lower. Only 46% of patients in Bulgaria [102] and 
32% in Tanzania [103] were admitted to hospital. This suggests that findings derived from 
hospital-based stroke registries in LMICs will underestimate the true incidence of stroke in a 
community by at least one third and possibly by two thirds. 
Nonetheless, in the setting of Viet Nam, there is a paucity of information on stroke occurrence 
with hospital-based studies being a feasible option to partially rectify this. There has been one 
previous hospital-based study of stroke using the STEPS-Stroke method in a provincial 
hospital in Da Nang City, central Viet Nam, from March 2010 through February 2012 [107]. 
In that study, nearly 50% of cases were haemorrhagic stroke (consisting of both ICH and 
SAH). The 28-day case fatality in the study was high at 36.4%. This study was conducted in a 
general public hospital without a stroke unit, and the authors noted that it was servicing a 
population in which the prevalence of untreated hypertension was high. The only other 
published data on stroke in Viet Nam come from a study conducted in the 1990s by Le at al. 
[108]. Those data were used as representative of Viet Nam in the recent review of Feigin et al. 
[2] of the global burden of stroke [2].  
 
Comparisons of stroke occurrence between HICs and LMICs 
It is important to note that summary measures of incidence of and mortality from stroke in a 
country may be presented as age-standardised rates. The crude rate is the summary measure of 
occurrence in a population. Age standardisation allows meaningful comparisons to be made 
between populations with different age distributions. By comparing the number of cases that 
would have occurred in a standard population such as the new WHO world standard 
population or Segi’s world population or the European standard population if subject to the 
age-specific rates of each country being compared, the differences caused by non-identical 
population age structures are removed. To facilitate international comparisons, it is good 
practice to present both crude and age-standardised rates. 
A systematic review of population-based studies of stroke incidence published from 1970 to 
2008 revealed that there has been a 42% reduction in stroke incidence in HICs over the last 40 
years [16]. In contrast, it was estimated that there has been more than 100% increase in stroke 
incidence in LMICs [16]. The overall incidence rates in LMICs was estimated to have 
exceeded that in HICs for the first time in 2000–08, and it did so by 20% [16].  
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Table 1.3: Global trends in age-adjusted annual stroke incidence per 100,000 person-years between 1990 and 2010.* 
  High income countries   Low and middle income countries  
  1990   2010   1990   2010  
Age < 75 years 
       
Ischaemic Stroke 110.8 (103.1, 118.5) 100.5 (94.0, 107.2 101.9 (89.290, 116.492 106.9 (93.6, 121.4) 
Haemorrhagic Stroke 41.9 (38.9, 45.2) 38.5 (35.6, 41.2) 61.6 (52.8, 71.5) 75.7 (64.9, 88.7) 
Total Stroke 152.7 (142.3, 163.2) 138.9 (130.6, 148.2) 163.5 (142.4, 187.2) 182.5 (158.9, 209.6) 
Age ≥ 75 years 
    
Ischaemic Stroke 2824.4 (2627.6, 3018.4) 2344.0 (2197.0, 2503.8) 2367.5 (2026.7, 2735.5) 2575.4 (2240.7, 2850.2) 
Haemorrhagic Stroke 417.5 (385.9, 450.8) 380.1 (351.4, 409.6) 713.8 (603.3, 847.4) 859.4 (729.2, 1012.6) 
Total Stroke 3241.9 (3020.9, 3458.8) 2724.1 (2553.9, 2899.8) 3081.4 (2631.0, 3562.0) 3434.8 (2979.2, 3952.1) 
* Estimates were obtained from data provided by the authors of the Global Burden of Disease Study 2010 [2,13]. Figures in parentheses present 95% confidence intervals per 
100,000person-years 
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Table 1.3 summarises findings from Feigin et al. (2014) [1] and shows the trend in age-
adjusted incidence of stroke in HICs and LMICs during the last 20 years. While the incidence 
of stroke in HICs decreased from 246.32/100,000 person-years in 1990 to 217.26/100,000 
person-years in 2010 in HICs, the incidence of stroke in LMICs increased from 
251.93/100,000 person-years in 1990 to 281.12/100,000 person-years in 2010.  
Figure 1.4 provides a heat map of incidence study of stroke standardised to the WHO world 
population by quartiles provided by Thrift et al. [109]. Viet Nam is not featured on the map 
because there were no available data on incidence of stroke in Viet Nam for this period. 
 
 
 
 
 
 
Figure 1.4: Heat map showing incidence of stroke adjusted to the WHO world 
population by quartiles. 
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Incidence of stroke in LMICs 
Dalal et al. [12] used the STEP-Stroke approach to estimate the annual crude incidence 
density of stroke in Mumbai, India, for the period from 2005 to 2006. The incidence density 
estimates were 145 (95% CI 120–170) per 100,000 person-years overall, and149/100,000 
person-years for males and 141/100,000 person-year for females [12]. The age-standardised 
rate by the direct method using Segi's 1996 world population was 152 (95% CI 132–172) per 
100,000 person-years for both sexes combined. Sridharan et al. [28] reported age- and sex-
standardised incidence density rates in Trivandrum, India. The estimates were 135 (95% CI 
123–146) per 100,000 person-years overall, 135 (95% CI 122–148) per 100,000 person-years 
for the urban population with 142/100,000 for males and 130/100,000 for females in those 
areas, and 138 (95% CI 112–164) per 100,000 person-years for the rural population with 
163/100,000 for males and 115/100,000 for females in those areas [28]. The crude annual 
incidence density of first-ever-in-a-lifetime stroke was estimated to be 108 (95% CI 85.7 to 
134.1) per 100 000 person- years in Matao, Brazil] [21], with a rate of 136 (95% CI 101–179) 
per 100,000 persons-years for males and 80 (95% CI 54–114) per 100,000 person-years for 
females [21].  
It is notable that in a recent review of stroke surveillance studies in LMICs using the WHO 
STEPS-Stroke approach by Sajjad et al. (2013) [104], the authors concluded that differences 
in estimates of age-standardised incidence of first-ever stroke between LMICs may be due to 
characteristics of the populations involved (urban vs rural), with differences in application of 
the methodology another possible contributor.  
 
Incidence of stroke in Viet Nam 
There has been only one study of the prevalence and incidence of stroke in Viet Nam. It was 
conducted as a door-to-door survey by Le at al. [108] in 1994/1995 in a single local 
community in each of the provinces of Ho Chi Minh City (urban), Tien Giang (rural) and 
Kien Giang (rural) in the south of Viet Nam. Overall, 54.7% of the study population was from 
Ho Chi Minh City. Le et al. [108] reported that the overall prevalence of stroke was 
608/100,000 person-years. The incidence density estimates were 250/100,000 person-years 
overall, and 142/100,000 person-years in Ho Chi Minh City, 290/100,000 person-years in 
Tien Giang and 385/100,000 person-years in Kien Giang. The overall estimate was greater 
than the estimates for the same period of time (1990/1999) made for other LMICs [16]. In the 
recent review of the global burden of stroke by Feigin et al. [2] and Krishnamurthi et al. [13], 
the estimated incidence of stroke in Viet Nam was projected from the incidences made in the 
study of Le et al. [108] in 1994/1995. Feigin et al. [2] projected that the incidence of stroke in 
Viet Nam during the period 1990 to 2010 would have increased from 213.58/100,000 person-
years to 254.78/100,000 person-years [2]. If incidence of stroke increased at a similar rate in 
Ho Chi Minh City, the community-based estimate of Le et al. [108] in 1993/1994 would have 
risen to 169/100,000 person-years in 2010. However, there are many assumptions and 
simplifications that have been made in calculating the global burden estimates. They relate to 
changes in incidence and population risk factors over time, both of which may result in 
inaccuracies in the projections of stroke incidence. The community samples were small and, 
in addition, there may not have been appropriate weighting of the estimates for urban and 
rural areas because 70% of the population of Viet Nam now lives in rural areas and more 
would have done so at the time. For these reasons, it is essential to obtain updated and more 
reliable estimates of incidence of stroke in Viet Nam  
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In summary, age-standardised incidence of stroke in HICs has been decreasing whereas the 
available evidence suggests that the incidence of stroke in LMICs has been increasing with 
the consequence that the age-standardised incidence of stroke in LMICs now exceeds that in 
HICs. However, there is a paucity of data on the occurrence of stroke in Viet Nam with which 
to confirm these findings apply to that country. To help fill the gap in data on incidence of 
stroke in Viet Nam, a hospital-based surveillance study (using Step 1 of the STEPS-Stroke 
methodology) was planned on the understanding that such studies are considered to be 
feasible in countries like Viet Nam. The results are reported in this thesis. 
 
1.3.2. Short-term outcomes following stroke 
In addition to examining the occurrence of stroke in Viet Nam by way of hospital-based 
surveillance, this thesis aims to describe the short-term outcomes after stroke in Viet Nam. 
This section outlines the different measures of outcomes after stroke onset. They include 
death, neurological impairment, the effects that these impairments have on the person’s ability 
to perform everyday tasks (functional outcomes), and their impacts on the physical and 
emotional well-being of survivors (HRQoL).  
 
1.3.2.1. Early stroke case fatality  
Case-fatality is the most commonly assessed outcome after stroke. It is defined as the 
proportion of deaths due to stroke among patients with stroke during a specified period of 
time. Table 1.4 summarises the findings in respect of 28-day case-fatality from previous 
surveillance studies conducted in LMICs. There is wide variation in the proportion of those 
with stroke that die within the first 28 days; however, these figures are generally higher than 
those for HICs (range 19-24%) [37,105,106,110,111]. 
 
Table 1.4: Summary of findings for 28-day case fatality from stroke surveillance studies 
conducted in LMICs. 
Location Source Methods Case-fatality 
Bangalore, India [26] Population-based 20.0% 
Trivandrum, India [28] Population-based 24.5% † 
Trivandrum, India [28] Population-based 37.1% ‡ 
Mumbai, India [12] Population-based 29.8% 
Qatar [112] Population-based 16.0%§ 
Chennai, India [19] Hospital-based 14.0% 
Izmir, Turkey [18] Hospital-based 19.7% 
Rural Nigeria [11] Hospital-based 23.8% 
Iran [113] Hospital-based 32.0% 
Northeast Malaysia [114] Hospital-based 34.2% 
Matao, Brazil [21] Population-based 18.5% 
†case-fatality for urban population 
‡case-fatality for rural population 
§case-fatality for first-ever stroke 
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1.3.2.2. Stroke-related neurological impairment 
Neurological impairment is a loss of normal function of the neurological system. As a 
consequence of stroke, when the blood supply to the brain is disturbed, there is a loss of brain 
function that may be apparent immediately or may develop over a number of hours and days. 
There is a wide range of impairments and downstream functional affects from a stroke, 
including reduced ability to move limbs, understand or formulate speech, experience 
sensations or perform cognitive tasks. 
The impairments causes by a stroke are measured in a neurological examination, which 
assesses a person’s ability to carry out various tasks related to neurological function. Such 
examinations have been formulated into validated measurement protocols such as the 
National Institutes of Health Stroke Scale (NIHSS) or the Scandinavian Stroke Scale. The 
studies described in this thesis used the NIHSS, which is one of the most widely used 
measures of neurological impairments after stroke [115]. It was initially developed for use in 
clinical trials and has been used as a marker of stroke severity [115]. It comprises 15 items, 
each of which includes either a three graded (from 0 to 2) or four graded (from 0 to 3) point 
score range with a total score range from 0 to 42. Greater scores denote more severe 
neurological impairment [115]. It has acceptable reliability and validity for the assessment of 
neurological impairment of patients with stroke in the acute period [116-120].  
 
1.3.2.3. Functional outcome following a stroke 
Functional outcomes, which are also commonly termed disabilities or activity limitations, 
describe a person’s ability to perform activities of daily living. These limitations of function 
are a result of the neurological impairments caused by the stroke 
One of the instruments commonly used to measure functional outcomes after stroke is the 
modified Rankin Scale (mRS). This originated as the Rankin Scale (RS) in Scotland in 1957 
[121] and had 5 grades representing no, slight, moderate, moderately severe and severe 
disability. It was designed to describe recovery from stroke at the time of discharge from 
hospital. The scale was modified to include measures of language and cognitive problems and 
renamed the modified Rankin Scale in 1998 for use in the UK-TIA study in 1988 [122]. The 
mRS is widely used as a measure of functional outcome after stroke [121,123-133]. 
The mRS has moderate inter-rater reliability for use with stroke patients [123,125]. There is 
some concern regarding the validity of the measure, and specifically whether it is solely 
measuring functional outcomes as specified in the International Classification of Functioning 
Disability and Health (ICF) concept [134], because the findings of some studies suggest that it 
also measures aspects of impairment [135,136].  
The mRS has been widely used as a measure of functional status of stroke survivors in 
community setting. It is increasingly used in acute stage assessment of the level of disability 
of inpatients [137-139]. The validity of assessments made of acute stroke patients in the 
hospital setting has been questioned [140,141], because patient self-assessment of ability to 
perform “usual duties and activities” or “previous activities” or “look after own affairs” may 
be unreliable when made from the hospital bed. These descriptors are used in defining mRS 
grades 1 and 2. Those used in defining mRS higher grades include ability “to walk without 
assistance” and “to attend to own bodily needs without assistance”, and being “bedridden, 
incontinent and requiring constant nursing care and attention”. Those grades are more 
readily able to be assessed in hospital. If this prompts greater error in self-assessment by 
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acute-care patients than by community-based survivors, particularly by those at the lower end 
of the scale, the net effect may be under-reporting of least severe disability. 
Although the mRS was developed in English, it is commonly used in countries with 
languages other than English as official language. This raises the possibility of reduced mRS 
reliability and validity in non-English speaking countries because the reliability and validity 
of the scale after translation into languages other than English has not been studied [142]. In 
Viet Nam, the mRS has been used commonly in clinical setting to assess the functional 
outcome of patients with a specific disease, such as tuberculous meningitis [143] or stroke 
[107,144]. 
Level of function during admission and in the post-acute period 
It is generally reported that most functional recovery occurs within the first three to six 
months after stroke onset [145-149]. However, some patients may continue to experience 
improvements for up to 18 months after stroke [148]. In this thesis, the author examines 
functional outcomes measured with the mRS three months after stroke. This time point was 
chosen because the functional recovery of stroke survivors is stable after three months 
[142,150]. In studies conducted in HICs, the proportion of moderate to severe disability 
assessed on the mRS (mRS≥ 3) during admission has ranged from 45.7% in the Virtual 
International Stroke Trial Archive [151] to 73.3% in the study of Silvestrelli at al. [152] in 
Spain. In LMICs, this proportion has ranged from 38.5% in Mumbai, India [12] to 57.5% in 
Trivandrum, India [28].  
Swedish data from the Riks-Stroke study showed that about 30% of stroke survivors were 
dependent in primary activities of daily living (ADL) at three months following stroke [153]. 
Glader et al. [154] showed that 57% of the patients were living at home without community 
support three months after stroke, and 19% were discharged to institutional living [153]. In a 
multicentre study conducted in Western and Central Europe, the proportions of survivors with 
dependent outcomes (mRS ≥ 3) ranged from 21% to 70%. In data from the Austrian Stroke 
Unit Registry, the proportion with moderate-to-severe outcomes (mRS ≥ 3) at three months 
was 37.6% [155]. Data from the Hospital-Based Perugia Stroke Registry in Italy in 2000-
2003 showed that the proportion with moderate-to-severe outcomes (mRS ≥ 3) at three 
months was 20.9%.  
In Asia, reports from studies conducted in China have shown that the percentage of patients 
with unfavourable functional outcomes (mRS ≥ 3) at three months were in the range 34.0-
39.7% [156,157]. The finding (37.1%) of a study in Korea fell in that range [158]. There is 
very limited data on the level of functional outcomes of stroke survivors in LMICs after 
hospital discharge. In Viet Nam, only one study by Nguyen et al. [144] has reported mortality 
and functional outcomes and this was for patients after r-tPA treatment for acute IS. In this 
study, 43.0% of 121 patients with acute IS who received thrombolysis over 3 years (2006-
2009) achieved independent function (mRS=0-1) and 8.3% of them were dead at three 
months. There is no information available on the functional outcomes after hospital discharge 
of patients with all types of stroke. 
 
Predictors of severe functional outcomes at three months 
There is interest in examining the factors that predict levels of function at various time points 
after stroke because understanding those factors could lead to strategies to improve function. 
The factors identified as being associated with reduced function after stroke include greater 
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age [159], greater severity of stroke [159], greater extent of co-morbid disease [160], pre-
stroke tobacco smoking and alcohol consumption [161-164], and lower socioeconomic status 
[165,166].  
Several studies have reported poorer outcomes for women in terms of function [24,155,167-
171]. One reason may be that atrial fibrillation is related to more severe stroke 
[24,167,172,173] and this condition is more prevalent among women, potentially due their 
different age profile compared to men who suffer stroke [155,174-179]. Delay in arrival to a 
stroke unit has been a strong predictor of functional outcomes at three months in some studies 
in HICs [152,158,180,181], and some studies [32,38,182-186] but not others [25,187-190] 
have reported that women more often present later to hospital compared to men. 
However, most of the previous studies of the factors associated with functional outcomes after 
stroke have been conducted in HICs. There is a lack of data from LMICs, with no such data 
available for Viet Nam. 
 
1.3.2.4. Health-related quality of life after stroke onset 
Quality of life (QoL) is defined by the WHO as “the perception that an individual has of his 
or her place in life, within the context of the culture and system values in which he or she 
lives, and in relation to the objectives, expectations, standards and concerns of this individual” 
[191]. In order to specifically relate this concept to health, WHO also defined the term health-
related quality of life (HRQoL) as “an integrative measure of physical and emotional well-
being, level of independence, social relationships and their relationship to salient features of 
their environment” [192]. This conceptualization of HRQoL recognises that HRQoL is 
subjective and multidimensional. 
In recent years, assessment of patient-centred outcomes – such as HRQoL – has been 
recognised as being essential for understanding outcomes following a stroke. A 
multidimensional approach to assessing the HRQoL of patients with stroke should include 
aspects of physical, psychological, and social functioning. Multidimensional measures of 
HRQoL reflect spiritual and material well-being within the cultural and environmental 
context.  
In stroke research, the increasing proportions of stroke survivors means that it is important to 
understand much more about their lives beyond simple measures of whether they can 
undertake basic tasks. HRQoL has been became an important patient-centred outcome due to 
the recognition that “the ultimate goal of healthcare is to restore or preserve functioning and 
well-being related to health, that is health-related quality of life” [193]. Relying only on 
assessment of clinical health status, such as determined by physician examination of 
neurological impairment or impaired functional status, is to ignore important factors of a 
patient’s subjective health status. The aim of the assessment of HRQoL among patients with 
stroke is to determine as best as possible the impact of stroke on the patient’s life and well-
being. Along with traditional measurement of outcomes (such as mortality and impaired 
functional outcome), HRQoL is an important indicator of the burden of stroke.  
HRQoL instruments  
HRQoL can be measured with generic or disease-specific instruments. An advantage of a 
generic instrument is that its results can be compared with reference values for the general 
population or for patients with other diseases. However, a disadvantage of generic instruments 
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is that they may not measure stroke- specific dimensions such as language, cognition or 
vision.  
There are two types of generic HRQoL instruments that are often used: health profile and 
utility measures. Health profile instruments include the WHO Quality of Life (WHO-QoL) 
[194], Short Form 36 (SF-36) [195], the Sickness Impact Profile [196], the Nottingham 
Health Profile [197], and the Duke Health Profile (DHP) [198]. The utility measures include 
the European Quality of Life (EQ-5D) [199], the Health Utilities Index [200], and Assessment 
of Quality of Life [201]. These instruments were developed for health economic evaluation, 
and can be used to calculate quality-adjusted life years (QALYs). These can be used as an 
outcome in cost effectiveness analyses, and are calculated by multiplying the time spent in a 
particular health state by the ‘value’ assigned to that health state.  
There are instruments developed specifically to assess the HRQoL of stroke survivors. They 
include the Stroke Impact Scale [202,203], the Stroke Specific Quality of Life Scale [204], the 
Burden of Stroke Scale [205], and the Stroke and Aphasia Quality of Life scale-39 [204]. 
Some of them have been translated for use in non-English language countries [206-211] to 
assess specific relevant domains for stroke survivors.  
However, among instruments used to measure HRQoL in Viet Nam, the DHP stands apart 
because it has been translated and culturally adapted for use among adolescents in Viet Nam. 
The internal consistency and the validity of the DHP were examined in a study [212] 
conducted in Ho Chi Minh City in the year 2000 with a sample of 1,408 adolescents selected 
by cluster sampling. The mean age of these adolescents was 15.7 years, and 50% of them 
were female. The reproducibility of the DHP was examined among 408 of the sample by 
retest after 2-weeks. It was found to be acceptable with intra-class correlation coefficients 
(ICCs) ranging from 0.7 to 0.8. Its construct validity was judged to be acceptable based on the 
correlations between DHP dimension scores and other study factors such as age, sex, 
residential location (urban or rural), family structure (family with single parent), drug use, 
alcohol consumption and presence of chronic disease. There are also some data available on 
the levels of HRQoL in the general population of Ho Chi Minh City [213], where the studies 
in this thesis were based. For these reasons, the DHP was selected to measure HRQoL after 
stroke in this study.  
The DHP is a generic HRQoL instrument that was developed by researchers at the Duke 
University in the United States of America. It is a brief self-report instrument with good 
acceptability for use among the general population [198,214]. The DHP has 17 questions 
from which 10 domains are measured. Six of the 10 domains refer to health function (higher 
scores indicate better health status): physical health (five items), mental health (five items), 
social health (five items), general health (combining the 15 items used for the physical, 
mental and social health dimensions to indicate overall well-being), perceived health (single 
item) and self-esteem (five of the items used for the mental and social health domains). The 
remaining four domains refer to health dysfunction (higher scores indicate poorer health 
status): anxiety (six of the items used for general health), depression (five of the items used 
for physical and mental health), pain (single item used for physical health) and disability 
(single item). Each question has three possible responses scored as 0, 1 or 2. Responses to the 
constituent items in each domain are added and the mean of the raw scores is normalized to 
lie on scale of 0 (poorest health) to 100 (best possible health) for each of the 10 dimensions.  
In previous studies on population samples, the DHP has been used in a study of the French 
general population [215] and the French adolescent population [216]. In clinical research, it 
20 
 
has been used for patients with cardiac failure [217], atrial fibrillation [218] and dementia 
[219]. 
The other instrument used in previous studies of HRQoL in Viet Nam was the EQ-5D. This 
instrument is a standardized measure of health status developed by the EuroQoL Group [199], 
to provide a simple, generic measure of health for clinical and economic appraisal [220-222]. 
It is applicable to a wide range of health conditions and treatments. It provides a simple 
descriptive profile and a single utility value. It contains the EQ-5D descriptive system and the 
EQ visual analogue scale (EQ-VAS). The descriptive system comprises five components: 
mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Each component 
has three response levels: no problems (0), some problems (1), and inability or extreme 
problems (2). The respondent is asked to indicate his/her health state by marking the box 
against the most appropriate statement in respect of each of the five components. The visual 
analogue scale (VAS) requires a respondent to record their self-rated health on a visual 
analogue scale with the endpoints labelled as “Best imaginable health state” and “Worst 
imaginable health state”. 
The EQ-5D is widely used to measure HRQoL in the general population and for patients with 
specific diseases including cardiovascular disease [223,224], irritable bowel syndrome [225], 
social phobia [226] and stroke [227]. The EQ-5D for use with stroke patients has been 
reported [228] to have good inter-observer agreement in all dimensions  and good correlations 
with stroke severity and level of impairment in activities of daily living [229]. The agreement 
between patient and proxy assessments of HRQoL after stroke using the EQ-5D has been 
found to be generally acceptable (ICC> 0.70) for the EQ-5D utility score [230]. There is an 
officially translated version of the EQ-5D, which was used in these studies. 
In Viet Nam, the EQ-5D has been used to measure HRQoL in an elderly population (> 60 
years) in the FilaBavi rural community in the north of Viet Nam [231]. The EQ-5D-5L, an 
extended version of EQ-5D, has been used to estimate the utility score for assessing the cost-
effectiveness of HIV/AIDS intervention programs in Viet Nam [232]. However, neither the 
EQ-5D nor the DHP have been examined for reliability or validity for use with patients with 
stroke in Viet Nam. 
Reliability of proxy respondents for patients with stroke  
Due to cognitive and communication disorders, many stroke survivors are unable to provide 
responses directly to self-report instruments. Asking caregivers to provide information on 
behalf of the patient may be preferable to excluding this highly relevant group of patients 
from HRQoL assessments. Agreement between stroke patients and their proxies has been 
shown [233] to be acceptable for generic instruments including the Sickness Impact Profile 
[234] and the EQ-5D [230], and for stroke-specific instruments such as the Stroke Impact 
Scale [235]. Nevertheless, proxies tend to report a poorer HRQoL for stroke patients than the 
patient self-report, particularly for physical dimensions [227,235]. 
Findings of studies that have assessed HRQoL of stroke survivors 
HRQoL of stroke patients compared with general population 
Most studies that have found the HRQoL of stroke patients is poorer than that of the general 
population were conducted in HICs [236-239]. Specifically, physical and social functions 
were significantly worse, on average, for stroke survivors one year post-stroke than the 
population norms in New Zealand [240] and Taiwan [236]. In studies with long-term follow-
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up, stroke survivors had poorer physical health [238,241,242], but comparable mental health 
[240], to the population norms for HICs. In LMICs, the average level of HRQoL of stroke 
survivors at 3-6 months after stroke was lower than that of the population in studies 
conducted in South Africa [243] and Saudi Arabia [244]. 
In Viet Nam, although mean levels of HRQoL have been reported for the general adult 
population of the largest city of Ho Chi Minh City and for people aged greater than 60 years 
in a rural community in the north of Viet Nam, there has been no study of the HRQoL of 
stroke patients relative to the HRQoL of members of the general population. 
Factors related to HRQoL after stroke 
Most studies conducted in HICs have found that lower levels of HRQoL among stroke 
survivors are associated with greater age, being female, having lower socio-economic status, 
having had a more severe stroke and having poor functional status after stroke [136,239,245-
247]. Studies conducted in Turkey [248], Nigeria [249], Saudi Arabia [248] and Thailand 
[241] have shown that, together with increasing age and severity of stroke at admission, 
functional status at three months has a strong influence on HRQoL of stroke patients at that 
time point. The first three months after stroke were found to be critical time of improvement 
in physical functioning and HRQoL for stroke survivors in the Asian countries of Taiwan 
[236,241] and Thailand [236,241]. Other factors related to poor HRQoL in the studies 
conducted in HICs, including comorbidity or socioeconomic status, have not been examined 
in studies conducted in LMICs.  
Assessment of HRQoL among stroke survivors has been conducted in HICs for many years, 
and in some LMICs more recently. Although studies of HRQoL have been conducted in 
general population or persons with some specific health conditions in Viet Nam, there has 
been no study of HRQoL among patients with stroke in Viet Nam. This is a critical deficiency 
because social and cultural values may influence some specific dimensions of HRQoL 
assessment [250], and these may vary significantly across different populations. It is essential 
to assess the HRQoL of stroke survivors, and to identify factors related to their HRQoL, in the 
cultural and social context of Viet Nam. 
 
1.3.2.5. Economic costs of stroke  
Data from HICs suggest that stroke imposes substantial economic costs on patients, their 
families, healthcare systems and society [251-255]. This is mainly due to the direct healthcare 
costs associated with diagnosing and treating strokes, particularly during hospitalisation. 
There are also associated indirect costs such as the value of time lost from productive activity 
[252]. Studies of the cost of stroke are valuable to inform decisions about service provision 
and resource allocation, and to estimate the cost-effectiveness of specific interventions to 
prevent or treat stroke.  
Methods to study the costs of stroke  
Studies of cost of illness (COI) can be divided into disease specific and general studies. A 
disease-specific study includes all relevant costs related to a specific disease, whilst a general 
study includes all relevant costs for all disease categories.  
Top-down and bottom-up approaches are estimation procedures used in COI studies. The top-
down approach estimates costs by using aggregated data on mortality, morbidity, hospital 
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admissions, and general practice consultations that are usually provided centrally by public 
and private healthcare providers. In a bottom-up procedure, a group of patients with a specific 
disease is asked to provide information on the costs of their disease including cost of 
resources used and loss of productivity. The mean cost per person is then extrapolated to a 
population level [256]. In LMICs, cost related to treatment of stroke can only be assessed by a 
bottom-up procedure because many of the inputs for a top-down analysis – such as mortality 
registers and access to electronic hospital admissions or discharge data – are not available 
[257].  
The type of costs included in a COI depends on the study perspective. The possible study 
perspectives include that of society, the healthcare system, third-party payers, or patients and 
their families. Total costs are the sum of direct costs and indirect costs. Direct costs are 
calculated as the sum of direct medical costs and direct non-medical costs. The direct medical 
costs include costs of accommodation (bed-day fees), laboratory tests, diagnostic imaging, 
cardiology-related investigations, medications, nursing, consultant services, and rehabilitation 
services in hospital [258]. Direct non-medical costs include those relating to transportation to 
hospital, special diets and purchasing medical aids such as wheelchairs or walking sticks. 
Indirect costs refer to changes in productivity resulting from illness or death, including 
productivity loss or time spent in treatment of the illness or being at the healthcare facility 
[259]. 
 
Previous findings on costs of treatment of stroke 
Mean cost of stroke in HICs and LMICs 
A critical review of 120 studies of cost of stroke using patient-level data conducted in 
countries in the Organization for Economic Cooperation and Development or the European 
Union [260] showed that 41% of studies included direct non-medical costs. Only a small 
proportion of studies included travel cost and out-of-pocket costs in the COI study. Only 9% 
of studies included productivity losses. After adjustment using the purchasing power parity 
(PPP) method to eliminate the price differences between countries, the mean cost of an acute 
stroke per admission was USD 19,018 (median USD 14,571), ranging from USD 468 to USD 
146,149. Around 65% of overall costs were attributable to initial hospitalisation. There was an 
association between follow-up duration and costs, with mean costs varying from USD 10,216 
at follow-up times ranging from three months to six months, to USD 28,525 one year after 
stroke onset. Even taking into account the differences in prices between countries, a main 
factor in the differences in estimated costs was the country where the study was conducted. 
There were, however, large differences in mean costs within the same country due to 
differences in cost structure between hospitals (community hospital vs provincial hospital, 
private hospital vs public hospital) and between different levels of stroke care (general 
department vs stroke unit). Other factors related to cost were length of follow up, allocated 
prices for use of resources rather than costs, inclusion of productivity costs and location of 
conducted study. Most studies of the cost of stroke are hospital-based with only 4% of studies 
classified as population-based. It should be kept in mind that the rate of hospitalisation for 
stroke and the study method (population-based or hospital-based) may affect ability to 
generalise the findings of a cost study to other regions of a country of other populations. 
Estimates of the costs of stroke in LMICs have varied widely across different countries. 
Table 1.5 summarises of average direct medical cost of stroke from a recent review of studies 
on cost of stroke in such countries [257]. The highest cost of stroke per case was found in 
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Nigeria [261] (USD 8,424), followed by Pakistan [262] (USD 5,230) and China [263] (USD 
3,626). The lowest cost of stroke per case was seen in Senegal [264] (USD 416). It should be 
kept in mind that non-communicable diseases have a lower priority than communicable 
disease in LMICs [257]. This may mean that costs are underestimated in these regions 
because patients with non-communicable disease are not receiving optimal evidence-based 
care. The out-of-pocket expenditure for patients in LMICs varies from 20% to 80% of the 
total health expenditure [265] because governments in those countries allocate only a very 
small proportion of the national annual budget to health expenditure compared to that in 
HICs. A recent report on health expenditure by WHO in 2011 showed that health expenditure 
per capita was over USD 3,000 in HICs while it was only USD 30 in LMICs [266]. 
Table 1.5: Summary of average direct medical cost of stroke in LMICs (in USD). 
    Administration type  
Country Source Average cost General ward Specific ward ICU 
Pakistan [267] 5,230 4,488 5,538 11,465 
Malaysia [268] 2,050    
India [269] 2,711    
China [263] 3,626    
Thailand [270] 2,115    
Brazil [271] 1,624*    
 [271] 3,501**    
Argentina [272] 3,548* 1,236*  1,759* 
 [272] 3,501** 3,081**  6,600** 
Turkey [273] 2,249    
Nigeria [261] 1,043†    
 [261] 8,424‡    
Senegal [264] 416    
* mean cost per case with IS,** mean cost per case with ICH stroke 
†mean cost per case in public hospital, ‡ mean cost per case in private hospital 
 
In terms of resources used for stroke treatment during hospitalisation, there have been 
consistent findings from studies in Asian countries such as Pakistan [262], Singapore [274], 
South Korea [275] and Japan [276] with diagnostic imaging (32% of average costs), 
medications (26%) and bed-day fees (23%) the largest contributors to direct medical costs. 
Factors related to costs of stroke treatment in LMICs  
Some researchers have also examined the different factors that are related to the level of costs 
following a stroke. Identifying predictors of costs is important because doing so may detect 
ways that economic savings can be made. Other than studies in India [269] and Malaysia 
[268] in which the cost of treating ICH and IS were similar, the cost of treating haemorrhagic 
stroke generally has been found to be greater than the cost of treating IS in both developed 
and developing countries [251,263,268-270,272,277,278]. Patients with ICH are likely to 
have more severe stroke and longer LOS in hospital, and hence greater treatment costs for 
those reasons. Costs of stroke related to treatment in hospital have been found to be largely 
attributable to stroke severity and LOS [262,263,268-271,279,280], and positively related to 
the income of patients and their families in studies conducted in India [269] and China [281]. 
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Role of health insurance  
A chronic illness, such as a stroke, is a major cause of economic hardship and poverty. A 
prospective study of stroke [281] conducted in China found that, three months after stroke, 
71% of stroke patients had experienced catastrophic healthcare payments. In that study, 
catastrophic healthcare payments were defined as expenditure of 30% or more of total 
reported household annual income [281]. One year after stroke onset, 62% patients with no 
health insurance fell below the poverty threshold as a result of out-of-pocket payments, 
compared with 23% of those with health insurance, in that study. However, in LMICs, the 
coverage of health insurance among stroke patients is generally  low with 24% coverage 
reported in one study in India [269] but with 62% coverage reported in China [281]. Although 
there have been some studies of the direct medical costs of stroke in LMICs, there have not 
been any studies of non-medical and indirect costs related to hospitalisation in LMICs. In 
addition, there has been no study of these costs of stroke in Viet Nam. 
1.4. Healthcare system in Viet Nam 
Understanding the healthcare system is crucial for understanding the journey of a patient who 
suffers from a stroke in Viet Nam, particularly in terms of the costs associated with the stroke 
treatment. The Government provides public healthcare that is delivered at four levels: central, 
provincial, district and community [282,283] (see Figure 1.5, from a report of Tien et al. 
[283] for the health insurance system in Viet Nam).  
 
Figure 1.5: The administrative structure of the healthcare system in Viet Nam. 
The district and community levels only provide primary healthcare. Specialised healthcare is 
mostly available at the central and provincial levels. At each of these levels, three types of 
public healthcare services are provided [282]:  
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(a) primary healthcare, preventive medicine and National Health Target Programs,  
(b) population and family planning, and  
(c) medical examination and treatment, 
The Ministry of Health (MoH) is the main authority responsible for healthcare. It formulates 
and executes health policies for the whole country. The Provincial Health Bureaus, each under 
the jurisdiction of a Provincial People’s Committee, is responsible for general administration 
of the provincial health system, including provincial services and the district, commune, and 
private services provided within the province [284]. The District Health Bureaus, each under 
the jurisdiction of a District People’s Committee, is in charge of administering the healthcare 
service both at the district and community levels [284]. Commune health stations and village 
(commune) health workers, under the supervision of the Commune People’s Committee, 
deliver healthcare services and carry out health programs in the community [284].  
 
Health Insurance 
Based on the Law on Health Insurance and its amendments (last updated June 13, 2014), 
public health insurance in Viet Nam has two schemes: compulsory and voluntary [285]. 
Public health insurance is compulsory for all employees. Health insurance fees, depending on 
categories of participants and residential areas [31], are shared between employers and 
employees [31]. Insured people in the community and insurance companies share the 
operational costs for in-patient and out-patient care with the insurers covering 30% to 100% 
of the cost depending on the grade of the referral hospital, with the remaining fee paid by 
patients as ‘out of pocket’ expenses. The overhead costs of the hospitals including labour 
costs and asset depreciation are covered by the government. The government also provides 
free health insurance schemes to impecunious people or those who are of ethnic minority, 
farmers or children under 6 years old. The coverage of public health insurance reached 66.8% 
in 2012 [286]. A recent report on health expenditure in Viet Nam by the World Bank 
Organisation showed that, during the period 2000-2011, the out-of-pocket expenditure 
contributed around 60% total health expenditure [287].  
Figure 1.6, from a report by Somanatha et al. (2014) [287], illustrates that while the trend of 
health insurance coverage increased sharply from 10% in 1995 to 60% in 2010, the out-of-
pocket share of total health expenditure fluctuated around 60% during this period in Viet 
Nam. Aiming to achieve universal healthcare in 2020, Viet Nam has been increasing the 
coverage of health insurance in population [288,287]. However, there has been a concern that 
high out-of-pocket costs may hinder achievement of the target of universal healthcare in Viet 
Nam.  
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Figure 1.6: Out-of-pocket share of Total Health Expenditure and social health insurance 
coverage in Viet Nam during the period 1990-2011. 
 
The 115 People’s Hospital 
This thesis uses data collected from stroke patients admitted to the 115 People’s Hospital in 
Ho Chi Minh City. This provincial hospital is ranked as grade 1 general hospital based on 
Circular 23/2005/TT-BYT issued in 2005 [289]. Under Decision 1895/1997/QĐ-BYT [290], 
a grade 1 hospital is a unit of medical examination and treatment under the Ministry of Health 
or the Provincial Peoples' Committees. The primary function of grade 1 hospitals is to provide 
general medical care that consists of emergency care, medical examination and general 
treatment for the population in some critical provinces and cities [290]. Grade 1 hospitals are 
also responsible for treatment of patients who are transferred from lower grade hospitals. 
Figure 1.7 from a report by Somanatha et al. (2014) [279] illustrates the National Health 
System Financing Flow in Viet Nam in 2010.  
The 115 People’s Hospital is a tertiary public hospital with 1,600 in-patient beds. It is also the 
main teaching hospital of Pham Ngoc Thach University of Medicine. It has had success in 
meeting the conditions required to operate as the first-class hospital in the city. According to 
the ranking guidelines for medical non-business units [285], a first-class hospital must be a 
leading hospital fulfilling specified criteria for medical functions, staffing, management, 
department structures and scales, infrastructure and facilities equipped with advanced 
technologies. 
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Consisting of 42 offices and departments and nearly 2,000 staff, the 115 People’s Hospital 
offers a complete range of integrated services. Its five fundamental specialist treatment fields 
are Neurology, Nephro-urology, Oncology-Nuclear medicine, Anaesthesia and Intensive Care 
(unpublished data from thee summary report of 25th anniversary of the hospital [291]). In 
2012, 67,441 in-patients were admitted to the hospital and 570,959 persons received treatment 
as out-patients (data from report of General Planning Department of the hospital [291]). This 
hospital is classified in Group 3 of the health financial management system, which gives it the 
authority to jointly manage its regular operational funds in combination with the 
government’s financial bodies [292]. 
Another role of the 115 People’s Hospital in the Ho Chi Minh City healthcare system is to 
provide overall medical support to four lower-level hospitals located around the 115 People’s 
Hospital: the Hoc Mon District Hospital, District 12 Hospital, District 10 Hospital and 
District 3 Hospital. Although it is a major provincial public hospital of Ho Chi Minh City, the 
Figure 1.7: National Health System Financing Flows (2010). 
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115 People’s Hospital is authorised by Circular 43/2013/TT-BYT [290] to provide healthcare 
service to residents of adjacent provinces [290], this hospital is responsible for providing 
professional consultative services to general public hospitals located in rural areas of Ho Chi 
Minh City such as Cu Chi hospital and to other provincial hospitals such as those of Tan Tru - 
Long An, Dak Lak, Tien Giang, Tra Vinh, Ca Mau and Phu Yen [290]. 
 
Care of stroke in Viet Nam 
There is very limited information about the level of care provided to stroke patients in Viet 
Nam. There are fewer than 10 stroke units across Viet Nam to service a population of more 
than 80 million [293], suggesting that the vast majority of patients may not receive optimal 
evidence-based care. Indeed, a recent report about stroke care in Viet Nam found that 
traditional methods such as coin rubbing or acupuncture are often the first management of 
stroke with only 40-50% patients transferred to hospital [293]. This is despite modern 
treatments such as r-tPA having been shown to be safe and feasible for use in Viet Nam [144]. 
Public mis-perceptions of stroke and of its treatment constitute a barrier to the wider use of 
modern treatments [293]. There is, therefore, an urgent need for greater public awareness of 
stroke as a medical emergency and greater provision of specialised care across the country. 
Since 2013, the Ministry of Health in Viet Nam in cooperation with the National Institute for 
Health and Care Excellence (NICE), an institute in the United Kingdom, has commenced to 
develop quality standard treatment guidelines to improve the quality of care and standardise 
the treatment of stroke in Viet Nam [294]. 
 
Cerebrovascular Department and Stroke Unit in the 115 People’s Hospital 
Patients with strokes admitted to this hospital are transferred to a specialised stroke treatment 
facility located in the Department of Cerebrovascular Diseases. The stroke unit was 
established on the 4th May 2007. The department has a general treatment facility with vascular 
ultrasound equipment and 100 beds, and an Intensive Care Unit (ICU) with 35 beds (9 beds 
with ventilators). In 2012, the overall bed occupancy rate was 104% (142/136). The 
Department of Cerebrovascular Diseases had 79 staff including 15 doctors, 52 nurses, 7 
technicians and 5 healthcare assistants in 2012. 
 
1.5. Summary 
Stroke was ranked as the second most common cause of death and the third most common 
cause of disability-adjusted life-years worldwide in 2010. Although the age-standardised rates 
of stroke mortality have decreased in HICs and LMICs in recent years, there is a growing 
recognition and some evidence that the burden of stroke may have been increasing in LMICs. 
There is limited data on the epidemiology of stroke in LMICs including Viet Nam. The 
studies reported in this thesis aim to provide information for Viet Nam that will be critical for 
healthcare planning and health policy formulation.  
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1.6. Research aims and specific objectives  
General aims 
The general aims were to investigate the occurrence, clinical presentation, costs and three-
month outcomes of stroke among patients admitted to a tertiary teaching hospital in Ho Chi 
Minh City, Viet Nam.  
The specific objectives were:  
1. To determine the frequency of stroke types, stroke severity and 28-day case-fatality.  
2. To estimate the incidence density of hospital-admitted first-ever stroke in Ho Chi Minh 
City. 
3. To investigate case-fatality and functional outcomes three months after stroke 
4. To estimate the societal costs of stroke, including direct medical costs of treatment and the 
associated direct non-medical and indirect costs incurred during hospitalisation. 
5. To assess the reliability and validity of assessments of HRQoL from patient and proxy 
responses to the Duke Health Profile. 
6. To assess the HRQoL of first-ever stroke survivors and to identify factors related to poor 
HRQoL at three months post stroke.  
 
1.7. Thesis outline  
In brief, the structure of the thesis is as follows: 
Chapter 1: Introduction 
This chapter summarises key topics related to thesis including the clinical manifestations 
of stroke, the occurrence of stroke, the measurement of outcomes after stroke, and a 
description of the healthcare system in Viet Nam and, in particular, the hospital in which 
the studies reported in this thesis were conducted. 
Chapter 2: Methods  
This chapter provides general information on the methods used in the surveillance study 
(Chapter 3) and the cohort study (Chapters 4-7). Specific information on each study are 
included in the relevant chapter. 
Chapter 3: Hospital-based surveillance of stroke over 12 months at a tertiary teaching 
hospital in Ho Chi Minh City, Viet Nam.  
This chapter describes a surveillance study of patients with stroke admitted to 115 People’s 
Hospital during a 12 month period to examine the age of stroke onset, type of stroke, 
severity of stroke at admission and 28-day case-fatality. The incidence density of hospital-
admitted first-ever stroke in Ho Chi Minh City is present in this chapter. At the time of 
submission of this thesis, the content of this chapter had been submitted as a manuscript in 
consideration of publication in the International Journal of Stroke. 
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Chapter 4: Case-fatality and functional status three months after first-ever stroke in 
Viet Nam.  
This chapter describes a follow-up of a cohort of 441 patients with first-ever stroke 
admitted to the Stroke Unit of 115 People’s Hospital in Ho Chi Minh City, Viet Nam, to 
examine the associations between study factors (demographic factors, socio-economic 
factors, health status before stroke onset, lifestyle risk factors, clinical status at admission) 
and severity of functional status at three months. At the time of submission of this thesis, 
the content of this chapter have been prepared as a manuscript for submission in 
consideration of publication in the European Journal of Neurology 
Chapter 5: Costs of first-ever stroke in Viet Nam.  
This chapter reports estimates of the direct medical, direct non-medical and indirect costs 
during hospitalisation from 437 members of the cohort of patients with first-ever stroke 
admitted to Stroke Unit of 115 People’s Hospital. At the time of submission of this thesis, 
the content of this chapter have been prepared as a manuscript for submission in 
consideration of publication in the Value in Health journal. 
Chapter 6: Health-related quality of life after stroke: reliability and validity of the Duke 
Health Profile for use in Viet Nam.  
This chapter reports an investigation of the reliability and validity of measurements of 
HRQoL of stroke survivors at three months made with the Duke Health Profile. The 
sample for this study consists of 108 of the first 135 participants in the cohort of patients 
with first-ever stroke admitted to Stroke Unit at 115 People’s Hospital who had survived to 
three months, and 94 of their caregivers. At the time of submission this thesis, the content 
of this chapter is accepted for publication in the International Journal of Quality of Life 
Research [1]. 
Chapter 7: Health-related to quality of life among survivors three month after stroke.  
This chapter reports measurements three months after stroke onset made with the Duke 
Health Profile and the EuroQoL EQ-5D of the HRQoL of 376 stroke survivors in the 
cohort of stroke patients with first-ever stroke admitted to Stroke Unit at 115 People’s 
Hospital. At the time of submission this thesis, the contents of this chapter have been 
prepared as a manuscript for submission in consideration of publication in the Stroke 
Journal.  
Chapter 8: Summary.  
This chapter draws together the major findings and conclusions, summaries the 
contributions of the thesis, and presents recommendation for future research. 
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Chapter 2: Methods 
 
2.1. Preface 
The aims of this thesis were to investigate the occurrence, presentation, costs and three-month 
outcomes of stroke in Ho Chi Minh City, Viet Nam. The findings in respect of occurrence and 
presentation of stroke in this thesis were derived from hospital-based surveillance of patients 
with stroke who were admitted to 115 People’s Hospital during the period from 9th December 
2009 to 8th December 2010. To obtain information on costs related to stroke treatment in 
hospital and on outcomes at three months, a cohort of patients with first-ever stroke was 
recruited and followed over a three month period in a study conducted from 1st February 2012 
to 31st December 2012. This chapter provides information firstly on the surveillance study, 
and secondly on the cohort study. The data obtained using the methods outlined in this 
chapter will be analysed in subsequent chapters. 
 
2.2. Surveillance of stroke 
The author of this thesis supervised the data collection and data management at the study site, 
cleaned the data, undertook the data analysis and interpretation, and drafted the manuscript 
reporting the results that is included as Chapter 3 of this thesis.  
 
Background 
The hospital-based surveillance of stroke was conducted as part of a larger project funded by 
The Atlantic Philanthropies to organise systems for surveillance of non-communicable 
diseases in Viet Nam. This project was a joint undertaking of the Ministry of Health of the 
Socialist Republic of Viet Nam and its technical advisers, the Menzies Institute for Medical 
Research (previously named the Menzies Research Institute and, when this study commenced, 
the Menzies Centre for Population Health Research) and the WHO.  
In respect of surveillance of stroke, major tertiary hospitals with stroke care in Ha Noi and Ho 
Chi Minh City were visited by Australian project leaders to identify potential sites based on 
certain selection criteria. These included the quality of systems for ascertainment of hospital 
admissions for stroke, facilities for the treatment of stroke, and the annual average number of 
admission for stroke. The sites chosen were 115 People’s Hospital, a major teaching hospital 
located in Ho Chi Minh City in the south of Viet Nam, and Bach Mai Hospital located in Ha 
Noi in the north of Viet Nam. This thesis presents findings of surveillance at 115 People’s 
Hospital in Ho Chi Minh City. 
 
Study site 
115 People’s Hospital was one of three tertiary hospitals (Cho Ray Hospital and Gia Dinh 
Hospital were the others) with stroke intensive care facilities in Ho Chi Minh City in 2007. At 
this hospital, the majority of stroke patients are admitted to the Stroke Unit of the 
Cerebrovascular Disease Department after transfer from the Emergency Department. Small 
numbers of patients with very severe stroke were at that time admitted to the Intensive Care 
Unit (ICU) or the Cardiology Department. For this study, a system for capture of data within 
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each of these departments in the hospital had to be devised to ensure that ascertainment of 
patients with stroke was as complete as possible. After the completion of this study, an 
Intensive Care Unit was established in 2012 for the treatment of severe stroke cases within the 
Cerebrovascular Disease Department. 
Trialling of systems organisation and piloting of the survey was undertaken from September 
2008 to August 2009. This included assessment of and improvements to methods of 
ascertainment of stroke admissions in the hospital, instruction and guidance in questionnaire 
administration, testing of follow-up processes, and training in data entry procedures. A study 
to examine the reliability of stroke diagnosis and recognition of neurological signs and 
symptoms of stroke by local physicians was conducted in the study hospital during that 
period. The performance of these tasks by local physicians was compared with that of an 
Australian specialist (Dr Velandai Srikanth) [295].  
 
Subjects 
During the 12-month period from 9th December 2009 to 8th December 2010, patients 
admitted with a diagnosis of stroke to the Emergency Department, ICU, the Stroke Unit of the 
Cerebrovascular Diseases Department, or the Cardiology Department were ascertained for 
possible recruitment in this study. The patients were considered for inclusion if they had been 
assessed by a neurologist in the ICU or Cerebrovascular Disease Department as having 
symptoms and signs of stroke. Confirmation by diagnostic neuro-imaging techniques – 
computerized tomography (CT) or magnetic resonance imaging (MRI) – was available for 
almost all cases. Exclusion criteria were transient ischemic attack (TIA) defined as focal 
neurologic symptoms lasting less than 24 hours, or discharge within 24 hours from the 
hospital. Ascertainment and recruitment of cases is believed to be high (greater than 90%) but 
this cannot be confirmed because the denominator number of eligible cases was not able to be 
quantified. 
 
Study tools 
This study was conducted using the Step 1 (events in hospital) protocol of “The WHO 
STEPwise approach to stroke surveillance (STEPS-Stroke)” survey methodology [98]. This is 
a standardized protocol developed by the WHO. The full protocol comprises three steps: Step 
1 (events in hospital) for identifying cases of stroke admitted to hospital, Step 2 (fatal events) 
for identifying fatal stroke cases in the community, and Step 3 (non-fatal events) for 
identifying non-fatal stroke cases in the community. Details of this protocol were provided in 
the previous Chapter. 
Two primary data collection instruments were developed. The first was the stroke log form 
(Appendix 2A), a simple record of stroke admissions to each department. This form captured 
name, age, sex, type of stroke, hospital record number and whether the patient was transferred 
between departments. The second was a brief questionnaire to capture essential information 
on demographic details, type of stroke, signs and symptoms of stroke onset, risk factors, 
disability and vital status 28 days post-stroke (Appendix 2B). These were developed in 
several iterations in conjunction with the clinicians involved, and with translation in 
Vietnamese and back-translation to check accuracy.  
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Study factors 
Clinical presentation of stroke 
Signs and symptoms of stroke 
Stroke signs including impaired consciousness, definite brainstem signs, limb weakness, face 
weakness, loss of sensation, visual field deficit, neglect, aphasia/dysphasia, apraxia and ataxic 
gait were assessed and recorded by neurologists. Symptoms of stroke including dizziness, 
headache, blurred vision, double vision, slurred speech, difficulty swallowing, confusion and 
seizures were recorded by neurologists from self-report of patients or their caregivers. 
Risk factors 
Vascular risk factors for stroke including atrial fibrillation, current smoking status, diabetes, 
hyperlipidaemia, hypertension and valvular heart disease were assessed by the treating 
physician. 
Type of stroke 
Type of stroke including ischaemic stroke (IS), intra-cerebral haemorrhage (ICH) and 
subarachnoid haemorrhage (SAH) was determined by neurologists using diagnostic neuro-
imaging (CT or MRI). 
First-ever stroke 
The first-ever stroke was defined as a stroke occurring for the first time during a patient’s 
lifetime. Previous stroke was determined by a neurologist using all available information 
including hospital records, neuroimaging results and self- or family-member report.  
 
Outcome factors 
Case-fatality at 28 days 
Deaths due to stroke occurring in hospital and during the 28 days post-stroke onset were 
ascertained by telephone interview of the stroke patient or a family member to allow 
calculation of 28-day case fatality. 
Functional status at admission 
Functional status of stroke patients at admission, or soon thereafter, was assessed on the 
modified Rankin Scale (mRS) by a neurologist. The mRS scores are a grading of disability  in 
six levels [122] ranging from 0 (normal) to 6 (death). For further details of this instrument, 
refer to section 3 of Introduction. 
Hospital-admitted incidence density 
The incidence density of hospital-admitted stroke was estimated from the number of patients 
with a first-ever stroke who were Ho Chi Minh City residents and had provided a residential 
address that could be geocoded to a ward of Ho Chi Minh City, and with the total of the 
populations of those wards as the denominator. The population data were provided by the 
General Statistics Office from Census data for 2010. 
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Data collection 
The log form (Appendix 2A) was filled in by nurses or physicians working in each 
department. The questionnaire (Appendix 2B) was completed by a treating physician in the 
Stroke Unit (one of 14 physicians) or ICU (one of two physicians). The treating neurologist 
assessed functional status of patients at admission using the mRS. Research nurses in the 
Stroke Unit contacted patients or their caregivers by telephone 28 days post-stroke to collect 
data on vital status, and entered data into the database.  
 
Data management 
Hard copies of the log forms and questionnaires were collected weekly from the sites and 
stored in locked filling cabinets in the Cerebrovascular Disease Department, 115 People’s 
Hospital. EpiData was used as a database to store data entered from the log forms and 
questionnaires. Data entry was conducted by research nurses. The data file was sent 
fortnightly to the Menzies Institute for Medical Research where it was checked for 
inconsistencies and potential errors, and with results communicated to the site for action or 
verification where necessary. 
When all data entry was completed, data cleaning –  particularly to identify duplicate records 
(of which there were around 10,000), to identify missing data and to replace with complete 
data where possible, and to correct errors – was undertaken at the Menzies Institute for 
Medical Research by the author of this thesis.  
 
2.3. Cohort of patients with first-ever stroke 
The research reported in Chapters 4–7 of this thesis was conducted as a part of the follow-up 
to three months of a cohort of patients with first-ever stroke that was conducted from 1st 
February  to 31st December, 2012. The author of this thesis participated in the design of the 
study, including by advising on appropriate methods of recruitment and determining the 
sample size required, and prepared the ethics applications submitted to the Tasmanian Health 
and Medical Human Research Ethics Committee, and to university and hospital ethics 
committees in Viet Nam. The author contributed to the design of questionnaires and data 
collection instruments, created written study protocols to standardise data collection in the 
field, recruited and trained the research staff who undertook the fieldwork, piloted and 
modified the methods of participant recruitment, and revised the questionnaires and data 
collection instruments in light of the pilot study experience. When the actual study was 
conducted, the author participated in the recruitment of participants, supervised data 
collection in the hospital and at the subsequent three-month follow-up in each patient’s home, 
contributed to the design of the database, supervised data entry and management (secure 
storage of the data in electronics files), and performed data linkage to the electronic 
administration system at the hospital to extract information on hospital costs. In addition, the 
author was involved in preparing budgets and monitoring research expenditure against 
budget.  
The author’s supervisors –  Associate Professor Leigh Blizzard, Associate Professor Velandai 
Srikanth and Dr Seana Gall – assisted in designing the study and supervising data collection 
in the field (by weekly teleconference with the author while the study was being conducted in 
Viet Nam). Associate Professor Velandai Srikanth, a specialist senior geriatrician with clinical 
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expertise in stroke, helped to train the research staff in assessment of functional status using 
the mRS. Dr Vo T.X. Hanh, who translated the DHP for first use among the adolescents in Ho 
Chi Minh City and assessed its validity for that purpose, helped to train research staff in the 
assessment of HRQoL using the DHP. Two research nurses in the Stroke Unit of the hospital 
assisted the author to identify patients with stroke admitted to the Cerebrovascular Disease 
Department each day, and to extract information on hospital fees from the database of hospital 
administration system. All stroke neurologists (14 physicians) in the department participated 
in the study by helping to complete the sections of the in-hospital questionnaire requiring 
clinical details. Data collection in hospital and during the three month follow up were 
conducted by four research staff (who were general practitioners) in the pilot study, and by 
five research staff (who were either general practitioners or medical students) in the actual 
cohort study.   
 
 Study design  
This was a prospective study of a cohort of patients with first-ever stroke who were treated in 
the Stroke Unit of 115 People’s Hospital, Ho Chi Minh City, Viet Nam. 
 
Study population 
The study population consisted of patients with first-ever stroke who were residents of Ho Chi 
Minh City, Viet Nam. 
 
Study sample 
The study sample consisted of 450 patients admitted to the Stroke Unit at 115 People’s 
Hospital during the period from 1st June 2012 to 10th September 2012 with a diagnosis of 
stroke confirmed by a neurologist working in Cerebrovascular Disease Department of the 
hospital. 
The study inclusion criteria were (1) definitive stroke meeting the WHO definition, (2) age 
greater than 16 years, (3) first-ever stroke, (4) stroke occurrence within the past 7 days, (5) 
treatment of stroke in the Cerebrovascular Disease Department, and (6) residence in Ho Chi 
Minh City. 
 
Study factors 
As described in Chapter 1, factors that have been found to be predictors of poor outcomes 
after stroke onset are advancing age, female sex, lower socioeconomic status, disability prior 
to stroke, comorbidity, ICH type of stroke, severity of stroke and severity of disability. They 
were the study factors that were measured in this study.  
Demographic and socioeconomic information 
Age 
In this study, patient age was calculated by deducting the patient’s year of birth from the year 
of their stroke onset.  
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Education 
Education in Viet Nam is classified into five levels: preschool, primary school (grades 1-5), 
secondary school (grades 6-9), high school (grades 10-12) and higher education. Formal 
education consists of twelve years of basic education (five years of primary education, four 
years of intermediate education, and three years of higher education). For this survey, 
education level attained was self-reported or reported by caregivers as no schooling, primary 
school not completed, completed primary school, completed secondary school, completed 
high school,  TAFE, university, post-university and unknown.  
Working status 
Working status was determined from self-report or report by caregivers of type of work 
performed, and was grouped into the three categories of manual work, office work and home 
duties/retired. 
Living arrangements 
Living arrangements were self-reported or reported by caregivers with six response options 
that were combined into the three categories of living with spouse, not living with spouse but 
living with offspring, and living with others (not living with spouse or offspring). 
Socio-economic status 
Socio-economic status was assessed as a wealth index based on the holdings, in the household 
of each patient, of assets included in the list of 2010 for Ho Chi Minh City published by the 
General Statistics Office of Viet Nam. A weighted sum of the assets held was calculated, with 
weights derived from the linear regression of household expenditure on binary (0=asset not 
held / 1=asset held) predictors for each asset in the list. Information on the average monthly 
income from the main source of income (main salary) and from other sources (such as rent, 
personal business income or bank interest) was collected for each patient’s household, 
together with average monthly expenditure of the household and the average number of 
persons living in the household. Patients or their caregivers were asked to provide information 
on the source of payments made for costs that were related to stroke and were incurred during 
the hospital stay.  
Health insurance 
Health insurance status was recorded from information contained in each patient’s hospital 
medical record. 
 
Lifestyle factors  
Cigarette smoking 
Smoking status (never, former or current) was determined from the responses of patients or 
their caregivers to the questions “Have you ever used tobacco in your life?” and “Do you 
currently smoke any tobacco products, such as cigarettes, cigars or pipes?”. Participants were 
considered a current smoker if they reported that they currently smoked any tobacco products. 
If the participant was a current smoker or an ex-smoker, information on average daily number 
of cigarettes and number of years of smoking was collected. 
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Alcohol consumption 
Alcohol consumption was determined from the responses of patients or their caregivers to the 
questions “Have you ever consumed an alcoholic drink such as beer, wine, spirits, fermented 
cider?”, “Have you consumed an alcoholic drink within the past 12 months?” and “During the 
past 12 months, how frequently have you had at least one alcoholic drink?”. For those who 
had consumed alcohol during the past 12 months, information was collected on the frequency 
with which alcohol was consumed, the average amount of alcohol (number of standard 
drinks) consumed per occasion and types of alcohol consumed. Visual representations 
(showcards) were used to illustrate a typical serving size that amounted to one standard drink 
such as a glass of beer (285 ml), a glass (120 ml) of wine or a small cup (30 ml) of spirit (see 
Appendix 2G). 
 
Health status prior to stroke 
Disability prior to stroke 
Disability prior to stroke was determined from the responses of patients or their care-givers to 
the questions “Before stroke onset, did patient have limited functional status (disability)?” and 
“If yes, please give details of the type and severity of disability”.  
Co-morbidities 
Patients were asked whether they had been told by a health worker that they had high blood 
pressure or diabetes, whether they had received treatment for those conditions, and whether 
they had had their blood pressure and blood glucose measured during the last 12 months. 
They were asked also whether they had chronic heart disease, lung disease, kidney disease, 
liver disease or cancer, and whether they had had a stroke in the past.   
 
Outcome factors measured 
The outcome factors measured were case fatality, functional status, health related quality of 
life at three months after stroke onset, and costs of treatment during the hospitalisation.  
Case fatality 
Case fatality was defined as the death of a study participant during the study period (three 
months). Information on deaths occurring in-hospital was collected from hospital 
administration records. Information on deaths occurring out-of-hospital during the following 
three months was provided by caregivers or family members. Case fatality is reported as a 
percentage after dividing the number of deaths by the total number in the cohort and 
multiplying by 100.  
Functional status 
Functional status was assessed on the mRS [122] that grades functional impairments with 
scores ranging from 0 (no symptom) to 6 (death). Functional status was assessed at the time 
of hospital admission or soon thereafter by a stroke neurologist in the Cerebrovascular 
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Disease Department. It was assessed again at three months post-stroke by research assistants 
during an interview conducted in each patient’s home. 
Health-related quality of life 
Health-related quality of life was measured using two generic instruments: the Duke Health 
Profile (DHP) ( Appendix 2C) and the EuroQoL EQ-5D-3L (Appendix 2D) The DHP was 
translated and culturally adapted for use with adolescents in Viet Nam [212], and had been 
used to measure HRQoL of members of a general adult population sample in Ho Chi Minh 
City, Viet Nam [213]. The official Vietnamese version of the EQ-5D was obtained from the 
EuroQol group. In the absence of a value set for Viet Nam, the values for South Korea were 
used [296]. The reliability and validity of these instruments in stroke is assessed in chapter 6. 
Costs of treatments 
Direct medical costs refer to the cost of medical resources used in stroke treatment during the 
hospital stay. The number of each kind of medical resource used, and its unit cost, were 
extracted from the electronic records of the hospital administration system. For patients with 
health insurance, the medical costs invoiced to patients and the health insurance co-payment 
were itemised.  
Direct non-medical costs included transportation fees, cost of food for patients or caregivers 
and other sundry expenses incurred during the hospital admission. This information was 
collected from reports of patients or their caregivers.  
Indirect cost included any loss of income of patients and their caregivers. It was estimated by 
multiplying the average daily income of the patient or caregiver by the number of days spent 
in the hospital. Information on income was self-reported by patients and their caregivers. 
Length of stay was extracted from hospital administration records. 
 
Study tools 
The study questionnaires were designed for this project by the author and were revised to take 
account of factors identified in the pilot study. The questions on cigarette smoking and 
alcohol consumption were modified from those used in “The WHO STEPwise approach to 
surveillance of non-communicable diseases (STEPS)” questionnaire developed by WHO [98]. 
The questions on the non-medical and indirect costs of treatment of stroke were adapted from 
the questionnaire developed previously by the author for a study of the costs of traumatic 
brain injury in Viet Nam [297]. The study questionnaires included an in-hospital 
questionnaire and a three-month follow-up questionnaire. 
The in-hospital questionnaire 
The in-hospital questionnaire (Appendix 2E) had two components. The first component was 
used to gather information on demographic and socio-economic factors and health status prior 
to stroke. It was administered by research staff in a face-to-face interview of patients or their 
care-givers. The second component was used to record information on the clinical 
presentation (type of stroke, severity of stroke and functional status) of each stroke patient. It 
was completed by a stroke neurologist. 
 39 
 
The three-month follow-up questionnaire 
The follow-up questionnaire (Appendix 2F) included questions to assess functional status and 
health-related quality of life of the patient three months after stroke onset. It was used also to 
collect data on costs incurred during the three months following stroke. Costs incurred after 
discharge from the hospital are not reported in this thesis.  
 
Data collection 
At baseline 
Each day, the research nurse identified from the electronic records of the administration 
system of the hospital all patients with stroke who had been admitted to the Cerebrovascular 
Disease Department. The author selected eligible participants by obtaining and matching 
information from the medical records on those patients who met the study inclusion criteria. 
The name of each patient who met the study inclusion criteria was notified to their treating 
stroke neurologist in the Stroke Unit. The neurologist introduced each eligible patient or their 
caregiver to research staff who explained the purposes of the study. If the patient or caregiver 
agreed to be involved in the study, the patient or their next-of-kin was given a consent form 
and the participant information sheet.  
Research staff then briefly interviewed the patient or their next-of kin to obtain demographic 
information, contact details, basic medical history, and information about health-related 
behaviours such as tobacco smoking and alcohol consumption prior to stroke onset. 
Information on non-medical costs – such as that of family care, food, transportation and loss 
of income – were gathered daily by self-report from patients or their caregivers during the 
hospital stay. After participants had completed stroke treatment and had been discharged from 
the hospital, the research nurse extracted information on hospital medical costs from the 
electronic records of the hospital administration system. 
Follow-up at one month and two month 
At one month and two months after stroke, patients or caregivers were contacted by telephone 
(call duration approximately 5-10 minutes) to collect data on vital status. Date of death of 
decedents was recorded at these times.  
Follow-up at three months  
Three months after the stroke onset, research staff visited patients in their homes to record 
information on their functional status and HRQoL. If the patient had a very severe cognitive 
impairment or difficulty communicating, their main caregiver was asked to provide 
information on their behalf as their proxy. This visit took around one hour to complete. 
 
Time frames for the pilot and main studies 
A pilot study was conducted prior to the main study. Stroke patients in the hospital who met 
eligibility criteria were recruited during the period from 1st February to 28th February 2012. 
They were followed up during the three months from March 2012 to May 2012. The study 
procedures and processes of data collection were evaluated, and revisions to them were made 
during the period from February 2012 to May 2012 by the main investigators. 
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Recruitment for the main study commenced on 1st June 2012 and continued until 10th 
September 2012. Three-month follow up was conducted during the period commencing on 1st 
September and was completed on 31st December 2012.  
 
Data management 
EpiData version 3.1 was used by research staff to enter data under the supervision of the 
author. Double-entry of 10% of questionnaires was undertaken to check the accuracy of the 
data entry process. All hard copies of questionnaires, including those used at baseline and for 
the three-month follow-up, were scanned and stored in electronic files. 
After completing data entry, the data files were exported to Stata software version 12.0 
(Statacorp, College Station, Texas, USA) for cleaning and linking to the database containing 
information on medical costs that had been extracted from the electronic records of the 
hospital administration system. 
 
Data analysis 
Methods of data analysis for each individual study are reported in the relevant chapters of this 
thesis. 
 
Sample size for the outcomes analyses 
In the hospital-based surveillance study, around 300 stroke patients were admitted to 115 
People’s Hospital per month. Of the total number admitted, 70% were residents of Ho Chi 
Minh City and 75% had had a first-ever stroke, and 12.2% with confirmed vital status were 
deceased at 28 days. 
The power calculations that follow are based on a final sample of n = 300. As shown in the 
next section, this number provides at least 80% power to detect in most cases the differences 
in key outcomes observed in other studies. 
Assuming that loss to follow-up (deaths and withdrawal) could be as high as 33%, 450 
patients would need to be recruited to obtain a sample of n = 300 at the three-month follow-
up. This would require around three months of recruitment of Ho Chi Minh City residents 
with first-ever stroke. A recruitment period of around three months was judged by the author 
to be feasible. 
As events transpired, however, there was less loss to follow-up than anticipated. Information 
was available at follow-up for 376 survivors. That total included 328 patients interviewed in 
person, and 48 persons for whom information was provided by a proxy respondent (17% of 
the proxy respondents were a spouse and 71% of the proxy respondents were a child. 
 
Statistical power for the outcomes analyses 
The tables below show the differences in proportions or means that could be detected with 
80% power (two-sided α=0.05) in a group of 300 stroke survivors at three months classified 
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by relevant study factors.  The calculations are based on the method of Rosner [298] for 
means, and Fleiss et al. [299] for proportions, as implemented in Stata command sampsi. 
Case fatality at three months  
Based on frequencies of the study factors (sex, age and type of stroke) in the hospital-based 
surveillance study conducted in the same study hospital, and the three-month case fatality 
reported in previous studies [300,301], the minimal detectable differences (MDDs) in case 
fatality are shown in Table 2.1. A sample size of n = 300 would provide at least 80% power 
(two-sided α=0.05) to detect the difference in three-month case fatalities for age and type of 
stroke found in previous studies. 
 
Table 2.1. Minimal detectable difference in case fatality at three months.  
Study factor 
Expected 
frequency of 
study factor* 
Expected 
prevalence of 
outcome† Source 
MDD  in 
prevalence of 
outcome‡ 
Sex     
Males 54.2% 15.2% [300] 15.2% 
Females 45.8% 20.2% [300] 28.7% 
Sex     
Males 54.2% 14.8% [301] 14.8% 
Females 45.8% 21.0% [301] 29.2% 
Age     
Less than 65 years  51.7%   6.9% [301]   6.9% 
65 years or greater  48.3% 22.8% [301] 18.2% 
Type of stroke     
Ischaemic stroke  78.8% 20.1% [110] 20.1% 
Intra-cerebral haemorrhage 21.2% 50.0% [110] 38.4% 
* Frequency of this study factor in the stroke surveillance study. 
† Prevalence of the outcome in this group reported in the source study. 
‡ MDD with 80% power (two-sided α=0.05) if prevalence of the outcome at the first-named level of the study 
factor is as reported in the source study. 
 
Functional outcomes at three months  
There are several different instruments used to measure functional status, and the proportions 
with good functional status reported in previous studies differ from study to study according 
to the measure used. In Table 2.2, results are reported for three different definitions of good 
functional status: mRS  3 by Gargano et al [300] in respect of differences by sex, as Barthel 
Index  95 by Eriksson et al. [302] in respect of differences by sex and age, and as mRS < 3 
by Hong et al [303] in respect of differences by grade of stroke severity. Based on the 
frequency of those study factors found in the hospital-based surveillance study conducted in 
the same study hospital, a sample size of n = 300 would provide at least 80% power (two-
sided α=0.05) to detect the differences in three-month good functional outcomes by level of 
study factors in previous studies other than the difference by sex reported by Gargano et al. 
[300]. 
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Table 2.2. Minimal detectable difference in prevalence of good functional status at three 
months.  
Study factor 
Expected 
frequency of 
study factor* 
Expected 
prevalence of 
outcome† Source 
MDD  in 
prevalence of 
outcome‡ 
Sex     
Males 54.2% 81.0% [300] 81.0% 
Females 45.8% 76.1% [300] 66.5% 
Sex     
Males 54.2% 68.8% [302] 68.8% 
Females 45.8% 49.4% [302] 52.4% 
Age     
Less than 60 years  37.7% 65.9% [302] 65.9% 
60 years or greater  62.3% 53.3% [302] 48.8% 
Severity of stroke     
Less severe (mRS < 3) 22.5% 80.0% [303] 80.0% 
Severe (mRS ≥ 3) 77.5% 31.6% [303] 61.4% 
* Frequency of this study factor in the stroke surveillance study. 
† Prevalence of the outcome in this group reported in the source study. 
‡ MDD with 80% power (two-sided α=0.05) if prevalence of the outcome at the first-named level of the study 
factor is as reported in the source study. 
Level of HRQoL at three months 
Table 2.3 shows that a sample size of n = 300 would provide at least 80% power (two-sided 
α=0.05) to detect the differences in mean HRQoL score of stroke survivors between subjects 
with less severe and most severe (mRS> 3) disability reported in a previous study (13). The 
actual sample size of n = 376 that was attained would make it possible to detect the difference 
by age reported by Abubakar and Isezuo [249]. In the source studies, HRQoL was measured 
on the Stroke Impact Scale by Abubakar and Isezuo [249], with the Stroke-Specific QoL 
instrument by Kim et al [304], and with the SF-36 by Rachpukdee et al [241]. 
Table 2.3. Minimal detectable difference in health-related quality of life at three months.  
Study factor 
Expected 
frequency of 
study factor* 
Expected 
mean (SD) of 
outcome† Source 
MDD  in 
mean of 
outcome‡ 
Sex     
Males 54.2% 70.8 (13.8) [249] 70.8 (19.0) 
Females 45.8% 66.8 (23.7) [249] 64.7 (19.0) 
Age     
Less than 45 years    6.8% 4.47 (0.62) [304] 4.47 (0.84) 
45 years or greater  93.2% 4.00 (0.85) [304] 3.93 (0.84) 
Severity of disability     
Less severe (mRS  3) 48.1% 33.6 (23.3) [241] 33.6 (46.2) 
Most severe (mRS = 4/5) 51.9% 75.0 (60.0) [241] 48.6 (46.2) 
* Frequency of this study factor in the stroke surveillance study. 
† Mean and standard deviation (SD) of the outcome in this group reported in the source study 
‡ MDD with 80% power (two-sided α=0.05) if the mean of the outcome at the first-named level of the study 
factor is as reported in the source study and the variances are pooled. 
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Costs of stroke  
Table 2.3 shows that a sample size of n = 300 would thus provide at least 80% power (two-
sided α=0.05) to detect the differences in mean costs by level of study factors reported in 
previous studies. 
Table 2.4: Minimal detectable difference (MDD) in costs of stroke. 
Study factor 
Expected 
frequency of 
study factor* 
Expected mean 
(SD) of outcome† Source 
MDD  in mean 
of outcome‡ 
Age     
Less than 65 years  51.7% £13,250 (11,228) [305] £13,250 (9,545) 
65 years or greater  48.3% £10,170 (7,322) [305] £10,180 (9,545) 
Severity of stroke     
Less severe  (mRS= 0-2) 22.5% £10,149 (7,826) [305] £10,149 (11,310) 
Severe (mRS ≥ 3) 77.5% £14,650 (12,135) [305] £14,496 (11,310) 
Type of stroke     
Ischaemic stroke 77.4%   $3,888 (4,018) [272]   $3,888 (7,663) 
Intra-cerebral haemorrhage 20.8% $12,285 (14,336) [272] $12,285 (7,663) 
* Frequency of this study factor in the stroke surveillance study. 
† Prevalence of the outcome in this group reported in the source study 
‡ MDD with 80% power (two-sided α=0.05) if the mean of the outcome at the first-named level of the study 
factor is as reported in the source study and the variances are pooled. 
 
Sample size and statistical power for the reliability study 
The first 135 patients alive at three months (including 55 participants in the pilot study, and 
the first 80 from the main study) were requested to participate in a reliability study that 
involved re-administration of the health-related quality of life questionnaires (the DHP and 
EQ-5D) one week later. The caregivers of these patients were also asked to complete again 
the DHP questionnaire for assessment of proxy-patient reliability. 
In their analysis of the reproducibility of assessments of HRQoL of adolescents in Ho Chi 
Minh City using the DHP, Hanh et al. [212] reported values of the intra-class correlation 
(ICC) in a single replication study in the range 0.72 – 0.80. Based on the tables provided by 
Walter et al. [306], a sample of 100 subjects for a single replication study would provide 80% 
power (one-sided α=0.05) to detect an ICC of 0.74 as being larger than 0.6 (a plausible 
benchmark value). In the classification system of Landis and Koch [307], values in the range 
0.41 – 0.60 represent moderate agreement. Hence a sample size of 100 would provide 
adequate power to conclude that values of the ICC of at least 0.74 – within the range reported 
by Hanh et al. [212] – represent better than moderate agreement.  
 
Ethics 
Ethics approvals to conduct these studies were obtained from the Tasmanian Health and 
Medical Human Research Ethics Committee and from the local ethics committees of Pham 
Ngoc Thach University of Medicine and 115 People’s Hospital. Written consent was obtained 
from each of the participants. 
 44 
 
2.4. Postscript 
This chapter has provided information on the methods used for collecting and managing data 
on the occurrence, presentation, costs and three-month outcomes of stroke. The chapters that 
follow provide the results of studies using those data to address the aims of this research. 
Specifically, Chapter 3 presents results of the stroke surveillance study in respect of the 
occurrence and hospital-based incidence of stroke in Ho Chi Minh City, Viet Nam. The 
remaining chapters utilise data from the cohort study of first-ever stroke to provide results in 
respect of the case fatality and functional status at three months post stroke (Chapter 4), the 
costs of treatment of stroke during the hospital admission (Chapter 5), the reliability and 
validity of the Duke Health Profile to measure HRQoL of stroke patients in Viet Nam 
(Chapter 6), and HRQoL of stroke survivors at three months post stroke (Chapter 7). A 
summary of, and conclusions drawn from the research, are provided in Chapter 8 together 
with directions for future research.  
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Appendix 2A: Log form of stroke registry in hospitals in Viet Nam 
Name Gender Age Year of 
 Birth  
(e.g. 1965) 
Hospital  
Record No. 
Date of 
Admission 
DD/MM/YYYY 
If Died in 
Hospital, Date  
of Death 
DD/MM/YYYY 
Transferred  
to which 
ward 
ID allocated Date of stroke, 
DD/MM/YYYY 
Type of stroke  
diagnosed  
(Ischaemic  
stroke; 
ICH; SAH) 
         /    /            /    /              /    /         
         /    /            /    /              /    /         
         /    /            /    /              /    /         
         /    /            /    /              /    /         
         /    /            /    /              /    /         
         /    /            /    /              /    /         
         /    /            /    /              /    /         
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Appendix 2 B: Stroke survey questionnaire in hospitals in Viet Nam  
 
 
Patient ID 
Fill ID              I1 
 
Stroke surveillance site code 
Fill code           I2  
 
Hospital record ID          I3 
 
Information of patient 
 
Patients Full Name                     
[_______________________________________________________] I4 
 
Patient common name                
[_______________________________________________________] I5 
 
Contact home phone number                
[_______________________________________________________] I6 
 
 
Contact mobile phone number                   
[_______________________________________________________] I7 
 
 
Address                   
[_______________________________________________________] I8 
 
Address                                                      
[_______________________________________________________] I9 
 
Demographic information of patient 
 
Age            I10 
 
 
Gender[choose onet]   Male   (1)    I11 
Female   (0) 
 
Date of stroke onset     
          I12 
(Write date that symptoms were first noticed) 
 
 
Did patient have another stroke prior this stroke? 
 
Yes    (1)    I13 
 
No    (0) 
 
     Insufficient data                          (9) 
 
   Date            Month                   Year 
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RECORDED CLINICAL MANIFESTATION OF STROKE FROM PHYSICIAN 
 
Did the symptoms happen suddenly?  Yes   (1)   I14 
 [select one ]                 No               (0) 
Insufficient data  (9) 
 
 Side of the body affected?  
[Select one]?      Left   (1)   I15 
      Right   (2) 
      Both               (3) 
      Unknown                    (9) 
 
What were the symptoms and signs at stroke onset? [Fill 1 for YES,  0 for NO, or  9 for UNKNOWN] 
 
Symptoms      Signs 
 
Dizziness    I16  Impaired consciousness                           I24 
 
Headache    I17  Definite brainstem signs                          I25 
 
Blurred vision    I18  Limb weakness                                        I26 
 
Double vision    I19  Face weakness                                        I27 
 
Slurred speech    I20  Loss of sensation                           I28 
 
Difficult swallowing                           I21             Visual field deficit                                   I29 
 
Confusion                              I22  Neglect                                                     I30 
 
Seizures    I23  Aphasia/dysphasia                         I31 
 
       Apraxia                                                    I32 
 
       Ataxic gait               I33 
 
 
Assessment disability on modified Rankin Scale 
 
Assign a score from 0 to 6 for the severity of disability when first seen in hospital [select onet]:  
   
No symptoms                                        (0)                           I34 
 
No significant disability despite symptoms,            (1) 
 
Slight disability,                                                               (2) 
 
Moderate disability                                       (3) 
 
Moderately severe disability                                              (4) 
 
Severe disability                                                     (5) 
 
Dead                 (6) 
 
Classification of stroke 
 
 What type of stroke is diagnosed? [chọn một] 
 
Ischaemic stroke               (1)                    I35 
 
Intracerebral haemorrhage                (2) 
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Subarachnoid heamorrahage                                             (3) 
Undetermined                 (4) 
 
 
If the answer to I35 was 1, go to I36. If the answer to I35 was 2, 3, 4 go to I37  
What is the presumed mechanism of stroke? 
Large artery atherosclerosis    (1)    I36 
 
Cardioembolism     (2) 
 
Small artery occlusion                 (3) 
 
Determined, other aetiology    (4) 
 
Undetermined      (9) 
 
 
Which of the following vascular risk factors is the patient known to have? [1=YES, 0=NO, 
9=UNKNOWN] 
 
Atrial fibrilation   I37  Hyperlipidaemia                                        I40 
Current smoker                       I38              High blood pressure                  I41 
Diabetes   I39  Valvular heart disease                 I42 
****************************************************************************** 
Follow-up the patient at 28th day after stroke 
 
Was it possible to follow-up the patient at day 28th after stroke? [select one] 
 
Yes       (1)                        I43 
 
No, no contact                 (2) 
No, patient refused    (3) 
 
What was vital status of the patient at 28th day?[select one] 
Use “i=unknown” if no follow-up completed 
 
Alive      (1)                   I44 
 
Dead      (2) 
 
Unknown     (9) 
 
Date of death?        I45 
 
 
 
 
 
 
   Day            Month                    Year 
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Appendix 2 C: The Duke Health Profile 
  
50 
Appendix 2 D: The Euro-QoL (EQ-5D) and Visual analogue scale 
  
51 
  
52 
Appendix 2 E: In-hospital questionnaire 
PART 1: PATIENT INFORMATION FROM MEDICAL RECORD Code  
1 Survey Assistant Code  1 
2 Patient ID  2 
3 Hospital medical record number  3 
4 Admission record number  4 
5 Patient Full Name  5 
6 Date of birth  6 
7 Sex 
    Male                (1) 
    Female            (2) 
 7 
8 Address  8 
9 Date of filling questionnaire  9 
10 Date of admission in hospital (hour/day/month/year)  10 
11 Date of admission to stroke unit) 
(hour/day/month/year) 
 11 
12 Time of stroke onset  12 
13 At admission time   
   Pulse  13 
   Blood pressure  14 
   Glycemie  15 
   Triglyceride  16 
14 NIHSS score at admission  17 
15 mRS at admission  18 
16 Type of stroke 
  IS                     (1) 
  ICH                  (2) 
  Unknown          (3) 
 19 
17 Does patient have health insurance?  
   Yes                                   (1) 
    No                                   (2) 
    Unknown                        (3) 
 20 
18 If yes, which type of insurance 
   Mandatory                        (1) 
   voluntary                          (2) 
   private                              (3) 
   other                                 (4) 
 21 
 If yes, give proportion of insurance co-payment 
 
 22 
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PART 2: FROM INTERVIEW PATIENTS 
19 Ethnicity 
   Kinh                                                     (1) 
   Chinese                                                (2) 
   Other                                                    (3) 
 23 
20 Marital status 
   Married                                                (1) 
   Single                                                   (2) 
   Divorce                                                (3) 
   Widowhood                                         (4) 
 24 
21 With whom is patient living 
   Spouse                                                  (1) 
   Siblings                                                 (2) 
   Offspring                                              (3) 
   Parents                                                  (4) 
   Friends                                                  (5) 
   Others                                                   (6)  
 25 
22 Education level 
   No school                                             (0) 
   Not complete primary school             (1)  
   Complete primary school                 (2) 
   Complete secondary school                 (3) 
   Complete high school     (4) 
   TAFE                                      (5)  
   University                                           (6) 
   Post University                                   (7) 
   Unknown                                            (8)  
  26 
23 Career status 
Manager                                                         (1) 
Professional including teacher, doctor          (2) 
Officer                                                           (3) 
Service including hotel, restaurant, security (4) 
Sale or simple manual work                          (5) 
Farm                                                              (6) 
Forest                                                            (7)  
Fish/seafood                                                 (8) 
Mineral                                                         (9) 
Builder                                                          (10) 
In industry                                                    (11) 
Operator                                                        (12) 
Driver                                                           (13) 
 27 
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Student                                                         (14) 
Housewife                                                    (15) 
Retired                                                          (16) 
Unknown                                                     ( 17) 
24 Type of job 
  full time                       (1) 
  part time                      (2) 
  unknown                     (3) 
 28 
 PATIENT’S CONTACT  
25 Patient’s phone number 
 
 29 
26 Name of caregiver 1  
 
 30 
27 Contact of caregiver 1  31 
28 Phone number of caregiver 1 
 
 32 
29 Relationship between patient and caregiver 1 
   Spouse                                           (1) 
   Siblings                                         (2) 
   Children                                        (3) 
   Parents                                          (4) 
   Friends                                          (5) 
   Others                                           (6) 
 33 
30 Name of caregiver 2  34 
31 Contact of caregiver 2  35 
32 Phone number of caregiver 2  36 
33 Relationship between patient and caregiver 2 
   Spouse                                           (1) 
   Siblings                                         (2) 
   Children                                        (3) 
   Parents                                          (4) 
   Friends                                          (5) 
   Others                                           (6)  
 37 
 RISK FACTORS  
34 Who is answering the following questions? 
  Patient                                      (1) 
  Caregiver                                 (2) 
 38 
 Cigarette smoking   
  
55 
35 Have you ever used tobacco in your life? 
   Yes    (1) 
   No     (2)   
(If yes, move to question 36; if no, move to 49) 
 39 
36 Do you currently smoke any tobacco products, such 
as cigarettes, cigars or pipes? 
   Yes    (1) 
   No     (2)   
 (If yes, move to question 37; if no, move to 43) 
    40 
37 Are you daily current smoker? 
  Yes    (1) 
   No     (2)  
            41 
38 How old were you when you started smoking daily? 
(If patient does not remember, ask question 39) 
 42 
39 How long ago it was? 
Number of year 
 43 
40 On average, how many of the following do you 
smoke each day? 
  
   Manufactory cigarette  44 
   Pipes  45 
   Cigar  46 
41 For those who current do not smoke daily: have you 
ever smoked daily? 
   Yes              (1) 
   No               (2) 
 (If yes, move to 42; if no, move to 45) 
 47 
42 If yes, how old were you when you started smoking 
daily? 
(If patient cannot remember, ask question 43) 
 48 
43 Do you remember how long ago it was? 
Year 
 49 
44 When you smoked, on average, how many of the 
following do you smoke everyday? 
  
   Manufactory cigarette  50 
   Pipes  51 
   Cigar  52 
45 How old were you when you stopped smoking 
daily? 
(If patient does not remember, move to question 46) 
 53 
46 Do you remember how long ago it was? 
Year 
 54 
  
56 
 
47 Do you currently use chewing tobacco? 
   Yes                  (1) 
   No                   (2)  
 55 
48 If yes, do you use tobacco chewing daily 
   Yes                  (1) 
   No                   (2)  
 56 
 Alcohol   
49 Have you ever consumed an alcoholic drink such as 
beer, wine, spirits, and fermented cider?   
   Yes                  (1) 
   No                   (2)  
 (If yes, move to 50; if no, move to 55) 
 57 
50 Have you consumed an alcoholic drink within the 
past 12 months 
   Yes                  (1) 
   No                   (2)  
 58 
51 During the past 12 months, how frequently have you 
had at least one alcoholic drink? 
   Daily                     (0) 
   5-6 days/week       (1) 
   1-4 days/week       (2) 
   1-3 days/month     (3) 
   <1time/month       (4) 
 59 
52 When you drank alcohol, on average, how many 
standard alcoholic drinks did you have in one day? 
(use picture) 
 60 
53 Have you consumed an alcoholic drink within the 
past 7 days? 
   Yes               (1) 
   No                (2) 
   Unknown     (9) 
 61 
54  Have you consumed an alcoholic drink within the 
past 30 days? 
   Yes               (1) 
   No                (2) 
   Unknown     (9) 
 62 
 COMORBIDITY   
 High blood pressure   
55 When was the last time your blood pressure was 
measured by a health worker? 
 63 
  
57 
   Less than 12 months                    (1) 
   1-5 years                                      (2) 
   Not any time during last 5 years  (3)  
56 Have you ever been told by a health worker that you 
have high blood pressure? 
   Yes               (1) 
   No                (2) 
   Unknown     (9) 
 64 
57 In the last 12 months, have you been told by a health 
worker that you had high blood pressure? 
   Yes               (1) 
   No                (2) 
   Unknown     (9) 
 65 
 Diabetes   
58 In the last 12 months, have you had your blood 
sugar level measured? 
   Yes               (1) 
   No                (2) 
   Unknown     (9) 
 66 
59 Have you ever been told by a health worker that you 
have diabetes? 
   Yes               (1) 
   No                (2) 
   Unknown     (9) 
 67 
60 Have you received any treatment for diabetes? 
   Yes               (1) 
   No                (2) 
   Unknown     (9) 
 68 
61 Has the patient ever had a stroke in the past? 
   Yes               (1) 
   No                (2) 
   Unknown     (9) 
 69 
 Current chronic diseases   
62 Heart chronic disease 
   Yes               (1) 
   No                (2) 
   Unknown     (9) 
 70 
63 Chronic lung disease 
   Yes               (1) 
   No                (2) 
   Unknown     (9) 
 71 
  
58 
64 Chronic kidney disease 
   Yes               (1) 
   No                (2) 
   Unknown     (9) 
 72 
65 Chronic liver disease 
   Yes               (1) 
   No                (2) 
   Unknown     (9) 
 73 
66 Cancer 
   Yes               (1) 
   No                (2) 
   Unknown     (9) 
 74 
67 Weight (kilogram) 
 
 75 
68 Weight by nurse or staff 
   Yes               (1) 
   No                (2) 
 76 
69 Is it estimated by nurse of by self-report from 
patients? 
  Yes               (1) 
   No                (2) 
 77 
70 Height (m) 
 
 78 
71 Height by nurse or staff 
   Yes               (1) 
   No                (2) 
 79 
72 Is it estimated by nurse of by self-report from 
patients? 
   Yes               (1) 
   No                (2) 
 80 
 Pre-stroke disability   
73 Before stroke onset, did patient have disability? 
   Yes               (1) 
   No                (2) 
   Unknown     (9) 
 81 
 If yes, give details for the severity and type of 
disability 
 
 82 
74 Dominant arm 
   Right                        (1) 
   Left                          (2) 
 83 
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   Unknown                 (3) 
75 Which side has weakness now 
   None of all               (1) 
   Right                        (2) 
   Lef                           (3) 
   Unknown                 (4) 
 84 
76 Does patient have dementia before stroke? 
   Yes               (1) 
   No                (2) 
   Unknown     (9) 
 85 
77 Before stroke, has patient had a disorder of  
speaking function such as slurred speech? 
   Yes               (1) 
   No                (2) 
   Unknown     (9) 
 86 
 Estimated costs related to another hospital, before admission to the 115 
People’s Hospital 
 
78 Has the patient been admitted to another hospital 
due to this stroke before he/she is in 115 Hospital? 
   Yes               (1) 
   No                (2) 
 87 
 In another hospital before 115   
79 Length of stay  88 
80 Estimated cost 
 
 89 
81 Medical cost (invoice)   90 
82 Non-medical cost  91 
83 Transportation  92 
84 Food  93 
85 Sundry expenses  94 
 Costs related to hospitalisation in the 115 People’s Hospital Hospital 
 Non-medical cost at Stroke Unit in 115 People’s Hospital 
86  Food for 
patient 
Food for 
caregiver 
Transportation Paid caregiver Sundry expense 
 Date 1      
 Date 2      
 Date 3      
 Date 4       
 Date 5       
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 Date 6      
 Date 7      
 Total (95) (96)  (97) (98) (99) 
 Indirect cost at 115 
87 Average income/day of patient  100 
88 Number of caregivers  101 
   Main job Daily income Number of day 
off 
Total  
89 Caregiver 1     (102) 
90 Caregiver 2     (103) 
91 Caregiver 3     (104) 
92 Caregiver 4     (105) 
93 Caregiver 5     (106) 
 If before admitted to 115, if patient stayed in other hospital longer than 1 day, 
ask indirect costs at that hospital? 
 
94 Average income of caregiver 1  107 
95 Number of day off  108 
96 Average income of caregiver 2  109 
97 Number of day off  110 
98 Average income of caregiver 3  111 
99 Number of day off  112 
 Source of payment   
100 What are the sources of money did the household get to pay for 
medical costs and other expenditure related to the stroke? 
       Yes (1) 
       No  (2)     
  
 Saving  113 
 Mortgage  114 
 Relative support       115 
 Sell assets/property  116 
 Loan  117 
 Insurance   118 
 Other (give detail) 
 
 119 
 Socio-economic status of family  
101 Number of person  in the family  120 
  
61 
102 Average income per month of household from salary   121 
103 Does the household have another income source  
(such as renting, interest, personal business etc) 
   Yes               (1) 
   No                (2) 
   Unknown     (9) 
 122 
104 If yes, average income per month of household from other  sources  123 
105 Expenditure for food for household per month  124 
106 Total expenditure per month for household  125 
 Wealth index   
107 Do you have which assets as follow 
      Yes                      (1) 
      No                       (2)     
  
 Telephone  126 
 Radio  127 
 Television  128 
 VCD/DVD player  129 
 Air conditioner  130 
 Fridge  131 
 Hot water machine  132 
 Computer  133 
 Gas cooker  134 
 Microwave  135 
 Bicycle  136 
 Motorbike  137 
 Car  138 
108 If patient survived hospitalisation, what was the discharge destination of  
the patient? 
   Home                                            (1) 
   Other hospital/nursing home        (2) 
   Rehabilitation                               (3) 
   Other (give detail)  A170 
 139 
109 If patients return to home, give detail place of their home 
  Ho Chi Minh City                (1) 
  Outside Ho Chi Minh City  (2)  
 140 
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PART 3: NEUROLOGISTS FILL THIS FORM 
Name of patient ………………………… Sex: Male/Female                Year of birth ……. 
Hospital ID ……………………….............Admission ID…………………………………. 
1. Severity of stroke (NIHSS score) 
 
 D1 
2. Disability level of stroke  (Modified Rankin score) 
 
 D2 
3. Type of stroke 
   IS                           (1)                                 
   ICH               (2) 
   SAH                      (3) 
   Undetermine d       (4) 
 D3 
4. Mechanism/ subtype of ischaemic stroke (TOAST) 
   Embolic in large vessel          (1) 
   Cardioembolic                        (2) 
   Embolic in small vessel          (3) 
   Other                                       (4) 
 D4 
 Place an X in the appropriate column Code 
  Yes (1) No (2)   Unknown (9)  
5 Risk factors     
   Atrial fibrillation    D5 
   High blood pressure    D6 
   Hyperlipidemia    D7 
   Valvular heart disease    D8 
   Diabetes    D9 
6 Complication Yes (1) No (2)   Unknown (9)  
   Pneumonia    D10 
   Urinary tract infection    D11 
   Extracranial bleeding    D12 
   Bed sore    D13 
   Falls    D14 
   Myocardial infraction    D15 
   Others    D16 
7 At discharge time, what is patient’s  condition? 
   Stable             (1) 
   Very severe    (2) 
   Unknown        (3) 
 D17 
8  Date of discharge  D18 
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Appendix 2F: Three-month follow-up questionnaire 
A. GENERAL INFORMATION 
1 Patient ID  C1 
2 Patient name  C2 
3 Admission ID  C3 
4 Survey Assistant Code  C4 
5 Date of filling questionnaire  C5 
6 Landline phone number  C6 
7 Mobile number  C7 
8 Address  C8 
9 Person respondent’s full name   C9 
10 The respondent person is 
   Patient                           (1) 
   Spouse                           (2) 
   Siblings                         (3) 
   Children                        (4) 
   Parents                          (5) 
   Friends                          (6) 
   Others                           (7) 
 C10 
11 
 
Who is main caregiver? 
   Spouse                           (2) 
   Siblings                         (3) 
   Children                        (4) 
   Parents                          (5) 
   Friends                          (6) 
   Others                           (7) 
 C11 
B. VITAL STATUS 
12 Was it possible to follow up the patient at three 
months post stroke? 
   Yes                          (1) 
 C12 
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   No                                      (2) 
   Unknown                           (9) 
13 What is the vital status at three months post stroke 
   Still alive                            (1) 
   Deceased                            (2) 
   Unknown                            (9) 
 C13 
14 If patient dead at three months, date of death 
(dd/mm/yyyy) 
 C14 
C. FOR RECURRENT STROKE 
15 In the past 1 month, have you ever had (new) 
following symptoms? 
  
 Face muscle weakness 
   Yes                                   (1) 
   No                                      (2) 
   Unknown                           (9) 
 C15 
 Arm or leg weakness 
   Yes                                   (1) 
   No                                      (2) 
   Unknown                           (9) 
 C16 
 Slurred speech 
   Yes                                   (1) 
   No                                      (2) 
   Unknown                           (9) 
 C17 
16 During last month, have you been readmitted to 
hospital as a consequence of another stroke or for 
any stroke related problems? 
   Yes                                   (1) 
   No                                      (2) 
   Unknown                           (9) 
 C18 
17 Is the patient currently at a hospital? 
   Yes                                   (1) 
 C19 
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   No                                      (2) 
   Unknown                           (9) 
18 If yes, please give detail  C20 
19 Number of time to re-admit a hospital  C21 
 For the first re-admission:   
20 In what hospital (give name of hospital and 
department) 
 
 
C22 
21 Reason to re-admission  C23 
22 How many days in hospital?  C24 
23 Total out of pocket expenditure for this 
 re-admission 
 C25 
 For the second re-admission:   
24 In what hospital (give name of hospital and 
department) 
 C26 
25 Reason to re-admission  C27 
26 How many days in hospital?  C28 
27 Total out of pocket expenditure for this 
 re-admission 
 C29 
 For the third re-admission:   
28 In what hospital (give name of hospital and 
department) 
 C30 
29 Reason to re-admission  C31 
30 How many days in hospita  C32 
31 Total out of pocket expenditure for this re-
admission) 
 C33 
D. FOR DIRECT COSTS 
 D1. Medical expenses (doctor, medication, 
rehabilitation) 
  
32 Did you use health insurance for health check up 
   Yes                                   (1) 
   No                                      (2) 
 C34 
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   Unknown                           (9) 
33 Total costs related to stroke treatment during last 
month 
 C35 
34 Source of payment for treatment of stroke (including 
hospital fees and other stroke-related fees)? 
   Yes                                   (1) 
   No                                      (2) 
  
  Saving  C36 
  Mortgage  C37 
  Relative support  C38 
  Sell assets/property  C39 
  Loan  C40 
  Insurance  C41 
  Other (give detail)  C41 b 
 Doctor consultant fee (total out of pocket money)   
35 Average doctor consult fee per time  C42 
36 Number of time for visit doctor during last  month 
(3rd month) 
 C43 
37 Where and how many times has patient meet his/her 
doctor 
 C44 
    Private consultant room                        (1)   
    115 hospital with health insurance        (2)   
    115 hospital, with no health insurance  (3)   
    Other place, give detail   
 Nurse consultant fee   
38 Average nurse consultant fee per  time 
 
 C45 
39 Number of time per month (3rd month)  C46 
 Medication   
40 How many prescriptions that doctor have given you 
during last month (3rd month)? 
 C47 
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41 How much have you paid for each prescriptions?   
 Prescription 1  C48 
 Prescription 2  C49 
 Prescription 3  C50 
 Prescription 4  C51 
 Traditional /Chinese medicine  C52 
 Rehabilitation   
42 Average fee for rehabilitation per time  C53 
43 Number of time in last month (3rd month)  C54 
44 Other medical costs  C55 
 D2. Estimated nonmedical expenses   
45 Special dietary  C56 
46 Transportation cost from home to hospital/doctor/ 
rehabilitation 
 C57 
47 Home modification  C58 
48 Special equipment and aids  C59 
49 Other  C60 
E. FOR INDIRECT COSTS: LOSS OF PRODUCTIVITY OF CAREGIVERS 
50 Caregiver 1      
  Income per day  C61 
  Days of care patients in last month  C62 
51 Caregiver 2   
  Income per day  C63 
  Days for take care patients in last month  C64 
52 Caregiver 3   
  Income per day  C65 
  Days for take care patients in last month  C66 
53 Caregiver 4   
  Income per day  C67 
  Days for take care patients in last month  C68 
  
68 
 F. EMPLOYMENT STATUS OF PATIENT 
54 During last month, did patient work? 
    Yes                       (1) 
    No                        (2) 
    Unknown             (9) 
(If say “yes”, move to next question; if not, move to 
question 59) 
 C70 
55 Details of work  C71 
56 Does patient currently work? 
    Yes                       (1) 
    No                        (2) 
    Unknown             (9) 
 C72 
57 If yes, what was the type of this work 
   full-time                (1) 
   part-time               (2) 
   Unknown              (9) 
 C73 
58 Compare to number of working hours before stroke 
   The same              (1) 
   Decreased             (2) 
 C74 
G. LIVING ARRANGEMENT 
59 Current residential status 
   Stay alone                                    (1) 
   With family/relative                    (2) 
   With friends                                (3) 
   Other                                           (4) 
   Unknown                                    (9) 
 C75 
62 As a consequence of stroke, have you needed to 
change your place of residence? 
    Yes                       (1) 
    No                        (2) 
    Unknown             (9) 
 C76 
  
69 
63 If yes, give reason  C77 
64 Number of person  in the family now  C78 
H. SOCIOECONOMIC STATUS OF FAMILY 
65 Average income per month of household from salary 
 
 C79 
66 Compared to income prior stroke, current income is: 
    Unchanged            (1) 
    Decreased             (2) 
    Increased              (3) 
    Unknown              (9) 
 C80 
67 Does the household have another income (such as 
renting, interest, personal business, etc) 
    Yes                       (1) 
    No                        (2) 
    Unknown             (9) 
 C81 
68 If yes, average income per month of household from 
other sources 
 C82 
69 Expenditure for food for household per last month  C83 
70 Total expenditure of last month for household  C84 
 Wealth index   
71 In your household now, do you have the following 
assets 
     Yes                  (1) 
     No                   (2)     
  
 Telephone  C85 
 Radio  C86 
 Television  C87 
 VCD/DVD player  C88 
 Air conditioner  C89 
 Fridge  C90 
 Hot water machine  C91 
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 Computer  C92 
 Gas cooker  C93 
 Microwave  C94 
 Bicycle  C95 
 Motorbike  C96 
 Car  C97 
72 Source of payment for treatment last three months 
    Yes                        (1) 
    No                        (2) 
    Unknown               (9) 
  
I. DISABILITY 
73 Modified Rankin Scale (give one score)  C105 
  No symptoms at all                                    (0) 
 No significant disability. Able to carry out all 
usual activities, despite some symptoms   (1) 
 Slight disability. Able to look after own affairs 
without assistance, but unable to carry out all 
previous activities                                      (2) 
 Moderate disability. Requires some help, but 
able to walk unassisted                               (3) 
 Moderately severe disability. Unable to attend 
to own bodily needs without assistance, and 
unable to walk unassisted                           (4) 
 Severe disability. Requires constant nursing 
care and attention, bedridden, incontinent (5) 
 Dead                                                           (6)       
  
74 Who is answering the following questionnaire for 
quality of life 
1.  Patient                 (1) 
2.  Caregiver            (2) 
 C106 
  
71 
Appendix 2G: Visual show card to estimate alcohol consumption 
A small cup (30 ml) of spirit 
 
A glass (120 ml) of wine 
 
A glass of beer (285 ml) 
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Chapter 3: Hospital-based surveillance of stroke over 12 months 
at a tertiary teaching hospital in Ho Chi Minh City, Viet Nam 
 
3.1. Preface 
In this chapter, the results of hospital-based surveillance of frequency of stroke types, stroke 
severity and 28-day case-fatality of stroke patients admitted to a tertiary teaching hospital in 
Ho Chi Minh City during a 12 months period are presented. The incidence density of hospital-
admitted first-ever stroke in Ho Chi Minh City is estimated. This surveillance study utilised 
Step 1 of a standardised method, “STEPwise approach to stroke surveillance”, which was 
developed by the WHO. In subsequent chapters, the author will present the outcomes of a 
cohort of first-ever stroke patients beyond the hospitalisation. The text in this chapter is under 
review as an original research manuscript for consideration of publication in the International 
Journal of Stroke. The appendix of this chapter (Appendix 3) has been prepared as online 
supplementary data for the manuscript. 
 
3.2. Introduction 
Stroke is the second most common cause of death worldwide [308], and a major contributor 
to morbidity and disability [308,309]. There is some evidence [2] that LMICs are now 
experiencing greater incidence of stroke than HICs. Reductions in communicable diseases 
have resulted in greater longevity [64,65] and increased numbers of people surviving to the 
ages at which stroke is more common. In Viet Nam, the percentage of the population aged 
greater than 60 years (the ageing index in the context of a LMIC) has risen from 24.3% in 
1999 to 35.5% in 2009, and is still rising [66]. Concurrently, the cardiovascular risk factor 
profile of the population has worsened with reductions in physical activity and increases in 
intake of fat, salt and sugar [310] and smoking [311]. It is therefore likely that stroke is 
becoming more common in Viet Nam, but there have been only two studies of stroke in the 
country [107,108] and one of those was conducted over 20 years ago [108].  
To remedy this critical lack of information, we conducted 12 months of surveillance of stroke 
at a tertiary teaching hospital in Ho Chi Minh City, Viet Nam’s largest city. Our aim was to 
determine the frequency of stroke types, stroke severity and 28-day case-fatality. A secondary 
aim was to estimate the incidence of hospital-admitted first-ever stroke in Ho Chi Minh City. 
 
3.3. Methods 
Subjects 
The study was conducted at 115 People’s Hospital, one of three hospitals in Ho Chi Minh 
City with a specialist stroke facility. During the 12-month period from 9 December 2009 to 8 
December 2010, we monitored admissions to the Emergency Department, Intensive Care 
Unit, Cardiology Department and Stroke Unit. A pilot study had confirmed that these 
departments captured almost all stroke patients with most treated in the Stroke Unit (70 beds 
with 14 physicians) [295]. Stroke was confirmed by stroke neurologists using the standard 
clinical definition of sudden onset of focal neurological symptoms of presumed vascular 
origin [3]. All patients received brain imaging (computed tomography or magnetic resonance 
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imaging) to exclude other causes and define stroke type. The exclusion criteria were transient 
ischemic attack, defined as focal neurologic symptoms lasting less than 24 hours, or discharge 
within 24 hours from the hospital.  
Stroke patients may be transferred to 115 People’s Hospital from other provinces to receive 
specialist care. Accordingly, only 61.5% (3,084/5,017) of the 5,017 patients registered in this 
study provided an address in Ho Chi Minh City as their residential location, with the 
remainder drawn from surrounding provinces.  
 
Data collection 
This study used Step 1 (events in hospital) of STEPS-Stroke methodology [98]. Data 
collection instruments were developed in consultation with local clinicians, and translated into 
Vietnamese and back-translated to check accuracy. Each department recorded patient details 
and dates of transfer between departments. A treating physician recorded stroke types, signs 
and symptoms at onset, risk factors (atrial fibrillation, smoking status, diabetes, 
hyperlipidaemia, hypertension and valvular heart disease), and assessed severity on the 
modified Rankin Scale (mRS) [122]. Nurses contacted patients or their caregivers by 
telephone at 28 days post-stroke to assess case-fatality. 
 
Geospatial analysis 
For 2,921 of the 3,083 stroke patients, residential addresses were geocoded to Ho Chi Minh 
City wards for which population data were sourced from the General Statistics Office. Age- 
and sex-specific population data for each ward in Ho Chi Minh City were provided by the 
General Statistics Office of Viet Nam (Statistical Office in Ho Chi Minh City, 2012). Crude 
stroke hospital-admitted incidence rates for each ward were calculated by dividing the total 
number of patients traced to each ward by the aggregate population of the ward. To produce 
Figure 3.1, these crude rates were smoothed by firstly taking a weighted average of the 
number of strokes among residents of each ward and of all surrounding wards, and secondly 
of the population of each ward and of all surrounding wards, and then dividing the smoothed 
number of strokes in each ward by its smoothed population. The weights used varied 
inversely with the distance (d) between the centres of wards. The particular weights used to 
produce Figure 1 were calculated as 1/(d+1). The smoothed rates were ranked and arbitrary 
cut-points (selected by the software used) were used to produce the coloured zones of Figure 
3.1. Zone 1 is the area closest to the hospital. Zone 2 encloses Zone 1 and extends to areas 
further from the hospital. Zone 3 encloses Zone 2 and extends to areas even further from the 
hospital. 
 
Data analysis 
Analysis of variance and chi-squared analysis was used to compare means and proportions 
respectively. Associations of severity of stroke with study factors (age, sex and stroke type) 
were analysed by log multinominal regression [312]. Risk and relative risk of case-fatality to 
28 days was estimated by Poisson regression with robust standard errors [313]. Hospital-
admitted stroke incidence density were age-standardised to the new World Standard 
Population [314] using the direct method. Details are provided in the Appendix 3. 
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Ethics 
All participants and their carers provided written consent. The study was approved by the 
Tasmanian Health and Medical Human Research Ethics Committee and the ethics committee 
of 115 People’s Hospital in Viet Nam. 
3.4. Results 
During the 12 month study period, 5,017 (54.3% male, 75.6% first-ever stroke) patients with 
stroke were registered (Table 3.1).  
Table 3.1: Characteristics of stroke patients admitted to 115 People’s Hospital in Ho Chi 
Minh City, Viet Nam, during the 12 month period December 2009 to 
December 2010. 
  Men (N=2,722)   Women (N=2,295)  
Characteristic % (n) % (n) 
Age group     
< 45 years 8.2 (224) 5.1 (118) 
45-54 years 23.8 (648) 13.6 (312) 
55-64 years 26.6 (724) 20.4 (468) 
65-74 years 21.7  (591)  25.2 (578) 
75-84 years 16.3 (444) 28.1 (646) 
85+ years 3.3 (91) 7.5 (173) 
Type of stroke * 
    
Ischaemic stroke 74.3 (2,013) 81.8 (1,856) 
ICH 24.3 (659) 16.6 (379) 
SAH 0.4 (11) 0.9 (21) 
Undetermined 1.0 (26) 1.7 (31) 
Stroke onset 
    
First-ever stroke 74.9 (2,031) 75.5 (1,729) 
Recurrent stroke 24.6 (668) 23.8 (544) 
Undetermined 0.5 (14)  0.7   (18) 
Functional status on admission † 
    
mRS=0 1.2    (32) 1.2 (28) 
mRS=1 8.5 (230) 7.5 (172) 
mRS=2 13.8 (375) 12.6 (290) 
mRS=3 27.6 (750) 23.1 (531) 
mRS=4 35.4 (961) 38.6 (886) 
mRS=5 13.3 (362) 16.8 (385) 
mRS=6 0.3 (7) 0.1 (3) 
Unknown 0.2 (5) 0 (0) 
Vital status at 28 days 
    
Alive 73.1 (1,989) 71.2 (1,634) 
Deceased 9.7 (265) 10.4 (239) 
Unknown 17.2 (468) 18.4 (422) 
* IS = ischaemic stroke, ICH = intra-cerebral haemorrhage, SAH = subarachnoid haemorrhage.  
† Disability assessed by the modified Rankin Scale (mRS) administered during hospital stay. 
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Mean ages were 61.8 (SD 13.1) years for men and 67.5 (SD 13.2) years for women, with 
more males (58.6%) than females (39.1%) aged < 65 years at onset. Relatively more women 
had severe disability (mRS=4/5) on admission (p<0.001) even after adjustment for age. 
Among patients with confirmed vital status, case-fatality at 28 days was 12.2% (males 11.8%, 
females 12.8%), with another 18% of patients having unknown vital status due to loss to 
follow-up. Patients lost to follow-up were similar to those followed up (Table A3.4 in the 
Appendix 3).Mean age of occurrence differed by stroke type (p<0.001): 65.5 (SD 13.2) years 
for ischaemic stroke (IS), 60.4 (SD 13.6) years for ICH (p<0.001), and 62.4 (SD 15.5) years 
for subarachnoid haemorrhage (SAH). Female patients were older than male patients at onset 
of IS (p <0.001) and ICH (p <0.001). Summary data on symptoms, signs and vascular risk 
factors of stroke are shown in Table A3.2 and Table A3.3 in the Appendix 3.In this study, 
77.5% (3,875/5,002) had moderate-to-severe disability (mRS=3/4/5) (Table 3.2).  
Table 3.2: Severity of disability classified by sex, age group and history of stroke. 
 
 
 
Least severe 
(mRS=0/1)*   
Intermediate 
(mRS=2/3)*   
More severe 
(mRS=4/5)* 
 
 N % (n) % (n) % (n) 
First-ever stroke        
Men 2,023 9.6 (194) 43.2 (874) 47.2 (955) 
< 45 years 202 13.9 (28) 41.6 (84) 44.5 (90) 
45-54 years 534 9.9 (53) 45.1 (241) 44.9 (240) 
55-64 years 526 11.0 (58) 42.2 (222) 46.8 (246) 
65-74 years 401 8.5 (34) 44.9 (180) 46.6 (187) 
75-84 years 305 5.6 (17) 42.6 (130) 51.8 (158) 
85 years+ 55 7.3 (4) 30.9 (17) 61.8 (34) 
Women 1,726 9.3 (161) 35.9 (619) 54.8 (946) 
< 45 years 100 15.0 (15) 36.0 (36) 48.0 (48) 
45-54 years 252 10.7 (27) 40.1 (101) 49.2 (124) 
55-64 years 351 8.8 (31) 42.2 (148) 49.0 (172) 
65-74 years 430 10.0 (43) 34.0 (146) 56.0 (241) 
75-84 years 471 7.9 (37) 33.3 (157) 58.8 (277) 
85 years+ 122 6.6 (8) 25.4 (31) 68.0 (83) 
Recurrent stroke        
Men 666 9.8 (65) 37.1 (247) 53.2 (354) 
< 45 years 20 15.0 (3) 40.0 (8) 45.0 (9) 
45-54 years 107 13.1 (14) 43.0 (46) 43.9 (47) 
55-64 years 190 12.1 (23) 39.0 (74) 49.0 (93) 
65-74 years 181 7.2 (13) 36.5 (66) 56.4 (102) 
75-84 years 133 7.5 (10) 31.6 (42) 60.9 (81) 
85 years+ 35 5.7 (2) 31.4 (11) 62.9 (22) 
Women 544 7.0 (38) 35.9 (195) 57.2 (311) 
< 45 years 18 16.7 (3) 38.9 (7) 44.4 (8) 
45-54 years 57 8.8 (5) 43.9 (25) 47.4 (27) 
55-64 years 115 7.0 (8) 36.5 (42) 56.5 (65) 
65-74 years 141 9.9 (14) 38.3 (54) 51.8 (73) 
75-84 years 165 4.2 (7) 35.2 (58) 60.6 (100) 
85 years+ 48 2.1 (1) 18.8 (9) 79.2 (38) 
* mRS = disability assessed on the modified Rankin Scale. 
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From Table 3.2, the risk of more severe disability (mRS=4/5) increased with age (men 
p<0.001, women p<0.001) similarly for men and women (interaction of age group with sex, 
p=0.368) and for recurrent and first-ever strokes (interaction of age group with recurrence, 
p=0.218) but in a more pronounced manner for IS than for ICH (interaction p<0.001, Table 
A3.5, Appendix 3). 
Table 3.3: Estimated incidence of hospital-admitted stroke at 115 People’s Hospital 
among residents of Ho Chi Minh City during the 12 month period December 
2009 to December 2010. 
       Age-standardised  
Sex Zone* Cases Pop Rate (95% CI) † Rate (95% CI) ‡ 
Men    1(a) 43 48,302 89.0  (62.4-115.6) 103.0 (70.1-135.9) 
    1(b) 110 100,867 109.1  (88.7-129.4) 124.1 (99.7-148.5) 
    1 117 124,166 94.2  (77.2-111.3) 109.2 (88.5-130.0) 
    1,2 309 411,287 75.1  (66.8-83.5) 91.4 (80.8-102.0) 
    1,2,3 524 784,623 66.8  (61.1-72.5) 85.0 (77.4-92.7) 
    All 1,182 3,450,515 34.3  (32.3-36.2) 56.6 (53.2-60.1) 
Women    1(a) 59 55,952 105.4 (78.5-132.4) 101.6 (74.8-128.4) 
    1(b) 119 118,596 100.3 (82.3-118.4) 91.1 (74.3-108.0) 
    1 134 146,777 91.3 (75.8-106.8) 82.3 (68.0-96.6) 
    1,2 293 473,789 61.8 (54.8-68.9) 58.9 (52.0-65.7) 
    1,2,3 500 895,498 55.8 (50.9-60.7) 56.5 (51.5-61.6) 
    All 1,038 3,760,092 27.6 (25.9-29.3) 36.7 (34.4-39.0) 
Persons    1(a) 102 104,254 97.8 (78.9-116.8) 104.8 (83.7-126.0) 
    1(b) 229 219,463 104.3 (90.8-117.9) 105.6 (91.5-119.7) 
    1 251 270,943 92.6 (81.2-104.1) 94.2 (82.2-106.2) 
    1,2 602 885,076 68.0 (62.6-73.5) 72.7 (66.7-78.6) 
    1,2,3 1,024 1,680,121 60.9 (57.2-64.7) 68.9 (64.5-73.2) 
    All 2,220 7,210,607 30.8 (29.5-32.1) 45.4 (43.5-47.4) 
* Zone 1(a)=all wards within Zone 1 with centres located ≤1 kilometre from the hospital. Zone 1(b)=all wards 
within Zone 1 with centres located ≤12 kilometres from the hospital. Zone 1=area closest to the hospital. 
Zone 2=area surrounding Zone 1. Zone 3=geographically-dispersed area. 
† Rate per 100,000 (95% confidence interval).  
‡ Rate per 100,000 age-standardised to the new world standard population 
 
Patients with ICH had greater risk of more severe disability (men p<0.001, women p<0.001) 
than those with IS (Table A3.5, Appendix 3). First-ever events were relatively more common 
among patients with ICH (adjusted for age, males p<0.001, females p<0.001) than among 
patients with IS (Table A3.5, Appendix 3). Those with ICH had greater 28 day case-fatality 
(adjusted for age and stroke recurrence, men p<0.001, women p<0.001) that was not fully 
accounted for by the higher proportions with first-ever stroke (adjusted for age and stroke 
recurrence, p<0.001).The characteristics of stroke patients who were Ho Chi Minh City 
residents are shown in Table A3.1 (Appendix 3).  
The annual incidence density of hospital-admitted stroke among those living closest to 115 
People’s Hospital (Zone 1) was as high as 109.1 per 100,000 population for males and 105.4 
per 100,000 for females. Age standardised to the new world standard population, the values 
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were 124.1 (95% confidence interval 99.7, 148.5) per 100,000 for males and 101.6 (95% 
confidence interval 74.8, 128.4) per 100,000 for females. Hospital admissions for stroke were 
greatest in regions closer to the hospital (Zone 1, red color), and declined with greater 
distance from the hospital (see Figure 3.1). 
 
 
 
3.5. Discussion 
Our principal findings from 12 months of surveillance of stroke in a major teaching hospital 
in Ho Chi Minh City, Viet Nam, are that incidence density was lower than that in other 
LMICs but mean age at diagnosis and stroke type distribution were similar. Female patients 
were on average older than male patients at the time of stroke, a large proportion of patients 
had severe deficits, and 28 day case-fatality was lower than expected. 
The only previous estimate of stroke incidence in Viet Nam was 142 per 100,000 from a 
community-based study [108] conducted during 1994-95 in three provinces of southern Viet 
Nam, including Ho Chi Minh City. Based on those data, Feigin et al. [2] projected that the 
incidence of stroke in Viet Nam in 2010 would have been 254.78 per 100,000 person-year. 
Our lower estimate may be explained by under-ascertainment and urban-rural differences. 
Hospital-based studies are estimated to miss 14% of cases in Australia [106], and possibly as 
Figure 3.1: Areas with high proportions of residents admitted to 115 People’s Hospital 
with a diagnosis of stroke during the study period.  
The figure illustrates Zone 1 (red colour), Zone 2 (orange colour) and Zone 3 
(yellow colour). 
  
115 People’s Hospital 
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much as 50% of cases in Viet Nam [315]. In addition, rates may be higher in rural areas 
where 70% of the population lives. Le et al. [108] provided estimates of incidence for each of 
two rural provinces and for Ho Chi Minh City. The rural rates were 2.0 and 2.7 times higher 
than their estimate for Ho Chi Minh City.  
The young age of onset of stroke in our study (64.4 years) is consistent with the average age 
of 64.2 years from hospital-based STEPS-Stroke surveys in five LMICs (India, Iran, 
Mozambique, Nigeria and Russia) [27], and around 5 to 6 years lower than in HICs [2], with 
important social and economic implications in these countries.  
Similar to the finding of the five LMICs review [27], females patients were generally older 
than male patients at the time of stroke. Approximately 40% of the age difference was 
attributable to differences in the age structure of the male and female populations of Ho Chi 
Minh City, with 60% left to be accounted for by differences in vascular risk factors and 
biological differences such as the protective effects of endogenous oestrogen for pre-
menopausal women [25]. Whilst we did not find differences in risk of stroke between self-
reported smokers and non-smokers in our patient group, or for self-reported alcohol intake, 
smoking and alcohol intake are likely candidates because around half of the adult Vietnamese 
male population are current smokers compared with 2.1% of women [73], and excessive 
alcohol intake is reported by 22.3% of men but by only 1.4% of women [73].  
Using the mRS as a marker of stroke severity, over 75% had moderate-to-severe deficits 
(mRS ≥ 3). This is greater than estimates of 38.5% from hospital-based studies in Mumbai 
[12] and 57.5% in Trivandrum [28]. One possible explanation is that 115 People’s Hospital 
received a disproportionate number of severe strokes referred from other hospitals. The 28-
day case-fatality (12.2%) among patients with known vital status was less than that (36.4%) 
of the only other Vietnamese study [107], which was conducted in the rural province of Da 
Nang, and smaller too than estimates for other LMICs [12,113]. Ours is likely to be an 
underestimate due to under-ascertainment of severe cases. The cultural beliefs in Viet Nam 
that favour palliation at home, with early discharge of patients with a poor prognosis, have 
been documented by Tirschwell et al. [107]. In addition, almost 20% of patients were lost to 
follow-up. Our estimated case-fatality would be higher if a disproportionately large number of 
these patients had died.  
The clinical presentations of the patients were typical with limb weakness, face weakness and 
slurred speech the most common signs and symptoms. These align with findings in HICs [77] 
and suggest that campaigns of the type used in HICs to raise awareness of the early signs and 
symptoms of stroke can be considered for adoption in Viet Nam. 
This study has several strengths. It was conducted in accordance with WHO protocols in a 
tertiary teaching hospital with a specialist stroke unit using modern imaging technology 
following a pilot study [295] to standardise diagnostic criteria. While most cases came from 
the stroke unit, other departments provided notification of potential cases ensuring hospital-
wide surveillance. Finally, by geocoding patient addresses, we were able to map an 
approximate catchment area of the hospital to provide an estimate of the incidence of 
hospital-admitted stroke.  
Nevertheless, our study has some limitations. There is no exclusive catchment area for the 
hospital because local residents can attend any other hospital, including one with a stroke unit 
that is close to 115 People’s Hospital. Possible under-ascertainment of cases at the extremes 
of severity cannot be discounted because patients with mild strokes may not attend hospital, 
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and more severe cases may be discharged or die early. Together with failure to recontact 
nearly 20% of patients, this means that our assessments of incidence and 28-day case-fatality 
are probably underestimates. 
 
 3.6. Conclusions 
In a tertiary hospital in urban Viet Nam, strokes occurred at an earlier age and resulted in 
more severe disability than is usual in HICs and some LMICs. These findings suggest that the 
burden of stroke in Viet Nam is substantial. 
 
3.7. Postscript 
Reported in this chapter were the findings of 12-month hospital-based surveillance study of 
stroke in Viet Nam including mean age of patients at stroke onset, frequency of stroke types, 
stroke severity 28-day case-fatality of patients with stroke admitted to a major teaching 
hospital in Ho Chi Minh City during 12 months. Estimates of the incidence of hospital-
admitted first-ever stroke in Ho Chi Minh City were also presented in this chapter. It was 
found that although the incidence density and 28-day case-fatality were lower than expected 
possibly due to under-ascertainment and Vietnamese cultural beliefs that favor palliation at 
home, the mean age at diagnosis and stroke type distribution were similar to other findings 
from LMICs. In particular, a large proportion of patients had severe deficits suggesting more 
severe stroke. Additional information on methods and results related to this surveillance study 
are reported in Appendix 3. In the next chapter, case-fatality and severity of functional 
outcomes of survivors at three months after stroke from a cohort study of patients with first-
ever stroke will be presented. 
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Appendix 3: Additional information on methods and findings derived from 
the 12-month hospital-based surveillance study 
 
Results 
Mean age at stroke onset 
Restricting the analyses to the 3,083 stroke patients from Ho Chi Minh City allowed us to 
examine whether differences in the age distributions of the male and female populations of 
Ho Chi Minh City accounted for the younger mean age of male patients (Table A3.1). 
 
 Table A3.1: Characteristics Ho Chi Minh City residents with a diagnosis of stroke 
admitted to 115 People’s Hospital, Viet Nam, during the period 9 
December 2009 to 9 December 2010. 
  Men (N=1645)   Women (N=1434)  
 % n/N % n/N 
Age group     
<45 years 8.9 (147) 5.2 (75) 
45-54 years 23.7 (390) 12.0 (172) 
55-64 years 26.3 (433) 19.3 (277) 
65-74 years 22.2 (365) 23.6 (339) 
75-84 years 15.5 (255) 30.9 (445) 
85+ years 3.4 (55) 9.0 (130) 
Confirmation of stroke      
Neuroimaging diagnosis 100.0 (1,645) 100.0 (1,438) 
Type of stroke *     
Ischaemic stroke 73.1 (1,198) 79.6 (1,141) 
ICH 25.1 (412) 18.0 (258) 
SAH 0.6 (10) 1.1 (16/) 
Undetermined 1.2 (20) 1.3 (19) 
Stroke onset†     
First-ever stroke 73.9 (1,212) 73.6  (1,056) 
Recurrent stroke 25.5 (419) 25.6 (365) 
Undetermined 0.6 (10) 0.8 (12) 
Vital status at 28 days‡     
Alive 75.5 (1,212) 72.7  (1,011) 
Deceased 11.4 (184) 12.6  (175) 
Unknown 13.1  (210) 14.7  (205) 
* Type of stroke: 5 cases with missing data, ICH = intra-cerebral haemorrhagic stroke, SAH = subarachnoid 
haemorrhagic stroke.; † 4 cases with missing data.; ‡ 86 cases with missing data. 
 
In 2010, the female population was markedly older (there were greater number of females 
than males in each successively higher-ordered five-year age group commencing with the 45-
49 years group). Standardised to the female population of Ho Chi Minh City, the mean age of 
male stroke patients was 64.1 (SD 13.4) years. Our sample included 1934 patients (1,077 
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males, 857 females) who provided a residential address outside of Ho Chi Minh City (Table 
A3.1).  
Compared with their city counterparts, they were more likely to have had an ischaemic stroke 
[80.4% vs 77.1% (2,339/3,035), p=0.006] and a first-ever stroke [77.8% (1492/1918) vs 
74.3% (2,268/3,054), p=0.005]. They also appeared to have lesser 28-day mortality [9.4% vs 
13.9%, p=0.001] and greater loss to follow-up [20.1% (389/1934) vs 16.3% (501/3083), 
p<0.001]. 
 
Signs and symptoms of stroke at admission time 
Signs and symptoms of stroke were similar for males and females (Table A3.2). More than 
half the patients experienced slurred speech. Limb weakness was present for about 90% of 
patients while face weakness was present for about 70%. 
 
 
Vascular risk factors among patients 
Table A3.3 shows the prevalence of vascular risk factors among the stroke patients. More 
than three-quarters of males and females had hyperlipidaemia, and nearly 90 per cent had 
Table A3.2: Symptoms and signs of stroke among patients with stroke admitted to 115 
People’s Hospital in Ho Chi Minh City, Viet Nam. 
  Males (N=2,718)   Females (N=2,295)  
 % (n)* % (n)* 
Symptoms     
Dizziness 28.7  (781) 26.5 (607) 
Headache 37.6 (1,021) 32.1 (737) 
Blurred vision 5.5   (150) 4.2 (97) 
Double vision 1.6  (43) 1.9 (43) 
Slurred speech 55.5 (1,507)  57.1 (1,309) 
Difficulty swallowing 15.3 (417) 17.6 (404) 
Confusion 17.0 (462) 21.9 (503) 
Seizure 2.5 (67)    2.5 (58) 
Signs     
Consciousness 17.2 (468) 22.0 (506) 
Brain stem sign 6.6 (178) 5.8 (133) 
Limb weakness 90.8 (2,465) 90.3 (2,069) 
Face weakness 72.3 (1,964) 69.2 (1,585) 
Loss of sensation 35.5 (964) 33.8 (775) 
Visual deficit 2.6   (71) 2.8 (65) 
Neglect 5.2 (140) 5.1 (118) 
Aphasia/dysphasia 19.8 (538) 21.8 (500) 
Apraxia 9.4   (256) 10.5 (240) 
Ataxic gait 2.9 (79) 2.6 (60) 
* The percentages of patients with symptoms and signs do not sum to 100 because some patients reported more 
than one symptom or sign. 
 82 
 
hypertension. Atrial fibrillation, diabetes and valvular heart disease were more common 
among female patients than male patients, and smoking was more common among the men. 
 
 
Comparison with other studies 
Relative to the summary data for males from the review of STEPS-Stroke surveys at nine 
sites in five low and middle income countries (India, Iran, Mozambique, Nigeria and 
Russia),[27] relatively more of the distribution of male Vietnamese patients fell in lower age 
categories (p<0.001) (Table A3.4). The distributions also differed for females (p<0.001) but 
not in the same systematic way: greater proportion of the Vietnamese distribution fell in the 
lowest and highest age categories. Had the relative frequencies of the three stroke types in this 
study matched those of the 5-country review, the median age of diagnosis for females in this 
study would have been 69.1 (95% confidence interval 68.1, 70.1) years.  
 
Distribution of type of stroke classified by sex, age group and stroke onset 
Among persons with ischaemic stroke, the trend of reduced proportions with first-ever stroke 
with increasing age was more pronounced for males than females (p<0.001, Table A3.5) and 
overall the proportion with first-ever stroke was greater for females than for males (p=0.024). 
Otherwise the trends were not statistically distinguishable by sex, and there were no 
differences by sex in the age-adjusted proportions with first-ever stroke (ICH p=0.286). First-
ever events were relatively more common among patients with ICH (adjusted for age, males 
p<0.001, females p<0.001) than among patients with IS. 
 
Comparison characteristics of patients who lost not follow up with those who were 
followed up at 28 days post stroke 
Table A3.6 shows characteristics of patients who were lost to follow up and those who were 
followed up at 28 days post stroke. Patients who were not followed up [mean age 65.5 (SD 
13.5) years] were older than those who were followed up [mean age 64.2 (SD 13.6) years]. 
Compares to patients who were followed up, those who were lost to follow up were less likely 
to be Ho Chi Minh City residents. There were no differences in sex, type of stroke, recurrent 
stroke and severity of disability. 
Table A3.3: Vascular risk factors among patients with stroke admitted to 115 People’s 
Hospital in Ho Chi Minh City, Viet Nam. 
  Males (N=2,674)   Females (N=2,223)  
Vascular risk factors (%) (n) % (n) 
Atrial fibrillation 4.5 (119) 9.3 (206) 
Current smoking 30.6 (819) 1.2 (26) 
Diabetes 13.0 (348) 21.1 (469) 
Hyperlipidemia 75.1 (2,009) 77.1 (1,714) 
Hypertension 89.6 (2,398) 88.9 (1,976) 
Valvular heart disease 4.9 (130) 9.8 (217) 
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Table A3.4: Comparison age of stroke onset in our study with that of other STEPS Stroke studies. 
  This study   STEPS stroke review study [27]  
  Male (N=2,722)   Female (N=2,295)   Male (N=2,981)   Female (N=2,484)  
Age: median (IQR) 61 (52-72) 70 (58-78) 65 (54-73) 69 (58-76) 
Age group         
<45 years 8.0% (224) 5.1% (118) 11.0% (335) 9.0% 214 
45-54 years 24.0% (648) 13.6% (312) 16.0% (465) 11.0% 261 
55-64 years 27.0% (724) 20.4% (468) 22.0% (659) 18.0% 448 
65-74 years 22.0% (591) 25.2% (578) 28.0% (847) 32.0% 789 
75-84 years 16.0% (444) 28.2% (646) 19.0% (572) 25.0% 614 
85+ years 3.0% (91) 7.5% (173) 3.0% (103) 9.0% 158 
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Table A3.5. Proportions of first-ever stroke, severe disability and 28-day survival status 
classified by sex, age group and type of stroke 
  First-ever stroke   
Severe disability 
(mRS=4/5)   28-day survival  
  % n/N % n/N % n/N 
All stroke 
75.6 (3760/4972)* 51.9 (2594/5002) 87.8 (3623/4124) 
Ischaemic 
73.7 (2828/3837)† 46.6 (1802/5002) 92.0 (2928/3182) 
Male 72.8 (1456/1999) 42.2 (848/2008) 92.8 (1539/1659) 
< 45 years 89.4 (126/141) 33.8 (48/142) 96.6 (112/116) 
45-54 years 80.9 (330/408) 33.8 (138/408) 93.6 (322/344) 
55-64 years 71.2 (385/541) 39.7 (216/544) 94.7 (431/455) 
65-74 years 67.2 (315/469) 46.2 (217/470) 90.4 (349/386) 
75-84 years 70.8 (259/366) 50.4 (186/369) 91.6 (274/299) 
85 years+ 55.4 (41/74) 57.3 (43/75) 86.4 (51/59) 
Female 74.7 (1372/1838) 51.4 (954/1856)   
< 45 years 81.9 (68/83) 42.2 (35/83) 94.2 (65/69) 
45-54 years 79.7 (181/227) 39.9 (91/228) 95.8 (183/191) 
55-64 years 73.4 (276/376) 44.6 (168/377) 96.3 (308/320) 
65-74 years 75.2 (357/475) 51.2 (247/482) 90.9 (360/396) 
75-84 years 72.8 (390/536) 57.8 (314/543) 88.7 (386/435) 
85 years+ 70.9 (100/141) 69.2 (99/143) 77.7 (87/112) 
Haemorrhagic 
81.2 (932/1148)‡ 69.6 (792/1138) 73.5 (695/945) 
Male 82.1 (575/700) 67.7 (475/702) 75.6 (450/595) 
< 45 years 93.4 (71/76) 67.5 (52/77) 77.9 (53/68) 
45-54 years 89.4 (203/227) 65.9 (147/223) 77.5 (155/200) 
55-64 years 82.4 (136/165) 75.3 (125/166) 72.6 (106/146) 
65-74 years 76.7 (79/103) 67.6 (71/105) 78.4 (58/74) 
75-84 years 66.7 (44/66) 79.7 (55/69) 69.5 (41/59) 
85 years+ 93.3 (14/15) 86.7 (13/15) 61.5 (8/13) 
Female 82.1 (357/435) 72.7 (317/436) 70.0 (245/350) 
< 45 years 89.7 (26/29) 65.5 (19/29) 81.8 (18/22) 
45-54 years 86.3 (63/73) 74.3 (55/74) 71.9 (41/57) 
55-64 years 83.8 (67/80) 82.3 (65/79) 64.6 (42/65) 
65-74 years 83.3 (65/78) 82.1 (64/78) 76.2 (45/59) 
75-84 years 82.4 (75/91) 69.6 (64/92) 63.6 (49/77) 
85 years+ 80.0 (20/25) 87.5 (21/24) 47.8 (11/23) 
* 45 cases with missing data on first-ever stroke, 
† 32 cases with missing data on stroke onset among patients with ischaemic stroke, 
‡ 13 cases with missing data on stroke onset among patients with haemorrhagic stroke. 
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Table A3.6. Characteristics of patients who were lost to follow up and  those who were 
followed up at 28 days  
  Lost to  follow up 
(N=890) 
  Followed-up 
(N=4127) 
 
 % (n) % (n) 
Sex     
Male 47.4 (422) 45.4 (1873) 
Age group     
< 45 years 6.5 (58) 6.9 (284) 
45-54 years 17.2 (153) 19.6 (807) 
55-64 years 21.1 (188) 24.3 (1004) 
65-74 years 25.6 (228) 22.8 (941) 
75-84 years 23.7 (211) 879 (21.3) 
85+ years 5.8 (52) 5.1 (212) 
Residence      
Ho Chi Minh City residence 56.3 (501) 62.6 (2582) 
Type of stroke*     
Ischaemic stroke 77.8 (687) 77.4 (3182) 
ICH 19.8 (175) 21.0 (863) 
SAH 0.7 (6) 0.6 (26) 
Undetermined 1.7 (15) 1.0 (42) 
Stroke onset†     
First-ever stroke 75.4 (667) 75.1 (3093) 
Recurrent stroke 24.3 (215) 24.2 (997) 
Undetermined 0.3 (3) 0.7 (29) 
Severity of stroke‡     
Least severe 8.6 (76) 9.4 386) 
Intermediate 39.5 (351) 38.8 (1595) 
Most severe 51.9 (461) 51.9 (2133) 
* Type of stroke: missing data of type of stroke for 7 lost follow-up cases and 14 followed up cases, ICH = intra-
cerebral haemorrhage, SAH = subarachnoid haemorrhage  
† 5 lost follow up cases and 8 followed up with missing data  
‡ 2 lost follow up cases and 13 followed up with missing data 
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Chapter 4: Case-fatality and functional status three months after 
first-ever stroke in Viet Nam 
 
4.1. Preface 
The previous chapter provided information on the occurrence and clinical manifestation of 
stroke in Viet Nam from a hospital-based surveillance study during 12 months. To investigate 
further outcomes of stroke after patients are discharged from the hospital, a cohort study of 
450 patients with first-ever stroke was conducted by the author. This chapter reports the case-
fatality and functional outcomes at three months. At the time of this thesis submission, the 
text in this chapter had been prepared as a a manuscript for submission in consideration of 
publication in the European Journal of Neurology. The appendix to this Chapter (Appendix 4) 
has been prepared as online supplementary data of the manuscript. 
 
4.2. Introduction 
In 2010, stroke was the second most common cause of death and the third most common 
cause of disability-adjusted life-years (DALYs) worldwide [2]. Reduced functional status 
(disability) is common among survivors, with approximately 30%-40% of patients having 
reduced function three months after stroke [159].  
These observations have come largely from HICs [2]. However, there is growing recognition 
that incidence and prevalence of stroke are increasing in LMICs although data describing the 
burden in such regions are limited [61]. The age-standardised incidence of stroke in LMICs is 
up to 23% greater than in HICs [2]. Moreover, stroke among patients aged < 75 years in 
LMICs is more than 3-fold that in HICs [2], translating to a greater burden at younger ages. 
Viet Nam is a LMIC in south east Asia that is undergoing rapid epidemiological transition. 
Currently, information on the occurrence and burden of stroke in Viet Nam is scarce. Given 
this critical lack of information, we followed a cohort of first-ever stroke patients admitted to 
a stroke unit in a tertiary teaching hospital to three months after stroke onset. The aim was to 
assess case-fatality and functional outcomes at three months after stroke, and thereby to 
provide critical information for planning the health system response to the growing burden of 
stroke in Viet Nam. 
 
4.3. Methods 
Subjects 
Patients in this cohort study were recruited from the stroke unit of 115 People's Hospital, a 
major teaching hospital in Ho Chi Minh City, Viet Nam. The study inclusion criteria were 
first-ever ischaemic stroke (IS) or intracerebral haemorrhage (ICH) confirmed by a 
neurologist, age≥ 16 years, living in Ho Chi Minh City, with occurrence in the last 7 days and 
acute stroke treatment completed within the stroke unit. Forty-seven patients died and 27 were 
lost to follow-up, resulting in 376 patients who completed the follow-up interview at three 
months (Figure 4.1). 
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Data collection 
At baseline, clinical states including type of stroke, severity of impairment on the National 
Institute Health Stroke Scale (NIHSS) [115], and severity of functional status (disability) on 
the modified Rankin Scale (mRS) [122], were assessed by a neurologist in the stroke unit. 
Patients or their main caregivers were interviewed by research assistants to collect data on 
sociodemographic and economic status, lifestyle and clinical risk factors, and health status 
before stroke (disability and co-morbidity). Patients were contacted by telephone at one 
month and two months after stroke onset to collect data on vital status. If the patient had died 
during follow up, date of death and cause of death were recorded from information provided 
by caregivers. Three months after stroke onset, patients or their proxies were interviewed in 
their homes by research assistants to assess severity of disability on the mRS.  
Figure 4.1: Flowchart for demonstration of participant recruitment and follow up to three 
months. 
960 admissions to stroke unit 
1/6/2012-10/9/2012 
450 stroke patients recruited 
441 stroke patients completed 
interview at baseline 
376 completed follow-up 
interview after three months 
Discharged in severe 
condition: 58 
Recurrent stroke: 322 
Not stroke: 93 
Refused: 2 
Transferred to other 
department: 18 
Stroke>1week: 18 
Deaths: 9 
Deaths pre-discharge: 6 
Deaths post-discharge: 
 by 28 days: 15 
 by 3 months: 32 
Total deaths: 38 
Lost to follow-up: 27 
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Data analysis 
Student’s t-tests and chi-squared tests were used to test differences between means and 
proportions respectively. Log multinomial regression [312] was used to estimate risk and 
relative risk (RR) of mRS disability category at the three-month follow-up. Results are 
presented for four optimal groupings of mRS scores: least severe (mRS=0/1), intermediate 
(mRS=2/3), more severe (mRS=4/5), and dead (mRS=6). Patients in the intermediate 
category (mRS=2/3) had an intermediate pattern of risk, and were excluded from estimation 
(as one category must be). It was not possible to estimate a single odds ratio or relative risk 
for these ordered data because none of the logit-link [316] or log-link [317] ordinal regression 
models could be fitted without statistically significant (p<0.003) loss of model fit. Risk and 
relative risk of change in mRS category was estimated by conditioning on baseline mRS 
category (the mRS score at three months then represents change in mRS category). For 
comparison with published data, linear regression methods were used to estimate mean 
change in mRS scores (calculated as mRS at three months less mRS at hospital) with positive 
mean values indicating worsening of functional status on average. Tests of trend of 
categorical factors with more than two attributes were undertaken by replacing binary 
covariates with a single ordinal covariate. Statistical interaction was assessed by testing the 
coefficient of the covariate formed as the product of covariates for the study factor and the 
potential modifier, or by multivariate tests of multiple product terms. The fit of each final 
model was carefully assessed, and covariates were rescaled where necessary to improve fit. 
All statistical tests were two-sided with a 5% allowance for type I error.  
 Modified Rankin Scale (mRS)       
No 
symptom  
No 
disability  
Slight 
disability  
Moderate 
disability  
Mod. 
severe 
disability  
Severe 
disability  Dead     
Information 
retained  
(mRS=0)  (mRS=1)  (mRS=2)  (mRS=3)  (mRS=4)  (mRS=5)  (mRS=6)  Levels  
-1β V β  (%) 
                  
0  1  2  3  4  5  6  7  367.3 (100%) 
                  
0 + 1  2  3  4  5  6  6  364.9 (99%) 
                  
0 + 1  2 + 3  4  5  6  5  359.7 (98%) 
                  
0 + 1  2 + 3    4 + 5  6  4  351.1 (96%) 
                  
  0 + 1 + 2 + 3  4 + 5  6  3  320.6 (87%) 
                  
0 + 1 + 2 + 3  4 + 5 + 6  2  230.0 (63%) 
Figure 4.2: Amalgamation of adjacent categories of the modified Rankin Scale (mRS) scores. 
The amalgamation shown at each step is that which retained the maximum information 
from the ordinal log-link regression of the mRS categories on covariates for age and sex. 
 
Figure 4.2 shows that for a forwards-descending continuation ratio log-link ordinal model 
[317] with age and sex as covariates, amalgamating categories of the mRS as we have done 
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resulted in almost no loss of information (96% of information is retained).  The index of 
precision used for this assessment was the multivariate Wald statistic ˆ ˆˆ -1β V β , where βˆ  is the 
vector of estimated coefficients and Vˆ  is the estimated covariance matrix of βˆ . Figure 2 also 
shows that any further amalgamation of categories would result in more substantial loss of 
information, and that the optimal binary classification for our data is at mRS=4 with the two 
groupings of mRS<4 and mRS≥ 4. 
 
4.4. Results  
From June to September 2012, 450 consecutive first-ever stroke patients were ascertained as 
being eligible for the study.   
Table 4.1: Characteristics of a cohort of patients with first-ever stroke in Ho Chi Minh 
City, Viet Nam, on discharge from hospital. * 
 Men (N=230) Women (N=211) 
Age     
Mean age (SD) 59.6 (12.8) 65.6 (14.5) 
Median age (IQR) 58.5  (50-69) 68.0  (55-77) 
< 45 years 11.7% (27) 7.1% (15) 
45-54 years 26.5% (61) 17.5% (37) 
55-64 years 26.5% (61) 21.8% (46) 
65-74 years 21.7% (50) 19.0% (40) 
75+ years 13.5% (31) 34.6% (73) 
Comorbidity     
None 73.9% (170) 67.3% (142) 
1 18.3% (42) 23.7% (50) 
2-6 7.8% (18) 9.0% (19) 
Pre-stroke disability †     
Yes 4.8% (11) 9.5% (20) 
No 95.2% (219) 90.5% (191) 
Type of stroke     
Ischaemic stroke 73.0% (168) 79.6% (168) 
ICH 27.0% (62) 20.4% (43) 
Severity of impairment (NIHSS)§     
Mean score (SD) 7.6 (5.4) 8.8 (6.1) 
Severe (NIHSS > 7) 41.3% (92) 48.0% (96) 
Not severe (NIHSS ≤ 7) 58.7% (131) 52.0% (104) 
Functional status (mRS)§     
 Mean score (SD) 3.1 (1.1) 3.2 (1.1) 
 Median score (IQR) 3.0 (3-4) 4.0 (3-4) 
  mRS = 1 11.0% (25) 11.1% (23) 
  mRS = 2 13.6% (31) 13.0% (27) 
  mRS = 3 28.5% (65) 23.7% (49) 
  mRS = 4 43.9% (100) 46.4% (96) 
  mRS = 5 3.1% (7) 5.8% (12) 
*. This information is provided for the 441 patients alive at discharge. 
† Patient self-report. 
§ Assessed during initial hospital stay. 
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Of these, 9 patients (7 men and 2 women) died prior to enrolment. Fifty two percent 
(230/441) of the remaining 441 patient participants were men (Table 1). The median age was 
67 (interquartile range IQR 52-74) years. Ischemic stroke (IS) accounted for 76.2% (75/108) 
of the cases and was slightly more common among women than men. Severity of impairment 
during initial hospital stay, assessed by mean NIHSS score, was 8.2 (SD 5.8). The median 
NIHSS score was 6.0 (IQR 4-12). Women had greater severity of impairment than men at 
admission (p=0.04).  The mean mRS of functional status at admission was 3.2 (SD 1.1) while 
the median score was 3.2 (IQR 3-4) There were only minor differences by sex in these clinical 
characteristics (Table 4.1). 
Socio-demographic information, tobacco smoking, alcohol consumption and comorbidities 
are summarised in Appendix 4 (Table A4.1). Whilst tobacco smoking and alcohol 
consumption were rare among women patients, three quarters of the men had smoked at any 
time (34.5 years average duration and 25.5 average pack-years of smoking), and one-half had 
consumed alcohol during the past 30 days. 
 
Table 4.2: Outcomes of stroke at three months. 
  Men   Women  
 % (n/N) % (n/N) 
Mortality     
In-hospital case fatality 4.2 (10/237) 2.3 (5/213) 
28-day case fatality 6.3 (15/237) 7.0  (15/213) 
3 month case fatality 9.3 (22/237) 11.7  (25/213) 
Functional status (mRS) at three  months     
Mean score (SD) 2.1 (1.4) 2.7 (1.4) 
Median  score (IQR) 2.0 (1-4) 3.0 (2-4) 
mRS=0 11.3 (23/204) 3.5 (6) 
mRS=1 29.9 (61/204) 21.5  (37/172) 
mRS=2 23.5 (48/204) 23.3 (40/172) 
mRS=3 12.3 (25/204) 18.6  (32/172) 
mRS=4 20.1 (41/204) 22.1 (38/172) 
mRS=5 2.9 (6/204) 11.1  (19/172) 
 
The outcomes of the 450 eligible subjects are summarised in Table 4.2. In-hospital case 
fatality was 3.3% (15/450), 28-day case fatality was 6.7% (30/450), and three-month case 
fatality was 10.4% (47/450). If one half of the 58 early discharges were first-ever cases and all 
had died, and if deaths occurred among the other non-participating (2) or lost (27) patients as 
it did for the remaining study participants, case-fatality would have been 9.1% in hospital, 
12.7% at 28 days and 16.4% at three months. 
Among the 376 survivors who completed the assessment of disability at three months follow-
up (Table 4.2), the average mRS was 2.7 (SD 1.7), while the median mRS was 2.0 (IQR 1-4). 
The average mRS score of female patients who were followed up was 28% (95% CI 14.4%, 
41.7%) greater (p<0.001) than the average mRS score of their generally younger male 
counterparts, and 18% (95% CI 5.1%, 31.4%) greater (p=0.007) adjusted for age. 
 91 
 
Table 4.3: Risk and relative risk of disability, and of death, at three months following first-ever stroke in Ho Chi Minh City, Viet Nam. 
   Least severe 
(mRS=0/1)   
Intermediate 
(mRS=2/3)   
Most severe 
(mRS=4/5)   
Death 
(mRS = 6) 
 
 N % (n) RR (95%CI) † % (n) % (n) RR (95%CI) † % (n) RR (95%CI) † 
Age group                
< 45 years 40 50.0 (20) 1.00  37.5 (15) 5.0 (2) 1.00  7.5 (3) 1.00  
45–54 years 95 44.2 (42) 0.88 (0.61,1.27) 36.8 (35) 15.8 (15) 3.17 (0.76,13.2) 3.2 (3) 0.42 (0.09,2.00) 
55–64 years 101 36.6 (37) 0.76 (0.51,1.12) 42.6 (43) 16.8 (17) 3.32 (0.80,13.7) 4.0 (4) 0.52 (0.12,2.23) 
65–74 years 82 18.3 (15) 0.37 (0.21,0.64)*** 31.7 (26) 41.5 (34) 8.25 (2.09,32.6)** 8.5 (7) 1.13 (0.31,4.15) 
75+ years 96 13.5 (13) 0.31 (0.17,0.56)*** 27.1 (26) 37.5 (36) 7.07 (1.78,28.2)** 21.9 (21) 2.77 (0.86,8.96) 
Trend    0.75 (0.68,0.84)***     1.41 (1.23,1.61)***   1.60 (1.23,2.10)** 
Sex                
Male 219 38.4 (84) 1.00  33.3 (73) 21.5 (47) 1.00  6.8 (15) 1.00  
Female 195 22.1 (43) 0.68 (0.51,0.92)* 36.9 (72) 29.2 (57) 1.10 (0.8,1.52) 11.8 (23) 1.19 (0.65,2.18) 
Co-morbidities                
None 291 35.7 (104) 1.00  33.7 (98) 23.7 (69) 1.00  6.9 (20) 1.00  
1  89 21.3 (19) 0.71 (0.47,1.06) 36.0 (32) 29.2 (26) 1.02 (0.71,1.45) 13.5 (12) 1.94 (1.05,3.61) 
2–6 34 11.8 (4) 0.40 (0.16,1.01) 44.1 (15) 26.5 (9) 0.91 (0.52,1.61) 17.6 (6) 2.00 (0.92,4.36) 
Trend    0.68 (0.51,0.93)*     0.98 (0.78,1.22)   1.43 (1.03,2.00)* 
Pre-disability                
No 384 32.0 (123)   36.2 (139) 23.7 (91) 1.00  8.1 (31) 1.00  
Yes 30 13.3 (4) 0.74 (0.29,1.88) 26.0 (6) 43.3 (13) 1.24 (0.80,1.91) 23.3 (7) 1.70 (0.86, 3.35) 
Type of stroke                
IS 313 31.9 (100) 1.00  34.8 (109) 24.3 (76) 1.00  8.9 (28) 1.00  
ICH 101 26.7 (27) 0.67 (0.48,0.92)* 35.6 (36) 27.7 (28) 1.42 (1.03,1.96)* 9.9 (10) 1.36 (0.73,2.52) 
Impairment §¶                
Not severe 221 47.1 (104) 1.00  36.7 (81) 13.6 (30) 1.00  2.7 (6) 1.00  
Severe  178 11.2 (20) 0.29 (0.19,0.45)*** 33.7 (60) 38.8 (69) 2.35 (1.58,3.49)*** 16.3 (29) 4.29 (1.77,10.4)*** 
Disability §¶#                   
Least severe 46 58.7% (27)  
1.00 
 41.3 (19) 0.0 (0)  
1.00 
 0.0 (0)  
1.00 
 
Intermediate 156 43.8% (71)   34.6 (56) 19.1 (31)   2.5 (4)   
More severe   201 14.4% (29)  0.40 (0.25,0.52)*** 33.8 (68) 35.8 (72)  1.98 (1.35,2.90)*** 15.9 (32)  6.03 (2.14, 17.0)** 
* denotes p<0.05; ** denotes p<0.01; *** denotes p<0.001; 
† RR(95%CI) = relative risk (95% confidence interval), adjusted for age and sex, but estimates for age adjusted for sex only and estimates for sex adjusted for age only; 
.§ During initial hospital visit;.¶ NIHSS >7 (severe) compared with NIHSS≤7 (not severe);.# Least severe (mRS = 0/1), Intermediate (mRS=2/3), More severe (mRS=4/5). 
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With the mRS scores (including death) at three months collapsed optimally to four groupings 
(see Methods), risk of least disability (mRS=0/1) was markedly lower for older patients and 
women (Table 4.3) and, adjusted for age and sex, for those with more comorbidities or ICH.  
Risk of most severe disability (mRS=4/5) were elevated among older patients and those with 
ICH. Risk of having died was greater for older patients and those with co-morbidity or pre-
stroke disability. The increased risks of most severe disability (RR 1.36, 95% CI 0.98, 1.80) 
and of death (RR 1.72, 95% CI 0.93, 3.20) for women were substantially reduced by 
adjustment for age.  
Association of these outcomes with education, tobacco smoking, socio-demographic factors, 
alcohol consumption and clinical factors were inconsistent and none was statistically 
significant (see Table A4.2, Appendix 4). 
Table 4.4 shows the estimates of relative risk additionally adjusted for severity of disability at 
admission. When conditioned on baseline severity in this way, the estimates represent relative 
risks of attaining (changing to) each mRS category during the 3 month period.  
The factors predictive of attaining each category during the three months (Table 4.4) were the 
same factors that were associated with elevated risk of each category at three months (Table 
4.3), and the relative risk estimates for factors other than pre-disability and baseline 
impairment were generally similar. In regression analyses of change in the mRS scores 
between baseline and three months (mRS at three months less mRS at baseline) conducted to 
allow comparison of results with published data, the same predictors of change were 
identified (see Table A4.4). 
 On average, functional status improved by 0.5 points (SD 1.6). The greatest improvements 
were experienced by patients less than 65 years of age for whom the average sex-adjusted 
improvement was 1.1 (95% confidence interval 0.9, 1.3) points, and particularly those 
younger than 45 years for whom the average improvement was 1.5 (95% CI 1.1, 2.0) points. 
There were statistically significant but smaller differences between subjects classified by sex 
(adjusted for age) and number of co-morbidities and pre-stroke disability (adjusted for age 
and sex). 
Among patients who had assessment of functional status at baseline and at three months 
(Figure 4.3), 50.0% (204/409) had improved over the three months with recovery relatively 
less common [17.4% (8/46)] among those with no significant disability (mRS=1) at 
admission, 23.5% (96/409) had the same functional status, and 26.7% (100/409) had 
deteriorated with 15.2% (28/181) of those with moderately severe disability (mRS=4) and 
23.5% (4/17) of those with severe disability (mRS=5) at baseline having died during follow-
up. 
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Table 4.4: Risk and relative risk of disability, and of death, at three months following first-ever stroke in Ho Chi Minh City, Viet Nam, 
with conditioning on disability at baseline. 
   Least severe 
(mRS = 0/1) 
  Intermediate 
(mRS = 2/3) 
  Most severe 
(mRS=4/5) 
  Death 
(mRS = 6) 
 
 N % (n) RR (95%CI) † % (n) % (n) RR (95%CI) † % (n) RR (95%CI) † 
Age group                
< 45 years 40 50.0 (20) 1.00  37.5 (15) 5.0 (2) 1.00  7.5 (3) 1.00  
45–54 years 95 44.2 (42) 0.65 (0.50,0.85)** 36.8 (35) 15.8 (15) 3.77 (0.92,15.45) 3.2 (3) 0.75 (0.16,3.46) 
55–64 years 101 36.6 (37) 0.62 (0.47,0.83)** 42.6 (43) 16.8 (17) 3.50 (0.86,14.21) 4.0 (4) 0.90 (0.25,3.25) 
65–74 years 82 18.3 (15) 0.40 (0.25,0.64)*** 31.7 (26) 41.5 (34) 7.85 (2.03,30.40)** 8.5 (7) 1.13 (0.31,4.15) 
75+ years 96 13.5 (13) 0.34 (0.20,0.58)*** 27.1 (26) 37.5 (36) 6.16 (1.58,24.0)** 21.9 (21) 2.48 (0.86,7.60) 
Trend    0.78 (0.70,0.86)***     1.32 (1.16,1.51)***   1.45 (1.11,1.89)** 
Sex                
Male 219 38.4 (84) 1.00  33.3 (73) 21.5 (47) 1.00  6.8 (15) 1.00  
Female 195 22.1 (43) 0.69 (0.53,0.90)** 36.9 (72) 29.2 (57) 1.20 (0.89,1.61) 11.8 (23) 1.04 (0.59,1.84) 
Co-morbidities                
None 291 35.7 (104) 1.00  33.7 (98) 23.7 (69) 1.00  6.9 (20) 1.00  
1  89 21.3 (19) 0.76 (0.52,1.17) 36.0 (32) 29.2 (26) 0.99 (0.71,1.39) 13.5 (12) 1.54 (0.90,2.65) 
2–6 34 11.8 (4) 0.43 (0.17,1.05) 44.1 (15) 26.5 (9) 0.89 (0.51,1.54) 17.6 (6) 3.32 (1.25,8.82) 
Trend    0.71 (0.53,0.95)*     0.96 (0.76,1.20)   1.69 (1.03,2.00)* 
Pre-disability                
   No 384 32.0 (123)   36.2 (139) 23.7 (91) 1.00  8.1 (31) 1.00  
   Yes 30 13.3 (4) 0.73 (0.30, 1.77) 20.0 (6) 43.3 (13) 1.03 (0.67,1.60) 23.3 (7) 8.24 (2.19,31.02) 
Type of stroke                
IS 313 31.9 (100) 1.00  34.8 (109) 24.3 (76) 1.00  8.9 (28) 1.00  
ICH 101 26.7 (27) 0.88 (0.63,1.22)* 35.6 (36) 27.7 (28) 1.36 (0.98,1.87) 9.9 (10) 0.76 (0.39,1.50) 
Impairment §¶                
Not severe 221 47.1 (104) 1.00  36.7 (81) 13.6 (30) 1.00  2.7 (6) 1.00  
Severe  178 11.2 (20) 0.40 (0.25,0.66)*** 33.7 (60) 38.8 (69) 1.86 (1.19,2.91)** 16.3 (29) 1.68 (0.61,4.60) 
* denotes p<0.05, ** denotes p<0.01, *** denotes p<0.001,  
† RR(95%CI) = relative risk (95% confidence interval), adjusted for age, sex and mRS category at admission, but estimates for age adjusted for sex and mRS category only, 
and estimates for sex adjusted for age and modified Rankin Scale category only, ‡ No test of trend is provided because no a priori ranking order exists. A likelihood ratio 
test of the three binary covariates yielded p=0.83  
§ During initial hospital visit, ¶ NIHSS >7 (severe) compared with NIHSS≤7 (not severe). 
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Figure 4.3: Distribution of disability assessed by mRS at admission and at 3 
month post stroke. 
 
4.5. Discussion 
In this cohort of consecutive first-ever stroke patients admitted to the stroke unit of a major 
teaching hospital in Ho Chi Minh City, one-third of survivors  had no significant disability 
(mRS=0/1) after three months, another one-third had slight or moderate disability (mRS=2/3), 
and the remaining one-third had most severe disability (mRS=4/5) or were dead. During the 
three months following stroke onset, one-half of surviving patients had reduced severity of 
disability, one quarter had remained unchanged, and the remaining one-quarter had worsened 
or had died.  
In relation to the distribution of functional status at three months assessed using the mRS, cut-
points mRS=1 [130,131] of mRS=2 [318] have been previously used to distinguish favourable 
outcomes from unfavourable outcomes among surviving patients.  The dichotomy at cut-point 
3 distinguishes independence from dependence in activities of daily living. In our study, 38.9 
% had mRS ≥ 3 and a further 9.2% of our cohort had died. The proportion of survivors with 
dependent outcomes (mRS ≥ 3) in our study (38.9%) was around the mid-point of the range 
(21-70%) of the proportion of survivors with dependent outcomes in the multicentre study in 
Western and Central Europe [319]. The proportion with dependent outcomes among survivors 
with IS was 37.4% in this study, higher than findings for survivors with IS in China (28.0%) 
[320] and South Korea (29.7%) [303]. 
mRS at 
admission 
mRS at three months 
Number of patients 
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In this study, however, the distribution of severity of disability of survivors at three months 
more naturally fell into three groups: a group with least severity disability (mRS=0/1), an 
intermediate group with slight or moderate disability (mRS=2/3) and a group with moderately 
severe or severe disability (mRS=4/5). Less severe disability was more common among 
younger patients (predominantly men) with IS whereas those with more severe disability 
tended to be compromised older persons with severe impairment or disability at admission. 
Greater age [159], increased severity of stroke and greater comorbidity [160]  have previously 
been found to be predictors of poor outcomes at three months, but the identification of a group 
of young men with IS at the least severe end of the spectrum of disability at three months has 
not been made previously. In contrast to previous studies [321], we found no evidence for an 
association between mRS and pre-stroke tobacco smoking, alcohol consumption [161,164] or 
lower socioeconomic status [165].  
The case-fatality in our study may be under-estimated due to under-ascertainment of cases 
with very severe stroke who either did not present to hospital or were discharged at the 
request of the family from the emergency department prior to admission to the stroke unit or 
from the stroke unit prior to registration for this study. The cultural beliefs in Viet Nam that 
would prompt patients with a poor prognosis to not present to hospital or to seek early 
discharge, in order to have the end of their lives at home among family members, have been 
documented by others [107]. Under conservative assumptions about their mortality outcomes, 
our case-fatality estimates would be higher (12.5% for 28-day mortality and 16.0% for three-
month mortality). They would then be more similar to the findings of our previous hospital-
based surveillance [322] (12.2% among patients with known vital status at 28 days post-
stroke), to estimates of 28-day case fatality in LMICs ranging from 16.0% in Qatar [112] to 
34.0% in Malaysia [114], and  to estimates of three-month mortality in European multicentre 
studies ranging from 12.6% to 35.9% in Heuschmann et al. (2010) [159] and from 17.4% to 
55.9% in Wolfe et al. [319]. 
In relation to recovery, half of the patients in this study had improved functional status at 
three-months. The greatest improvements were experienced by younger patients, particularly 
among those less than 45 years of age for whom the average improvement was 1.5 points.  
Huybrechts et al. [323] reported that a shift of 1 point in mRS score at three months post-
stroke predicts long-term functional independence and mortality. In this study, patients 
without comorbidities or disability before stroke had statistically significant improvements in 
functional status that were less than 1 point on the mRS scale. These findings are consistent 
with those of other studies in respect of age [324], co-morbidities [325], and pre-stroke 
disability [159].  
Interestingly, women were 36% more likely to have severe disability at three months and 72% 
more likely to have died than men, but most of this elevation was due to their older age (mean 
age 65.6 years for women versus 59.6 years for men). When adjusted for age, the increases in 
risk were reduced to 10% for severe disability and 19% for death. The average recovery in 
functional status of women was significantly less than that of men when assessed as age-
adjusted change over three months in mRS, but the difference was less than one point. These 
findings are generally consistent with those of several other studies that have reported poorer 
outcomes for women in terms of survival and functional status [167,245].  
This study has several strengths. Firstly, the stroke patients were a consecutive series of 
patients from a specialist stroke unit with comprehensive clinical assessments made by stroke 
neurologists at admission and with complete imaging for confirmation of diagnosis. Secondly, 
there was follow-up of these patients over three months for clinical outcomes and with 
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functional status at three months assessed by well-trained research assistants who were 
general medical practitioners in Ho Chi Minh City. Thirdly, our low proportion of loss to 
follow-up (6.1% at three months compared to 23.4-29.8% for studies in HICs [159,160]) 
reduces concerns about bias. All data collection was standardised and well-controlled, 
limiting measurement error as far as possible and with minimal item non-response. Lastly, 
functional status was assessed on the mRS both at admission and follow-up, and analyses 
were conducted without unnecessary data reduction in the categories of functional status.  
However, our study has some limitations. At baseline, it is likely that we failed to fully 
ascertain cases at each end of the severity spectrum. Under-ascertainment of severe cases 
would explain our relatively low case fatality. Information on lifestyle risk factors and on co-
morbidities and pre-stroke disability were collected by self-report, and could be subject to 
random error or bias. Another limitation is the reliance on reports by caregivers of deaths 
among patients. This information may not be accurate, but more reliable sources of data were 
not available.  
 
4.6. Conclusion 
Case-fatality in this study was low, possibly due to cultural preferences for end-of-life care at 
home that may prevent severe cases of stroke of being admitted to the stroke unit. The 
dependency burden was relatively high, however, and this provides evidence of significant 
pressure on the healthcare system and society. 
 
4.7. Postscript 
Reported in this chapter was an investigation of case-fatality and functional outcomes at three 
months following stroke of a cohort of patients with first-ever stroke admitted to a Stroke 
Unit in a major teaching hospital in Ho Chi Minh City, Viet Nam. The next chapter will 
present findings on economic aspects of the burden of stroke on patients, their families, the 
healthcare system and society.
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Appendix 4: Additional reports on functional outcomes at three months 
after stroke  
 
Characteristics of patients 
Table A4.1 summarises socio-demographic characteristics of the participants and information 
on their pre-stroke comorbidity, tobacco smoking and alcohol consumption 
Table A4.1: Characteristics of a cohort of patients with first-ever stroke in Ho Chi Minh 
City, Viet Nam.* 
Characteristic  Men (N=230)   Women (N=211)  
Ethnicity †     
Vietnamese 91.7% (211) 91.5% (193) 
Chinese 8.2% (19) 8.6% (18) 
BMI †     
Mean (SD) 22.8 (3.2) 22.9 (4.0) 
Underweight (BMI < 18.5%) 9.6% (22) 12.8% (27) 
Normal (18.5% ≤ BMI <23.0%) 42.6% (98) 38.9% (82) 
Overweight (23.0% ≤ BMI < 27.5%) 39.6% (91) 37.0% (78) 
Obese (BMI≥ 27.5%) 8.2% (19) 10.9% (23) 
Marital status †     
Married 89.1% (205) 55.9% (118) 
Single 5.2% (12) 6.2% (13) 
Divorced 2.2% (5) 1.9% (4) 
Widowhood (widower/widow) 3.5% (8) 36.0% (76) 
Highest education level †     
No schooling 11.2% (24) 43.5% (83/191) 
Primary school 24.3% (52) 31.9% (61) 
Secondary school 25.2% (54) 15.7% (30) 
High school 24.8% (53) 6.8% (13) 
College/university 14.5% (31) 2.1% (4) 
Working status †     
Manual work 24.6% (56) 5.7% (12) 
Office work 19.7% (45) 16.6% (35) 
Home duties/retired 55.7% (127) 77.7% (164) 
Wealth index †     
1st quarter (richest) 25.9% (58) 23.0% (48) 
2nd quarter 23.2% (52) 21.5% (45) 
3rd quarter 27.7% (62) 23.9% (50) 
4th quarter (poorest) 23.2% (52) 31.6% (66) 
Living with spouse †     
Yes 76.8% (173) 37.0% (76) 
No – living with children 17.5% (177) 55.8% (177) 
No – living with others 5.7% (20) 7.2% (19) 
Tobacco smoking †     
Never smoker 24.3% (56) 94.8% (200) 
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Characteristic  Men (N=230)   Women (N=211)  
Former smoker 20.9% (48) 2.4% (5) 
Year smoked: mean(SD) 32.6 (12.7) 33.4 (18.2) 
Cigarettes/day: mean(SD) 16.1 (13.1) 14.4 (20.1) 
Pack-years: mean(SD) 28.2 (2.2) 19.3 (27.1) 
Current smoker 54.8% (126) 2.8% (6) 
Year smoked: mean(SD) 34.7 (12.0) 48.2 (15.8) 
Cigarettes/day: mean(SD) 13.2 (8.8) 14.4 (7.1) 
Pack-years: mean(SD) 24.2 (19.7) 36.3 (21.6) 
Alcohol consumption †     
Not last 12 months 29.1% (67) 99.5% (210) 
Not last 30 days 21.7% (50) 0.0% (0) 
Not last 7 days 16.1% (37) 0.0% (0) 
Last 7 days 33.0% (76) 0.5% (1) 
Last 12 months 70.9% (163) 99.5% (1) 
Days/month: mean (SD) 10.4 (10.5) 30 (n.a.) 
Drinks/occasion: mean (SD) ‡ 4.9 (4.6) 6.0 (n.a.) 
High blood pressure †     
No 48.3% (111) 33.6% (71) 
Yes, untreated 12.6% (29) 7.6% (16) 
Yes, treated 39.1% (90) 58.8% (124) 
Diabetes †     
No 87.4% (201) 84.4% (178) 
Yes, untreated 2.2% (5) 1.4% (3) 
Yes, treated 10.4% (24) 14.2% (30) 
Dementia †     
No 98.7% (14) 93.4% (197) 
Yes 1.3% (3) 6.6% (14) 
Heart disease †     
No 86.9% (206) 79.2% (167) 
Yes 10.4% (14) 20.8% (44) 
Lung disease †     
No 95.2% (220) 98.1% (207) 
Yes 4.8% (11) 1.9% (4) 
Kidney disease †     
No 95.7% (220) 94.8% (200) 
Yes 4.8% (11) 1.9% (4) 
Liver disease †     
No 95.7% (220) 94.8% (200) 
Yes 4.3% (10) 5.2% (11) 
Cancer †     
No 96.5% (222) 99.0% (209) 
Yes 3.5% (8) 1.0% (2) 
Pre-stroke disability †     
Yes 4.8% (11) 9.5% (20) 
No 95.2% (219) 90.5% (191) 
* The cohort consists of 450 patients, 9 of whom died in-hospital prior to commencement of follow-up. This 
information is provided for the 441 patients alive at discharge. 
† Patient self-report. 
‡ Number of standard drinks consumed on a typical drinking occasion. 
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Greater proportions of women than men were widowed and living with children. Around 
three times as many male patients as female patients had progressed beyond grade 5 of 
education. Three quarters of the women were involved in home duties only. Hypertension was 
self-reported by 48.5% (214/441) of participants, diabetes mellitus by 12.2% (54/441), 
dementia prior to stroke by 3.9% (17/441) and disability prior to stroke by 7.0% (31/441).  
Greater proportions of women than men were treated for hypertension, and there were slightly 
greater proportions of women treated for diabetes, dementia, or disability prior to stroke 
(Table A4.1). 
 
Risk and relative risk of functional status and of death at three months after stroke 
onset 
There were not significant elevations in estimated risk of least severe disability (mRS=0/1), 
most severe disability (mRS=4/5) or death (mRS=6) – the optimal groupings of mRS scores – 
for subjects classified by education level, tobacco smoking or pre-stroke disability (Table S2). 
However, the risk of least disability tended to be greatest and risk of death tended to be least 
among patients with more education, non-smokers, and those without pre-disability. The 
associations between mRS groupings and other socio-demographic factors (working status, 
living arrangements and household wealth), alcohol consumption and clinical factors (high 
blood pressure, dementia, delayed admission and individual comorbidities) were inconsistent 
and not statistically significant (Table A4.2). 
 
Change in functional status over the three months of follow-up 
Table A4.3 shows the estimates of relative risk additionally adjusted for severity of disability 
at admission. The factors predictive of attaining each category during the three months (Table 
A4. 3) were the same factors that were associated with elevated risk of each category at three 
months (Table A4.2), and the relative risk estimates were generally similar. 
On average, functional status improved by 0.5 (SD 1.6) points. Table A4.4 shows that the 
recovery was progressively lesser for older patients (adjusted for sex), smaller for women 
(adjusted for age), and least for those with pre-stroke disability and those with greater 
numbers of comorbidities (adjusted for sex and age). There were no significant associations 
between the change of severity of disability over three months of stroke first-stroke onset and 
other socio-demographic factors (education, working status, and wealth index), tobacco 
smoking, alcohol consumption and other health status prior stroke (Table A4.4). 
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Table A4.2: Risk and relative risk of disability at three months following onset of first-ever stroke, and of death following first-ever 
stroke, in Ho Chi Minh City, Viet Nam. 
   Least severe 
(mRS=0/1)   
Intermediate 
(mRS=2/3)   
Most severe 
(mRS=4/5)   
Death 
(mRS = 6) 
 
 N % (n) RR (95%CI) * % (n) % (n) RR (95%CI) * % (n) RR (95%CI) * 
Weight status 
 
              
Underweight 47 21.3 (10) 1.00  31.9 (15) 27.7 (13) 1.00  19.1 (9) 1.00  
Normal 170 30.6 (52) 1.19 (0.69,2.03) 32.9 (56) 26.5 (45) 1.14 (0.70,1.85) 10.0 (17) 0.70 (0.35,1.40) 
Overweight 157 34.4 (54) 1.29 (0.75,2.23) 37.6 (59) 21.7 (34) 0.95 (0.56,1.62) 6.4 (10) 0.60 (0.26,1.37) 
Obese 39 25.6 (10) 1.10 (0.54,2.26) 38.5 (15) 30.8 (12) 1.27 (0.68,2.33) 5.1 (2) 0.40 (0.10,2.14) 
Trend    1.05 (0.89,1.23)     1.02 (0.84,1.23)   0.77 (0.54,1.09) 
Education 
 
              
No schooling 134 17.9 (24) 1.00  34.3 (46) 30.6 (41) 1.00  17.2 (23) 1.00  
Primary school 104 29.8 (31) 1.21 (0.76,1.94) 39.4 (41) 24.0 (25) 1.07 (0.72,1.60) 6.7 (7) 0.50 (0.21,1.19) 
Secondary school 79 39.2 (31) 1.41 (0.89,2.24) 32.9 (26) 22.8 (18) 1.27 (0.75,2.17) 5.1 (4) 0.51 (0.16,1.60) 
High school 63 39.7 (25) 1.30 (0.79, 2.12) 34.9 (22) 20.6 (13) 1.24 (0.68, 2.78) 4.8 (3) 0.51 (0.13, 1.96) 
College/ university 34 47.1 (16) 1.96 (1.21, 3.19)* 29.4 (10) 20.6 (7) 0.85 (0.41, 1.75) 2.9 (1) 0.26 (0, 1.96) 
Trend    1.13 (1.02, 1.27)*     1.00 (0.87, 1.15)   0.74 (0.53, 1.05) 
Working status  
 
              
Manual work 70 47.1 (33) 1.00  37.1 (26) 12.9 (9) 1.00  2.9 (2) 1.00  
Office work 74 47.3 (35) 1.14 (0.81,1.62) 35.1 (26) 13.5 (10) 1.01 (0.44,2.31) 4.1 (3) 1.22 (0.21,7.09) 
At home/retired 268 21.6 (58) 0.84 (0.55,1.28) 34.3 (92) 31.7 (85) 1.17 (0.52,2.63) 12.3 (33) 2.27 (0.41,12.7) 
Living with spouse 
 
              
Yes 240 36.7 (88) 1.00  37.1 (89) 21.3 (51) 1.00  5.0 (12) 1.00  
No, with children 146 20.5 (30) 1.13 (0.78,1.65) 30.1 (44) 33.6 (49) 0.87 (0.60,1.25) 15.8 (23) 1.82 (0.81,4.08) 
No, with others 24 33.3 (8) 0.91 (0.54,1.56) 41.7 (10) 16.7 (4) 0.84 (0.35,2.00) 8.3 (2) 1.69 (0.43,6.74) 
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   Least severe   Intermediate   Most severe   Death  
 N % (n) RR (95%CI) * % (n) % (n) RR (95%CI) * % (n) RR (95%CI) * 
Wealth index 
 
              
1st qu. (richest) 102 36.3 (37) 1.00  30.4 (31) 23.5 (24) 1.00  9.8 (10) 1.00  
2nd quarter 89 22.5 (20) 0.57 (0.37,0.85) 43.8 (39) 24.7 (22) 1.17 (0.74,1.86) 9.0 (89) 1.09 (0.48,2.47) 
3rd quarter 104 32.7 (34) 0.80 (0.59,1.08) 28.8 (30) 31.7 (33) 1.53 (1.03,2.27) 6.7 (7) 0.82 (0.35,1.96) 
4th qu. (poorest) 111 31.5 (35) 0.83 (0.62,1.11) 36.9 (41) 20.7 (23) 0.92 (0.58,1.47) 10.8 (12) 1.15 (0.55,2.42) 
Trend    0.96 (0.86,1.08)     1.00 (0.88,1.14)   1.02 (0.8,1.29) 
Tobacco 
 
              
Never smoker 241 26.1 (63) 1.00  36.1 (87) 27.8 (67) 1.00  10.0 (24) 1.00  
Former smoker 48 27.1 (13) 0.94 (0.57,1.55) 29.2 (14) 29.2 (14) 0.98 (0.58,1.65) 14.6 (7) 1.65 (0.70,3.93) 
Current smoker 124 40.3 (50) 0.98 (0.69,1.37) 35.5 (44) 18.5 (23) 0.93 (0.54,1.59) 5.6 (7) 1.40 (0.47,4.17) 
Trend    0.99 (0.83,1.17)     0.97 (0.74,1.26)   1.22 (0.72,2.08) 
Alcohol consumed 
 
              
Not last year 258 24.0 (62) 1.00  35.7 (92) 29.1 (75) 1.00  11.2 (29) 1.00  
Not last 30 days 46 30.4 (14) 0.89 (0.52,1.51) 50.0 (23) 15.2 (7) 0.60 (0.28,1.26) 4.4 (2) 0.61 (0.14,2.73) 
Not last 7 days 35 57.1 (20) 1.48 (0.95,2.29) 17.1 (6) 14.3 (5) 0.74 (0.33,1.65) 11.4 (4) 2.05 (0.57,7.34) 
In last 7 days 75 41.3 (31) 1.06 (0.7,1.63) 32.0 (24) 22.7 (17) 1.11 (0.67,1.85) 4.0 (3) 0.73 (0.2,2.68) 
Trend    1.11 (0.98,1.26)     1.05 (0.87,1.27)   0.95 (0.64,1.43) 
HBP (self-report)                
 No 216 34.7 (75) 1.00  32.9 (71) 24.1 (52) 1.00  8.3 (18) 1.00  
 Yes 198 26.3 (52) 0.99 (0.74,1.32) 37.4 (74) 26.3 (52) 0.91 (0.67,1.23) 10.1 (20) 0.94 (0.54,1.65) 
Delayed admission 
               
No 305 30.2 (92) 1.00  34.8 (106) 25.9 (79) 1.00  9.2 (28) 1.00  
Yes 109 32.1 (35) 1.15 (0.87,1.52) 35.8 (39) 22.9 (25) 0.82 (0.57,1.19) 9.2 (10) 0.91 (0.47,1.73) 
High cholesterol 
               
No 122 32.0 (39) 1.0  32.8 (40) 23.8 (29) 1.0  11.5 (14) 1.0  
Yes 291 30.2 (88) 1.02 (0.77, 1.34) 36.1 (105) 25.8 (75) 1.0 (0.72, 1.41) 7.9 (23) 0.61 (0.35, 1.08) 
* RR(95%CI) = relative risk (95% confidence interval) adjusted for age and sex. 
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Table A4.3: Risk and relative risk of disability at three months following onset of first-ever stroke, and of death following first-ever 
stroke, in Ho Chi Minh City, Viet Nam, with conditioning on disability at baseline.  
   Least severe 
(mRS=0/1)   
Intermediate 
(mRS=2/3)   
Most severe 
(mRS=4/5)   
Death 
(mRS = 6) 
 
 N % (n) RR (95%CI) † % (n) % (n) RR (95%CI) † % (n) RR (95%CI) † 
Weight status 
 
              
Underweight 47 21.3 (10) 1.00  31.9 (15) 27.7 (13) 1.00  19.1 (9) 1.00  
Normal 170 30.6 (52) 1.09 (0.68,1.75) 32.9 (56) 26.5 (45) 1.20 (0.75,1.92) 10.0 (17) 1.00 (0.50,1.99) 
Overweight 157 34.4 (54) 1.13 (0.71,1.82) 37.6 (59) 21.7 (34) 0.98 (0.59,1.62) 6.4 (10) 0.77 (0.34,1.76) 
Obese 39 25.6 (10) 0.43 (0.21,0.89)* 38.5 (15) 30.8 (12) 1.70 (0.95,3.04) 5.1 (2) 0.69 (0.18,2.72) 
Trend    0.90 (0.77,1.04)     1.07 (0.90,1.29)   0.87 (0.64,1.19) 
Education  
              
No schooling 134 17.9 (24) 1.00  34.3 (46) 30.6 (41) 1.00  17.2 (23) 1.00  
Primary school 104 29.8 (31) 1.00 (0.62,1.62) 39.4 (41) 24.0 (25) 1.08 (0.74,1.57) 6.7 (7) 0.58 (0.27,1.26) 
Secondary school 79 39.2 (31) 1.43 (0.94,2.16) 32.9 (26) 22.8 (18) 1.33 (0.83,2.16) 5.1 (4) 0.45 (0.12,1.63) 
High school  39.7 (25) 1.34 (0.85, 2.10) 34.9 (22) 20.6 (13) 1.20 (0.68, 2.14) 4.8 (3) 0.54 (0.14, 2.07) 
College/ university  47.1 (16) 2.20 (1.35, 3.57)** 29.4 (10) 20.6 (7) 0.77 (0.37, 1.57) 2.9 (1) 0.28 (0, 2.03) 
Trend    1.19 (1.07, 1.33)**     0.98 (0.86, 1.12)   0.75 (0.54, 1.04) 
Working status ‡  
 
              
Manual work 70 47.1 (33) 1.00  37.1 (26) 12.9 (9) 1.00  2.9 (2) 1.00  
Office work 74 47.3 (35) 0.95 (0.68,1.32) 35.1 (26) 13.5 (10) 1.15 (0.53,2.50) 4.1 (3) 1.60 (0.28,9.13) 
At home/retired 268 21.6 (58) 0.77 (0.53,1.11) 34.3 (92) 31.7 (85) 1.14 (0.53,2.44) 12.3 (33) 2.48 (0.45,13.6) 
Living with spouse 
 
              
Yes 240 36.7 (88) 1.00  37.1 (89) 21.3 (51) 1.00  5.0 (12) 1.00  
No, with children 146 20.5 (30) 1.13 (0.79,1.62) 30.1 (44) 33.6 (49) 0.83 (0.59,1.17) 15.8 (23) 1.89 (0.83,4.32) 
No, with others 24 33.3 (8) 1.06 (0.64,1.74) 41.7 (10) 16.7 (4) 0.75 (0.31,1.79) 8.3 (2) 0.98 (0.15,6.60) 
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   Least severe   Intermediate(   Most severe   Death  
 N % (n) RR (95%CI) † % (n) % (n) RR (95%CI) † % (n) RR (95%CI) † 
Wealth index 
 
              
1st qu. (richest) 102 36.3 (37) 1.00  30.4% (31) 23.5 (24) 1.00  9.8 (10) 1.00  
2nd quarter 89 22.5 (20) 0.51 (0.35,0.76)** 43.8% (39) 24.7 (22) 1.14 (0.74,1.74) 9.0 (89) 0.88 (0.40,1.96) 
3rd quarter 104 32.7 (34) 0.62 (0.46,0.84)** 28.8% (30) 31.7 (33) 1.83 (1.23,2.73) 6.7 (7) 1.00 (0.42,2.37) 
4th quarter 111 31.5 (35) 0.72 (0.54,0.95)* 36.9% (41) 20.7 (23) 0.95 (0.61,1.48) 10.8 (12) 1.16 (0.58,2.33) 
Trend    0.94 (0.84,1.06)     1.02 (0.90,1.15)   1.03 (0.82,1.30) 
Tobacco 
 
              
Never smoker 241 26.1 (63) 1.00  36.1 (87) 27.8 (67) 1.00  10.0 (24) 1.00  
Former smoker 48 27.1 (13) 1.17 (0.76,1.81) 29.2 (14) 29.2 (14) 0.86 (0.49,1.51) 14.6 (7) 2.22 (0.66,7.49) 
Current smoker 124 40.3 (50) 1.00 (0.73,1.36) 35.5 (44) 18.5 (23) 0.87 (0.51,1.49) 5.6 (7) 1.82 (0.52,6.35) 
Trend    0.99 (0.86,1.15)     0.94 (0.73,1.22)   1.24 (0.72,2.14) 
Alcohol consumed 
 
              
Not last year 258 24.0 (62) 1.00  35.7 (92) 29.1 (75) 1.00  11.2 (29) 1.00  
Not last 30 days 46 30.4 (14) 1.01 (0.62,1.66) 50.0 (23) 15.2 (7) 0.62 (0.30,1.27) 4.4 (2) 0.22 (0.04,1.06) 
Not last 7 days 35 57.1 (20) 1.56 (1.00,2.40)* 17.1 (6) 14.3 (5) 0.93 (0.40,1.15) 11.4 (4) 3.57 (0.73,18.09) 
In last 7 days 75 41.3 (31) 1.30 (0.84,2.02) 32.0 (24) 22.7 (17) 0.96 (0.59,1.55) 4.0 (3) 0.27 (0.07,1.07) 
Trend    1.11 (0.97,1.27)     0.99 (0.82,1.19)   0.79 (0.51,1.25) 
HBP (self-report)                
No 216 34.7 (75) 1.00  32.9 (71) 24.1 (52) 1.00  8.3 (18) 1.00  
Yes 198 26.3 (52) 0.93 (0.73,1.20) 37.4 (74) 26.3 (52) 1.00 (0.75,1.34) 10.1 (20) 1.08 (0.63,1.83) 
Delayed admission                
No 305 30.2 (92) 1.00  34.8 (106) 25.9 (79) 1.00  9.2 (28) 1.00  
Yes 109 32.1 (35) 1.10 (0.85,1.42) 35.8 (39) 22.9 (25) 0.86 (0.60,1.23) 9.2 (10) 1.08 (0.56,2.07) 
Hypercholesterol 
               
No 122 32.0 (39) 1.0  32.8 (40) 23.8 (29) 1.0  11.5 (14) 1.0  
Yes 291 30.2 (88) 0.93 (0.73, 1.17) 36.1 (105) 25.8 (75) 1.11 (0.80, 1.55) 7.9 (23) 0.73 (0.41, 1.28) 
* denotes p<0.05, ** denotes p<0.01, *** denotes p<0.001. 
† RR(95%CI) = relative risk (95% confidence interval) adjusted for age, sex and modified Rankin Scale category at admission. 
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Table A4.4: Recovery of functional status over the three months of follow-up assessed in 
terms of change in functional status (mRS) scores. 
Characteristic N Mean (SD) Diff (95% CI)† 
All patients 409 –0.50 (1.55)   
Age group      
< 45years 39 –1.41 (1.46) ref  
45–54years 95 –0.85 (1.43) 0.54 (0,1.08)* 
55–64years 99 –0.84 (1.46) 0.55 (0,1.08)* 
65–74years 80 –0.10 (1.46) 1.27 (0.71,1.82)*** 
75+years 96 0.24 (1.47) 1.51 (0.96,2.06)*** 
Trend    0.37 (0.26,0.48)*** 
Sex      
Male 217 –0.78 (1.56) ref  
Female 192 –0.18 (1.48) 0.37 (0.08,0.66)* 
Education      
No schooling 133 –0.06 (1.56) ref  
Primary school 102 –0.57 (1.50) –0.25 (–0.63,0.13) 
Secondary school 78 –0.76 (1.57) –0.18 (–0.62,0.25) 
High school 96 –0.73 (1.51) –0.10 (–0.57,0.38) 
College/university    -0.39 (-0.97, 0.19) 
Trend    –0.06 (–0.18,0.06) 
Working status      
Manual work 70 –1.04 (1.47) ref  
Office work 73 –1.05 (1.46) –0.12 (–0.60,0.36) 
At home/retired 264 –0.19 (1.51) 0.10 (–0.35,0.56) 
    P = 0.58‡ 
Living with spouse      
Yes 143 –0.79 (1.53) ref  
No, with children 22 0.01 (1.43) 0.17 (–0.20,0.54) 
No, with others 4 –1.0 (1.41) –0.31 (–0.94,0.32) 
    P = 0.86‡ 
Wealth index      
1st qu. (richest) 104 –0.66 (1.44) ref  
2nd quarter 81 –0.27 (1.58) 0.38 (–0.04,0.80) 
3rd quarter 104 –0.49 (1.63) 0.24 (–0.16,0.63) 
4th quarter 109 –0.53 (1.58) 0.14 (–0.25,0.53) 
Trend    0.03 (–0.09,0.16) 
Tobacco smoking      
Never smoker 236 –0.34 (1.48) ref  
Former smoker 46 –0.39 (1.91) 0.14 (–0.40,0.68) 
Current smoker 123 –0.87 (1.50) 0.07 (–0.36,0.51) 
Trend    0.03 (–0.19,0.25) 
Alcohol consumed      
Not last year 256 –0.25 (1.53) ref  
Not last 30 days 45 –0.76 (1.42) –0.19 (–0.74,0.36) 
Not last 7 days 34 –0.71 (1.62) –0.07 (–0.54,0.67) 
In last 7 days 75 –1.09 (1.50) –0.35 (–0.84,0.13) 
Trend    –0.10 (–0.26,0.06) 
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Characteristic N Mean (SD) Diff (95% CI)† 
HBP (self–report)      
No 215 –0.6 (1.55) ref  
Yes 194 –0.39 (1.55) –0.06 (–0.34,0.23) 
Comorbidity      
0 288 -0.66 (1.53) ref  
1 88 -0.15 (1.54) 0.34 (0, 0.68) 
2+  33 -0.06 (1.54) 0.41 (-0.11, 0.93) 
Trend    0.25 (0.03, 0.47)* 
Pre-stroke disability      
No 379 –0.56 (1.54) ref  
Yes 30 0.33 (1.42) 0.54 (0, 1.08)* 
Delayed admission      
No 301 –0.52 (1.59) ref  
Yes 108 –0.44 (1.45) –0.11 (–0.43,0.21) 
Type of stroke      
IS 312 –0.45 (1.56) ref  
ICH 97 –0.66 (1.50) 0.05 (–0.28,0.39) 
* denotes p<0.05, ** denotes p<0.01, *** denotes p<0.001. 
† Adjusted for age and sex but estimates for age adjusted for sex only and estimates for sex adjusted for age only. 
‡ Indicates p-value for differences 
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Chapter 5: Costs of first-ever stroke in Viet Nam 
 
5.1. Preface 
 
The previous chapters provided on the occurrence and clinical presentation of stroke and 
outcomes at three months after stroke onset in Viet Nam. Although early and three-month 
case-fatalities may be underestimated, the burden of stroke in Viet Nam seems to be 
substantial due to the severity of stroke at hospital admission and the severity of functional 
outcomes at three months. In this chapter, the burden of stroke is investigated in terms of its 
economic aspects. The data presented in this chapter were collected, during the period of 
hospitalisation of first-ever stroke patients in the cohort from electronic records of the hospital 
administration system and from patient interview. The text that follows in this Chapter and 
the Appendix 5 has been prepared for submission in consideration of publication in the Value 
in Health journal. 
 
5.2. Introduction 
 
Stroke was the second most common cause of death and the third most common cause of 
disability-adjusted life-years (DALYs) worldwide in 2010 [309]. The economic burden of 
stroke includes direct (medical and non-medical) and indirect (lost productivity or loss of 
income and caregiver burden) costs. These costs are specific to, and need to be estimated 
separately for, each country due to differences in hospital diagnostic procedures, treatment 
regimens and the costs assigned for resource use between countries [326,327]. 
The data describing the cost of stroke in low and middle income countries (LMICs) are 
limited [257]. In addition, most studies of the costs of stroke in LMICs have focused on direct 
costs without estimation of indirect costs. This is a major shortcoming for health system 
planning, because the burden of stroke has been estimated to be greater in LMICs than that in 
HICs due to higher incidence, prevalence, disability and case fatality in such countries [2]. 
Information on the cost of stroke is critical to assist policy makers in planning and prioritising 
the delivery of stroke care.   
Viet Nam is a LMIC in south-east Asia that is undergoing epidemiological transition. Similar 
to other LMICs [27], stroke in Viet Nam occurs at younger ages [322] than in HICs. 
Currently, there are fewer than 10 stroke units in all of Viet Nam with a population of more 
than 80 million [293].. While we know that stroke severity is greater in Viet Nam than in 
other LMICs [12,28], there has been no study of the costs of stroke in Viet Nam.  
The aims of this study were to estimate the societal costs of stroke, including direct medical 
costs of treatment and the associated direct non-medical and indirect costs incurred during 
hospitalisation in a stroke unit at a tertiary teaching hospital in Ho Chi Minh City. 
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5.3. Methods 
 
Subjects 
This cohort study was conducted in the stroke unit (Cerebrovascular Disease Department) of 
115 People’s Hospital, a major teaching hospital in Ho Chi Minh City, Viet Nam. Subject 
recruitment commenced on 1st June 2012 and continued until the targeted number of 10th 
September 2012. The study inclusion criteria were first-ever ischaemic or haemorrhagic 
stroke confirmed by a neurologist, age≥ 16 years, living in Ho Chi Minh City, occurrence 
within 7 days prior to admission, completion of acute stroke treatment in the stroke unit, and 
information available on direct medical costs of stroke treatment from hospital administration 
records.  
 
Data collection 
Clinical information was determined by a neurologist in the stroke unit on type of stroke, 
severity of impairment assessed on the National Institute Health Stroke Scale (NIHSS) [115] 
and severity of disability assessed on the modified Rankin Scale (mRS) [328]. Patients or 
their main caregivers were interviewed by research assistants to collect data on socio-
demographic factors (marital status, education, occupation, working status), health insurance, 
economic status (household assets, monthly income per household, monthly expenditure per 
household), lifestyle risk factors (tobacco smoking, alcohol consumption) and health status 
before stroke (disability, co-morbidities including hypertension, diabetes, heart disease, 
chronic lung disease, chronic liver disease, chronic renal disease, cancer).  
The bottom-up method [256] was used to estimate the costs of stroke. Medical cost data were 
extracted from electronic records of the hospital administration system. Data were classified 
into 9 categories (medication, laboratory tests, diagnostic imaging, consultant fees, bed-day 
fees, rehabilitation including physiotherapy and minor operations and procedures, medical 
consumables, special meals and feeding, other fees) for analysis. Direct non-medical costs 
included costs of in-hospital food for patients and caregivers, transportation costs from home 
to hospital and return for caregivers, and other sundry expenses. These costs were collected 
by daily interviews of patients or their caregivers. The indirect costs included loss of income 
of patients and caregivers during the period of treatment in the hospital. It was estimated as 
the product of income foregone per day by patients and caregivers, and the length of stay in 
the hospital. This cost was zero for patients and caregivers who were retired, in unpaid work 
or unemployed. The total costs of stroke treatment in a stroke unit in this study were the sum 
of direct medical cost, direct non-medical cost and indirect cost. The source of money used in 
payment of costs was determined by interviewing the patients or caregivers. 
 
Data analysis 
Severity of stroke assessed on the NIHSS with 42 as maximum was categorized into two 
groups as severe stroke (NIHSS > 7) and non-severe stroke (NIHSS ≤ 7) [329]. Disability 
assessed on the mRS with 5 as maximum for survivors was grouped into 3 categories of least 
severe (mRS=0/1), intermediate (mRS=2/3) and more severe (mRS=4/5). Socio-economic 
status was assessed from the holdings in the household of each patient of assets included in 
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the list of 2010 for Ho Chi Minh City published by the General Statistics Office of Viet Nam. 
A weighted sum of the assets held was calculated, with weights derived from the regression 
coefficient for each asset from the linear regression of household expenditure on binary 
(0=asset not held / 1=asset held) predictors for each asset in the list. Unit costs were converted 
from Vietnamese currency (Viet Nam Dong, VND) to US dollars using the general 
purchasing power parities (PPPs) index. This index measures the purchasing power of 
different national currencies, and is recommended for comparing costs across countries 
[326,330]. 
Summary values of continuous data are presented as median and interquartile range (IQR) 
and/or as mean and standard deviation (SD). Linear regression methods were used to compare 
means after transformation (e.g. by taking logarithms) of the right-skewed cost data.  
Summary values of categorical data are presented as percentages. Poisson regression with 
robust standard errors [331] and log multinomial regression [312] were used to estimate 
relative risk for binary and multinomial outcome data respectively. Confounding was assessed 
by the 10% change-in-parameter-estimate method [332]. Statistical interaction was assessed 
from the coefficient and standard error of the covariate formed as the product of the covariates 
for the study factor and the potential mediator, or by multivariate tests of multiple product 
terms. The fit of each final model was carefully assessed, and covariates were rescaled where 
necessary to improve fit. All statistical tests were two-sided with a 5% allowance for type I 
error. 
 
5.4. Results 
 
Characteristics of patients 
Four hundred and fifty patients were ascertained from records of 960 admissions to the stroke 
unit from 1 June 2012 until 10 September 2012. We excluded 322 recurrent cases of stroke, 
and 58 persons with severe conditions who were discharged to home at the request of the 
family (probable deaths). Clinical records were unavailable for these severely-affected 
patients. After 9 deaths prior to enrolment, and exclusion of 4 cases without comprehensive 
information on direct medical costs, 437 patients provided data on hospital treatment costs. 
Characteristics of the 437 patient participants in this cohort study are summarised in Table 
5.1. They comprised 52.4% (229/437) males. The mean age was 62.4 years (IQR 52-74 years) 
for all patients. Around three times as many male patients as female patients had proceeded 
beyond primary school. Three quarters of the women were involved in home duties or had 
retired. Greater proportions of female patients than of male patients were widowed and living 
with children (Table A5.1 in Appendix 5). The most common age groups were 45-64 years 
for men, and at 55-64 years for females.  
Ischaemic stroke accounted for 76.0% (332/437) of the cases and was slightly more common 
among females than among males. Severity of impairment at admission assessed by mean 
NIHSS score was 8.2 (SD 5.8). The median NIHSS score was 6.0 (IQR 4-12). Female 
patients had greater severity of impairment at admission than male patients.  
Regarding functional status at admission, the mean mRS score was 3.2 (SD 1.1; median 3.0, 
IQR 3-4). There were only minor differences by sex in these clinical characteristics (Table 
5.1). Overall, 53.8% of patients (54.6% for male patients and 52.9% for female patients) had 
health insurance that provided co-payment for hospital costs, and 21.7% of patients had at 
least one comorbidity (Table 5.1).  
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Table 5.1: Characteristics of participants in the follow-up study of stroke patients 
admitted to 115 Hospital in Ho Chi Minh City, Viet Nam. 
 Men (N=229) Women (N=208) 
Age     
Mean (SD*) 59.5 (12.8) 65.8 (14.5) 
Median (IQR†) 58 (50–69) 68 (55–77) 
< 45 years 11.8% (27/229) 7.2% (15/208) 
45–54 years 26.6% (61/229) 17.3% (36/208) 
55–64 years 26.6% (61/229) 21.6% (45/208) 
65–74 years 21.8% (50/229) 18.8% (39/208) 
75+ years 13.1% (30/229) 35.1% (73/208) 
Highest education level‡     
< Primary 11.3% (24/213) 43.1% (81/188) 
Primary school 24.4% (52/213) 31.9% 60/188) 
Secondary school 25.4% (54/213) 16.0% (30/188) 
Higher secondary 24.4% (53/213) 6.9% (13/188) 
College/university 14.5% (31/213) 2.1% (4/188) 
Working status‡     
Manual work 26.0% (59/227) 5.3% (11/208) 
Office work 19.8% (45/227) 16.8% (35/208) 
Home duties/retired 54.2% (123/227) 77.9% (162/208) 
Living with spouse‡     
Yes 76.7% (173/227) 36.6% (75/205) 
No – living with children 17.6% (40/227) 56.1% (115/205) 
No – living with others 5.7% (13/227) 7.3% (15/205) 
Type of stroke     
Ischaemic stroke (IS) 72.9% (167/229) 79.3% (165/208) 
Intra-cerebral haemorrhage (ICH) 27.1% (62/229) 20.6% (43/208) 
Impairment at admission (NIHSS§)     
Mean (SD*) 7.6 (5.4) 8.8 (6.1) 
Not severe (NIHSS≤7) 58.6% (130/222) 51.8% (102/197) 
Severe (NIHSS>7) 41.4% (92/222) 48.2% (95/197) 
Functional status at admission (mRS)      
Mean (SD*) 3.1 (1.1) 3.2 (1.1) 
Least severe (mRS=0/1) 11.0% (25/227) 10.8% (22/204) 
Intermediate (mRS=2/3) 41.9% (95/227) 36.8% (75/204) 
More severe (mRS=4/5) 47.1% (107/227) 52.5% (107-204) 
Length of stay (days)     
Mean (SD*) 6.7 (4.4) 6.4 (4.1) 
0–4 days 34.1% (74/229) 35.1% (73/208) 
5–7 days 38.0% (87/229) 36.1% (75/208) 
8+ days 28.0% (64/229) 28.9% (60/208) 
* SD = standard deviation, † IQR = interquartile range, ‡ Patient self-report 
§ NIHSS= National Institutes of Health Stroke Scale. 
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When household assets were considered, relatively more participants lived in households 
holding each category of household asset in the list of 2010 for Ho Chi Minh City published 
by the General Statistics Office of Viet Nam (Table A5.2 in Appendix 5) compared with the 
general population of Ho Chi Minh City, suggesting that participants were drawn from a 
relatively affluent sub-population. In addition, the median per adult household income of 25–
64 year old participants was nearly 50% greater than that of 25-64 year olds in the general 
population of Ho Chi Minh City (Table A5.2 in Appendix 5). Conversely, patients with 
stroke aged 25–64 years had lower levels of educational attainment than their counterparts in 
the general population.  
 
Direct medical costs 
Table 5.2 shows that the mean direct medical costs per stroke patient were USD 560 [SD 
562; median 385, IQR (285, 565)]. The mean hospital costs per day for each patient were 
USD 93.1 [SD 81.6; median 72.0, (IQR 56.1, 97.9)]. Other than for the very youngest 
patients, mean costs increased with age and, adjusted for age and sex, with the number of co-
morbidities, severity of impairment, severity of disability and LOS.  
The associations were reduced by adjusting, where relevant, for severity of impairment and 
LOS. Adjusted for age and sex, costs were higher on average for patients with ICH but this 
was reversed after adjustment for severity of impairment and LOS. The direct medical costs 
incurred were progressively lower for patients with lesser wealth irrespective of age and sex, 
and this association was attenuated but not removed by adjustment for severity of impairment 
and LOS.  
 
Distribution of total costs and out-of-pocket costs of patients 
The greatest contributors to direct medical costs were diagnostic imaging (approximately 32% 
of average costs and 36% of median costs) and bed-day fees (23%) (Table 5.3). After 
insurance co-payments were taken into account, these items remained the greatest 
contributors to median out-of-pocket costs with bed-day fees contributing relatively more of 
the total because insurance co-payments provided comparatively little reimbursement. 
Insurance provided assistance with four lower-cost items – medical consumables, 
medications, lab tests and rehabilitation – and with costs of diagnostic imaging, but made no 
or almost no contribution to the costs of the other items. The mean total out-of-pocket costs 
per patients were USD 380 (SD 389; median 275, IQR 155, 449) USD. The mean out-of-
pocket costs per day were USD 64.0 (SD 62.8; median 50.2, IQR 29.2, 74.2).  
The trend for less wealthy patients to incur lower direct medical costs (Table 5.2) was 
replicated for most of the categories in Table 5.3 and, after adjustment for age and sex, was 
statistically significant for diagnostic imaging (p=0.014). The main exception to this was 
consultant fees that were higher on average for patients in lower wealth categories (trend 
p=0.016). Regarding the out-of-pocket component, less wealthy patients incurred lower bed-
day fees (trend p=0.05) partly explained by their generally less severe condition (trend 
p=0.153 adjusted additionally for severity of impairment), but higher consultant fees 
(p=0.005) and higher costs of lab testing (p=0.023).  
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Table 5.2: Direct medical costs (USD) of treatment of stroke patients at 115 People’s Hospital, Ho Chi Minh City, and associations with 
putative explanatory factors. 
  LOS (days)   Mean costs (USD) and ratios of means  
 Mean (SD) Median (IQR) Mean (SD) Ratio (95% CI)* Ratio (95% CI)† 
All patients 6.6 (4.2) 385 (282,565) 560 (562)     
Sex          
Male 6.7 (4.4) 391 (271, 557) 565 (576) 1.00  1.00  
Female 6.4 (4.0) 384 (287, 568) 554 (548) 0.97 (0.87, 1.08) 0.97 (0.88, 1.06) 
Age group          
<45 years 7.2 (4.6) 438 (302, 537) 580 (582) 1.00  1.00  
45-54 years 6.1 (4.2) 356 (269, 479) 467 (376) 0.85 (0.68, 1.02) 0.95 (0.79, 1.11) 
55-64 years 5.9 (3.6) 358 (258, 506) 476 (393) 0.82 (0.66, 0.98) 0.94 (0.78, 1.09) 
65-74 years 6.5 (3.6) 379 (286, 545) 557 (561) 0.93 (0.74, 1.12) 1.00 (0.83, 1.17) 
75+ years 7.4 (5.1) 464 (296, 876) 728 (780) 1.11 (0.88, 1.34) 1.09 (0.91, 1.28) 
Trend      P = 0.01 P = 0.09 
Wealth index 
         
4th quarter (richest) 6.9 (4.8) 470 (287,780) 679 (662) 1.00  1.00  
3rd quarter 6.5 (3.9) 374 (286, 544) 528 (433) 0.88 (0.75, 1.02) 0.95 (0.83, 1.07) 
2nd quarter 6.5 (4.1) 376 (271, 541) 546 (575) 0.85 (0.71, 0.97) 0.87 (0.76, 0.97) 
1st quarter (poorest) 6.3 (4.0) 368 (274, 483) 499 (546) 0.82 (0.70, 0.94) 0.88 (0.77, 0.98) 
Trend      P = 0.04 P = 0.01 
Health insurance 
         
No 6.3 (3.8) 384 (286, 534) 533 (441) 1.00  1.00  
Yes 6.7 (4.6) 385 (272, 578) 583 (649) 0.96 (0.85, 1.06) 0.93 (0.84, 1.00) 
Comorbidity          
No comorbidity 6.4 (4.2) 357 (273, 522) 513 (475) 1.00  1.00  
1 comorbidity 6.1 (2.9) 446 (294, 621) 573 (508) 1.14 (0.99, 1.29) 1.12 (1.00, 1.24) 
2-6 comorbidities 8.5 (6.2) 428 (323, 1040) 934 (1058) 1.35 (1.06, 1.63) 1.17 (0.97, 1.36) 
Trend      P = 0.03 P = 0.02 
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  LOS (days)   Mean costs (USD) and ratios of means  
 Mean (SD) Median (IQR) Mean (SD) Ratio (95% CI)* Ratio (95% CI)† 
Type of stroke          
Intracerebral haemorrhage 8.7 (5.9) 433 (302, 605) 637 (691) 1.00  1.00  
IS‡ 5.9 (3.3) 366 (276, 542) 535 (514) 0.88 (0.77, 0.99) 1.17 (1.04, 1.30) 
IS§ 5.8 (3.3) 346 (274, 506) 458 (369) 0.83 (0.73, 0.93) 1.09 (0.98, 1.20) 
Severity of impairment ¶          
Not severe (NIHSS ≤ 7) 5.5 (3.4) 308 (263, 452) 390 (256) 1.00  1.00  
Severe (NIHSS > 7) 7.9 (4.8) 506 (346, 941) 786 (754) 1.54 (1.38, 1.71) 1.33 (1.20, 1.45) 
Severity of disability#          
Least severe (mRS 0/1) 5.1 (3.0) 300 (251, 429) 373 (205) 1.00  1.00  
Intermediate (mRS 2/3) 5.6 (3.5) 309 (273, 456) 424 (363) 1.04 (0.88, 1.20) 0.96 (0.82, 1.10) 
Most severe (mRS 4/5) 7.7 (4.7) 479 (316, 876) 713 (698) 1.45 (1.22, 1.68) 1.03 (0.85, 1.20) 
Trend       P < 0.01 P = 0.53 
Length of stay           
0-4 days NA  269 (243, 391) 362 (378) 1.00  1.00  
5-7 days   568 (403, 905) 807 (715) 2.00 (1.78, 2.21) 1.76 (1.57, 1.95) 
8+ days   344 (293, 502) 478 (377) 1.31 (1.18, 1.44) 1.29 (1.16, 1.43) 
Trend       P < 0.01 P < 0.01 
* Ratio of means (95% confidence interval) adjusted for age and sex. 
† Ratio of means (95% confidence interval) adjusted for age, sex, severity of impairment. 
‡ Including including cost of thrombolitic treatment. 
§ Excluding cost of thrombolitic treatment. 
¶ Severity of impairment assesed on the National Institutes of Health Stroke Scale (NIHSS) scale.. 
# Severity of disability assessed on the modified Rankin Scale (mRS). 
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Table 5.3: Distribution of direct medical costs.  
  Total cost    Patient out-of-pocket cost   Out-of-pocket 
as % of total 
cost Item n mean (SD) % median (IQR) n median (IQR) % 
Consultant fees 430 1.4 (1.1) 0.2 1.5 (0.3, 1.5) 417 1.5 (0, 1.5) 0.5 100.0 
Bed-day fees 437 127.2 (117.3) 22.7 93.2 (62.1, 139.8) 436 88.2 (62.1, 139.8) 32.0 94.6 
Lab tests 437 58.0 (28.4) 10.4 51.5 (44.8, 59.3) 422 33.5 (10.0, 50.3) 12.2 65.0 
Diagnostic imaging 436 178.8 (99.8) 31.9 138.6 (117.5, 228.2) 429 98.2 31.4, 148.6) 35.6 70.9 
Rehabilitation* 174 54.5 (221.8) 9.7 12.4 (6.3, 27.9) 169 8.1 (2.7, 15.5) 2.9 65.3 
Medications 436 147.5 (351.3) 26.3 26.5 (14.5, 68.1) 419 14.0 (4.1, 33.5) 5.1 52.8 
Medical consumables 314 11.3 (16.7) 2.0 6.5 (1.8, 13.9) 306 2.5 (0.8, 9.3) 0.9 38.5 
Meals and feeding† 15 35.4 (23.4) 6.3 26.4 (22.2, 49.7) 15 26.4 (22.2, 49.7) 9.6 100.0 
Other  437 15.3 (10.9) 2.7 11.7 (8.5, 18.7) 437 11.7 (8.5, 18.7) 4.2 100.0 
Total 437 560.2 (562.8) 100.0 385.6 (282.7, 566.1) 437 275.6 (155.7, 449.6) 100.0 49.2 
* includes physiotherapy and costs of minor surgical procedure 
†included special diet and feeding 
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Table 5.4: Distribution of out-of-pocket expenditure on direct medical costs. 
  Uninsured patient   Insured patient   Ratio of means  
 n mean (SD) median (IQR) n mean (SD) median (IQR) Ratio (95% CI) 
Consultant fees 198 2.01 (1.2) 1.5 (1.5, 2.0) 219 0.7 (1.0) 0.06 (0.06, 1.5) 0.19 0.14, 0.23) 
Bed-day fees 202 126.9 (115.8) 93.2 (62.1, 139.8) 234 122.3 (115.7) 87.3 (58.8, 133.2) 0.94 (0.82, 1.05) 
Lab tests 202 54.5 (19.8) 50.3 (44.6, 56.7) 220 12.4 (12.5) 10.0 (7.8, 11.4) 0.19 (0.17, 0.21) 
Diagnostic imaging 202 187.4 (105.1) 148.6 (126.9, 247.0) 227 53.8 (54.2) 41.6 (22.2, 62.1) 0.23 0.20, 0.27) 
Rehabilitation* 77 22.9 (39.3) 10.9 (6.6, 20.7) 92 51.6 (279.1) 3.6 (2.0, 11.4) 0.90 (0.43, 1.37) 
Medications 202 127.4 (286.5) 24.2 (14.8, 62.4) 217 24.7 (63.2) 4.8 (2.2, 11.4) 0.16 (0.11, 0.20) 
Medical consumables 161 9.2 (10.6) 5.5 (1.4, 13.3) 145 5.2 (12.7) 1.2 (0.4, 3.6) 0.30 (0.20, 0.41) 
Meals and feeding† 6 52.8 (27.1) 51.0 (27.4, 74.5) 9 23.8 (11.1) 23.3 (16.0, 25.8) 0.47 (0.20, 0.74) 
Other  202 14.9 (9.5) 11.4 (8.5, 18.1) 235 15.7 (12.1) 11.9 (8.5, 19.3) 1.00 (0.90, 1.11) 
Total 202 533.7 (441.9) 384.7 (286.6, 534.3) 235 249.6 (277.5) 167.5 (118.4, 277.3) 0.40 (0.36, 0.44) 
* Includes physiotherapy and costs of minor surgical procedure 
† Includes special diet and feeding 
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Health insurance 
Insured patients were generally older (p<0.001), had greater wealth (p=0.008) and larger 
numbers of comorbidities (p=0.002) (Table 5.4). Their severity of impairment was 0.86 
points greater (p=0.13) on the NIHSS scale, and their LOS was longer (p=0.30) by 0.42 days, 
but these differences did not reach statistical significance. The direct medical cost of insured 
patients was 9.8% (95% CI 1.7%, 17.9%) lower than that of non-insured patients after 
adjustment for age, sex, wealth, comorbidity, severity of impairment (NIHSS) and LOS. 
Significantly lower costs were incurred by insured patients for diagnostic imaging (p=0.008) 
and bed-day fees (p=0.02). Out-of-pocket costs were greater on average for patients without 
health insurance (USD 533 (SD 441) than for patients with health insurance (USD 249 (SD 
277), p<0.01. Out-of-pocket expenditure was 71.3% of total direct treatment costs for all 
stroke patients, and 43.4% of total direct treatment costs for insured patients. Only for bed-
day fees, rehabilitation and other costs did health insurance not result in a statistically 
significant reduction in total direct treatment costs that had to be met out-of-pocket. 
 
Direct non-medical costs 
The majority of patients (98.2%) incurred some direct non-medical costs (Table 5.5). The 
characteristics of patients (n=429) who incurred these costs were not distinguishable from 
those of patients (n=8) who did not. The mean costs incurred were USD 171 (SD 486; median 
105, IQR 67, 169). The direct medical costs incurred were greater for patients with ICH (but 
not after adjustment for severity of impairment and LOS), for those with more severe 
impairment, for those with more severe disability (but not after adjustment for severity of 
impairment and LOS), and for those whose LOS exceeded 4 days. 
 
Indirect costs 
Patients who incurred indirect costs tended to be younger and have lesser comorbidity than 
patients who did not incur these costs (Table 5.6). The average costs incurred were USD 240 
(SD 392; median 124, IQR 53, 2498). Indirect medical costs were greater on for younger 
patients, those who were wealthier, those with ICH, those with more severe impairment, those 
with greater disability (but not after adjustment for severity of impairment and LOS), and 
those whose LOS exceeded 4 days. 
 
Total costs 
Mean total costs were USD 963 (SD 968; median 684, IQR 467, 1047) (Table 5.7). Non-
medical costs, including direct non-medical cost and indirect cost, contributed 33.6% of total 
cost for all stroke patients. The total costs were greater for patients who were wealthier, those 
with comorbidity and those with ICH (but not in either case after adjustment for severity of 
impairment and LOS), those with more severe impairment, those with greater disability (but 
not after adjustment for severity of impairment and LOS), and those whose LOS exceeded 4 
days. Results are shown for the wealth index, but total costs were also positively associated 
with average monthly income of household (p=0.01) and with their average monthly 
expenditure (p<0.001).Information collected on the sources of money used in payment of 
costs indicated that 51.5% (225/434) of patients used family savings, 72.5% (317/434) used 
money provided by relatives, 8.5% (37/434) borrowed money from other sources, and 0.9% 
(4/434) sold family assets to pay the hospital fee. 
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Table 5.5: Direct non-medical costs (USD) of treatment of stroke patients at 115 People’s Hospital, Ho Chi Minh City, and associations 
with putative explanatory factors. 
     Cost incurred  
  Patients who incurred cost    Mean cost and ratio of means  
 % (n/N) RR (95% CI) * Median (IQR) Mean (SD) Ratio   (95% CI)† Ratio (95% CI)‡ 
All patient     105 (67, 169) 171 (486)     
Sex             
Male 97.4% (223/229) 1.00 104 (63, 156) 179 (633) 1.00  1.00  
Female 99.0% (206/208) 1.02 (0.99, 1.04) 106 (69, 171) 162 (241) 1.08 (0.90, 1.25) 1.04 (0.89, 1.20) 
Age group             
< 45 years 100.0% (42/42)   98 (63, 173) 147 (161) 1.00  1.00  
45-54 years 100.0% (97/97) 1.00  93 (67, 150) 223 (949) 0.98 (0.68, 1.28) 1.12 (0.80, 1.43) 
55-64 years 96.2% (102/106)   96 (61, 146) 124 (105) 0.85 (0.59, 1.11) 1.04 (0.75, 1.33) 
65-74 years 96.6% (86/89) 0.98 (0.94, 1.02) 118 (71, 193) 172 (179) 1.12 (0.77, 1.47) 1.20 (0.86, 1.55) 
75+ years 99.0% (102/103) 1.01 (0.98, 1.03) 115 (74, 201) 179 (301) 1.12 (0.77, 1.46) 1.08 (0.78, 1.39) 
Trend 
  
P = 0.19     P = 0.17 P = 0.58 
Wealth index 
            
4th quarter (richest) 97.2% (104/107) 1.00  114 (65, 200) 153 (127) 1.00  1.00  
3rd quarter 97.8% (90/92) 1.00 (0.96, 1.05) 106 (68, 207) 268 (991) 1.07 (0.81, 1.32) 1.11 (0.87, 1.35) 
2nd quarter 98.2% (110/112) 1.01 (0.97, 1.05) 106 (68, 170) 170 (298) 0.98 (0.75, 1.21) 1.01 (0.81, 1.22) 
1st quarter (poorest) 99.2% (117/118) 1.02 (0.98, 1.06) 100 (63, 145) 114 (88) 0.82 (0.64, 1.01) 0.88 (0.70, 1.06) 
Trend   P = 0.28     P = 0.06 P= 0.13 
Health insurance 
            
No 99.0% (200/202) 1.00  99 (66, 154) 184 (668) 1.00  1.00  
Yes 97.5% (229/235) 0.98 (0.96, 1.00) 109 (68, 172) 160 (229) 1.03 (0.86, 1.20) 1.01 (0.86, 1.16) 
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     Cost incurred  
  Patients who incurred cost    Mean cost and ratio of means  
 % (n/N) RR (95% CI) * Median (IQR) Mean (SD) Ratio   (95% CI)† Ratio (95% CI)‡ 
Comorbidity 
            
No comorbidity 98.7% (306/310) 1.00  104 (66, 163) 181 (569) 1.00  1.00  
1 comorbidity 97.8% (89/91) 0.99 (0.96, 1.02) 95 (63, 159) 133 (138) 0.89 (0.71, 1.07) 0.89 (0.72, 1.05) 
2-6 comorbidities 94.4% (34/36) 0.96 (0.88, 1.04) 172 (106, 259) 184 (110) 1.39 (0.97, 1.82) 1.20 (0.87, 1.54) 
Trend    P = 0.24     P = 0.31 P = 0.74 
Type of stroke             
IS 98.8% (328/332) 1.00  97 (62, 153) 127 (112) 1.0  1.00  
ICH 96.2% (101/105) 0.97 (0.94, 1.01) 138 (87, 255) 314 (971) 1.71 (1.39, 2.03) 1.23 (1.0, 1.47) 
Severity of impairment¶             
Not severe (NIHSS ≤ 7) 98.7% (229/232) 1.00  91 (62, 129) 149 (621) 1.0  1.00  
Severe (NIHSS > 7) 97.9% (183/187) 0.99 (0.97, 1.02) 137 (77, 231) 192 (254) 1.55 (1.30, 1.80) 1.29 (1.09, 1.50) 
Severity of disability#             
Least severe (mRS 0/1) 100.0% (47/47)   87 (63, 104) 82 (42) 1.00  1.00  
Intermediate (mRS 2/3) 98.8% (168/170) 1.00  95 (62, 148) 175 (724) 1.36 (1.00, 1.72) 1.22 (0.92, 1.53) 
Most severe (mRS 4/5) 97.2% (208/214) 0.98 (0.96, 1.00) 124 (77, 217) 188 (250) 1.86 (1.40, 2.34) 1.21 (0.87, 1.55) 
Trend   P = 0.07     P < 0.001 P = 0.32 
Length of stay             
0-4 days 98.0% (148/151) 1.00  77 (49, 108) 89 (80) 1.00  1.00  
5-7 days 98.2% (159/162) 1.00 (0.97, 1.03) 156 (92, 292) 281 (779) 2.29 (1.89, 2.69) 1.94 (1.58, 2.29) 
8+ days 98.4% (122/124) 1.00 (0.97, 1.04) 108 (74, 153) 127 (90) 1.48 (1.21, 1.76) 1.40 (1.14, 1.65) 
Trend   P = 0.82     P < 0.001 P = 0.001 
* Relative risk (95% confidence interval) ; † Ratio of means (95%CI) adjusted for age, sex. 
‡ Ratio of means (95%CI) adjusted for age, sex, severity of impairment and LOS. 
¶ Severity of impairment assessed on the National Institutes of Health Stroke Scale (NIHSS); # Severity of disability assessed on the modified Rankin Scale (mRS). 
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Table 5.6: Indirect costs (USD) of stroke patients (loss of income of patients and their caregivers) at 115 People’s Hospital, Ho Chi Minh 
City, and associations with putative explanatory factors. 
     Cost incurred  
  Patients who incurred cost    Mean costs and ratio of means  
 % (n/N) RR (95% CI) * Median (IQR) Mean (SD) Ratio   (95% CI)† Ratio (95% CI)‡ 
All patient     124 (53, 2498) 240 (392)     
Sex             
Male 70.3% (161/229) 1.00 124 (6, 259) 265 (456) 1.00 1.00 
Female 72.6% (151/208) 1.03 (0.92, 1.16) 114 (49,  249) 214 (309) 0.98 (0.71, 1.25) 0.86 (0.63, 1.09) 
Age group             
<45 years 92.9% (39/42) 1.00 145 (78, 259) 261 (374) 1.00 1.00 
45-54 years 82.5% (80/97) 0.89 (0.78, 1.00) 132 (78, 236) 247 (445) 1.00 (0.54, 1.46) 1.10 (0.61, 1.60) 
55-64 years 73.6% (78/106) 0.79 (0.69, 0.91) 91 (41, 259) 256 (453) 0.81 (0.43, 1.19) 0.97 (0.53, 1.41) 
65-74 years 55.1% (49/89) 0.59 (0.48, 0.73) 134 (50, 326) 213 (227) 0.86 (0.42, 1.29) 0.84 (0.43, 1.24) 
75+ years 64.1% (66/103) 0.69 (0.58, 0.82) 93 (31, 223) 220 (361) 0.69 (0.35, 1.02) 0.70 (0.37, 1.02) 
Trend 
  
P < 0.001     P = 0.05 P = 0.02 
Wealth index             
4th quarter (richest) 66.4% (71/107) 1.00  165 (62, 528) 378 (544) 1.00 1.00 
3rd quarter 77.2% (71/92) 1.16 (0.98, 1.39) 145 (52, 316) 283 (431) 0.85 (0.52, 1.19) 0.88 (0.55, 1.21) 
2nd quarter 75.9% (85/112) 1.14 (0.96, 1.36) 108 (52, 221) 166 (170) 0.61 (0.39, 0.85) 0.62 (0.40, 0.85) 
1st quarter (poorest) 67.8% (80/118) 1.02 (0.85, 1.23) 99 (41, 176) 166 (341) 0.55 (0.34, 0.76) 0.62 (0.39, 0.85) 
Trend   P = 0.89     P < 0.001 P = 0.001 
Health insurance             
No 72.8% (147/202) 1.00  102 (50, 225) 228 (423) 1.00 1.00 
Yes 70.2% (165/235) 0.96 (0.86, 1.09) 138 (62, 259) 251 (363) 1.22 (0.89, 1.56) 1.17 (0.82, 1.41) 
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     Cost incurred  
  Patients who incurred cost    Mean costs and ratio of means  
 % (n/N) RR (95% CI) * Median (IQR) Mean (SD) Ratio   (95% CI)† Ratio (95% CI)‡ 
Comorbidity             
No comorbidity 74.8% (232/310) 1.00  124 (52, 242) 257 (436) 1.00 1.00 
1 comorbidity 63.7% (58/91) 0.85 (0.72, 1.00) 99 (51, 249) 178 (179) 0.95 (0.62, 1.28) 0.97 (0.64, 1.30) 
2-6 comorbidities 61.1% (22/36) 0.82 (0.62, 1.07) 121 (71, 259) 230 (285) 1.18 (0.55, 1.79) 1.11 (0.55, 1.68) 
Trend   P = 0.03     P = 0.77 P = 0.83 
Type of stroke             
IS 70.2% (233/332) 1.00  103 (50, 228) 220 (365) 1.00 1.00 
ICH 75.2% (79/105) 1.07 (0.94, 1.22) 155 (83, 373) 301 (460) 1.34 (0.92, 1.76) 0.97 (0.65, 1.30) 
Severity of impairment¶             
Not severe (NIHSS ≤ 7) 72.0% (167/232) 1.00  93 (38, 207) 182 (324) ref  1.00 
Severe (NIHSS > 7) 71.1% (133/187) 0.99 (0.87, 1.12) 158 (73, 378) 315 (463) 1.85 (1.35, 2.35) 1.60 (1.17, 2.03) 
Severity of disability#             
Least severe (mRS 0/1) 59.6% (28/47) 1.00  98 (46, 219) 162 (171) ref  1.00 
Intermediate (mRS 2/3) 75.3% (128/170) 1.26 (0.98, 1.62) 90 (41, 197) 209 (409) 0.96 (0.50, 1.42) 0.80 (0.42, 1.17) 
Most severe (mRS 4/5) 71.0% (152/214) 1.19 (0.93, 1.53) 150 (69, 357) 284 (407) 1.52 (0.79, 2.26) 0.92 (0.44, 1.40) 
Trend   P= 0.49     P = 0.02 P = 0.93 
Length of stay             
0-4 days 68.9% (104/151) 1.00  80 (31, 145) 150 (270) ref  1.00 
5-7 days 68.5% (111/162) 1.00 (0.86, 1.16) 186 (73, 466) 358 (538) 2.26 (1.56, 2.96) 1.74 (1.17, 2.32) 
8+ days 78.2% (97/124) 1.14 (0.99, 1.31) 124 (57, 223) 202 (249) 1.49 (1.02, 1.96) 1.39 (0.94, 1.83) 
Trend   P= 0.09     P = 0.03 P = 0.07 
* Relative risk (95% confidence interval); † Ratio of means (95%CI) adjusted for age, sex. 
‡ Ratio of means (95%CI) adjusted for age, sex, severity of impairment and LOS; ¶ Severity of impairment assessed on the National Institutes of Health Stroke Scale (NIHSS); 
# Severity of disability assessed on the modified Rankin Scale (mRS). 
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Table 5.7: Total costs (USD) of treatment of stroke patients at 115 People’s Hospital, Ho Chi Minh City, and associations with putative 
explanatory factors.  
   Mean costs and ratios of means  
 Median (IQR) Mean (SD) Ratio (95% CI)* Ratio  (95% CI)† 
All patient 619 (424, 1012) 901 (903)     
Sex         
Male 634 (432, 1025) 928 (978) 1.00  1.00  
Female 616 (417, 1002) 871 (814) 0.99 (0.87, 1.10) 0.96 (0.87, 1.04) 
Age group         
< 45 years 677 (439, 1248) 971 (812) 1.00  1.00  
45-54 years 617 (450, 892) 895 (1122) 0.90 (0.70, 1.10) 1.00 (0.82, 1.18) 
55-64 years 574 (374, 912) 785 (671) 0.80 (0.62, 0.97) 0.93 (0.76, 1.09) 
65-74 years 617 (417, 974) 842 (681) 0.89 (0.69, 1.09) 0.94 (0.77, 1.11) 
75+ years 723 (471, 1141) 1047 (1063) 1.05 (0.81, 1.29) 1.00 (0.82, 1.18) 
Trend     P = 0.29 P = 0.85 
Wealth index         
4th quarter (richest) 758 (471, 1284) 1079 (872) 1.00  1.00  
3rd quarter 667 (430, 997) 1011 (1200) 0.89 (0.74, 1.04) 0.97 (0.84, 1.11) 
2nd quarter 606 (413, 907) 840 (873) 0.81 (0.68, 0.94) 0.83 (0.73, 0.94) 
1st quarter (poorest) 539 (411, 771) 727 (650) 0.74 (0.62, 0.85) 0.80 (0.70, 0.90) 
Trend     P < 0.001 P < 0.001 
Health insurance         
No 604 (417, 953) 883 (933) 1.00  1.00  
Yes 665 (439, 1047) 916 (878) 1.03 (0.91, 1.15) 0.99 (0.90, 1.09) 
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   Mean costs and ratios of means  
 Median (IQR) Mean (SD) Ratio (95% CI)* Ratio  (95% CI)† 
Comorbidity         
No comorbidity 601 (417, 953) 884 (940) 1.00  1.00  
1 comorbidity 649 (413, 983) 818 (609) 1.02 (0.87, 1.16) 1.00 (0.88, 1.11) 
2-6 comorbidities 878 (565, 1407) 1250 (1118) 1.35 (1.04, 1.66) 1.13 (0.93, 1.33) 
Trend     P = 0.04 P = 0.32 
Type of stroke         
IS 599 (411, 932) 817 (680) 1.00  1.00  
ICH 722 (500, 1254) 1166 (1361) 1.27 (1.09, 1.45) 0.92 (0.81, 1.03) 
Severity of impairment¶         
Not severe (NIHSS≤ 7) 502 (386, 738) 670 (755) 1.00  1.00  
Severe (NIHSS> 7) 847 (593, 1522) 1199 (1012) 1.63 (1.45, 1.82) 1.38 (1.24, 1.52) 
Severity of disability#         
Least severe (mRS 0/1) 421 (386, 680) 552 (275) 1.00  1.00  
Intermediate (mRS 2/3) 542 (385, 744) 756 (914) 1.14 (0.95, 1.33) 1.03 (0.87, 1.19) 
Most severe (mRS 4/5) 768 (545, 1324) 1099 (950) 1.61 (1.34, 1.89) 1.08 (0.89, 1.27) 
Trend     P < 0.001 P = 0.38 
Length of stay         
0-4 days 424 (343, 592) 554 (487) 1.00  1.00  
5-7 days 1014 (650, 1547) 1330 (1216) 2.16 (1.91, 2.42) 1.85 (1.63, 2.06) 
8+ days 619 (451, 879) 762 (503) 1.42 (1.26, 1.57) 1.37 (1.22, 1.52) 
Trend     P < 0.001 P < 0.001 
* Ratio of means (95%CI) adjusted for age, sex. 
† Ratio of means (95%CI) adjusted for age, sex, severity of impairment and LOS. 
¶ Severity of impairment assessed on the National Institutes of Health Stroke Scale (NIHSS). 
# Severity of disability assessed on the modified Rankin Scale (mRS). 
Figures in bold in table indicate that the risk ratios is statiscally significant at the 95% confidence level. 
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5.5. Discussion 
 
This is the first published study of the hospitalisation costs of stroke in Viet Nam. Our 
principal findings are that average total costs per stroke admission were USD 963 comprising 
USD560 for direct medical cost, USD 171 for direct non-medical cost, and USD 240 for 
indirect costs. Severity of impairment and LOS were predictors of all cost categories and each 
was greater for patients with ICH (but not independently of severity and LOS). Wealthier 
patients had higher average direct medical costs and indirect cost, and total cost. Patients with 
comorbidity incurred higher direct medical costs.  
The mean LOS of 6.6 days (5.9 days for IS and 8.7 days for ICH) was less than the range (9-
35 days) in a European comparison [326] and was also less than estimates of 17 days and 13.9 
days reported for Singapore [274] and Korea [275] respectively. Consistent with the findings 
of Mamoli et al. [333], type and severity of stroke contributed independently to LOS but the 
proportion of patients at this hospital with each major stroke type was similar to published 
results [12,18,19,21] for other LMICs whilst the proportion with severe disability at 
admission was higher [334]. The stroke unit in this study had 130 beds at the time of this 
study, but the average number of patients requiring treatment was greater than 140 per day 
(unpublished annual report of hospital).Our shorter LOS could be due to the overload of 
stroke patients and the pressure this places for early discharge once patients have overcome 
the acute phase and started to recover. It could also be due to patients and their families not 
being able to afford the direct medical costs, although a majority of participants asked a 
relative to cover the costs related to stroke treatment during the hospitalisation. 
Our findings were broadly consistent with findings of other studies on distribution of resource 
use in other Asian countries/LMICs such as Pakistan [262], Singapore [274], Korean [275] 
and Japan [276], with diagnostic imaging (32% of average costs), medications (26%) and bed-
day fees (23%) the largest contributors to direct medical costs. 
The average costs per discharge in 115 People’s Hospital of USD 560 is relatively low 
compared to estimates for HICs and at the low end of the range for LMICs of USD 416 in 
Senegal to USD 8,424 in Nigeria [257]. This could be due to administrative charges – 
particularly the low salaries of hospital medical staff – not adequately reflecting the cost of 
resource use in Viet Nam. Economic costs are difficult to estimate in any setting, and 
problematic in countries such as Viet Nam where diagnosis-related group (DRG) 
classification systems and activity-based funding are yet to replace historic budgets. The 
hospital charges billed to patients was the only source of cost data that was available to us.  
Our study provided novel and important data on indirect costs of stroke incurred by patients 
and their caregivers.  The indirect costs were estimated by assessing the loss of income due to 
time absent from work (other than sick leave or annual leave) for patients and caregivers who 
were working and earning regular income before the stroke onset. Loss of income, including 
that of caregivers, contributed 13% of total cost. The burden of informal care in Viet Nam 
may be due to the overcrowding of patients in hospital and the limited number of nurses in the 
stroke unit, requiring family members to contribute to the care of patients [293]. If valued 
according to productivity lost (including household productivity) as well as accounting for 
lost leisure time rather than focussing on just loss of income of patients and their caregivers, 
our indirect costs could be much higher.  
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Similar to findings for HICs [335] and other LMICs [262,263,268-271], severity of stroke and 
LOS were independent predictors of direct medical costs. Direct medical costs were higher 
for ICH than for IS partly due to greater severity and longer LOS. These findings are similar 
to those of studies conducted in China [263] and Italy [251,277,278]. Unless risk factors for 
non-communicable disease – particularly high blood pressure, which is important in the 
pathogenesis of ICH – are controlled better in the future, the total costs of treating stroke in 
LMICs will increase due to elevated proportions of ICH.  
The direct medical cost of insured patients was nearly one-tenth lower than that of non-
insured patients after adjustment for age, sex, wealth, comorbidity, severity of impairment 
(NIHSS) and LOS. In particular, costs of diagnostic imaging and bed-day fees were 
significantly lower for insured patients than for uninsured patients. Out-of-pocket expenditure 
was around three-quarters of total direct treatment costs for all stroke patients, and nearly half 
of total direct treatment costs for insured patients. In contrast, hospital charges for stroke 
patients were associated positively with health insurance status in studies conducted in China 
[263,336], prompting concerns [336] about over-use of resources for insured patients. In Viet 
Nam, health insurance is mostly provided by government, and covers 50-100% of treatment 
costs depending on type of health insurance (voluntary or commitment) and the particular mix 
of medical resources used for treatment. We found that the health insurance co-payment for 
bed-day fees was only around 5%, possibly because the reimbursement is for a standard bed 
(fee 10,000 VND/day) in a large room (with 10 beds) and with limited facilities in the room. 
The mean bed-day fee for a bed in a "service room" with 1-4 beds and better facilities 
including air conditioner and private toilet (range 150,000–500,000 VND/day) or an ICU bed 
(200,000 VND/day) is 15–50 times higher.  
The financial burden of stroke on the families of patients with stroke and their caregivers is an 
important finding of our study. For a relatively high proportion of cases, stroke in Viet Nam 
occurs with severe impairment and disability, and these patients incur higher hospital costs for 
acute treatment and higher total costs overall. In addition, out-of-pocket expenditure is high 
due the incomplete population coverage of health insurance in Viet Nam – reportedly about 
60% [283] but 54% in our study, compared to 62% in China [281] – and the limited co-
payments received by insured persons. Despite reimbursement from health insurance, insured 
patients paid nearly half of direct treatment cost of stroke in the hospital. In this study, median 
direct medical costs and total costs of stroke were respectively 1.33 and 2.38 times higher 
than the median household income of respondents in this study (2,000,000 VND). The median 
direct medical costs and total costs of stroke were respectively 0.81 and 1.95 times higher for 
an insured patient, and 1.86 and 2.92 times higher for non-insured persons. These ratios 
would be 41% higher had they been calculated relative to the mean income per capita 
(3,399,000 VND) in Ho Chi Minh City in 2012. The out-of-pocket costs were similar to those 
reported by Kaur et al. [257] for LMICs. Three quarters of our patients relied on financial 
support from a relative to cover out-of-pocket costs, and almost one-in eleven had taken out a 
loan and 1% had sold household assets. In north-west India, 11% of stroke patients in 2012 
had taken a loan to pay for treatment for stroke [269].   
The 115 People’s Hospital is a tertiary public hospital in Ho Chi Minh City where treatment 
of cerebral vascular disorders, such as stroke, is one of the treatment foci of the hospital. It is 
located in District 10, one of central business districts of Ho Chi Minh City and an area of 
relative affluence. Patients are referred to it from all areas of the city, but the stroke patients in 
our study had a higher median household income per adult than that of the general population 
of Ho Chi Minh City. In addition, the 25-64 year olds among them were less well educated 
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than their counterparts in the general population. This was not unexpected because studies in 
Viet Nam  have shown that people with lower education are more likely to be tobacco 
smokers [73] and to have been diagnosed with high blood pressure and diabetes [337,338], 
which are important risk factors for stroke in Viet Nam [339].  
The stroke unit in this hospital is one of leading stroke units in public hospitals in Ho Chi 
Minh City with a high standard of diagnostic imaging techniques and adherence to intensive 
stroke treatment guidelines. We assume that the direct medical costs of stroke treatment in our 
study would be broadly similar to treatment costs in other leading stroke units in the country, 
but higher than treatment costs in general departments in other public hospitals without a 
specialist stroke unit. With this caveat, our estimates of costs of stroke should provide a 
reliable, evidence-based guide for public health practitioners and health policy-makers in Viet 
Nam. 
Our study has several strengths. First, we calculated the costs of stroke from a societal 
perspective. Our costs included direct medical costs and also non-medical costs and loss of 
income that are rarely reported in other studies due to procedural complexities in data 
collection. Most cost-of-illness studies have reported direct medical costs sourced from 
hospital administrative systems. Our findings provide a fuller and broader account of the costs 
of stroke in Viet Nam. Second, we conducted a prospective cohort study collecting clinical 
information from a treating neurologist, direct medical costs from the hospital administrative 
system, and non-medical costs and out-of-pocket expenses of patients and their caregivers as 
they occurred. There was less reliance on recall by patients or caregivers than would have 
occurred in a retrospective study, Third, rather than using possibly non-representative data on 
income and expenditure of the general population published by the General Statistics Office 
in Ho Chi Minh City, we collected information on the actual income and expenditure of a 
well-ascertained sample of our patient population to estimate the costs of stroke treatment. 
That this sample was recruited with high response proportions and minimal drop-out is a 
further strength. 
However, our study has some limitations. First, all information on income and expenditure 
was collected by self-report of patients and their caregivers. The summary values appeared 
plausible in comparison with published data for the general population, but it might be subject 
to bias. Second, the direct medical costs used in this study are sourced from administrative 
charges that are influenced by government policy in respect of subsidisation of hospital 
treatment, and may not reflect adequately the true economic costs of treatment.  Last, our 
findings on treatment costs extrapolate to major public hospitals with sophisticated stroke 
units. In addition, the non-medical costs and loss of income calculated in this study may not 
be representative of all stroke patients because our stroke patients had high incomes relative 
to the general population. 
 
5.6. Conclusion 
For the first time we present comprehensive estimates of the costs of hospital care for stroke 
in Viet Nam. Severity of stroke, LOS and household wealth were the major predictors of cost. 
Despite relatively short average LOS, the average out-of-pocket expenditure on direct medical 
costs was in the middle range of estimates for LMICs. Total direct and indirect costs 
amounted to almost two times median annual income of insured patients, and almost 3 times 
that of non-insured patients.  
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5.7. Postscript 
This chapter has presented findings on the economic aspect of the burden of stroke including 
direct (medical and non-medical) and indirect costs during the hospitalisation. Severity of 
stroke, haemorrhagic stroke, LOS in hospital and the affluence of patient’s families are found 
to be factors related to costs of stroke during hospitalisation. A chapter that follows (Chapter 
7) reports on a study of the patient-centred outcome of HRQoL. There were not any tested 
HRQoL instruments available for use in stroke patients in Viet Nam at the time that study was 
conducted, however, and that made it necessary to assess the reliability and validity of the 
instrument selected. That instrument was the Duke Health Profile (DHP). The next chapter 
(Chapter 6) reports an assessment of the DHP for use with stroke patients or their caregivers. 
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Appendix 5: Additional findings on costs of stroke 
 
Table A5.1: Characteristics of a cohort of patients with first-ever stroke in Ho Chi Minh 
City, Viet Nam, on discharge from hospital. * 
 Men (N=229) Women (N=208) 
Ethnicity †    
 
Vietnamese 91.7% (210) 91.5% (190) 
Chinese 8.3% (19) 8.7% (18) 
Marital status †     
Married 89.1% (204) 55.9% (115) 
Single 5.2% (12) 6.2% (13) 
Divorced 2.2% (5) 1.9% (4) 
Widower/widow 3.5% (8) 36.0% (76) 
Living with spouse  †     
Yes 76.7% (173) 36.6% (75) 
No – living with children 17.6% (40) 56.1% (115) 
No – living with others 5.7% (13) 7.3% (15) 
Wealth index †  
 
 
 
1st quarter (richest) 27.4% (61) 22.3% (46) 
2nd quarter 21.5% (48) 21.4% (44) 
3rd quarter 27.8% (62) 24.3% (50) 
4th quarter (poorest) 23.3% (52) 32.0% (66) 
BMI †    
 
Mean (SD‡) 22.8 (3.2) 22.9 (4.0) 
Underweight (BMI< 18.5) 9.6% (22) 13.0% (27) 
Normal (18.5 ≤ BMI < 23.0) 42.4% (97) 39.1% (81) 
Overweight (23.0 ≤ BMI < 27.5) 39.7% (91) 37.2% (77) 
Obese (BMI≥ 27.5) 8.3% (19) 10.6% (22) 
Comorbidity †  
 
 
 
No 74.3% (170) 67.3% (140) 
1 comorbidity 18.3% (42) 23.6% (49) 
2+ comorbidities 7.4% (17) 9.1% (19) 
Pre-disability †  
 
 
 
Yes 4.8% (11) 9.6% (20) 
No 95.2% (219) 90.4% (191) 
* The cohort consisted of 450 patients, 9 of whom died in-hospital prior to commencement of follow-up and 4 of 
whom had incomplete hospital cost data. This information is provided for the 437 patients alive at discharge 
with complete hospital cost data. 
† Patient self-report. 
‡ SD = standard deviation 
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Table A5.2: Comparison of members of the cohort of stroke patients from 115 People’s 
Hospital in Ho Chi Minh City with the general population. 
 Stroke patients General population 
All persons* 
    
Monthly average income per person †     
Median (IQR‡) 2,000,000 (1,560,000)   
Mean (SD§) 2,641,000 (2,179,000) 3,399,000  
1st fifth of distribution 891,000 (290,000) 1,230,000  
2nd fifth of distribution 1,544,000 (134,000) 1,960,000  
3rd fifth of distribution 2,092,000 (160,000) 2,599,000  
4th fifth of distribution 2,892,000 (300,000) 3,470,000  
5th fifth of distribution 5,911,000 (2,946,000) 7,717,000  
     
Average number of person per household 4.1  3.8  
Average monthly expenditure/person †      
Median (IQR‡) 1,500,000 (1,000,000)   
Mean (SD§) 1,708,000 (1,076,000) 2,363,000  
1st fifth of distribution 709,000 (164,000) 1,209,000  
2nd fifth of distribution 1,110,000 (105,000) 1,780,000  
3rd fifth of distribution 1,480,000 (110,000) 2,115,000  
4th fifth of distribution 1,963,000 (159,000) 2,512,000  
5th fifth of distribution 3,328,000 (1,276,000) 4,165,000  
Household assets: percentage with     
Telephone 97.7% (422/432) 93.4%  
Television 99.8% (431/432) 94.3%  
VCD/DVD player 87.2% (375/430) 57.0%  
Air conditioner 26.5% (114/430) 23.2%  
Refrigerator 90.0% (387/431) 66.1%  
Hot water system 26.9% (116/431) 21.2%  
Computer 47.6% (205/431) 41.9%  
Motor cycle 94.2% (407/432) 93.9%  
Car 3.5% (15/432) 2.7%  
Education     
<Primary school 32.3% (141/437) 12.1%  
Primary school 25.6% (112/437) 21.5%  
Secondary school 19.2% (84/437) 28.1%  
Higher secondary 14.9% (65/437) 25.0%  
College/university 8.0% (35/437) 13.3%  
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 Stroke patients General population 
Persons aged 25–64 years ¶ 
    
Monthly income per person# †     
Median (IQR‡) 2,062,000 (1,805,000) 1,400,000 (1,500,000) 
Mean (SD§) 2,715,000 (2,359,000) 1,791,000 (1,590,000) 
1st fifth of distribution 849,000 (318,000) 470,000 (211,000) 
2nd fifth of distribution 1,525,000 (126,000) 987,000 (88,000) 
3rd fifth of distribution 2,089,000 (163,000) 1,492,000 (1,591,000) 
4th fifth of distribution 2,880,000 (303,000) 2,187,000 (238,000) 
5th fifth of distribution 6,060,000 (3,107,000) 4,355,000 (1,945,000) 
Average number of person# per household 4.1 (2.5) 3.4 (1.8) 
Education     
<Primary school 21.2% (52/245) 15.9% (257/1615) 
Primary school 24.5% (60/245) 21.1% (341/1615) 
Secondary school 25.3% (62/245) 22.4% (361/1615) 
Higher secondary 19.2% (47/245) 24.7% (398/1615) 
College/university 9.8% (24/245) 16.0% (258/1615) 
Education (males)     
<Primary school 14.8% (22/149) 11.1% (80/725) 
Primary school 19.5% (29/149) 20.2% (146/725) 
Secondary school 26.5% (38149) 22.4% (163/725) 
Higher secondary 26.2% (39/149) 27.1% (196/725) 
College/university 14.2% (21/149) 19.2% (140/725) 
Education (females)     
<Primary school 31.3% (30/96) 23.4% (208/890) 
Primary school 32.3% (31/96) 22.5% (200/890) 
Secondary school 25.0% (24/96) 22.3% (198/890) 
Higher secondary 8.3% (8/96) 20.9% (186/890) 
College/university 3.1% (3/96) 11.0% (98/890) 
* Data for the Ho Chi Minh City general population taken from the report from General Statistics Office of Ho 
Chi Minh City, Viet Nam for the year 2012. For these comparisons, the general population data have not been 
weighted to age, sex and urban/rural distribution of the cohort of generally older stroke patients. 
† Expressed in Viet Nam Dong (VND). 
‡ IQR = interquartile range, expressed as 75th percentile less 25th percentile of the distribution. 
§ SD = standard deviation. 
¶ Data for the Ho Chi Minh City general population taken from the Viet Nam STEPS Survey 2009–10 (Bui et al, 
2015) and re-weighted to the age, sex and urban/rural distribution of the cohort of stroke patients. 
# Number of persons per household includes children less than 18 years old of age living in the households of 
stroke patients, but is restricted to adults 18 years or older in the general population taken from the Viet Nam 
STEPS Survey 2009–10.   
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Table A5.3: Direct medical costs (USD) of treatment of stroke patients at 115 People’s Hospital, Ho Chi Minh City, and associations with 
other putative explanatory factors. 
  LOS (days)   Mean costs (USD) and ratios of means  
 Mean (SD) Median (IQR) Mean (SD) Ratio (95% CI)* Ratio (95% CI)† 
Disability before stroke 
          
No 4.3 (6.5) 386 (282, 562) 555 (564) 1.00  1.00  
Yes 6.7 (3.0) 397 (287, 636) 623 (554) 1.05 (0.83, 1.27) 1.02 (0.85, 1.20) 
Smoking           
No 6.7 (4.3) 391 (287, 590) 586 (590) 1.00  1.00  
Yes 6.3 (4.0) 377 (270, 536) 501 (493) 0.91 (0.78, 1.04) 0.96 (0.85, 1.07) 
Alcohol consumption 
          
No 6.6 (4.2) 387 (287, 578) 579 (561) 1.0  1.00  
Yes 6.5 (4.3) 383 (266, 541) 535 (566) 0.89 (0.73, 1.05) 0.94 (0.79, 1.08) 
High blood pressure           
No 6.6 (4.2) 383 (270, 541) 547 (549) 1.00  1.00  
Yes 6.5 (4.3) 387 (287, 578) 574 (578) 1.03 (0.92, 1.14) 1.03 (0.94, 1.13) 
BMI 
          
Underweight (BMI< 18.5) 7.0 (4.3) 324 (258, 599) 613 (707) 1.0  1.00  
Normal (18.5≤ BMI ≤ 22.9) 6.5 (4.2) 368 (268, 565) 537 (556) 1.05 (0.88, 1.23) 1.13 (0.97, 1.28) 
Overweight(23.0 ≤BMI≤ 27.4) 6.4 (4.0) 389 (289, 561) 548 (457) 1.13 (0.94, 1.32) 1.23 (1.05, 1.40) 
Obese (BMI≥ 27.5) 7.0 (5.1) 464 (306, 569) 653 (772) 1.27 (0.97, 1.57) 1.31 (1.06, 1.57) 
Trend       P= 0.03 P= 0.003 
* Ratio of means (95% confidence interval) adjusted for age and sex. 
† Ratio of means (95% confidence interval) adjusted for age, sex, severity of impairment. 
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Table A5.4. Distribution of medical resource use by severity of impairment of stroke. 
  NIHSS≤ 7 (N=232)   NIHSS> 7 (N=187)   Ratio of means  
 mean (SD) median (IQR) mean (SD) median (IQR) ratio 95%CI 
Consultant fees 1.4 (1.4) 1.5 (0.3, 1.5) 1.3 (0.8) 1.5 (0.3, 1.5) 1.06 (0.87, 1.24) 
Bed-day fees 95.9 (81.2) 77.6 (62.1, 108.7) 166.5 (143.8) 124.3 (77.6, 186.4) 1.58 (1.39, 1.77) 
Lab tests 53.5 (20.6) 50.3 (44.8, 54.2) 63.9 (35.5) 54.4 (47.9, 67.7) 1.14 (1.07, 1.21) 
Diagnostic imaging 171.8 (96.3) 133 (117, 221) 190.7 (105.8) 148.6 (126.5, 248.1) 1.10 (0.98, 1.23) 
Rehabilitation* 3.0 (18.1) 0 (0,0) 45.7 (214.4) 6.3 (0, 18.4) 26.97 (9.90, 44.03) 
Medications 48.5 (134.3) 18.8 (12.2, 30.0) 276.7 (485.2) 52.6 (24.2, 302.2) 3.43 (2.53, 4.32) 
Medical consumables 3.1 (6.6) 0.6 (0, 3.0) 14.1 (19.9) 8.7 (3.0, 18.6) 17.05 (8.15, 25.94) 
Meals and feeding† 0.31 (2.7) 0 (0, 0) 2.2 (11.0) 0 (0,0) 4.69 (-4.02, 13.41) 
Other  11.4 (7.1) 9.6 (7.5, 12.5) 20.1 (13.0) 16.7 (11.7, 25.0) 1.65 (1.49, 1.81) 
Total 390.9 (256.3) 308.0 (263.4, 452.7) 786.3 (754.0) 506.8 (346.4, 941.1)   
* includes physiotherapy and costs of minor surgical procedure 
† included special diet and feeding 
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Table A5.5. Distribution of medical resource use by length of stay (LOS). 
  LOS< 6 (N=218)   LOS≥ 6 (N=219)   Ratio of means  
 mean (SD) median (IQR) mean (SD) median (IQR) diff 95% CI 
Consultant fees 1.4 (1.4) 1.6 (0.3, 1.6) 1.3 (0.8) 1.6 (0.3, 1.6) 0.93 (0.78, 1.09)  
Bed-day fees 68.8 (37.4) 62.2 (46.6, 77.7) 185.4 (139.1) 134.6 (108.8, 207.2) 2.38 (2.16, 2.61) 
Lab tests 52.4 (16.2) 50.3 (44.7, 54.4) 63.6 (36.0) 53.2 (47.3, 65.5) 1.13 (1.06, 1.20) 
Diagnostic imaging 164.3 (90.7) 133.1 (116.2, 193.9) 192.6 (107.0) 148.7 (126.9, 247.1) 1.16 (1.03, 1.29) 
Rehabilitation* 21.9 (182.8) 0 (0,0) 21.6 (84.9) 5.2 (0, 15.5) 10.05 (4.08, 16.03) 
Medications 70.2 (206.4) 16.0 (10.4, 24.2) 223.8 (438.4) 47.3 (27.2, 138.0) 3.65 (2.77, 4.54) 
Medical consumables 3.8 (7.7) 0.9 (0, 4.4) 12.5 (18.9) 8.3 (0.8, 15.8) 7.94 (3.64, 12.24) 
Meals and feeding† 0.3 (2.6) 0 (0,0) 2.1 (10.5) 0 (0,0) 4.09 (-3.39, 11.59) 
Other  9.2 (3.1) 8.7 (7.1, 10.4) 21.5 (12.5) 18.5 (13.2, 26.8) 2.08 (1.93, 2.24) 
Total 392.6 (382.5) 286.8 (251.2, 413.0) 727.2 (657.2) 522.3 (378.0, 851.6)   
* includes physiotherapy and costs of minor surgical procedure 
† included special diet and feeding 
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Table A5.6: Average direct non-medical costs (USD) of treatment of stroke patients at 115 People’s Hospital, Ho Chi Minh City, and 
associations with putative explanatory factors. 
   Mean costs and ratio of means (N=437)  
 Median IQR Mean SD Ratio   (95% CI)* Ratio (95% CI)† 
All patient 104 (64, 168) 168 (482)     
Sex         
Male 103 (62, 154) 175 (626) 1.00  1.00  
Female 106 (68, 171) 161 (241) 1.13 (0.91, 1.36) 1.10 (0.90, 1.31) 
Age group 
        
< 45 years 98 (63, 173) 147 (161) 1.00  1.00  
45-54 years 93 (67, 150) 223 (949) 1.00 (0.62, 1.37) 1.12 (0.72, 1.52) 
55-64 years 95 (51, 146) 119 (106) 0.74 (0.46, 1.02) 0.90 (0.58, 1.22) 
65-74 years 114 (66, 191) 166 (179) 1.00 (0.62, 1.38) 1.04 (0.66, 1.42) 
75+ years 115 (74, 201) 179 (301) 1.07 (0.67, 1.47) 1.05 (0.67, 1.43) 
P value     P=0.52  P=0.99  
Wealth index 
        
4th quarter (richest) 114 (63, 199) 149 (128) 1.00  1.00  
3rd quarter 100 (67, 206) 262 (981) 1.13 (0.80, 1.46) 1.22 (0.89, 1.56) 
2nd quarter 105 (65, 162) 167 (297) 1.03 (0.74, 1.31) 1.07 (0.79, 1.35) 
1st quarter (poorest) 98 (61, 145) 114 (89) 0.85 (0.61, 1.09) 0.91 (0.67, 1.15) 
P value     P=0.18  P=0.32  
Health insurance 
        
No 98 (65, 153) 183 (666) 1.00  1.00  
Yes 109 (63, 171) 156 (228) 0.98 (0.77, 1.18) 0.98 (0.79, 1.17) 
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   Mean costs and ratio of means (N=437)  
 Median IQR Mean SD Ratio   (95% CI)* Ratio (95% CI)† 
Comorbidity 
        
No comorbidity 104 (65, 160) 179 (566) 1.00  1.00  
1 comorbidity 94 (52, 159) 131 (138) 0.85 (0.63, 1.06) 0.86 (0.65, 1.06) 
2-6 comorbidities 151 (89,233) 174 (116) 1.14 (0.73, 1.54) 0.94 (0.61, 1.26) 
P value     P=0.91  P=0.33  
Type of stroke         
IS 96 (62, 152) 126 (112) 1.0  1.00  
ICH 135 (83, 254) 302 (954) 1.60 (1.25, 1.95) 1.19 (0.90, 1.47) 
Severity of impairment¶         
Not severe (NIHSS ≤ 7) 90 (61, 129) 148 (618) 1.0  1.00  
Severe (NIHSS > 7) 135 (74, 229) 188 (253) 1.50 (1.21, 1.80) 1.25 (1.00, 1.49) 
Severity of disability#         
Least severe (mRS 0/1) 87 (63, 105) 83 (43) 1.00  1.00  
Intermediate (mRS 2/3) 94 (61, 148) 174 (720) 1.36 (0.89, 1.86) 1.24 (0.83, 1.66) 
Most severe (mRS 4/5) 121 (74, 211) 183 (249) 1.74 (1.13, 2.36) 1.24 (0.78, 1.70) 
P value     P=0.002  P=0.38  
Length of stay         
0-4 days 77 (47, 108) 88 (80) 1.00  1.00  
5-7 days 155 (92, 284) 277 (773) 2.44 (1.89, 2.99) 2.09 (1.59, 2.58) 
8+ days 107 (68, 152) 125 (91) 1.50 (1.13, 1.87) 1.38 (1.04, 1.72) 
P value     P=0.002  P=0.002  
* Ratio of means (95%CI) adjusted for age, sex. 
† Ratio of means (95%CI) adjusted for age, sex, severity of impairment and LOS. 
¶ Severity of impairment assessed on the National Institutes of health Stroke Scale (NIHSS). 
# Severity of disability assessed on the modified Rankin Scale (mRS). 
 134 
 
 
 
Table A5.7: Direct non-medical costs (USD) of treatment of stroke patients at 115 People’s Hospital, Ho Chi Minh City, and 
associations with other putative explanatory factors. 
   Mean costs and ratio of means  
 Median IQR Mean SD Ratio   (95% CI)* Ratio (95% CI)
† 
Disability before stroke 
        
No 106 (65, 168) 171 (503) 1.00  1.00  
Yes 114 (80, 205) 170 (135) 1.22 (0.82, 1.61) 1.22 (0.86, 1.57) 
Smoking         
No 104 (67, 171) 188 (577) 1.00  1.00  
Yes 109 (66, 157) 133 (107) 0.96 (0.75, 1.17) 1.02 (0.82, 1.22) 
Alcohol consumption         
No 104 (68, 172) 160 (226) 1.00  1.00  
Yes 109 (62, 154) 188 (703) 0.93 (0.67, 1.20) 1.02 (0.76, 1.29) 
High blood pressure         
No 104 (63, 160) 192 (661) 1.00  1.00  
Yes 108 (71, 170) 148 (132) 1.03 (0.86, 1.20) 1.06 (0.90, 1.22) 
BMI         
Underweight (BMI < 18.5) 118 (78, 181) 152 (126) 1.00  1.00  
Normal (18.5 ≤ BMI ≤ 22.9) 107 (66, 172) 218 (748) 0.95 (0.68, 1.21) 1.02 (0.76, 1.28) 
Overweight(23.0 ≤ BMI≤ 27.4) 100 (62, 161) 137 (123) 0.89 (0.64, 1.14) 0.97 (0.72, 1.22) 
Obese (BMI≥ 27.5) 100 (77, 162) 139 (111) 0.97 (0.62, 1.33) 0.97 (0.64, 1.30) 
Trend     P= 0.61 P= 0.62 
* Ratio of means (95%CI) adjusted for age, sex. 
† Ratio of means (95%CI) adjusted for age, sex, severity of impairment and LOS. 
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Table A5.8: Average direct non-medical costs (USD) of treatment of stroke patients at 115 People’s Hospital, Ho Chi Minh City, and 
associations with other putative explanatory factors. 
   Mean costs and ratio of means  
 Median IQR Mean SD Ratio   (95% CI)* Ratio (95% CI)† 
Disability before stroke 
        
No 104 (63, 165) 169 (499) 1.00  1.00  
Yes 113 (78, 205) 165 (137) 1.12 (0.69, 1.54) 1.15 (0.73, 1.56) 
Smoking         
No 103 (65, 170) 185 (572) 1.00  1.00  
Yes 109 (63, 154) 131 (107) 0.99 (0.72, 1.25) 1.09 (0.81, 1.36) 
Alcohol consumption         
No 104 (68, 172) 158 (225) 1.00  1.00  
Yes 107 (61, 150) 182 (692) 0.85 (0.57, 1.14) 0.97 (0.66, 1.29) 
High blood pressure         
No 103 (62, 159) 191 (658) 1.00  1.00  
Yes 107 (66, 170) 144 (132) 0.92 (0.73, 1.11) 0.97 (0.78, 1.15) 
BMI         
Underweight (BMI< 18.5) 108 (76, 178) 145 (127) 1.00  1.00  
Normal (18.5 ≤ BMI≤ 22.9) 106 (63, 170) 213 (740) 1.07 (0.71, 1.43) 1.18 (0.80, 1.56) 
Overweight(23.0≤ BMI ≤27.4) 100 (62, 161) 136 (123) 1.03 (0.67, 1.38) 1.10 (0.74, 1.46) 
Obese (BMI ≥ 27.5) 96 (77, 145) 136 (112) 1.02 (0.56, 1.48) 0.93 (0.52, 1.33) 
Trend     P= 0.90 P= 0.56 
* Ratio of means (95%CI) adjusted for age, sex. 
† Ratio of means (95%CI) adjusted for age, sex, severity of impairment and LOS. 
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Table A5.9: Average indirect costs (USD) of treatment of stroke patients at 115 People’s Hospital, Ho Chi Minh City, and associations 
with putative explanatory factors.  
   Mean costs and ratios of means  
 Median IQR Mean SD Ratio (95% CI)* Ratio  (95% CI)† 
All patient 62 (0, 186) 172 (349)     
Sex 
        
Male 62 (0, 166) 187 (401) 1.00  1.00  
Female 62 (0, 186) 156 (280) 1.47 (0.66, 2.29) 1.23 (0.55, 1.90) 
Age group 
        
<45 years 124 (62, 249) 243 (367) 1.00  1.00  
45-54 years 120 (36, 186) 204 (415) 0.56 (0.06, 1.06) 0.60 (0.07, 1.12) 
55-64 years 55 (0, 186) 189 (405) 0.29 (0.03, 0.55) 0.37 (0.04, 0.70) 
65-74 years 21 (0, 141) 118 (199) 0.09 (0, 0.18) 0.10 (0, 0.21) 
75+ years 29 (0, 155) 141 (308) 0.13 (0, 0.26) 0.12 (0, 0.25) 
Trend     P< 0.001 P< 0.001 
Wealth index 
        
4th quarter (richest) 62 (0, 259) 251 (477) 1.00  1.00  
3rd quarter 85 (19, 224) 219 (397) 1.55 (0.34, 2.76) 1.89 (0.44, 3.33) 
2nd quarter 67 (9, 168) 126 (164) 1.01 (0.23, 1.79) 1.05 (0.26, 1.85) 
1st quarter (poorest) 43 (0, 140) 113 (291) 0.55 (0.11, 0.98) 0.63 (0.13, 1.12) 
Trend     P= 0.06 P= 0.09 
Health insurance 
        
No 62 (0, 155) 166 (375) 1.00  1.00  
Yes 62 (0, 197) 177 (325) 1.45 (0.61, 2.30) 1.37 (0.59, 2.15) 
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   Mean costs and ratios of means  
 Median IQR Mean SD Ratio (95% CI)* Ratio  (95% CI)† 
Comorbidity 
        
No comorbidity 73 (0, 186) 193 (394) 1.00  1.00  
1 comorbidity 41 (0, 160) 114 (167) 0.53 (0.14, 0.92) 0.44 (0.11, 0.77) 
2-6 comorbidities 56 (0, 171) 141 (249) 0.56 (0, 1.17) 0.45 (0, 0.94) 
Trend     P= 0.05 P= 0.007 
Type of stroke         
IS 58 (0, 155) 155 (322) 1.00  1.00  
ICH 93 (8, 225) 227 (419) 1.43 (0.51, 2.35) 1.05 (0.29, 1.81) 
Severity of impairment¶         
Not severe (NIHSS ≤ 7) 50 (0, 140) 131 (287) 1.00  1.00  
Severe (NIHSS > 7) 86 (0, 228) 224 (416) 1.94 (0.86, 3.02) 1.70 (0.72, 2.69) 
Severity of disability#         
Least severe (mRS 0/1) 38 (0, 128) 97 (154) 1.00  1.00  
Intermediate (mRS 2/3) 62 (5, 150) 158 (367) 2.55 (0, 5.33) 1.76 (0.01, 3.51) 
Most severe (mRS 4/5) 86 (0, 212) 202 (366) 3.77 (0, 7.76) 1.58 (0, 3.34) 
Trend     P= 0.05 P= 0.60 
Length of stay         
0-4 days 41 (0, 120) 104 (235) 1.00  1.00  
5-7 days 83 (0, 259) 245 (475) 2.45 (0.79, 4.11) 1.61 (0.48, 2.73) 
8+ days 88 (19, 188) 158 (236) 2.42 (0.69, 4.16) 1.95 (0.59, 3.31) 
Trend     P= 0.05 P= 0.11 
* Ratio of means (95%CI) adjusted for age, sex. 
† Ratio of means (95%CI) adjusted for age, sex, severity of impairment and LOS. 
¶ Severity of impairment assessed on the National Institutes of Health Stroke Scale (NIHSS). 
# Severity of disability assessed on the modified Rankin Scale (mRS). 
Figures in bold in table indicate that the risk ratios is statiscally significant at the 95% confidence level 
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Table A5.10: Indirect costs (USD) of treatment of stroke patients at 115 People’s Hospital, Ho Chi Minh City, and associations with 
other putative explanatory factors. 
   Mean costs and ratio of means  
 Median IQR Mean SD Ratio   (95% CI)* Ratio (95% CI)† 
Disability before stroke 
        
No 124 (56, 249) 242 (392) 1.00  1.00  
Yes 82 (21, 155) 222 (402) 0.71 (0.31, 1.11) 0.81 (0.37, 1.24) 
Smoking         
No 108 (41.4, 233.0) 216 (319) 1.00  1.00  
Yes 136 (70.3, 343.7) 295 (512) 1.47 (0.93, 2.02) 1.57 (1.02, 2.12) 
Alcohol consumption         
No 120 (48, 254) 229 (322) 1.00  1.00  
Yes 124 (62, 230) 256 (472) 0.87 (0.44, 1.29) 0.83 (0.45, 1.22) 
High blood pressure         
No 130 (62, 249) 264 (461) 1.00  1.00  
Yes 93 (50, 249) 216 (289) 0.93 (0.67, 1.19) 0.94 (0.69, 1.18) 
BMI         
Underweight (BMI < 18.5) 103 (51, 311) 261 (378) 1.00  1.00  
Normal (18.5 ≤ BMI ≤ 22.9) 94 (41, 207) 205 (351) 0.77 (0.43, 1.11) 0.92 (0.53, 1.31) 
Overweight(23.0 ≤ BMI≤ 27.4) 136 (62, 346) 275 (408) 0.99 (0.54, 1.43) 1.10 (0.62, 1.58) 
Obese (BMI≥ 27.5) 158 (93, 316) 235 (221) 1.15 (0.45, 1.84) 1.32 (0.53, 2.11) 
Trend     P= 0.29 P= 0.20 
* Ratio of means (95%CI) adjusted for age, sex. 
† Ratio of means (95%CI) adjusted for age, sex, severity of impairment and LOS. 
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Table A5.11: Average indirect costs (USD) of treatment of stroke patients at 115 People’s Hospital, Ho Chi Minh City, and 
associations with other putative explanatory factors. 
   Mean costs and ratio of means  
 Median IQR Mean SD Ratio   (95% CI)* Ratio (95% CI)† 
Disability before stroke 
        
No 67 (0, 186) 175 (350) 1.00  1.00  
Yes 17 (0, 93) 137 (331) 0.56 (0, 1.22) 0.57 (0, 1.25) 
Smoking         
No 50 (0, 176) 149 (283) 1.00  1.00  
Yes 91 (17, 218) 227 (466) 2.46 (0.59, 4.34) 2.84 (0.74, 4.95) 
Alcohol consumption         
No 62 (0, 190) 164 (292) 1.00  1.00  
Yes 65 (0, 155) 182 (414) 0.89 (0.04, 1.74) 0.91 (0.05, 1.76) 
High blood pressure         
No 87 (10, 186) 197 (416) 1.00  1.00  
Yes 50 (0, 166) 145 (257) 0.63 (0.26, 1.00) 0.62 (0.27, 0.98) 
BMI         
Underweight (BMI< 18.5) 62 (21, 176) 197 (347) 1.00  1.00  
Normal (18.5≤BMI≤ 22.9) 60 (0, 149) 149 (312) 0.55 (0.07, 1.03) 0.64 (0.08, 1.21) 
Overweight (23.0≤ BMI≤ 27.4) 70 (0, 214) 194 (409) 0.53 (0.05, 1.00) 0.60 (0.06, 1.15) 
Obese (BMI≥ 27.5) 93 (0, 186) 155 (211) 0.36 (0, 0.80) 0.38 (0, 0.87) 
Trend     P= 0.11 P= 0.14 
* Ratio of means (95%CI) adjusted for age, sex. 
† Ratio of means (95%CI) adjusted for age, sex, severity of impairment and LOS. 
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Table A5.12: Average indirect costs (USD) of treatment of stroke patients at 115 People’s Hospital, Ho Chi Minh City, and 
associations with other putative explanatory factors. 
   Mean costs and ratio of means  
 Median IQR Mean SD Ratio   (95% CI)* Ratio (95% CI)† 
Disability before stroke 
        
No 620 (424, 1013) 899 (904) 1.00  1.00  
Yes 595 (411, 807) 924 (903) 0.98 (0.76, 1.20) 0.97 (0.79, 1.14) 
Smoking         
No 630 (419, 1028) 920 (952) 1.00  1.00  
Yes 610 (432, 953) 859 (780) 0.94 (0.80, 1.09) 1.02 (0.90, 1.15) 
Alcohol consumption         
No 620 (417, 1029) 902 (821) 1.00  1.00  
Yes 617 (436, 974) 899 (1005) 0.90 (0.72, 1.08) 0.97 (0.81, 1.12) 
High blood pressure         
No 611 (436, 1010) 936 (1049) 1.00  1.00  
Yes 639 (417, 1016) 863 (714) 0.99 (0.87, 1.10) 1.00 (0.90, 1.09) 
BMI         
Underweight (BMI < 18.5) 570 (463, 1132) 955 (844) 1.00  1.00  
Normal (18.5≤ BMI≤ 22.9) 602 (411, 918) 900 (1101) 0.94 (0.76, 1.12) 1.03 (0.87, 1.19) 
Overweight (23.0≤ BMI≤ 27.4) 640 (421, 1057) 878 (691) 1.00 (0.81, 1.20) 1.11 (0.93, 1.28) 
Obese (BMI ≥ 27.5) 698 (541, 1223) 944 (810) 1.11 (0.82, 1.40) 1.13 (0.89, 1.37) 
Trend     P= 0.25 P= 0.09 
* Ratio of means (95%CI) adjusted for age, sex. 
† Ratio of means (95%CI) adjusted for age, sex, severity of impairment and LOS. 
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Chapter 6: Health-related quality of life after stroke: reliability 
and validity of the Duke Health Profile for use in Viet Nam 
 
6.1. Preface 
Health-related quality of life (HRQoL) is one of outcomes following a stroke that was 
assessed at three months in the cohort study. However, there was not an instrument available 
that had been examined for reliability and validity in use with stroke patients in Viet Nam. 
This chapter presents findings of an assessment of the reliability and validity of the Duke 
Health Profile that was the instrument used to assess the HRQoL of stroke survivors three 
months after stroke in the cohort study. The text of this chapter is accepted for  publication in 
the International Journal of Quality of Life Research [1]. The appendix is online 
supplementary data for the publication.  
 
6.2. Introduction 
HRQoL is an important patient-centred outcome following a stroke. There are several 
instruments designed to assess HRQoL. They include generic instruments (such as the Short 
Form 36, the Assessment of Quality of Life, the Sickness Impact Profile and the EuroQoL) 
and stroke-specific instruments (such as the Stroke Impact Scale and the Stroke Specific 
Quality of Life Scale). The Duke Health Profile (DHP) is a generic instrument that includes a 
wide range of dimensions not covered by some other instruments. It has been used for patients 
with cardiac failure [217], atrial fibrillation [218] and dementia [219]. For these reasons, and 
because the DHP had been translated and culturally adapted for use among adolescents in 
Viet Nam [212], and comparative data for the general adult population were available for this 
instrument [213], we selected it  for measurement of HRQoL in a three-month follow-up 
study of stroke patients in Ho Chi Minh City, Viet Nam.  
The problem in so doing was that the DHP had not been validated for use with stroke patients. 
Examination of the psychometric properties of an instrument when applied in novel 
circumstances is important. This prompted us to undertake a study of the reliability and 
validity of the DHP for use with stroke patients in Viet Nam. This would also provide novel 
information about the use of the DHP with stroke patients worldwide. 
A possibly important issue was to ascertain whether proxy respondents could provide reliable 
information for patients who were cognitively impaired or otherwise in poor health. The DHP 
has not been validated for completion by a proxy respondent, and undertaking a validation 
study of proxy reports was also important as a precursor for monitoring the outcomes of 
stroke in Viet Nam and to provide information relevant for understanding the limitations of 
proxy responses to the DHP in other cultural settings. 
The objectives of this study were to assess the reliability and validity of assessments of 
HRQoL from patient and proxy responses to the DHP. We did so in the advantageous 
circumstances of a follow-up study with near complete ascertainment and recruitment of 
stroke patients admitted with subsequent confirmation of diagnosis by neuroimaging to a 
major public hospital with a specialist stroke unit in Ho Chi Minh City, Viet Nam. 
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6.3. Methods 
Subjects 
This study was part of a cohort study of first-ever stroke patients (n=545) admitted to the 
Cerebrovascular Disease Department at 115 People’s Hospital during the period 05/02/2012 
to 15/09/2012. Stroke was diagnosed by neurologists using standard clinical criteria and brain 
imaging to confirm type (ischaemic or haemorrhagic) [3]. The cohort study was preceded by a 
pilot study from February 2012 to May 2012. The current sample was recruited from 
participants in the pilot and main studies. Inclusion criteria for stroke patients were (1) 
absence of cognitive impairment preventing communication with study personnel or 
comprehension of study requirements, (2) willingness to be contacted again after three 
months, and (3) willingness to have the DHP and EQ-5D instruments administered at that 
time and re-administered after 1 week. Inclusion criteria for caregivers were (1) being the 
daily caregiver of the stroke patient, and (2) willingness to provide responses to the DHP and 
the EQ-5D on behalf of the patient at the three-month contact and again one week later. 
Data collection 
Within the first 24 hours following admission, data were gathered on demographics and 
clinical presentation including stroke type and health status prior stroke. Severity of 
impairment following stroke was assessed by a neurologist using the National Institutes of 
Health Stroke Scale (NIHSS) [122] that grades severity according to clinical manifestations 
with scores ranging from 0 (no symptom) to 42 (very severe). Disability  was assessed on the 
modified Rankin Scale (mRS) that grades functional impairments with scores ranging from 0 
(no symptom) to 6 (death) [115]. At three months after stroke, patients and their proxies self-
administered the DHP and a comparison instrument (EuroQoL EQ-5D), under the supervision 
of study staff (time 1). Instruments were re-administered 1 week later (time 2). Patients and 
proxies completed questionnaires separately when possible. The study staff responded to 
questions from participants, but provided pre-scripted answers where possible. Disability at 
three months was assessed using the mRS. 
HRQoL Instruments 
The DHP is a generic self-report instrument referenced to today or the last 7 days (full details 
are in the online supplement). In brief, there are six domains referring to health function 
(higher scores = better health): physical health, mental health, social health, general health, 
perceived health and self-esteem. Four domains refer to health dysfunction (higher scores = 
poorer health): anxiety, depression, pain and disability. With scoring reversed for those four 
domains, the scores on each domain range from 0 (poorest health) to 100 (best possible 
health). The DHP has previously been translated into the Vietnamese language (with accuracy 
of translation verified by back translation) [212].  
The EQ-5D comprises 5 domains: mobility, self-care, usual activities, pain/discomfort and 
anxiety/depression (full details in online supplement). The EQ VAS records the respondent’s 
self-rated health on a visual analogue scale with the endpoints labelled as “best imaginable 
health state” and “worst imaginable health state”. The overall EQ-5D utility score (range: -
0.263 [worst] to 1 [best]) was computed using weights for the South Korean general 
population [296] in the absence of a value set for Viet Nam. 
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Statistical Analysis 
For each DHP dimension, mean scores were calculated over non-missing item scores and with 
stratification by study factors (sex, age, type of stroke, stroke severity at admission, disability 
at admission and at three months post stroke).  
Absolute reliability was assessed by paired t-tests of the test-retest differences on each DHP 
and EQ-5D dimension and by calculating the standard error of measurement (SEM) and 
minimal detectable difference (MDD). Linear regression was used to assess whether 
differences in scores varied by study factors. Patterns of departure between test and retest 
values were assessed from Bland Altman plots. Relative reliability was estimated by the intra-
class correlation coefficient (ICC). In this study an ICC value >0.81 was considered almost 
perfect agreement, 0.61-0.80 as substantial agreement, 0.41-0.60 as moderate agreement, 
0.21-0.40 as fair agreement  and 0.0-0.20 as slight agreement [307]. The same procedures 
were used to examine reliability of the proxy responses. 
Convergent validity was assessed with an inter-instrument comparison by calculating rank 
correlations of the DHP dimension scores with EQ-5D component scores, utility score and 
EQ-VAS scores and with measures of impairment and disability. The rank correlation 
calculated for the EQ-5D individual components were not materially different to product 
moment correlations calculated with responses weighted using the South Korean value set 
(see Table A6.3 in Appendix 6). Because the DHP dimensions are not independent, Monte-
Carlo procedures were used to approximate the extract permutation distribution of the set of 
DHP dimensions with each EQ-5D score and with each measure of impairment and disability. 
The false discovery rate (FDR) for each dimension was calculated from the tails of the 
relevant permutation distribution. To control the FDR, the step-up procedure of Benjamini-
Hochberg [340] under independent assumptions was applied to the permutation distributions. 
For comparison, without control for multiple comparisons, the correlations providing FDRs of 
0.05, 0.01 and 0.005 in this sample size (n=108) are approximately 0.190, 0.247 and 0.312. 
Patterns of departure between the scores from each instrument were assessed by Bland 
Altman plots. 
Ethics 
All participants and their caregivers provided written consent. The study was approved by the 
Tasmanian Health and Medical Human Research Ethics Committee and ethics committees at 
Pham Ngoc Thach University of Medicine and 115 People’s Hospital in Viet Nam. 
 
6.4. Results 
Characteristics of the 108 stroke patients are summarized in Table 6.1. They comprised 
49.1% (53/108) females, with a mean age of 60.9 (SD 12.0) years. At admission, mean 
NIHSS was 7.7 (SD 0.6). Mean mRS was 3.3 (SD 0.1) at admission and 2.2 (SD 0.1) three 
months post-stroke. The 108 participants in the validation study were generally similar to the 
remaining 310 survivors at three months in the main study. The frequency of responses for 
each EQ-5D component, and the mean utility and VAS scores are presented in Table A6.1 
(see Appendix 6) 
.
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Table 6.1: Characteristics of stroke patients who participated in the validation study. 
Characteristics Male (N=55) Female(N=53) 
Age : Mean (SD*) 59.4 (11.2) 62.4 (12.8) 
Type of stroke 
    
Ischemic stroke 72.7% (40/55) 66.0% (35/53) 
Intra-cerebral hemorrhage 27.3% (15/55) 34.0% (18/53) 
Severity of impairment at admission 
    
Not severe stroke (0 ≤ NIHSS ≤ 7) 62.3% (33/53) 56.0% (28/50) 
Severe stroke (8 ≤ NIHSS ≤ 42) 37.7% (20/53) 44.0% (22/50) 
Severity of disability at admission 
    
Not severe (mRS ≤ 2) 25.0% (13/52) 20.7% (11/53) 
Severe (mRS ≥ 3) 75.0% (39/52) 79.3% (42/53) 
Severity of disability at 3month  
    
Not severe (mRS ≤ 2) 63.6% (35/55) 58.5% (31/55) 
Severe (mRS ≥ 3) 36.4% (20/55) 41.5% (22/55) 
The Duke Health Profile: Mean (SD*)     
Physical health 59.1 (26.2) 49.4 (25.4) 
Mental health 65.3 (22.3) 64.5 (22.8) 
Social health 56.9 (11.5) 58.5 (12.9) 
General health 60.4 (15.1) 57.5 (15.5) 
Perceived health 35.5 (34.3) 33.1 (35.3) 
Self-esteem 75.8 (15.2) 75.8 (18.4) 
Anxiety 73.3 (17.2) 72.5 (19.0) 
Depression 68.7 (21.4) 64.2 (22.9) 
Pain 63.6 (36.6) 59.4 (38.0) 
Disability 68.2 (43.4) 75.5 (37.5) 
*denotes standard deviation 
 
Table 6.2 shows mean differences on retest after one week for DHP. Each difference is small 
relative to its SD, SEM and MDD, and generally less than 3 points. Most differences are 
positive showing that the time 2 scores generally were greater, and not consistently associated 
with age, type of stroke, NIHSS or mRS. Bland-Altman plots of difference against average 
did not reveal systematic patterns in the differences or greater than expected numbers of 
outlying values on multi-item components.  
There were greater than expected numbers of outliers and large SDs (Table 6.2) for perceived 
health, pain and disability indicating changes in assessments had occurred. The ICCs ranged 
from 0.60 for social health, self-esteem and anxiety to 0.86 for disability. The test -retest 
results for the EQ-5D was similar to the DHP and is provided in the online supplement (Table 
A6.4, Appendix 6). 
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Table 6.2: Test and retest reliability of assessments of HRQoL made one week apart  from patient responses to the DHP (n=108). 
   Test   Re-test   Difference   Reliability index  
  Mean (SD*) Mean (SD*) Mean  (SD*) SEM† MDD‡ ICC§ 95% CI 
Physical health 54.4 (26.1) 54.8 (25.6) 0.6 (17.0) 12.0 33.2 0.78 (0.70, 0.85) 
Mental health 64.9 (22.5) 67.5 (20.9) 2.6 (16.7) 11.9 33.0 0.70 (0.59, 0.78) 
Social health 57.7 (12.2) 59.4 (13.3) 1.7 (11.4) 8.1 22.5 0.60 (0.46, 0.71) 
General health 58.9 (15.3) 60.6 (16.3) 1.7 (11.0) 7.8 21.7 0.75 (0.66, 0.83) 
Perceived health 34.3 (34.6) 35.2 (35.0) 0.9 (25.6) 18.0 49.9 0.73 (0.63, 0.81) 
Self-esteem  75.8 (16.8) 78.1 (15.7) 2.3 (14.6) 10.4 28.8 0.60 (0.46, 0.70) 
Anxiety 72.9 (18.0) 75.8 (18.6) 2.9 (16.2) 11.6 32.2 0.60 (0.47, 0.71) 
Depression 66.5 (22.2) 69.1 (22.1) 2.6 (18.9) 13.4 37.1 0.64 (0.51, 0.74) 
Anxiety-depression 71.6 (18.9) 74.1 (18.8) 2.4 (16.0) 11.4 31.5 0.64 (0.51, 0.73) 
Pain 61.6 (37.2) 64.9 (34.5) 3.3 (30.9) 21.9 60.7 0.63 (0.50, 0.73) 
Disability 71.8 (40.6) 73.1 (39.5) 1.4 (21.0) 14.8 41.1 0.86 (0.81, 0.90) 
* denotes  standard deviation,  
† denotes denotes standard error of measurement,  
‡ denotes minimal detectable difference,  
§ denotes intra-class correlation coefficient 
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Table 6.3: Rank correlation of DHP dimensions with EQ-5D components, utility score and visual analogue scale (VAS) assessed from 
patient report and with measures of impairment and disability (n=108). 
  Dimensions of Duke Health Profile  
 PH MH SH Per SE Anx Dep AD Pain Dis GH 
EQ-5D            
Morbidity -0.66*** -0.28** -0.16 -0.32** -0.22* -0.25* 0.36*** -0.34*** -0.26* -0.52*** -0.54*** 
Self-care -0.55*** -0.27** -0.19 -0.38*** -0.16 -0.18 -0.30** -0.30** -0.24* -0.60*** -0.49*** 
Usual activities -0.62*** -0.33** -0.11 -0.38*** -0.16 -0.25* -0.39*** -0.35*** -0.26* -0.59*** -0.54*** 
Pain/Discomfort -0.37*** -0.35*** -0.16 -0.24* -0.29** -0.33*** -0.36*** -0.38*** -0.65*** -0.30** -0.45*** 
Anxiety/Depression -0.28** -0.62*** -0.17 -0.37*** -0.43*** -0.41*** -0.53*** -0.56*** -0.30** -0.25** -0.53*** 
Utility score 0.69*** 0.46*** 0.24* 0.43*** 0.33** 0.35*** 0.49*** 0.48*** 0.37*** 0.63*** 0.68*** 
VAS 0.55*** 0.49*** 0.17 0.47*** 0.37*** 0.48*** 0.55*** 0.55*** 0.41*** 0.49*** 0.61*** 
NIHSS (impairment) at admission -0.30** -0.24* -0.14 -0.17 -0.19 -0.12 -0.26* -0.23* -0.16 -0.16 -0.34** 
mRS (disability) at admission -0.32** -0.18 -0.11 -0.34*** -0.16 -0.18 -0.25* -0.20 -0.12 -0.25* -0.30** 
mRS (disability) at 3 month  -0.60*** -0.32*** -0.26** -0.48*** -0.23* 0.27** -0.32*** -0.34*** -0.25** -0.61*** -0.56*** 
* denotes p<0.05 
** denotes p<0.01 
*** denotes p<0.001 
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Table 6.3 summarizes the associations of DHP dimensions with the EQ-5D components, 
utility score and VAS scores assessed from patients. The strongest association was between 
the DHP general health dimension and the EQ-5D utility score (r = 0.68), but its correlations 
with each of the EQ-5D components (range –0.45 to –0.54) were somewhat weaker. 
Otherwise the correlations are generally modest in size unless they measured similar 
constructs, such as between DHP physical health and EQ-5D components on physical 
function (morbidity r = –0.66, self-care r = –0.55, usual activities r = – 0.62); and between 
DHP mental health and EQ-5D anxiety/depression (r = –0.62). There were strong associations 
between mRS and DHP physical health (r = –0.60), disability (r = –0.61) and general health (r 
= –0.56) (Table 6.3).  
The assessments of 94 patients were compared with those of a nominated proxy. The 91 
proxies of known relationship to patients included 86% (78/91) who were next-of-kin 
(husband/wife/children/parents). Information is provided in Table A6.2 (Appendix6). The 
assessments of patient HRQoL by the proxies were correlated with mRS and NIHSS of the 
patient on admission, and particularly with mRS at three months (DHP social health r = -0.16; 
DHP other than social health: r = –0.29 to r = –0.67).  
Table 6.4 shows that mean differences between patient and proxy assessment were small 
relative to SDs, but indicate that the patient derived scores were greater than those from 
proxies. The differences were greatest for physical health (p = 0.067), social health (p = 
0.005), general health (p <0.001), self-esteem (p = 0.015), anxiety (p= 0.01) and depression (p 
= 0.09).  
The two dimensions with greatest variability were perceived health and pain. Male proxies 
tended to over-estimate the perceived health and pain of male patients but under-estimate the 
perceived health and pain of female patients. Female proxies tended to under-estimate the 
HRQoL of patients and particularly that of female patients. Of note is that other than the ICCs 
for mental health and perceived health, the ICCs for proxy-patient variation were generally 
similar to those for the patient test-retest. The proxy-patient differences were at most weakly 
associated with patient and proxy characteristics (Table A6.3 in Appendix 6). The patient-
proxy reliability for the EQ-5D was similar to the DHP and is provided in the online 
supplement (Table A6.4 in Appendix 6). 
Table 6.5 summarizes the associations of DHP dimensions with the EQ-5D components, 
utility score and VAS scores assessed from information provided by caregivers, and with 
measures of impairment and disability. The rank correlations were generally similar to, but 
slightly greater than, those assessed from patient reports (see Table 6.3). 
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Table 6.4: Patient-proxy reliability of measurements of HRQoL using the DHP. 
   Patient ( N=94)   Proxy (N=94)   Difference   Reliability index  
  Mean (SD*) Mean (SD*) Mean  (SD*) SEM† MDD‡ ICC§ 95% CI 
Physical health 53.7 (26.7) 50.9 (26.6) -2.9 (15.0) 10.7 29.7 0.83 (0.75, 0.88) 
Mental health 64.1 (22.4) 62.9 (22.1) -1.2 (20.8) 14.6 40.6 0.55 (0.41, 0.67) 
Social health 58.4 (12.2) 55.2 (12.0) -3.2 (10.8) 7.9 21.9 0.57 (0.42, 0.69) 
General health 59.1 (15.3) 54.8 (16.3) -4.3 (10.4) 7.8 21.7 0.75 (0.62, 0.83) 
Perceived health 31.4 (35.2) 28.7 (35.2) -2.7 (29.7) 21.0 58.1 0.61 (0.48, 0.72) 
Self-esteem  77.0 (15.9) 73.3 (16.5) -3.7 (14.5) 10.5 29.1 0.59 (0.45, 0.70)  
Anxiety 73.8 (16.4) 69.4 (18.3) -4.3 (16.2) 11.8 32.6 0.57 (0.43, 0.69) 
Depression 66.6 (21.5) 63.1 (24.5) -3.5 (19.8) 14.1 39.1 0.62 (0.49, 0.72) 
Anxiety-depression 72.0 (18.1) 67.9 (20.4) -4.1 (15.4) 11.2 31.1 0.66 (0.54, 0.76) 
Pain 61.2 (36.8) 58.5 (37.8) -2.7 (28.7) 20.3 56.3 0.69 (0.58, 0.78) 
Disability 69.6 (41.2) 70.7 (41.4) 1.1 (7.3) 5.2 14.4 0.98 (0.97, 0.99) 
* denotes  standard deviation, † denotes standard error of measurement, ‡ denotes minimal detectable difference, § denotes intra-class correlation coefficient 
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Table 6.5: Rank correlation of DHP dimensions with EQ-5D components, utility score and visual analogue scale (VAS) assessed from 
proxy reports and with measures of impairment and disability of the patients (n=94). 
  Dimensions of Duke Health Profile  
 PH MH SH Per SE Anx Dep AD Pain Dis GH 
EQ-5D            
  Morbidity -0.67*** -0.47* -0.16 -0.34 -0.29 -0.41*** -0.49** -0.50** -0.48*** -0.67*** -0.63*** 
  Self-care -0.58*** -0.42*** -0.19 -0.13** -0.28* -0.42*** -0.46*** -0.45*** -0.42*** -0.56*** -0.59*** 
  Usual activities -0.65*** -0.31** -0.14 -0.17 -0.23* -0.38*** -0.40*** -0.40*** -0.42*** -0.64*** -0.55*** 
  Pain/Discomfort -0.56*** -0.42*** -0.08 -0.30** -0.28** -0.42*** -0.50*** -0.48*** -0.73*** -0.39*** -0.55*** 
  Anxiety/Depression -0.37*** -0.63*** -0.19 -0.48*** -0.47*** -0.47*** -0.54*** -0.57*** -0.38*** -0.33** -0.57*** 
  Utility score 0.74*** 0.47*** 0.17 0.28* 0.34** 0.50*** 0.55*** 0.55*** 0.57*** 0.64*** 0.69*** 
  VAS 0.62*** 0.42*** 0.16 0.32** 0.34** 0.41*** 0.50*** 0.50*** 0.42*** 0.48*** 0.59*** 
NIHSS (impairment) at admission -0.37** -0.27* -0.14 -0.22* -0.22* -0.27** -0.31* -0.31** -0.34** -0.23* -0.37** 
mRS (disability) at admission -0.39** -0.23* -0.17 -0.24* -0.20* -0.29** -0.38** -0.32** -0.28* -0.33** -0.37*** 
mRS (disability) at 3 month  -0.67*** -0.47*** -0.16 -0.34** -0.29** -0.41*** -0.49*** -0.50*** -0.48*** -0.67*** -0.63*** 
* denotes false discovery rate (FDR)<0.05, ** denotes FDR<0.01 and *** denotes FDR<0.005. 
PH: physical health, MH: mental health, SH: social health, Per: perceived health, SE: self-esteem, Anx: anxiety, Dep: depression, AD: anxiety-depression, Dis: disability, GH: 
general health. 
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6.5. Discussion 
This is the first study to assess the reliability and validity of the DHP for use in the field of 
stroke.  The reliability of the DHP was moderate for assessments made by patients or by 
caregivers. When compared with scores on similar components of the EQ-5D, moderate 
convergent validity was found. The assessments of patient HRQoL by proxies were 
systematically lower than those by the patients themselves, but the patient-proxy differences 
were not clinically meaningful. 
Attesting to their construct validity, HRQoL measured with the DHP was lower for women, 
decreased with age, and was lowest for patients with the most severe disability , consistent 
with findings in general population and adolescent samples in France [215,341] and Viet Nam 
[212,213]. Our findings, in respect of age, sex, stroke severity, and severity of disability were 
also consistent with studies of stroke survivors, but with HRQoL measured using SF-36 
[248,342], Stroke-Specific Quality of Life [249], and the Stroke Impact Scale-16 [248]. 
We found patient test-retest differences were lower than various thresholds for determining 
clinically meaningful differences in measurements of HRQoL [343,344]. Despite this, scores 
were greater on second occasion for both HRQoL instruments, and mostly among male 
patients, suggesting that male patients upgraded assessments of HRQoL on the second 
occasion. The relative reliability of DHP for use with stroke patients was moderate to good. 
We were unable to find other studies of the reliability of DHP for use with stroke patients 
with which to compare our results. In addition, DHP dimensions of physical health, disability 
and general health were strongly correlated with severity of disability (mRS) at 3 month 
follow up (range -0.56 to -0.60). Our results comparing to EQ-5D are similar to those from a 
study of hospital patients aged 65-79 years old in France [345], showing moderate to good 
rank correlations between DHP and SF-36 dimensions of physical health (r = 0.59), mental 
health (r =0. 37) and general health (r = 0.56). 
The patient-proxy differences generally fell below the values that could be considered to be 
clinically meaningful differences for HRQoL measurements [343,344]. We also found 
moderate ranking stability with a lowest ICC of 0.55. Generally, the patient-proxy ranking 
agreement appeared stronger for DHP dimensions involving physical than mental health, as 
might be expected. Our findings also revealed a tendency for women to provide lower 
assessments of HRQoL when reporting on behalf of stroke patients. Despite using other 
HRQoL instruments, other studies of proxy assessments of stroke patients HRQoL have 
produced similar findings. For example, using the Stroke Impact Scale, Duncan et al. [346] 
found moderate ICCs between patient and proxy assessments (0.50 to 0.83). Several other 
investigators have found that proxies report lower HRQoL scores than patients themselves 
[233,235,346,347]. This suggests that under reporting of HRQoL by proxies is not 
instrument-specific but rather a limitation of proxy assessment. 
This study has several strengths. Firstly, our participants were recruited with high response 
(81.8% for patients and 87.0% for proxies) from the stroke unit of a major public hospital. 
Importantly, they were similar to the subjects in the larger cohort study. Secondly, 
information was gathered by trained local medical personnel, and using instruments culturally 
adapted for the Vietnamese population, and with minimal interference by staff. Thirdly, in 
addition to the assessment of reliability and validity of the patient-administered DHP, we also 
assessed this for proxy respondents.  
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Readers need to be aware of some possible limitations. Firstly, the DHP had only moderate 
reliability and validity in its original target USA population [198]. It was chosen because it 
retained its psychometric properties when used in other populations [345], and partly because 
it had already undergone translation and cultural adaption in Viet Nam [212]. Further, it 
includes dimensions of HRQoL, such as mental health, not covered by other translated 
instruments such as EQ-5D. Secondly, the weights for the South Korean general population 
were used to sum the responses to components of the EQ-5D. These weights may not reflect 
accurately the preferences of the Vietnamese population. Thirdly, because the DHP 
instrument requires recall of today or the previous week, it was necessary to re-test within a 
short time frame in order to limit the impact of real changes in the condition of the patient on 
the assessed stability of responses. Patients may have recalled their previous responses and, if 
so, this may influence their current responses. The time interval for previous studies of 
specific disease groups, such as dementia and stroke patients, has usually been short (around 2 
weeks) [202,219,348]. Supporting our choice of one week, Marx et al. [349] found no 
clinically or statistically significant difference between the test-retest reliability of SF-36 for 
measurements of health status performed with a two-day interval and a two-week interval. 
Fourthly, though the interviewers separated patients from proxies during interviews, the 
confined living environment in Viet Nam sometimes meant that separation between some sets 
of respondents was limited. Finally, a limitation inherent to all validation of proxy 
assessments is that we cannot be sure of their validity for patients who actually require a 
proxy, such as those with cognitive impairment, severe aphasia or unconsciousness.   
 
6.6. Conclusion 
In conclusion, the DHP has moderate reliability and validity for use with stroke patients in 
Viet Nam including when it is necessary to obtain information from proxy respondents. 
 
6.7. Postscript 
Prior to using the DHP as a study instrument to assess HRQoL of stroke survivors from 
patient’s self-report or from their caregivers as proxies, it was necessary to test the DHP for 
use with stroke patients. This chapter presented findings from a study of the reliability and 
validity of the DHP. In the next chapter, the findings of an assessment of the HRQoL of 
stroke survivors at three months and factors associate with poorer HRQoL are reported. 
 
. 
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Appendix 6: Additional findings on examination on the reliability and 
validity of the EuroQoL (EQ-5D) and the DHP  
 
Methods 
 
HRQoL Instruments 
The Duke Health Profile (DHP) is a generic health-related quality of life (HRQoL) 
instrument. It is a brief self-report instrument with good acceptability [198,214]. The DHP has 
17 questions that form 10 domains. Six of the 10 domains refer to health function (higher 
scores indicate better health status): physical health (5 items), mental health (5 items), social 
health (5 items), general health (combining the 15 items used for the physical, mental and 
social health dimensions to indicate overall well-being), perceived health (single item) and 
self-esteem (5 of the items used for the mental and social health domains). The remaining four 
domains refer to health dysfunction (higher scores indicate poorer health status): anxiety (6 of 
the items used for general health), depression (5 of the items used for physical and mental 
health), pain (single item used for physical health) and disability (single item). Each question 
has 3 possible responses scored as 0, 1 or 2. Responses to the constituent items in each 
domain are added and the mean of the raw scores is normalized to lie on scale of 0 to 100. In 
reporting the results of this study, the scores for anxiety, depression, pain and disability were 
subtracted from 100 so the scale ranged from 0 (poorest health) to 100 (best possible health) 
for each of the 10 dimensions. Prior to use, the DHP was translated and back-translated. This 
version has previously been validated among healthy adolescents in Viet Nam [212]. 
The EQ-5D instrument is a standardized measure of health status developed by the EuroQoL 
Group in order to provide a simple, generic measure of health for clinical and economic 
appraisal [220-222]. Applicable to a wide range of health conditions and treatments, it 
provides a simple descriptive profile and a single index value for health status. The version of 
the EQ-5D used in this study was the EQ-5D-3L. It contains the EQ-5D descriptive system 
and the EQ visual analogue scale (EQ-VAS). The descriptive system comprises 5 
components: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. 
Each component has 3 response levels: no problems (0), some problems (1), and inability or 
extreme problems (2). The respondent is asked to indicate his/her health state by marking the 
box against the most appropriate statement in respect of each of the 5 components. The EQ 
VAS requires a respondent to record their self-rated health on a visual analogue scale with the 
endpoints labelled as “Best imaginable health state” and “Worst imaginable health state”. 
Statistical Analysis 
The ten dimensions of the DHP were coded and calculated according to the manual [214]. To 
calculate an EQ-5D utility score, the components were weighted and summed using weights 
for the South Korean general population [296] in the absence of a value set specific for the 
population of Viet Nam. 
Inter-method comparisons were undertaken to assess convergent validity by calculating rank 
correlations between the DHP dimension scores and EQ-5D component scores, overall score 
or EQ-VAS scores. Patterns of departure between the scores from each instrument were 
assessed by visual inspection of Bland Altman plots. For this purpose, the score from each 
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instrument was standardized by subtracting the mean of its scores from the instrument and 
dividing by the standard deviation of all scores from that instrument. Linear regression 
methods were used to investigate whether the differences between standardized scores varied 
systematically with study factors such as sex, age and severity of stroke severity of disability 
at admission, severity of disability at 3 month follow up and type of stroke. 
 
Results 
Characteristics of the total cohort 
Characteristics of the 108 participants (66 participants from the cohort study) in the validation 
study are summarized in Table 6.1. The remaining 315 subjects, in the cohort of 381, 
included 54.9% (173/315) males and with mean age at time of diagnosis of 58.3 (SD 12.8) 
years for males and 64.7 (SD 14.4) years for females. Ischemic stroke accounted for 76.5% 
(241/315) of their diagnoses, 41.5% (127/306) had severe impairment at admission, 73.2% 
(229/315) had severe disability at admission and 43.2% (134/313) had severe disability at 
three months. In these key respects, the participants in the validation study and non-
participants were generally alike. Characteristics of 94 caregivers are summarized in Table 
A6.1. 
 
Table A6.1: Characteristics of caregivers who participated in the study. 
Characteristics % (n/N) 
Age: Mean(SD) 48.3 (12.1) 
Female sex 77.0% (67/87) 
Relationship with patients   
Spouse 41.8% (38/91) 
Children 41.8% (38/91) 
Siblings 6.6% (6/91) 
Parents 2.2% (2/91) 
Others 7.6% (7/91) 
 
Assessment of HRQOL made with EQ-5D 
The assessments of HRQoL made with EQ-5D are also shown in Table A6.2. The overall 
scores were slightly greater (indicating better HRQoL) for males than for females, and 
decreased with age (r = –0.33), severity of disability at admission (r = –0.45), severity of 
impairment at admission (r = –0.45) and severity of disability at three months (r = –0.83). 
Contrary to the results for DHP, they were slightly greater for patients with ICH than for 
patients with IS. The scores on individual components mirrored the associations with the 
overall score. With higher scores reflecting poorer HRQoL, the component scores were 
slightly greater for females but none of the differences by sex reached statistical significance. 
Consistent with those for EQ-5D, the EQ-5D visual analogue scale (EQ-VAS) scores were 
slightly greater (indicating better health) for patients with ICH than for patients with IS (p = 
0.72). The VAS scores were greater on average (p = 0.40) for men [65.7 (SD 17.9)] than for 
women [62.3 (SD 23.7)], and decreased with age (r = –0.06), and with severity of impairment 
at admission (r = –0.19), severity of disability at admission (r = –0.18) and at three months (r 
= –0.49). 
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Table A6.2: EQ-5D domains, utility score and visual analogue scale (VAS). 
  Male (N=55)   Female (N=53)  
 % (n/N) % (n/N) 
Mobility     
No problem 45.5 (25/55) 34.0 (18/53) 
Some problem 41.8 (23/55) 56.6 (30/53) 
Extreme problem 12.7 (7/55) 9.4 (5/53) 
Self-care 
    
No problem 61.8 (34/55) 54.7 (29/53) 
Some problem 9.1 (5/55) 22.6 (12/53) 
Extreme problem 29.1 (16/55) 22.6 (12/53) 
Usual activity 
    
No problem 46.3 (25/54) 41.5 (22/53) 
Some problem 25.9 (14/54) 26.4 (14/53) 
Extreme problem 27.8 (15/54) 32.1 (17/53) 
Pain/Discomfort 
    
No problem 47.3 (26/55) 43.4 (23/53) 
Some problem 50.9 (28/55) 49.1 (26/53) 
Extreme problem 1.8 (1/55) 7.6 (4/53) 
Anxiety/Depression 
    
No problem 56.4 (31/55) 54.7 (29/53) 
Some problem 40.0 (22/55) 37.7 (20/53) 
Extreme problem 3.6 (2/55) 7.6 (4/53) 
Utility score: Mean (SD*) 
0.68 (0.30) 0.67 (0.30) 
VAS: Mean (SD*) 
65.7 (17.9) 62.3 (23.7 
* Standard Deviation 
 
Test and retest reliability of EQ-5D 
Additional findings of rank correlation of patient-proxy difference on assessments of DHP 
dimensions with study factors were shown in Table A6.3, Table A6.4 and Table A6.5 
contains the results for the components of the EQ-5D, its overall score, and the EQ-VAS. 
Consistent with the re-test measurements made using the DHP, the assessments of HRQoL 
using the EQ-5D were generally higher on the second occasion. For the EQ-5D utility score, 
the mean difference of 0.01 (SD 0.04) was significantly greater than zero (p = 0.02). The 
component score with the greatest mean difference was anxiety/depression (p = 0.11). After 
weighting, however, the greatest contributor to the mean difference in EQ-5D overall scores 
was usual activities (p = 0.18), ahead of anxiety/depression (p = 0.36). The change in usual 
activities occurred because six (an unusually large number) of the most severely-affected 
patients reassessed their capacity to perform usual activities from 3 (“I am unable to perform 
my usual activities”) to 2 (“I have some problems with performing my usual activities”) on the 
second occasion. On each of the component items, and in respect of the overall score (p = 
0.17) for which the mean differences were 0.16 (SD 0.50) for men and 0.04 (SD 0.03) for 
women, the disagreements were principally due to men upgrading their assessment of HRQoL 
on the second occasion.  
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Table A6.3: Rank correlation of patient-proxy difference on assessments of DHP dimensions with study factors. 
  The DHP dimensions  
 PH MH SH Per SE Anx Dep AD Pain Dis GH 
Patient characteristics            
Age 0.17 0.03 0.17 0.15 0.25 0.03 0.11 0.13 -0.02 -0.15 0.22 
Female sex 0.15 -0.04 -0.08 -0.03 0.02 0.10 0.06 -0.12 -0.12 0.00 0.07 
Severe stroke at admission  -0.11 0.00 -0.03 -0.03 -0.03 -0.16 -0.10 -0.14 -0.19 -0.12 -0.13 
Severe disability at admission -0.13 -0.13 -0.03 0.15 -0.02 -0.15 -0.23 -0.18 -0.15 -0.15 -0.13 
Severe disability at three months -0.03 -0.14 0.13 0.20 0.02 -0.09 -0.18 -0.16 -0.17 -0.08 -0.05 
Proxy characteristics            
Age 0.15 -0.03 0.05 -0.05 -0.02 -0.02 0.03 -0.04 0.06 -0.04 0.05 
Female sex 0.01 -0.01 0.01 0.06 -0.19 -0.11 -0.16 -0.20 -0.03 0.09 -0.13 
PH: physical health, MH: mental health, SH: social health, Per: perceived health, SE: self-esteem, Anx: anxiety, Dep: depression, AD: anxiety-depression, Dis: disability, GH: 
general health. 
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Table A6.4: Test and retest reliability of measurements of HRQoL made one week apart of patient responses to the EQ-5D. 
   Test   Re-test   Difference   
  Mean SD Mean SD Mean  SD ICC* SEM† MDD‡ 
Morbidity 0.094 (0.123) 0.092 (0.129) -0.001 (0.052) 0.915 0.037 0.102 
Self-care 0.043 (0.058) 0.041 (0.056) -0.001 (0.024) 0.909 0.017 0.048 
Usual activity 0.076 (0.089) 0.068 (0.084) -0.007 (0.052) 0.818 0.037 0.103 
Pain/Discomfort 0.025 (0.033) 0.025 (0.033)       0 (0.023) 0.777 0.017 0.046 
Anxiety/Depression 0.026 (0.038) 0.027 (0.037) 0.004 (0.042) 0.433 0.030 0.083 
EQ-5D overall score 0.676 (0.299) 0.686 (0.304) 0.010 (0.04) 0.989 0.031 0.084 
VAS 64.1 20.9 64.7 (18.4)     1.00 (18.8) 0.545    13.20 30.80 
* ICC= Intra-class Correlation Coefficient, 
† SEM= Standard Error of Measurement,  
‡  MDD= Minimal Detectable Difference 
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Table A6.5: Percent agreement and weighted Kappa for test-retest measurements 
made one week apart of patient responses to the EQ-5D. 
EQ-5D components Percent agreement Weighted Kappa 
Morbidity 96.3% 0.86 
Self-esteem 94.1% 0.86 
Usual activity 91.6% 0.80 
Pain/discomfort 93.8% 0.65 
Anxiety/Depression 87.3% 0.40 
 
The test-retest differences were not influenced strongly by age (r = 0.03), type of stroke (r = 
0.20), severity of impairment (r = 0.06), or severity of disability at admission (r = 0.11) and at 
three months (r = -0.04). Inspection of Bland-Altman plots of difference against average did 
not reveal systematic patterns in the differences or greater than expected numbers of outlying 
values. The greatest number of differences (n=35) occurred on re-measurement of anxiety. 
The intra-class correlation coefficients (ICC) ranged from 0.41 for anxiety to 0.89 for self-
care. It was 0.99 for the overall score, in which the component scores are weighted and the 
penalty for the overwhelmingly most frequent change (moving from 1 = least severely 
affected to 2 = moderately affected, or conversely) is minor. 
Consistent with the measurements made by the DHP and EQ-5D, the EQ-VAS scores on the 
EQ-5D instrument were generally greater on re-test but the mean difference was small (p = 
0.58). The mean differences were almost identical for males (1.02 [SD 16.6]) and females 
(1.00 [SD 20.8]) and, whilst not influenced strongly by the following factors, decreased with 
age (r = –0.08), severity of impairment at admission (r= –0.12), severity of disability at 
admission (r = –0.08) and at three months (r = –0.02). Inspection of Bland-Altman plots of 
difference against average did not reveal systematic patterns in the differences or greater than 
expected numbers of outlying values. Reflecting the greater contribution of within-person 
differences, the ICC was moderate (0.56). 
 
Patient-proxy reliability of EQ-5D 
Also shown in Table A6.6 and Table A6.7 are the mean proxy-patient differences for 
components of the EQ-5D and its overall score, and for the EQ-VAS. The assessments of 
morbidity (p = 0.16), usual activity (p = 0.06) and pain (p = 0.37) using the EQ-5D were 
greater on proxy assessment. For all components of EQ-5D, the proxy-patient differences 
were more extreme when the proxy was a male than when the proxy was a female but these 
differences were not statistically significant. The proxy-patient differences in self-care (p = 
0.01), usual activity (p = 0.01) and EQ-5D overall score (p = 0.01) were associated with age 
of the patient. For most EQ-5D components, the proxy-patient differences were greater for 
patients with ischemic stroke and for patients with severe impairment or disability at 
admission or severe disability after three months. 
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Table A6.6: Patient-proxy reliability of measurements of HRQoL using the EQ-5D. 
   Test   Re-test   Difference   
  Mean SD Mean SD Mean  SD ICC* SEM† MDD‡ 
Morbidity 
0.100 (0.130) 0.094 (0.132) -0.006 (0.068) 0.845 0.049 0.134 
Self-care 0.459 (0.596) 0.047 (0.059) 0.014 (0.031) 0.854 0.022 0.060 
Usual activity 0.084 (0.091) 0.074 (0.088) -0.089 (0.046) 0.855 0.033 0.091 
Pain/Discomfort 0.027 (0.035) 0.026 (0.037) -0.001 (0.034) 0.513 0.024 0.067 
Anxiety/Depression 0.026 (0.038) 0.029 (0.047) 0.003 (0.039) 0.571 0.027 0.076 
EQ-5D overall score 0.66 (0.31) 0.67 (0.32)  0.01 (0.16) 0.858 0.113 0.160 
VAS 63.0 (20.5) 62.7 (18.8)       -1.40 (18.8) 0.539 13.25 36.74 
* ICC= Intra-class Correlation Coefficient,  
† SEM= Standard Error of Measurement,  
‡ MDD= Minimal Detectable Difference 
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Table A6.7: Percent agreement and weighted Kappa for measurements of patient 
responses and proxy responses to the EQ-5D. 
EQ-5D components Percent agreement Weighted Kappa 
Morbidity 95.4% 0.84 
Self-esteem 93.3% 0.85 
Usual activity 93.0% 0.84 
Pain/discomfort 91.0% 0.56 
Anxiety/Depression 88.6% 0.51 
 
The proxy-patient differences on EQ-5D were relatively smaller than those on the DHP, and 
without a consistent pattern but with proxies providing slightly lower HRQoL assessments 
overall and on the EQ-VAS. The stratified results indicate that, other than by the EQ-VAS,  
male proxies tend to over-estimate HRQoL relative to patients and/or relative to female 
proxies (data not shown), and that female proxies tend to underestimate HRQoL relative to 
patients and/or relative to male proxies (data not shown). The ICC for proxy-patient variation 
in overall EQ-5D was lower, and the ICC for the anxiety component was higher, but 
otherwise the ICCs were generally similar to the corresponding values for patient test-retest. 
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Chapter 7: Health-related quality of life among survivors three 
month after stroke 
 
7.1. Preface 
In previous chapters, the case-fatality and functional outcomes following stroke of survivors 
in a cohort of patients with first-ever stroke. An assessment of their health-related quality of 
life (HRQoL), measured using the tool assessed the reliability and validity in Chapter 6, is 
presented in this chapter to provide more evidence of the current burden of stroke in Viet 
Nam. At the time of thesis submission, the texts of this chapter and had been prepared as a 
manuscript for submission in consideration of publication in the Stroke journal. The appendix 
to this chapter (Appendix 7) has been prepared as online supplementary data for the 
manuscript. 
 
7.2. Introduction 
In recent years, mortality rates from stroke have been decreasing in both HICs and LMICs 
due to better treatment [2]. As a result of the neurologic impairments caused, however, 
approximately 30%-40% of all patients with stroke require assistance three months after the 
stroke to perform basic activities of daily living [159]. Although case-fatality and functional 
status following stroke have been assessed in a few studies conducted in LMICs, there is 
limited understanding of how stroke influences patients’ lives. Quantifying the impacts that 
the symptoms, impairments and psychological sequela associated with stroke have on the 
individual’s QoL enables a more comprehensive understanding of the extent of the burden 
caused by the disease and its treatment, and this has been emerging as a particular need in 
LMICs. 
QoL can be defined in both a general sense and in a health-related context. HRQOL has been 
defined by the WHO as “an integrative measure of physical and emotional well-being, level 
of independence, social relationships and their relationship to salient features of their 
environment” [192]. HRQoL is thus both subjective and multidimensional. 
The limited investigations conducted to date in LMICs have shown that, relative to apparently 
healthy adults or population norms, survivors of stroke have reduced HRQoL particularly in 
domains related to physical functioning [238,241,242]. The first three months after stroke 
have been found to be a critical time for improvement in physical functioning and HRQoL in 
Taiwan and Thailand [241,236]. In studies conducted in both HICs and LMICs, poorer 
HRQoL among survivors of stroke has been associated with advanced age, female sex, lower 
socio-economic status, more severe stroke and poorer functional status [241,245]. 
Given the subjectivity of HRQoL assessment and differences in cultural values that influence 
specific dimensions [250], it is not certain that these findings are generalizable to other 
countries such as Viet Nam where patients with stroke on average are of younger age, have 
more severe symptoms at stroke onset and more functional disability at three month post-
stroke [334] (Chapter 3) compared to those from HICs. To date there are limited data on 
HRQoL of survivors of stroke in Viet Nam. The aims of this study were to assess the HRQoL 
of first-ever stroke survivors at three month post stroke in Viet Nam, and to identify factors 
related to poor HRQoL.  
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7.3. Methods 
Participants 
The participants were a consecutive series of stroke patients from the stroke unit at 115 
People's Hospital, which is a major teaching hospital in Ho Chi Minh City, Viet Nam. Patients 
were eligible if they had suffered a first-ever ischaemic or haemorrhage stroke confirmed by a 
neurologist, were aged>16 years, lived in Ho Chi Minh City, the stroke had occurred within 
the preceding 7 days, and treatment was received within the stroke unit. We excluded patients 
with recurrent stroke and early discharge to home (usually with a poor prognosis). 
Recruitment commenced on the 1st of June 2012 and continued until the targeted number of 
450 eligible subjects (from 960 admissions) was reached on the 10th of September 2012.  
Data collection 
During the hospital admission, stroke and type of stroke were confirmed by a neurologist in 
the Stroke Unit using the standard clinical definition of sudden onset of focal neurological 
symptoms of presumed vascular origin, with all patients receiving brain imaging [computed 
tomography (CT) or magnetic resonance imaging (MRI)] to exclude other causes of 
neurological symptoms and to define stroke type. Severity of neurological impairment graded 
on the NIHSS [115], and functional status graded on the mRS [122], were assessed by a 
neurologist on the Stroke Unit. 
Patients or their main caregivers were interviewed by research assistants to collect data on (1) 
socio-demographic factors such as marital status, education, job and working status; (2) health 
insurance; (3) economic status such as household assets, monthly income and monthly 
expenditure per household; (4) lifestyle risk factors, such as tobacco smoking and alcohol 
consumption; and (5) health status before stroke, including disability and co-morbidities such 
as hypertension, diabetes, heart disease, chronic lung disease, chronic liver disease, chronic 
renal disease and cancer.  
Three months after stroke, patients were interviewed in their homes to assess their HRQoL 
and functional status. Functional status was again graded on the mRS. When the patient had 
severely impaired cognition, the main caregiver provided information on behalf of the patient. 
The Duke Health Profile (DHP) and EQ-5D health questionnaires were used to assess the 
HRQoL of patients. 
The DHP is a generic, self-report HRQoL instrument with a reference period either of today 
or the past week. Full details of the instrument are given in the online supplement. In brief, 
the six domains of health function comprise physical health, mental health, social health, 
general health, perceived health and self-esteem, and greater scores indicate better health. The 
four domains of health dysfunction comprise anxiety, depression, pain and disability, and 
higher scores indicate poorer health. The scoring was reversed for the four dysfunctional 
domains so that the scores on each domain range from 0 (poorest health) to 100 (best possible 
health). The general health domain provides a summary score covering physical health, 
mental health and social health.  
The EQ-5D refers to current health. It comprises 5 components: mobility, self-care, usual 
activities, pain/discomfort and anxiety/depression. The EQ VAS records the respondent’s 
self-rated health on a visual analogue scale (VAS) with the endpoints labelled as “Best 
imaginable health state” and “Worst imaginable health state”. To calculate an overall EQ-5D 
utility score [range -0.263 (worst) to 1 (best)], the components were summed using weights 
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for the South Korean general population [296] in the absence of a value set for Viet Nam. The 
mean EQ-5D utility score of stroke patients aged more than 60 years was compared to that of 
a study sample of 2873 persons over 60 years of age from the rural community of FilaBavi in 
the north of Viet Nam [231]. The latter study also used the South Korean value set to 
calculate the EQ-5D utility score. 
Data analysis 
Summary values are presented as median and interquartile range (IQR) and/or as mean and 
standard deviation (SD) for continuous data, and as percentages for categorical data. For each 
DHP dimension, mean scores were calculated over non-missing item scores if less than 50% 
of item scores were missing. Mean scores were calculated for the entire sample and with 
stratification by sex, age, severity of impairment, severity of functional status and type of 
stroke. Linear regression methods were used to estimate mean differences in DHP dimension 
scores and the EQ-5D utility and VAS scores according to differing patient characteristics 
such as age, sex, and stroke severity. Functional status graded on the mRS was grouped into 3 
levels of impaired functional outcome (disability): least severe (mRS=0/1), moderate 
(mRS=2/3) and most severe (mRS=4/5). All statistical tests were two-sided with a 5% 
allowance for type I error. To compare mean DHP scores and EQ-5D utility scores of stroke 
patient with population values, the age- and sex- specific mean scores of a general adult 
population of Ho Chi Minh City [213] were weighted to the age-and sex-distribution of the 
stroke patients, and the age-specific mean scores of the FilaBavi sample [231] were weighted 
to the age-distribution of the stroke patients.  
 
7.4. Results 
During the recruitment process, there were 441 patients completing the baseline interview. Of 
these, 38 were confirmed to have died during follow-up over the next three months, 27 were 
lost to follow-up and 4 refused assessment of HRQoL at the planned interview three months 
post-stroke. The remaining 372 participants were followed up to three month and are included 
in this study (Table 7.1).  
 
Table 7.1: Baseline characteristics and three-month functional status in three-month 
survivors of first-ever stroke in Ho Chi Minh City, Viet Nam.  
 Men  
(n=204) 
Women  
(n=172) 
Age 
    
Mean (SD) 58.6 (12.3) 64.3 (14.2) 
Median (IQR) 57.0 (49-68) 64.0 (53-76) 
< 45 years 12.4% (25) 7.0% (12) 
45-54 years 28.9% (58) 19.9% (34) 
55-64 years 26.9% (54) 23.4% (40) 
65-74 years 20.9% (42) 18.7% (32) 
75+ years 11.0% (22) 31.0% (53) 
Marital status *     
Married 92.0% (185) 59.1% (101) 
Single 4.0% (8) 5.3% (9) 
Divorced 1.5% (3) 1.8% (3) 
Widowhood (widower/widow) 2.5% (5) 33.9% (58) 
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 Men  
(n=204) 
Women  
(n=172) 
Highest education level * 
    
No schooling 15.9% (32) 46.2% (79) 
Grades 1–5 22.9% (46) 29.8% (51) 
Grades 6–9 23.9% (48) 15.2% (26) 
Grades 10–12 23.9% (48) 7.0% (12) 
College/university 13.4% (27) 1.8% (3) 
Working status * 
    
Manual work 28.6% (57) 6.4% (11) 
Office work 20.1% (40) 17.0% (29) 
Home duties/retired 51.3% (102) 76.6% (131) 
Living with spouse * 
    
Yes 79.0% (158) 39.6% (67) 
No – living with children 16.0% (32) 53.9% (91) 
No – living with others 5.0 (10) 6.5% (11) 
Comorbidity * 
    
No 77.6% (156) 65.5% (112) 
1 16.4% (33) 25.7% (44) 
2+ 6.0% (12) 8.8% (15) 
Pre-stroke disability * 
    
No 96.0% (193) 91.2% (156) 
Yes 4.0% (8) 8.8% (15) 
Type of stroke 
    
Ischaemic stroke 72.1% (145) 80.7% (138) 
ICH 27.9% (56) 19.3% (33) 
Severity of impairment (NIHSS) † 
    
Mean score (SD) 7.3 (5.3) 8.0 (5.6) 
Severe (NIHSS> 7) 38.5% (75) 43.0% (71) 
Not severe (NIHSS≤ 7) 61.5% (120) 57.0% (94) 
Functional status (mRS) † 
    
Mean score (SD) 3.1 (1.1) 3.1 (1.1) 
Least severe (mRS=0/1) 12.1% (24) 12.9% (22) 
Intermediate (mRS=2/3) 44.7% (89) 40.0% (68) 
Most severe (mRS=4/5) 43.2% (86) 47.1% (80) 
Functional status (mRS) at follow-up ‡ 
    
Mean score (SD) 2.1 (1.4) 2.7 (1.4) 
Least severe (mRS=0/1) 41.3% (83) 25.2% (43) 
Intermediate (mRS=2/3) 35.3% (71) 41.5% (71) 
Most severe (mRS=4/5) 23.4% (47) 33.3% (57) 
* Patient self-report. 
† Assessed during initial hospital stay 
‡ Assessed at follow-up three months post-stroke   
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They comprised 54.3% (204/376) men with a mean age of 61.2 (SD 13.4) years. Women were 
approximately 6 years older than men, and only one quarter of them were still working at 
stroke onset compared to half of the men. Almost all of the men, but only three-fifths of the 
women, were married with one-third of the women having been widowed and with three-
fifths of them living with children or others. Men had greater educational attainment than 
women. 
The majority of patients had suffered an ischaemic stroke (IS). Women more often had co-
morbidities and a greater average severity of neurological impairment on the National 
Institutes of Health Stroke Scale (NIHSS) at admission than men. At follow-up more women 
had impaired functional status at three month than men. Men and women had similar mean 
scores for the DHP dimensions of social health, self-esteem and disability but on other 
dimensions the mean scores of men were markedly more than for women (Table 7.2).  
For general health, which provides an overall score for DHP dimensions other than perceived 
health and disability, the mean score in men was 7.7 points (14%) more than that of women 
and this difference was high relative to sampling variability. Men also performed better on the 
EQ-5D utility scores and VAS scores. On the EQ-5D utility score, 6.7% (25/373) of survivors 
had assessments of HRQoL that were negative (rated as worse than death). 
Adjustments were made for proxy assessments (n=48) as these were on average 27.2% lower 
than assessments for patients who provided their own information. The mean values of the 
DHP decreased with age group, were greater for men than for women, and were greater for 
those with greater severity of neurological impairment and impaired functional status at 
admission (Table 7. 2).  
 
Table 7.2: Mean scores of DHP dimensions, EQ-5D utility, and visual analogue scale 
(VAS) in three-month survivors of stroke. 
  All   Male (n=201)   Female (n=172)  
 Mean (SD) Mean (SD) Mean (SD) 
DHP       
Physical health 53.5 (26.7) 60.1 (26.4) 45.7 (25.0) 
Mental health 64.4 (24.8) 67.5 (23.9) 60.8 (25.5) 
Social health 57.7 (15.2) 58.5 (15.8) 56.8 (14.4) 
General health 58.7 (17.8) 62.2 (17.4) 54.5 (17.5) 
Perceived health 28.7 (36.1) 32.0 (36.8) 24.9 (35.0) 
Self-esteem 75.1 (18.8) 76.3 (17.9) 73.7 (19.8) 
Anxiety 72.5 (20.1) 74.5 (19.4) 70.2 (20.7) 
Depression 66.4 (24.3) 70.6 (22.9) 61.6 (25.1) 
Pain 63.7 (35.8) 70.0 (34.0) 56.4 (36.6) 
Disability 69.0 (43.1) 69.5 (43.1) 68.3 (43.2) 
EQ-5D       
Utility score 0.67 (0.33) 0.72 (0.31) 0.62 (0.34) 
VAS 61.3 (20.4) 64.1 (20.1) 58.0 (20.4) 
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There were also sex differences in the dimensions of physical health, mental health, self-
esteem, depression and pain (Tables A7.1-Table A7.3 in Appendix 7). The mean DHP 
general health score of those with least severity of impaired functional status (mRS=0/1) at 
admission was similar to that of a general population sample of Ho Chi Minh City (Table 
A7.4-Table A7.10 in Appendix 7). 
Age-adjusted to the sex-specific distribution of the patients with stroke, the mean overall 
score of the population sample was 62.8 (SD 18.2). In patients with intermediate severity of 
stroke at admission (mRS=2/3) the mean DHP general health score was 5.1 points less than 
the general population and 14.3 less points than those with the most severe severity of 
impaired functional status (mRS=4/5).  
Three months later those with the least severity of impaired functional status (mRS=0/1) had a 
substantially greater mean DHP general health score than the general population sample. 
Those in each grouping of functional status at three month had similar mean DHP general 
health scores irrespective of the severity of their impaired functional status at admission 
(Table 7.3). Similar results were found for the EQ-5D utility scores and EQ-5D VAS scores. 
The mean EQ-5D utility score of stroke survivors who were aged greater than 60 years, age 
adjusted to a rural community in the north of Viet Nam, was 0.58 (SD 0.35) (Table A7.11 in 
Appendix 7), compared to 0.88 for those living in the rural population. Similar to the DHP 
general health score, survivors of stroke with least severity of impaired functional status 
(mRS=0/1) at three months had a greater EQ-5D utility score (0.95) than the rural population 
sample (0.88). Patients with intermediate impaired functional status (mRS=2/3) or most 
severe impaired functional status (mRS= 4/5) at three months had lower EQ-5D utility score 
than that of the rural population. 
The mean DHP general health score, EQ-5D utility score and EQ-5D VAS score between 
levels of the study factors were attenuated when adjusted for age, sex severity of impairment, 
and proxy response (Table 7.4). Further adjustment for impaired functional status at three 
months further attenuated the differences.  
For each of the HRQoL dimensions, the differences in mean scores between subjects 
classified by level of impaired functional status at three months were statistically significant, 
and only the sex differences for the DHP dimensions of physical health, depression, pain and 
impaired functional status remained statistically significant after adjustment for the grouped 
mRS levels of impaired functional status at three months (Tables A7.12-Table A7.14 in 
Appendix 7).  
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Table 7.3: Mean scores* of DHP general health, EQ-5D utility and visual analogue scale (VAS) in three-month survivors of stroke.  
  DHP general health (n=369)   EQ-5D utility score (n=372)   EQ-5D VAS (n=367)  
 Num Mean (95% CI) Num Mean (95% CI) Num Mean (95% CI) 
Age          
<45 years 37 67.6 (62.5, 77.8) 37 0.83 (0.72, 0.93) 37 72.1 (66.0, 78.2) 
45-54 years 92 60.0 (56.6, 63.3) 92 0.75 (0.69, 0.82) 91 62.4 (58.4, 66.4) 
55-64 years 94 62.2 (58.9, 65.5) 94 0.71 (0.64, 0.77) 92 64.9 (60.9, 68.8) 
65-74 years 73 54.5 (50.7, 58.3) 74 0.54 (0.47, 0.61) 74 57.8 (53.4, 62.3) 
75+ years 73 54.6 (50.7, 58.5) 75 0.51 (0.44, 0.58) 73 56.3 (51.8, 60.9) 
Trend  -2.9 (-4.2, -1.5)†  -0.09 (-0.11, -0.1)*  -3.2 (-4.8, -1.6)* 
Sex          
Male 199 62.5 (60.3, 64.8) 201 0.70 (0.66, 0.75) 200 64.4 (61.7, 67.1) 
Female 170 55.2 (52.7, 57.7) 171 0.60 (0.55, 0.65) 167 58.8 (55.8, 61.8) 
Difference  -7.4 (-10.7, -4.0)*  -0.11 (-0.17, -0.04)*  -5.6 (-9.7, -1.6)* 
Marital status          
Married 89 60.8 (58.9, 62.7) 286 0.68 (0.65, 0.72) 284 63.7 (61.4, 66.0) 
Single 79 63.5 (55.8, 71.2) 17 0.73 (0.57, 0.89) 17 58.9 (49.5, 68.2) 
Divorced 96 49.1 (35.6, 62.6) 6 0.69 (0.42, 0.96) 6 66.4 (51.0, 81.9) 
Widowhood(widower/widow) 99 50.8 (46.5, 55.0) 63 0.50 (0.42, 0.58) 60 55.5 (48.5, 58.6) 
Wealth index    
 
      
1st quarter (richest) 89 63.1 (59.7, 66.5) 91 0.65 (0.58, 0.72) 87 63.8 (59.7, 68.0) 
2nd quarter 79 57.7 (54.0, 61.4) 80 0.62 (0.55, 0.70) 80 60.5 (56.1, 64.8) 
3rd quarter 96 57.6 (54.2, 61.0) 96 0.63 (0.56, 0.70) 96 60.3 (56.3, 64.3) 
4th quarter (poorest) 99 58.4 (55.1, 61.7) 99 0.71 (0.64, 0.78) 98 62.7 (58.8, 66.6) 
Trend  -1.4 (-3.0, 0.1)  0.02 (-0.01, 0.05)  -0.3 (-2.2, 1.5) 
Type of stroke   
       
ICH 89 56.9 (53.4, 60.4) 89 0.58 (0.51, 0.65) 88 59.6 (55.5, 63.8) 
IS 280 59.9 (59.9, 57.9) 283 0.68 (0.64, 0.72) 279 62.6 (60.3, 64.9) 
Difference  2.9 (-1.1, 7.0)  0.10 (0.02, 0.18)  3.0 (-1.8, 7.7) 
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  DHP general health (n=369)   EQ-5D utility score (n=372)   EQ-5D VAS (n=367)  
 Num Mean (95% CI) Num Mean (95% CI) Num Mean (95% CI) 
Severity of impairment           
NIHSS≤ 7 212 63.1 (60.9, 65.2) 214 0.77 (0.73, 0.82) 210 65.8 (63.3, 68.4) 
NIHSS> 7 145 53.7 (51.1, 56.4) 146 0.49 (0.45, 0.54) 145 56.3 (53.1, 59.5) 
Difference  -9.3 (-12.8, -5.9)*  -0.28 (-0.34, -0.22)*  -9.5 (-13.6, -5.4)* 
Disability at 3 month  
 
  
      
Least severe (mRS= 0/1) 126 71.8 (69.5, 74.1) 126 0.93 (0.90, 0.96) 124 75.1 (72.2, 78.0) 
Least severe at admission 27 73.2 (68.4, 78.1) 27 0.93 (0.87, 0.99) 26 71.9 (65.6, 78.2) 
Intermediate at admission 70 71.7 (68.6, 74.7) 70 0.93 (0.89, 0.97) 69 77.1 (73.2, 81.0) 
Most severe at admission 29 71.0 (66.3, 75.8) 29 0.92 (0.86, 0.98) 29 73.3 (67.3, 79.2) 
Intermediate (mRS=2/3) 140 57.6 (55.4, 59.8) 140 0.74 (0.72, 0.77) 141 60.3 (57.5, 63.1) 
Least severe at admission 19 57.2 (53.7, 60.8) 19 0.74 (0.67, 0.82) 19 58.1 (50.5, 65.8) 
Intermediate at admission 55 57.2 (53.7, 60.8) 56 0.78 (0.73, 0.82) 55 60.7 (56.2, 65.2) 
Most severe at admission 64 58.6 (55.3, 61.9) 65 0.71 (0.67, 0.75) 65 49.0 (42.9, 55.2) 
Most severe (mRS=4/5) 102 45.6 (42.9, 48.4) 104 0.28 (0.25, 0.32) 102 47.5 (44.1, 51.0) 
Least severe at admission 0 n.a.  0 n.a.  0 n.a.  
Intermediate at admission 30 47.0 (52.0, 52.1) 31 0.38 (0.32, 0.44) 31 49.0 (42.9, 55.2) 
Most severe at admission 72 45.0 (41.6, 48.3) 72 0.24 (0.20, 0.28) 70 47.2 (43.0, 51.4) 
Trend †   -13.4 (-15.3, -11.5)  -0.32 (-0.34, -0.30)  -14.1 (-16.5, -11.7) 
* denotes p<0.05 
 †Trend over three category means 
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Table 7.4: Mean scores* and difference in mean scores of the DHP general health, EQ-5D utility and  visual analogue scale (VAS) in 
three-month survivors of stroke.  
  DHP general health   EQ-5D utility score   EQ-5D VAS  
  Adjusted*    Adjusted also 
for disability 
at 3 months  
  Adjusted*   Adjusted also 
for disability 
at 3 months 
  Adjusted*   Adjusted also 
for disability 
at 3 months 
 
 Mean (95% CI) Mean (95% CI) Mean (95% CI) Mean (95% CI) Mean (95% CI) Mean (95% CI) 
Age       
< 45 years 68.8 (63.9, 73.7) 62.9 (58.7, 67.2) † 0.85 (0.75, 0.94) 0.71 (0.66, 0.77) 72.3 (66.3, 78.3) 65.5 (60.1, 70.9) 
45-54 years -9.5 (-15.3, -3.7)  -5.4 (-10.3, -0.5) -0.11 (-0.22, 0) 0 (-0.06, 0.06) -10.2 (-17.4, -3.1) -5.4 (-11.7, 0.9) 
55-64 years -7.1 (-12.9, -1.3) -2.1 (-7.0, 2.8) -0.16 (-0.27, -0.05) -0.03 (-0.09, 0.03) -8.2 (-15.3, -1.1) -2.7 (-9.0, 3.6) 
65-74 years -14.6 (-20.7, -8.5) -5.2 (-10.5, 0.09) -0.29 (-0.40, -0.17) -0.06 (-0.13, 0.01) -14.6 (-22.1, -7.2) -3.9 (-10.7, 2.8) 
75+ years -12.5 (-18.8, -6.3) -3.0 (-8.4, 2.4) -0.30 (-0.42, -0.19) -0.06 (-0.13, 0.01) -14.4 (-22.1, -6.8) -3.7 (-10.6, 3.2) 
Trend -2.6 (-3.9, -1.3) -0.2 (-1.3, 1.0) -0.08 (-0.1, -0.05) -0.02 (-0.03, 0) -2.9 (-4.5, -1.3) -0.2 (-1.7, 1.2) 
Sex          
Male 61.7 (59.6, 63.9) 61.0  (59.2, 62.8) † 0.68 (0.64, 0.72) 0.68 (0.65, 0.70) 63.2 (60.6, 65.9) 62.3 (60.0, 64.6) 
Female -5.3 (-8.6, -2.0) -3.3 (-6.0, -0.5) -0.03 (-0.09, 0.03) 0.01 (-0.02, 0.05) -2.9 (-6.9, 1.1) -0.8 (-4.2, 2.7) 
Marital status          
Married 59.8 (58.0, 61.7) 59.8 (58.3, 61.3) † 0.66 (0.63, 0.70) 0.68 (0.66, 0.70)† 62.8 (60.5, 65.0) 62.7 (60.7, 64.6) 
Single 5.1 (-2.8, 13.0) 5.5 (-1.0, 11.9) 0.02 (-0.12, 0.16) 0.04 (-0.04 0.12) -7.3 (-17.1, 2.6) -6.9 (-15.4, 1.6) 
Divorced -12.0 (-24.7, 0.8) -10.8 (-21.3, -0.2) -0.02 (-0.24, 0.20) 0 (-0.13, 0.13) 2.0 (-13.0, 17.1) 3.4 (-9.5, 16.2) 
Widowhood -3.3 (-8.4, 1.8) -2.6 (-6.8, 1.6) -0.03 (-0.12, 0.06) -0.02 (-0.07, 0.04) -3.8 (-10.1, 2.5) -2.9 (-8.3, 2.5) 
Wealth index †        
1st quarter (richest) 64.5 (61.3, 67.7) 61.9 (59.1, 64.6)† 0.69  (0.63, 0.75) 0.65 (0.62, 0.69) 65.1 (61.1, 69.0)† 62.0 (58.5, 65.5) 
2nd quarter -7.1 (-11.8, -2.4) -2.8 (-6.8, 1.2) -0.07 (-0.15, 0.02) 0.02 (-0.03, 0.07) -4.9 (-10.7, 0.9) -0.4 (-5.5, 4.7) 
3rd quarter -7.5 (-11.9, -3.0) -3.8 (-7.5, 0) -0.05 (-0.14, 0.03) 0.03 (-0.02, 0.08) -4.9 (-10.4, 0.6) -0.8 (-5.6, 4.0) 
4th quarter (poorest) -5.9 (-10.4, -1.5) -2.8 (-6.6, 1.0) 0 (-0.08, 0.08) 0.07 (0.02, 0.11) -3.1 (-8.6, 2.5) 0.7 (-4.2, 5.6) 
Trend -1.8 (-3.3, -0.4) -0.9 (-2.1, 0.3) 0 (-0.02, 0.03) 0.02 (0, 0.04) -0.9 (-2.7, 0.9) 0.2 (-1.4, 1.7) 
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  DHP general health   EQ-5D utility score   EQ-5D VAS  
  Adjusted*    Adjusted also 
for disability 
at 3 months  
  Adjusted*   Adjusted also 
for disability 
at 3 months 
  Adjusted*   Adjusted also 
for disability 
at 3 months 
 
 Mean (95% CI) Mean (95% CI) Mean (95% CI) Mean (95% CI) Mean (95% CI) Mean (95% CI) 
Type of stroke        
ICH 58.2 (54.6, 61.8) 58.9 (55.9, 61.9) † 0.61 (0.55, 0.68)† 0.66 (0.62, 0.69) 60.6 (56.2, 65.0) 61.1 (57.3, 64.9) 
IS 1.4 (-2.7, 5.6) 0.7 (-2.7, 4.1) 0.06 (-0.01, 0.13) 0.03 (-0.01, 0.07) 1.7 (-3.4, 6.7) 1.1 (-3.2, 5.5) 
Severity of impairment        
NIHSS ≤ 7 62.8 (60.7, 64.9) 59.3 (57.5, 61.1) † 0.77  (0.73, 0.81) 0.70 (0.68, 0.72) 65.6 (63.1, 68.1) 61.6  (59.3, 63.9) 
NIHSS > 7 -8.7 (-12.0, -5.3) 0.4 (-2.6, 3.4) -0.27 (-0.33, -0.21) -0.05 (-0.09, 0) -8.9 (-13.0, -4.9) 0.9 (-2.9, 4.8) 
Disability       
Least severe (mRS=0/1) 62.6 (57.8, 67.4) 59.3 (55.2, 63.3) † 0.72 (0.63, 0.81) 0.66 (0.61, 0.71) 61.2 (55.2, 67.1) 57.6 (52.5, 66.3) 
Intermediate (mRS=2/3) -2.9 (-8.0, 2.3) 0.2 (-4.1, 4.5) -0.03 (-0.13, 0.06) 0.04 (-0.02, 0.09) 2.5 (-3.9, 8.9) 5.9 (0.4, 11.5) 
More severe (mRS=4/5) -4.3 (-10.2, 1.6) 0.5 (-4.5, 5.5) -0.10 (-0.20, 0.01) 0.01 (-0.05, 0.08) -0.7 (-8.1, 6.6) 4.0 (-2.4, 10.4) 
Trend -2.0 (-4.9, 0.9) -0.4 (-5.7, 4.9) -0.05 (-0.10, 0) 0 (-0.03, 0.03) -0.9 (-4.5, 2.6) 1.2 (-1.9, 4.3) 
Disability at 3 months       
Least severe (mRS=0/1) 71.0 (68.5, 73.5) n.n.  0.90 (0.87, 0.93) n.n. 74.0 (70.8, 77.3) n.n. 
Intermediate (mRS=2/3) -12.8 (-16.1, -9.5)  -0.15 (-0.19, -0.11)  -13.5 (-17.8, -9.2)  
More severe (mRS=4/5) -24.9 (-29.3, -20.5)  -0.57 (-0.63, -0.52)  -25.6 (-31.2, -20.0)  
Trend -12.7 (-15.0, -10.5)  -0.28 (-0.31, -0.25)  -13.0 (-15.9, -10.2)  
* Adjusted for age, sex, proxy response and severity of impairment at admission 
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7.5. Discussion 
In this follow-up at three months of a cohort of first-ever stroke patients in Ho Chi Minh City, 
Viet Nam, the stroke patients on average had lower HRQoL than both the general population 
of Ho Chi Minh City [213], and a rural community in the north of Viet Nam [231]. Women 
had poorer HRQoL than men. The poor HRQoL was most evident in those with the greatest 
impaired functional status at three months. Surprisingly, those with the least severity of 
impaired functional status at three months had greater HRQoL than the general population 
sample from Ho Chi Minh City [213] and rural Viet Nam [231].  
The mean EQ-5D utility score (0.67) at three months of the Vietnamese stroke patients in this 
study was similar to that reported for people with stroke in Sweden (mean utility score 0.65, 
mean age 63.2 years) [350], Canada (mean utility score 0.70, mean age 67.3 years) [351] and 
Singapore (mean utility score 0.65) [238]. In this study, 6.7% of stroke survivors rated their 
HRQoL was poorer than death (negative utility score) compared to 12.5% of generally older 
(by almost a decade) stroke survivors in a multi-centre trial of the efficacy of nitric oxide 
(ENOS) [352]. When comparing the QoL among the general population, previous 
investigators [227,241,353] found that survivors of stroke at three months on average had 
poorer HRQoL assessed using the SF-36 than the persons accompanying them to hospital. 
Studies using EQ-5D and other instruments [236-238] have found the HRQoL of long-term 
stroke patients to be lower than the norm for their population. Hackett et al. [240] and Shyu et 
al. [236] found that physical and social functioning were significantly lower among stroke 
survivors than was normal for their populations [213,231,238,350-352].  
Notably, the long-term stroke survivors with compromised physical and social functioning in 
an Auckland study using the SF-36 nevertheless had mental health comparable to the norm 
[240]. In this study, there were much larger differences at three months on some DHP 
dimensions than others, and the reduced  mental health relative to population values was 
marked only among those with most severe disability (mRS=4/5). This was true also for DHP 
physical health, and for DHP general health that combines scores for the DHP physical, 
mental and social health dimension. For patients overall, the EQ-5D seemed most sensitive in 
detecting divergence from population values. If this is not an artefact of different population 
samples, it may be because the DHP is a generic questionnaire that covers multiple 
dimensions of HRQoL. In this study, some of these – social health, self-esteem, anxiety and 
depression – appeared unresponsive to stroke in the sense that even for the most severely 
impaired functional patients, there were only minor divergences from the mean values for the 
population sample. The EQ-5D is not a stroke-specific questionnaire either, but it places 
relatively more focus on physical health and functioning that were markedly poorer for the 
most severely disabled patients in this study [1]. 
In developed countries, survivors of stroke are commonly found to have poorer mental and 
social HRQoL than the general population [241,245]. That was not the case in our study. 
While this could be due to inadequacies of the DHP instrument in detecting the psychological 
and social aspects of coping with stroke, it is also possible that cultural differences could play 
a role. After having a stroke in developed countries, many stroke survivors are moved from 
their home to a nursing home or rehabilitation centre due to the absence of an available 
caregiver [354,355]. In contrast, in Viet Nam, survivors of stroke mostly stay in their usual 
home with support and care from close family members. While the burden of caring for a 
stroke patient can cause problems for the caregiver, such care has been shown to improve the 
mental health and social health of stroke survivors. For example, Theeke et al. [356] showed 
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that patients who were discharged to a nursing home had poorer QoL at three months than 
those who were discharged to home after controlling for age, sex and comorbidity. In a 
Nigerian study [357], the functional and mental status of stroke survivors improved with the 
involvement of the stroke patient’s spouse as the caregiver [357]. This finding is consistent 
with those of others where active partnership with important family members or main 
caregivers influences the success of self-management of patients with chronic illness 
[358,359]. 
The factors that we found to be associated with HRQoL across domains and instruments at 
three months were broadly consistent with those reported from studies conducted in 
developed countries. These included older age [227,353], female sex [302,360,361], stroke 
severity [227,241,353] and poor functional status after stroke [227,241,249,353,362]. Of 
these, only female sex was a predictor of HRQoL at three months in this study independently 
of attained functional status. The findings in relation to functional status are consistent with 
previous findings in respect of short-term [360] and long-term [245,363,364] outcomes of 
stroke. Some authors have suggested that poorer HRQoL among female stroke patients 
[227,245,365-367] is mainly due to advancing age, lower socioeconomic status, higher 
prevalence of impaired functional status, comorbidities and depressive symptoms. In this 
study, the women with stroke reported poorer HRQoL than men after adjustment for age, 
proxy response, severe of stroke at admission and functional status at three months. In 
general, women report poorer HRQoL than men in general population studies [368-370] 
including those conducted in Viet Nam [213,231], and in studies of patient groups including 
those with general chronic disease [371], chronic obstructive pulmonary disease [372], 
sarcoidosis [373], diabetes [374] and lumbar spinal stenosis [375]. In relation to stroke, 
studies in HICs have identified sex differences in access to and effectiveness of stroke 
treatment and rehabilitation therapy [25,175,376]. Relatively fewer of the female patients than 
of the male patients in this cohort had improved functional outcomes, but recovery in 
functional status over the three months did not contribute to HRQoL independently of 
attained functional status at three months. 
This study has several strengths. First, the cohort of patients was of adequate size and its 
members were recruited with extremely high ascertainment and participation, and with 
minimal loss to follow-up over three months. Secondly, the instruments used to assess 
HRQoL – the DHP and the EQ-5D-3L – were official translations and had been used 
previously in Vietnamese populations. The validity of the DHP for use in the Vietnamese 
adolescent population had been tested [212] and, in preparation for this study, we had 
assessed its reliability and validity for use in this sample of stroke patients [377] (Chapter 6). 
Thirdly, assessment of HRQoL was available for almost all of the patients because caregivers 
had been used as proxy respondents for patients who had cognitive impairments or 
communication difficulties. Using proxy assessments can prevent exclusion of severely 
affected stroke patients from a study, and thereby avoid systematic bias from that source 
[378]. Fourthly, we established in the validation study that proxy assessments of HRQoL 
using the DHP and EQ-5D are as reliable and valid as assessments based on information 
provided by the patients in this cohort [377]. Whilst the proxy assessments for patients were a 
little lower on average than assessments by the patients themselves, we corrected for the 
difference in the analyses.  
Our study also has some limitations. Firstly, because there is not a value set for the 
Vietnamese population with which to weigh responses to the EQ-5D, we used the value set 
for South Korea that is likely to approximately but not exactly reflect the preferences of 
Vietnamese people. Lacking normative data for the Vietnamese population, we were able 
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only to compare the mean utility score of a subset of the cohort (those aged over 60 years) 
with that of a similarly aged sample from a small rural community in northern Viet Nam. 
Secondly, the comparison of DHP scores of stroke patients to the general population was 
problematic because of the different sampling frame for the population sample. We corrected 
for differences in the age and sex distributions, but not for other factors such as 
socioeconomic status that may have differentiated the stroke patients. In addition, the 
population sample was drawn around 8 years earlier in 2004, and changes over the 
intervening period may have rendered as out-of-date the general population values. Thirdly, 
although depression was an important factor to predict poor HRQoL after stroke in many 
studies [227,237,357,379], we did not assess depression in our study. Finally, we established 
in the validation study that the DHP has only moderate reliability and validity for use with 
stroke patients [377] (Chapter 6). Part of the reason for this is that the DHP is a generic 
questionnaire that may underestimate the specific effects of stroke on HRQoL [227]. 
 
7.6. Conclusions 
In conclusion, this first study of the HRQoL of survivors of stroke in Viet Nam, and one of 
the few to report longer term HRQoL from the developing world, has confirmed that stroke 
reduces the physical well-being of survivors with the most affected being those with the 
greatest impairment of functional status, and with greater reported deficits for women than 
men. The similarity of mean levels of HRQoL of survivors of stroke in this study with those 
of survivors in other countries, and in the factors associated with HRQoL, suggests that 
programs verified as being successful in improving the outcomes of stroke survivors in HICs 
can be considered for adoption in Viet Nam 
 
7.7. Postscript 
This chapter has reported findings in respect of the survivors at three months in a cohort of 
patients with first-ever stroke in Viet Nam. It completes the reporting of the outcomes of 
those survivors. 
The next chapter (Chapter 8) summarises the work within this thesis and suggest the 
implications this may have for patients with stroke, public health professionals and health 
policy makers in Viet Nam. 
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Appendix 7: Additional findings on HRQoL of stroke on assessment of the DHP and the EuroQoL 
Table A7.1: Mean scores of DHP physical health, DHP mental health and DHP social health in three-month survivors of stroke with 
adjustment for proxy response. 
  Physical health (n=371)   Mental health (n=371)   Social health (n=369)  
 Num Mean (95% CI) Num Mean (95% CI) Num Mean (95% CI) 
Age          
< 45 years 37 65.0 (55.6, 74.3) 37 68.3 (60.3, 76.3) 37 66.4 (62.0, 70.8) 
45-54 years 92 55.7 (50.1, 61.3) 92 63.2 (58.2, 68.3) 92 57.1 (54.2, 60.0) 
55-64 years 94 56.3 (50.7, 61.9) 95 67.4 (62.4, 72.4) 94 59.2 (56.4, 62.1) 
65-74 years 74 42.5 (36.8, 48.2) 73 59.1 (53.5, 64.7) 74 55.3 (52.1, 58.5) 
75+ years 74 38.9 (33.2, 44.5) 74 62.7 (57.0, 68.4) 73 56.8 (53.5, 60.1) 
Trend  -6.3 (-8.4, -4.2)*  -1.3 (-3.3, 0.7)  -1.6 (-2.7, -0.4)* 
Sex 
         
Male 200 57.3 (53.5, 61.2) 200 66.9 (63.4, 70.3) 200 58.8 (56.8, 60.8) 
Female 171 43.1 (39.3, 46.9) 171 60.4 (56.8, 64.1) 170 57.3 (55.2, 59.5) 
Difference  -14.2 (-19.6, -8.8)*  -6.4 (-11.4, -1.4)*  -1.5 (-4.4, 1.5)  
Marital status 
         
Married 286 53.5 (50.3, 56.7) 285 65.3 (62.5, 68.2) 286 59.2 (57.6, 60.8) 
Single 17 59.8 (46.2, 73.3) 18 67.2 (55.9, 78.4) 17 56.3 (49.6, 63.1) 
Divorced 6 52.4 (30.6, 74.2) 6 31.9 (13.6, 50.2) 6 60.3 (49.0, 71.6) 
Widowhood(widower/widow) 62 35.4 (29.4, 41.3) 62 59.3 (53.3, 65.3) 61 53.2 (49.5, 56.8) 
Wealth index    
 
      
1st quarter (richest) 91 54.0 (48.2, 59.9) 90 68.0 (62.9, 73.1) 90 60.4 (57.4, 63.3) 
2nd quarter 79 49.4 (43.3, 55.5) 80 63.1 (57.7, 68.5) 79 56.7 (53.6, 59.9) 
3rd quarter 96 50.6 (45.0, 56.2) 96 61.6 (56.7, 66.5) 96 55.9 (53.0, 58.7) 
4th quarter (poorest) 99 48.0 (42.6, 53.5) 99 62.9 (58.0, 67.7) 99 59.9 (57.1, 62.7) 
Trend  -1.7 (-4.2, 0.8)  -1.7 (-3.9, 0.5)  -0.2 (-1.5, 1.1) 
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  Physical health (n=371)   Mental health (n=371)   Social health (n=369)  
 Num Mean (95% CI) Num Mean (95% CI) Num Mean (95% CI) 
Type of stroke   
       
ICH 89 50.2 (44.4, 55.9) 90 59.4 (54.3, 64.4) 89 56.7 (53.7, 59.7) 
IS 282 50.6 (47.3, 53.9) 281 65.3 (62.5, 68.2) 281 58.6 (56.9, 60.2) 
Difference  0.4 (-6.2, 7.1)  5.9 (0.1, 11.7)  1.9 (-1.5, 5.3) 
Severity of impairment           
NIHSS ≤ 7 214 57.2 (53.4, 60.9) 212 68.2 (64.9, 71.4) 213 60.1 (58.2, 61.9) 
NIHSS > 7 145 41.4 (37.2, 45.5) 147 59.0 (55.1, 62.8) 145 56.0 (53.7, 58.3) 
Difference  -15.8 (-21.4, -10.2)*  -9.2 (-14.3, -4.2)*  -4.1 (-7.1, -1.0)* 
Disability at 3 month  
 
  
      
Least severe (mRS= 0/1) 126 72.9 (68.5, 77.2) 126 75.3 (71.3, 79.4) 126 65.2 (62.9, 67.5) 
Least severe at admission 27 77.1 (67.7, 86.4) 27 80.1 (71.4, 88.8) 27 61.5 (56.6, 66.4) 
Intermediate at admission 70 71.6 (65.9, 77.3) 70 75.1 (69.6, 80.5) 70 66.4 (63.4, 69.4) 
Most severe at admission 29 72.7 (63.9, 81.6) 29 72.0 (63.7, 80.4) 29 66.0 (61.3, 70.6) 
Intermediate (mRS=2/3) 141 49.0 (45.4, 52.6) 142 63.8 (60.1, 67.6) 140 57.1 (55.0, 59.3) 
Least severe at admission 19 55.7 (45.6, 65.8) 19 60.5 (50.3, 70.7) 19 53.8 (47.8, 59.7) 
Intermediate at admission 56 48.2 (42.6, 53.9) 55 63.4 (57.4, 69.4) 55 57.9 (54.4, 61.3) 
Most severe at admission 64 49.0 (43.7, 54.2) 66 65.6 (60.1, 71.1) 64 58.1 (54.9, 61.3) 
Most severe (mRS=4/5) 104 29.8 (26.1, 33.4) 103 50.7 (46.3, 55.1) 104 50.9 (48.3, 53.6) 
Least severe at admission 0 n.a.  0 n.a.  0 n.a.  
Intermediate at admission 31 32.8 (26.0, 39.5) 30 51.4 (43.3, 59.4) 31 50.6 (45.9, 55.3) 
Most severe at admission 72 28.7 (24.4, 33.1) 72 49.9 (44.6, 55.1) 72 51.3 (48.2, 54.5) 
Trend†  -20.3 (-22.8, -12.7)*  -12.2 (-15.2, -9.2)*  -7.3 (-9.1, -5.5)* 
* idenotes p<0.05 
† Trend over three category means 
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Table A7.2: Means of DHP perceived health, DHP self-esteem and DHP anxiety scores of stroke survivors to three months at levels of 
study factors with adjustment for proxy response. 
  Self-esteem (n=370)   Depression (n=371)   Anxiety (n=370)  
 Num Mean (95% CI) Num Mean (95% CI) Num Mean (95% CI) 
Age          
< 45 years 37 81.7 (76.9, 86.6) 37 72.3 (64.8, 79.7) 37 78.6 (73.0, 84.2) 
45-54 years 92 76.2 (72.9, 79.5) 92 67.1 (62.3, 71.9) 92 73.2 (69.5, 76.9) 
55-64 years 95 78.2 (75.0, 81.3) 94 70.2 (65.5, 74.9) 94 76.3 (72.7, 79.9) 
65-74 years 73 75.3 (71.5, 79.1) 74 63.5 (58.2, 68.8) 74 72.0 (67.8, 76.2) 
75+ years 73 77.9 (74.2, 81.6) 74 63.0 (57.6, 68.5) 73 73.4 (69.1, 77.6) 
Trend  -0.5 (-1.8, 0.8)  -2.0 (-3.9, -0.1)*  -0.9 (-2.4, 0.6) 
Sex 
         
Male 200 78.3 (76.1, 80.4) 200 70.8 (67.6, 74.0) 200 76.0 (73.5, 78.4) 
Female 170 76.4 (74.0, 78.9) 171 62.3 (58.8, 65.7) 170 72.4 (69.7, 75.2) 
Difference  -1.8 (-5.1, 1.5)*  -8.5 (-13.2, -3.8)*  -3.6 (-7.2, 0.1) 
Marital status 
         
Married 285 78.2 (76.4, 80.0) 286 68.8 (66.1, 71.4) 286 75.6 (73.5, 77.6) 
Single 18 79.9 (72.8, 87.0) 17 73.7 (62.9, 84.5) 17 78.8 (70.6, 86.9) 
Divorced 6 64.3 (49.0, 79.6) 6 44.5 (25.4, 63.6) 6 64.9 (49.3, 80.4) 
Widowhood(widower/widow) 61 74.0 (69.8, 78.2) 62 58.5 (52.7, 64.3) 61 68.0 (63.2, 72.7) 
Wealth index    
 
      
1st quarter (richest) 90 79.2 (75.9, 82.4) 91 70.0 (65.2, 74.8) 90 76.2 (72.5, 79.8) 
2nd quarter 79 77.5 (74.0, 81.0) 79 65.6 (60.5, 70.8) 79 72.4 (68.3, 76.4) 
3rd quarter 96 75.4 (72.1, 78.7) 96 65.5 (60.8, 70.2) 96 72.1 (68.4, 75.7) 
4th quarter (poorest) 99 77.9 (74.8, 81.1) 99 66.2 (61.6, 70.9) 99 76.3 (72.8, 79.8) 
Trend  -0.6 (-2.0, 0.9)  -1.2 (-3.3, 1.0)  0 (-1.6, 1.7) 
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  Self-esteem (n=370)   Depression (n=371)   Anxiety (n=370)  
 Num Mean (95% CI) Num Mean (95% CI) Num Mean (95% CI) 
Type of stroke   
       
ICH 89 75.2 (71.8, 78.6) 89 64.3 (59.4, 69.2) 89 73.7 (69.9, 77.4) 
IS 281 78.1 (76.3, 80.0) 282 67.7 (65.0, 70.4) 281 74.6 (72.5, 76.7) 
Difference  2.9 (-1.0, 6.8)  3.4 (-2.2, 9.0)  0.9 (-3.4, 5.2) 
Severity of impairment           
NIHSS≤ 7 212 80.2 (78.2, 82.2) 214 71.1 (68.0, 74.1) 213 76.8 (74.4, 79.1) 
NIHSS> 7 146 74.2 (71.5, 76.8) 145 61.5 (57.7, 65.2) 145 71.0 (68.0, 74.0) 
Difference  -6.0 (-9.4, -2.7)*  -9.6 (-14.5, -4.7)*  -5.8 (-9.6, -1.9)* 
Disability at 3 month  
 
  
      
Least severe (mRS= 0/1) 126 85.0 (82.6, 87.4) 126 78.6 (74.9, 82.3) 126 82.2 (79.4, 85.0) 
Least severe at admission 27 85.6 (80.6, 90.6) 27 82.0 (74.2, 89.9) 27 83.2 (77.3, 89.1) 
Intermediate at admission 70 84.9 (81.7, 88.0) 70 78.4 (73.5, 83.4) 70 81.9 (76.1, 87.7) 
Most severe at admission 29 85.1 (80.2, 89.9) 29 76.1 (68.4, 83.8) 29 73.3 (65.6, 80.9) 
Intermediate (mRS=2/3) 142 76.0 (73.6, 78.5) 141 66.6 (63.1, 70.1) 140 73.5 (70.6, 76.3) 
Least severe at admission 19 72.8 (65.7, 79.9) 19 67.2 (57.7, 76.8) 19 72.4 (67.9, 76.9) 
Intermediate at admission 55 77.1 (73.2, 81.0) 56 66.1 (60.5, 71.7) 55 75.2 (71.1, 79.3) 
Most severe at admission 66 76.5 (72.8, 80.1) 64 67.4 (62.2, 72.7) 64 66.5 (60.1, 72.9) 
Most severe (mRS=4/5) 102 69.4 (66.1, 72.7) 104 53.5 (49.2, 57.8) 104 65.6 (62.0, 69.1) 
Least severe at admission 0 n.a.  0 n.a.  0 n.a.  
Intermediate at admission 30 70.6 (64.8, 76.4) 31 55.3 (47.6, 63.0) 31 66.5 (60.1, 72.9) 
Most severe at admission 71 69.2 (65.2, 73.1) 72 52.2 (47.0, 57.4) 72 65.0 (60.7, 69.4) 
Trend†  -8.3 (-10.5, -6.1)*  -3.7 (-4.5, -2.8)*  -8.6 (-11.1, -6.2)* 
*denotes p<0.05 
† Trend over three category means 
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Table A7.3: Means of DHP perceived health, DHP pain and DHP disability of stroke survivors to three months at levels of study factors 
with adjustment for proxy response. 
  Perceived health (n=369)   Pain (n=371)   Disability (n=372)  
 Num Mean (95% CI) Num Mean (95% CI) Num Mean (95% CI) 
Age          
<45 years 37 37.2 (25.7, 48.7) 37 72.6 (61.2, 83.9) 37 84.5 (70.9, 98.1) 
45-54 years 92 32.5 (25.1, 39.8) 92 66.4 (59.2, 73.6) 92 74.9 (66.2, 83.5) 
55-64 years 93 30.7 (23.4, 38.0) 94 71.2 (64.1, 78.4) 95 72.8 (64.3, 81.4) 
65-74 years 73 25.8 (17.7, 34.0) 74 57.0 (49.0, 65.1) 74 60.6 (50.9, 70.2) 
75+ years 74 20.2 (11.9, 28.5) 74 53.2 (45.1, 61.4) 74 57.2 (47.4, 67.0) 
Trend  -4.1 (-7.0, -1.2)*  -4.8 (-7.7, -2.0)*  -6.7 (-10.2, -3.3)* 
Sex 
         
Male 200 31.9 (26.9, 36.8) 200 69.9 (65.0, 74.7) 200 69.3 (63.4, 75.3) 
Female 169 25.0 (19.6, 30.4) 171 56.6 (51.3, 61.8) 172 68.5 (62.1, 74.9) 
Difference  -6.9 (-14.2, 0.4)  -13.3 (-20.5, -6.1)*  -0.8 (-9.6, 7.9) 
Marital status 
         
Married 285 29.8 (25.7, 34.0) 286 65.9 (61.9, 70.0) 286 69.3 (64.4, 74.3) 
Single 18 42.3 (25.8, 58.8) 17 80.0 (63.4, 96.6) 18 78.5 (58.7, 98.3) 
Divorced 6 22.9 (-5.7, 51.5) 6 81.8 (53.9, 109.8) 6 47.6 (13.3, 82.0) 
Widowhood(widower/widow) 60 20.1 (11.0, 29.1) 62 47.5 (38.8, 56.2) 62 66.5 (55.8, 77.2) 
Wealth index    
 
      
1st quarter (richest) 90 35.1 (27.7, 42.6) 91 63.6 (56.3, 71.0) 92 73.4 (64.6, 82.2) 
2nd quarter 78 30.6 (22.6, 38.5) 79 63.1 (55.2, 71.0) 79 62.6 (53.2, 72.1) 
3rd quarter 96 25.4 (18.3, 32.6) 96 64.0 (56.8, 71.1) 96 70.2 (61.6, 78.8) 
4th quarter (poorest) 99 24.9 (17.8, 32.0) 99 64.0 (56.9, 71.0) 99 67.8 (59.3, 76.3) 
Trend  -3.6 (-6.8, -0.3)  0.2 (-3.0, 3.4)  -1.0 (-4.9,2.9) 
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  Perceived health (n=369)   Pain (n=371)   Disability (n=372)  
 Num Mean (95% CI) Num Mean (95% CI) Num Mean (95% CI) 
Type of stroke   
       
ICH 90 29.2 (21.7, 36.6) 89 59.9 (52.5, 67.3) 90 61.9 (53.1, 70.7) 
IS 279 28.6 (24.4, 32.8) 282 65.0 (60.8, 69.1) 282 71.2 (66.2, 76.2) 
Difference  -0.6 (-9.1, 7.9)  5.1 (-3.4, 13.6)  9.3 (-0.8, 19.5) 
Severity of impairment    
 
     
 
NIHSS ≤ 7 211 34.2 (29.4, 39.0) 214 69.0 (64.2, 73.7) 214 76.7 (71.1, 82.3) 
NIHSS > 7 146 21.4 (15.6, 27.2) 145 55.8 (50.0, 61.6) 146 59.8 (53.0, 66.6) 
Difference  -12.8 (-20.4, -5.2)*  -13.1 (-20.7, -5.6)*  -17.0 (-25.8, -8.1)* 
Disability at 3 month  
 
  
      
Least severe (mRS= 0/1) 126 46.0 (40.0, 51.9) 126 76.9 (70.9, 82.9) 126 94.1 (88.1, 100.1) 
Least severe at admission 27 47.7 (34.9, 60.6) 27 79.4 (66.7, 92.1) 27 96.4 (83.7, 109.1) 
Intermediate at admission 70 47.7 (39.6, 55.7) 70 73.1 (65.2, 81.1) 70 93.8 (85.8, 101.8) 
Most severe at admission 29 40.6 (28.2, 53.0) 29 84.1 (71.9, 96.4) 29 93.3 (81.0, 105.6) 
Intermediate (mRS=2/3) 141 20.6 (15.0, 26.1) 141 63.9 (58.2, 69.5) 142 77.1 (71.5, 82.7) 
Least severe at admission 18 24.0 (8.2, 39.7) 19 76.0 (60.9, 91.2) 19 79.1 (63.9, 94.3) 
Intermediate at admission 55 22.1 (13.1, 31.1) 56 59.9 (51.1, 68.8) 56 75.8 (67.0, 84.7) 
Most severe at admission 66 18.1 (10.0, 26.3) 64 64.8 (56.6, 73.1) 65 80.0 (71.8, 88.2) 
Most severe (mRS=4/5) 102 18.7 (12.0, 25.4) 104 47.7 (41.0, 54.3) 104 27.3 (20.7, 34.0) 
Least severe at admission 0 n.a.  0 n.a.  0 n.a.  
Intermediate at admission 30 23.7 (11.5, 35.8) 31 59.8 (48.0, 71.6) 31 30.6 (18.7, 42.4) 
Most severe at admission 72 16.5 (8.5, 24.5) 72 42.9 (35.0, 50.9) 72 26.0 (18.1, 34.0) 
Trend†  -14.1 (-18.7, -9.5)*  -14.5 (-19.1, -10.0)*  -32.8 (-37.4, -28.1)* 
*denotes p<0.05 
† Trend over three category means 
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Table A7.4: Mean score of DHP of all patients and population (after age and sex standardisation). 
  Males   Females  
 Population All stroke Difference p-value Population All stroke Difference p-value 
Physical health 
60.1 60.1 0.04 1.0 53.5 45.7 -57.8 0.57 
Mental health 74.0 67.5 -6.5 0.66 72.7 60.8 -11.9 0.39 
Social health 57.7 58.5 0.8 0.94 52.8 56.8 4.0 0.61 
General health 63.9 62.2 -1.7 0.88 59.7 54.5 -5.2 0.58 
Perceived health 56.0 32.0 -24.0 0.30 48.3 24.9 -21.9 0.22 
Self-esteem 73.3 76.3 11.2 0.79 69.9 73.7 3.9 0.72 
Anxiety 69.1 74.5 3.0 0.79 67.7 70.3 2.6 0.82 
Depression 66.7 70.6 3.9 0.79 61.4 61.6 0.2 0.99 
Pain 54.0 70.0 16.0 0.45 53.7 56.4 2.8 0.89 
Disability 97.4 69.5 -25.2 0.30 95.0 68.3 -26.7 0.26 
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Table A7.5: Mean score of DHP of least severe (mRS=0/1) at three months patients and population (after age and sex standardisarion). 
  Males   Females  
 Population All stroke Difference p-value Population All stroke Difference p-value 
Physical health 
63.7 79.4 15.7 P=0.07 55.9 66.1 10.1 P=0.15 
Mental health 73.7 76.0 2.4 P=0.81 70.4 77.7 7.2 P=0.16 
Social health 59.0 65.4 6.4 P=0.30 54.3 66.3 12.0 P<0.001 
General health 65.5 73.6 8.2 P=0.18 60.2 70.0 9.8 P=0.005 
Perceived health 58.2 50.0 -8.2 P=0.63 49.8 40.7 -9.1 P=0.44 
Self-esteem 73.4 83.3 9.8 P=0.13 69.8 87.4 17.7 P<0.001 
Anxiety 70.0 81.6 11.7 P=0.12 67.2 82.8 15.6 P=0.003 
Depression 68.5 79.8 11.3 P=0.23 61.8 77.9 16.1 P=0.02 
Pain 58.0 82.5 24.6 P=0.07 54.1 67.4 13.3 P=0.16 
Disability 98.0 94.0 P=-4.0 P=0.66 95.0 94.2 -0.8 P=0.87 
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Table A7.6: Mean score of DHP of intermediate severe (mRS=2/3) at three months patients and population (after age and sex 
standardisation). 
  Males   Females  
 Population All stroke Difference p-value Population All stroke Difference p-value 
Physical health 60.5 55.0 -5.5 P=0.50 54.3 45.6 -8.6 P=0.28 
Mental health 73.9 65.9 -8.0 P=0.44 71.3 62.3 -9.1 P=0.30 
Social health 58.2 56.3 -1.9 P=0.78 53.5 57.0 3.5 P=0.53 
General health 64.2 59.1 -5.1 P=0.41 59.7 55.1 -4.6 P=0.40 
Perceived health 56.4 22.5 -33.9 P=0.02 49.0 18.6 -30.4 P=0.01 
Self-esteem 73.5 73.7 0.1 P=0.99 69.7 73.1 3.5 P=0.66 
Anxiety 69.3 72.9 3.6 P=0.65 67.3 70.7 3.4 P=0.63 
Depression 67.0 69.1 2.2 P=0.82 61.2 63.0 1.8 P=0.84 
Pain 54.4 69.3 14.9 P=0.27 53.6 58.5 4.8 P=0.73 
Disability 97.2 72.1 P=-25.1 P=0.15 94.9 81.9 -12.9 P=0.32 
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Table A7.7: Mean score of DHP of most severe (mRS=4/5) at three months patients and population (after age and sex standardisation). 
  Males   Females  
 Population All stroke Difference p-value Population All stroke Difference p-value 
Physical health 
52.9 33.6 -19.3 P=0.04 50.6 30.4 -20.2 P=0.007 
Mental health 74.6 54.4 -20.3 P=0.04 76.2 46.3 -29.9 P=0.001 
Social health 54.9 49.6 -5.3 P=0.45 50.9 49.5 -1.5 P=0.76 
General health 60.8 46.5 -14.3 P=0.03 59.2 42.1 -17.2 P=0.002 
Perceived health 51.4 14.1 -37.2 P=0.002 46.2 20.5 -25.6 P=0.03 
Self-esteem 72.7 67.6 -5.1 P=0.56 70.2 63.9 -6.3 P=0.33 
Anxiety 67.3 64.2 -3.1 P=0.56 68.5 60.2 -8.3 P=0.25 
Depression 63.4 56.6 -6.8 P=0.49 61.3 47.5 -13.8 P=0.10 
Pain 46.4 48.9 2.6 P=0.87 53.4 45.6 -7.8 P=0.56 
Disability 96.5 22.3 16.9 P<0.001 95.2 31.6 -63.6 P<0.001 
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Table A7.8: Mean score of DHP of least severe (mRS=0/1) at admission patients and population (after age and sex standardisation). 
  Males   Females  
 Population All stroke Difference p-value Population All stroke Difference p-value 
Physical health 
62.4 79.4 17.0 P=0.05 55.9 66.1 10.2 P=0.15 
Mental health 73.5 76.0 2.6 P=0.80 71.0 77.7 6.7 P=0.19 
Social health 58.7 65.4 6.8 P=0.28 54.7 66.3 11.6 P<0.001 
General health 64.8 73.6 8.8 P=0.15 60.5 70.0 9.5 P=0.01 
Perceived health 57.2 50.0 16.9 P=0.67 49.2 40.7 -8.5 P=0.48 
Self-esteem 73.2 83.3 10.1 P=0.12 70.4 87.4 17.1 P<0.001 
Anxiety 70.1 81.6 11.5 P=0.13 67.7 82.8 15.1 P<0.001 
Depression 67.8 79.8 12.0 P= 0.20 62.1 77.9 15.8 P=0.02 
Pain 55.9 82.5 26.6 P=0.05 53.7 67.4 13.7 P=0.15 
Disability 97.4 94.0 -3.4 P=0.71 95.4 94.2 -1.2 P=0.81 
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Table A7.9: Mean score of DHP of intermediate  (mRS=2/3) at admission patients and population (after age and sex standardisation). 
  Males   Females  
 Population All stroke Difference p-value Population All stroke Difference p-value 
Physical health 60.4 63.6 3.2 P=0.79 53.1 49.0 -4.1 P=0.64 
Mental health 74.0 67.1 -7.0 P=0.58 71.8 66.9 -4.9 P=0.56 
Social health 58.0 60.2 2.3 P=0.79 52.7 59.9 7.2 P=0.14 
General health 64.1 64.1 0 P=1.0 59.2 58.5 -0.7 P=0.91 
Perceived health 56.2 36.9 -19.3 P=0.28 48.4 30.6 -17.8 P=0.16 
Self-esteem 73.5 76.7 3.3 P=0.71 69.3 78.7 9.4 P=0.16 
Anxiety 69.0 74.9 5.9 P=0.51 67.1 73.8 6.6 P=0.37 
Depression 66.9 71.1 4.2 P=0.68 60.6 67.1 6.5 P=0.45 
Pain 54.5 71.4 16.9 P=0.28 53.3 58.8 5.5 P=0.69 
Disability 97.5 74.2 -22.8 P=0.24 94.6 75.0 -19.6 P=0.19 
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Table A 7.10: Mean score of DHP of most severe  (mRS=4/5) at admission patients and population (after age and sex standardisation). 
  Males   Females  
 Population All stroke Difference p-value Population All stroke Difference p-value 
Physical health 
58.9 53.1 -5.9 p=0.63 53.1 38.6 -14.5 P=0.15 
Mental health 74.1 65.5 -8.6 p=0.39 74.1 53.8 -20.3 P=0.06 
Social health 57.2 57.9 0.7 p=0.92 52.4 53.6 1.3 P=0.83 
General health 63.4 58.9 -4.5 p=0.57 59.9 48.8 -11.0 P=0.12 
Perceived health 55.3 23.8 -31.4 P=0.06 47.9 17.9 -30.0 P=0.03 
Self-esteem 73.2 75.7 2.5 P=0.76 70.2 68.5 -1.7 P=0.83 
Anxiety 68.8 72.8 4.0 P=0.66 68.1 66.2 -1.9 P=0.83 
Depression 66.2 67.3 1.1 P=0.92 61.9 54.9 -7.0 P=0.51 
Pain 52.8 65.9 13.1 P=0.43 54.0 50.6 -3.4 P=0.82 
Disability 97.2 60.0 -37.2 P=0.08 95.2 58.0 -37.2 P=0.05 
 
 
 186 
 
 
Table A7.11: Comparison EQ-5D utility score between patients with stroke and the 
aging general population (FilaBavi). 
Aging general population (60+ years) 0.88 (95% CI 0.87, 0.88) 
All 60+ years patients (unweighted) 0.57 (SD 0.36) 
All 60+ years patients (weighted) 0.58 (SD 0.35) 
Patients with less severe disability (mRS=0/1) at 3 months 0.95 (SD 0.08) 
Patients with less severe disability (mRS=2/3) at 3 months 0.71 (SD 0.13) 
Patients with less severe disability (mRS=4/5) at 3 months 0.25 (SD 0.27) 
All 60+ years patients (weighted)  
Patients with less severe disability (mRS=0/1) at admission 0.82 (SD 0.15) 
Patients with less severe disability (mRS=2/3) at admission 0.69 (SD 0.31) 
Patients with less severe disability (mRS=4/5) at admission 0.45 (SD 0.35) 
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Table A7.12: Means and difference of means of DHP physical health, DHP mental health and DHP social health scores of stroke 
survivors to three months at levels of study factors with adjustment for age, sex, proxy response , severity of stroke at 
admission and disability at three months 
  DHP physical health   DHP mental health   DHP social health  
  Adjusted*    Adjusted also 
for disability 
at 3 months  
  Adjusted*   Adjusted also 
for disability 
at 3 months 
  Adjusted*   Adjusted also 
for disability 
at 3 months 
 
 Mean (95% CI) Mean (95% CI) Mean (95% CI) Mean (95% CI) Mean (95% CI) Mean (95% CI) 
Age       
< 45 years 66.8 (57.9, 75.7) 56.6 (49.4, 63.8) 70.1 (62.2, 77.8) 64.2 (56.8, 71.5) 67.7 (63.3, 72.1) 64.5 (60.2, 68.8) 
45-54 years -12.6 (-23.0, -2.3) -5.3 (-13.6, 2.9) -7.0 (-16.2, 2.1) -2.8 (-11.4, 5.7) -10.2  (-15.5, -5.0) -8.1 (-13.1, -3.1) 
55-64 years -11.6 (-21.9, -1.3) -2.8 (-11.2, 5.5) -2.6 (-11.8, 6.5) 2.4 (-6.2, 11.0) -8.5 (-13.8, -3.3) -5.8 (-10.9, -0.8) 
65-74 years -24.7 (-35.2, -14.3) -9.0 (-17.8, -0.2) -10.8 (-20.3, -1.2) -1.4 (-10.6, 7.9) -12.2 (-17.7, -6.7) -7.1 (-12.5, -1.7) 
75+ years -24.5 (-35.2, -13.8) -8.4 (-17.5, 0.6) -5.6 (-15.3, 4.2) 3.8 (-5.5, 13.2) -10.7 (-16.3, -5.1) -5.6 (-11.1, -0.1) 
Trend -5.5 (-7.6, -3.5) -1.8 (-3.6, 0.1) -1.1 (-3.1, 0.9) 1.2 (-0.7, 3.2) -1.8 (-3.0, -0.6) -0.5 (-1.6, 0.7) 
Sex 
      
Male 55.6 (51.9, 59.2) 54.5 (51.5, 57.5) 66.7 (63.3, 70.1) 65.9 (62.8, 69.0) 58.4 (56.5, 60.4) 58.0 (56.1, 59.9) 
Female -10.4 (-15.6, -5.1) -7.4 (-11.8, -3.0) -4.9 (-10.0, 0.1) -2.9 (-7.6, 1.8) 0 (-2.9, 3.0) 1.1 (-1.8, 3.9) 
Marital status       
Married 51.4 (48.4, 54.4) 51.5 (49.0, 53.9) 64.7 (61.9, 67.5) 64.8 (62.2, 67.4) 59.1 (57.4, 60.8) 59.0 (57.5, 60.6) 
Single 10.3 (-3.4, 24.1) 10.8 (-0.5, 22.1) 5.0 (-6.9, 16.8) 4.9 (-6.1, 15.8) -1.7 (-9.0, 5.5) -1.6 (-8.4, 5.3) 
Divorced -1.2 (-21.2, 18.8) 0.7 (-16.1, 17.4) -33.3 (-51.4, -15.2) -32.0 (-49.1, -14.9) 0.4 (-10.8, 11.7) 1.1 (-9.5, 11.7) 
Widowhood -6.4 (-14.4, 1.6) -5.3 (-12.0, 1.3) 0.5 (-7.2, 8.2) 0.9 (-6.2, 8.0) -3.7 (-8.4, 0.9) -3.4 (-7.8, 1.0) 
Wealth index †       
1st quarter (richest) 55.8 (50.4, 61.2) 51.9 (47.5, 56.4) 70.1 (65.2, 75.1) 67.5 (62.9, 72.2) 61.5 (58.7, 64.4) 60.1 (57.4, 62.9) 
2nd quarter -6.9 (-14.7, 0.9) -0.4 (-7.0, 6.1) -7.0 (-14.2, 0.3) -2.8 (-9.7, 4.0) -4.8 (-9.1, -0.6) -2.6 (-6.7, 1.5) 
3rd quarter -6.3 (-13.6, 1.1) -0.7 (-6.9, 5.5) -8.8 (-15.7, -1.9) -5.0 (-11.5, 1.5) -5.7 (-9.7, -1.6) -3.8 (-7.6, 0.1) 
4th quarter (poorest) -7.0 (-14.4, 0.3) -2.3 (-8.5, 3.8) -7.1 (-14.0, -0.2) -4.0 (-10.4, 2.5) -1.5 (-5.5, 2.5) 0.1 (-3.7, 4.0) 
Trend -2.0 (-4.3, 0.2) -0.7 (-2.7, 1.2) -2.3 (-4.5, -0.1) -1.4 (-3.4, 0.7) -0.5 (-1.8, 0.8) -0.1 (-1.3, 1.2) 
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  DHP physical health   DHP mental health   DHP social health  
  Adjusted*    Adjusted also 
for disability 
at 3 months  
  Adjusted*   Adjusted also 
for disability 
at 3 months 
  Adjusted*   Adjusted also 
for disability 
at 3 months 
 
 Mean (95% CI) Mean (95% CI) Mean (95% CI) Mean (95% CI) Mean (95% CI) Mean (95% CI) 
Type of stroke       
ICH 51.1 (45.3, 56.9) 52.1 (47.3, 57.0) 61.9 (56.4, 67.4) 62.7 (57.6, 67.7) 57.8 (54.6, 61.1) 58.1 (55.1, 61.2) 
IS -0.5 (-7.2, 6.2) -1.4 (-7.0, 4.1) 3.2 (-3.1, 9.5) 2.5 (-3.4, 8.3) 0.8 (-2.9, 4.5) 0.4 (-3.1, 4.0) 
Severity of impairment  
      
NIHSS ≤ 7 56.7 (53.2, 60.2) 51.3 (48.4, 54.2) 68.0 (64.8, 71.2) 64.5 (61.4, 67.6) 60.0 (58.1, 61.8) 58.1 (56.2, 59.9) 
NIHSS > 7 -14.5 (-19.7, -9.3) -0.7 (-5.6, 4.2) -8.8 (-13.9, -3.8) 0.3 (-4.9, 5.5) -3.8 (-6.8, -0.8) 1.0 (-2.1, 4.1) 
Disability 
      
Least severe (mRS=0/1) 61.5 (53.3, 69.7) 56.1 (49.5, 62.8) 67.1 (59.7, 74.6) 63.8 (56.8, 70.7) 56.3 (51.9, 60.6) 54.3 (50.1, 58.5) 
Intermediate (mRS=2/3) -10.2 (-18.9, -1.5) -5.0 (-12.1, 2.1) -3.0 (-11.0, 5.0) 0.2 (-7.3, 7.6) 3.2 (-1.5, 7.9) 5.0 (0.5, 9.4) 
More severe (mRS=4/5) -13.7 (-23.6, -3.8) -6.0 (-14.2, 2.2) -3.5 (-12.7, 5.8) 1.4 (-7.2, 10.0) 2.1 (-3.3, 7.5) 4.8 (-0.3, 10.0) 
Trend -5.9 (-10.4, -1.5) -2.5 (-6.4, 1.3) -1.5 (-5.9, 3.0) 0.8 (-3.4, 5.0) 0.6 (-2.0, 3.2) 1.9 (-0.6, 4.3) 
Disability at 3 months       
Least severe (mRS=0/1) 70.4 (65.9, 75.0) n.n.  74.9 (70.5, 79.2) n.n. 65.6 (63.1, 68.1) n.n. 
Intermediate (mRS=2/3) -20.8 (-26.5, -15.0)  -9.9 (-15.6, -4.1)  -8.0 (-11.3, -4.7)  
More severe (mRS=4/5) -39.2 (-46.0, -32.5)  -23.8 (-31.1, -16.5)  -14.9 (-19.2, -10.6)  
Trend -18.6 (-21.6, -15.6)  -11.7 (-15.3, -8.1)  -7.6 (-9.8, -5.4)  
* Adjusted for age, sex, proxy response and severity of impairment at admission 
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Table A7.13: Means and difference of means of DHP self-esteem, DHP anxiety and DHP depression scores of stroke survivors to three 
months at levels of study factors with adjustment for age, sex, proxy response , severity of stroke at admission and 
disability at three months 
  DHP self-esteem   DHP anxiety   DHP depression  
  Adjusted*    Adjusted also 
for disability 
at 3 months  
  Adjusted*   Adjusted also 
for disability 
at 3 months 
  Adjusted*   Adjusted also 
for disability 
at 3 months 
 
 Mean (95% CI) Mean (95% CI) Mean (95% CI) Mean (95% CI) Mean (95% CI) Mean (95% CI) 
Age       
< 45 years 82.9 (78.1, 87.6) 79.6 (74.8, 84.4) 79.7 (74.1, 85.2) 75.3 (69.8, 80.8) 73.6 (66.4, 80.9) 67.4 (60.5, 74.2) 
45-54 years -6.6 (-12.4, -0.9) -4.4 (-10.1, 1.3) -6.5 (-13.2, 0.1) -3.6 (-10.0, 2.9) -7.2 (-15.8, 1.4) -2.8 (-10.8, 5.2) 
55-64 years -4.7 (-10.4, 1.0) -1.9 (-7.6, 3.7) -3.6 (-10.2, 3.0) 0.1 (-6.3, 6.5) -3.5 (-12.1, 5.1) 1.9 (-6.1, 9.9) 
65-74 years -7.1 (-13.1, -1.0) -1.7 (-7.8, 4.3) -8.0 (-14.9, -1.0) -0.9 (-7.8, 6.0) -10.4 (-19.4, -1.4) -0.2 (-8.8, 8.3) 
75+ years -4.4 (-10.5, 1.7) 0.9 (-85.2, 6.9) -5.6 (-12.7, 1.5) 1.4 (-5.6, 8.4) -8.6 (-17.8, 0.6) 1.6 (-7.1, 10.3) 
Trend -0.5 (-1.8, 0.8) 0.8 (-0.5, 2.1) -0.9 (-2.4, 0.6) 0.9 (-0.6, 2.3) -1.7 (-3.6, 0.2) 0.8 (-1.0, 2.7) 
Sex 
      
Male 78.3 (76.1, 80.4) 77.8   (75.7, 79.9) 75.8 (73.3, 78.3) 75.2 (72.9, 77.6) 70.5 (67.3, 73.6) 69.8 (66.9, 72.7) 
Female -1.0 (-4.3, 2.3) 0.2 (-2.9, 3.4) -2.8 (-6.6, 0.9) -1.4 (-5.0, 2.1) -7.1 (-11.9, -2.4) -5.1 (-9.5, -0.8) 
Marital status 
       
Married 78.3 (76.4, 80.1) 78.3 (76.5, 40.0) 75.3 (73.2, 77.4) 75.3 (73.4, 77.3) 67.9 (65.3, 70.6) 68.0 (65.6, 70.4) 
Single 3.0 (-4.5, 10.4) 2.9 (-4.1, 10.0) 5.1 (-3.6, 13.8) 5.3  (-2.8, 13.4) 8.1 (-3.2, 19.5) 8.4 (-1.8, 18.7) 
Divorced -14.5 (-29.8, 0.9) -13.6 (-27.9, 0.8) -10.8 (-26.3, 4.7) -9.9 (-24.3, 4.5) -24.2 (-42.8, -5.6) -23.1 (-40.2, -5.9) 
Widowhood -2.4 (-7.6, 2.8) -2.2 (-7.1, 2.8) -5.5 (-11.5, 0.5) -5.0 (-10.6, 0.6) -4.0 (-11.3, 3.4) -3.3 (-10.0, 3.4) 
Wealth index †       
1st quarter (richest) 80.5 (77.3, 83.6) 78.9 (75.9, 82.0) 77.1 (73.4, 80.7) 75.3 (71.8, 78.8) 71.4 (66.8, 76.1) 69.0 (64.7, 73.3) 
2nd quarter -3.0 ( -7.7, 1.7) -0.6 (-5.1, 4.0) -4.6 (-10.1, 0.8) -1.6 (-6.8, 3.6) -5.6 (-12.5, 1.3) -1.4 (-7.8, 5.0) 
3rd quarter -4.9 (-9.5, -0.4) -2.7 (-7.1, 1.6) -5.8 (-11.0, -0.6) -3.2 (-8.1, 1.7) -6.7 (-13.2, -0.2) -3.1 (-9.2, 2.9) 
4th quarter (poorest) -2.5 (-6.9, 2.0) -0.6 (-4.9, 3.7) -0.6 (-5.7, 4.5) 1.6 (-3.2, 6.4) -4.8 (-11.3, 1.7) -1.8 (-7.8, 4.2) 
Trend -1.0 (-2.4, 0.5) -0.4 (-1.8, 1.00 -0.3 (-1.9, 1.4) 0.3 (-1.2, 1.9) -1.6 (-3.6, 0.5) -0.7 (-2.6, 1.2) 
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  DHP self-esteem   DHP anxiety   DHP depression  
  Adjusted*    Adjusted also 
for disability 
at 3 months  
  Adjusted*   Adjusted also 
for disability 
at 3 months 
  Adjusted*   Adjusted also 
for disability 
at 3 months 
 
 Mean (95% CI) Mean (95% CI) Mean (95% CI) Mean (95% CI) Mean (95% CI) Mean (95% CI) 
Type of stroke 
      
ICH 77.3 (73.6, 80.9) 77.6 (74.2, 81.1) 75.2 (71.1, 79.7) 75.7 (71.9, 79.5) 66.3 (61.1, 71.5) 67.0 (62.3, 71.8) 
IS 0.7 (-3.5, 4.9) 0.3 (-3.6, 4.2) -0.9 (-5.6, 3.8) -1.4 (-5.8, 3.0) 1.2 (-4.8, 7.2) 0.5 (-5.0, 6.0) 
Severity of impairment  
      
NIHSS≤ 7 80.1 (78.1, 82.2) 78.1 (76.1, 80.2) 76.7 (74.3, 79.0) 74.2 (71.9, 76.5) 70.8 (67.8, 73.8) 67.0 (62.3, 71.8) 
NIHSS> 7 -5.9 (-9.3, -2.5) -0.7 (-4.2, 2.8) -5.5 (-9.3, -1.7) 0.9 (-3.0, 4.8) -9.0 (-13.8, -4.2) 0.5 (-5.0, 6.0) 
Disability 
      
Least severe (mRS=0/1) 77.9 (73.0, 82.8) 75.9 (71.1, 80.7) 76.9 (71.5, 82.4) 74.5 (69.3, 79.7) 71.9 (64.9, 78.8) 68.5 (62.0, 74.9) 
Intermediate (mRS=2/3) 0.4 (-4.8, 5.7) 2.3 (-2.8, 7.4) -2.4 (-8.2, 3.5) 0 (-5.6, 5.6) -4.5 (-12.0, 3.0) -1.3 (-8.2, 5.6) 
More severe (mRS=4/5) -0.5 (-6.5, 5.5) 2.4 (-3.5, 87.2) -3.1 (-9.9, 3.7) 0.4 (-6.0, 6.9) -6.3 (-14.9, 2.4) -1.2 (-9.2, 6.8) 
Trend -0.4 (-3.3, 2.6) 0.9 (-1.8, 3.7) -1.4 (-4.8, 2.0) 0.3 (-2.8, 3.4) -7.6 (-18.0, 2.9) -0.5 (-4.4, 3.4) 
Disability at 3 months 
      
Least severe (mRS=0/1) 85.2 (82.6, 87.8) n.n. 82.6 (79.6, 85.7) n.n. 78.0 (74.0, 82.0) n.n. 
Intermediate (mRS=2/3) -8.6 (-12.2, -5.0)  -8.4 (-12.6, -4.3)  -10.4 (-15.7, -5.1)  
More severe (mRS=4/5) -16.0 (-20.9, -11.0)  -18.4 (-24.0, -12.8)  -24.4 (-31.3, -17.5)  
Trend -8.5 (-11.2, -5.8)  -9.5 (-12.4, -6.5)  -12.2 (-15.6, -8.7)  
* Adjusted for age, sex, proxy response and severity of impairment at admission 
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Table A7.14: Means and difference of means of DHP perceived health, DHP pain and DHP disability scores of stroke survivors to three 
months at levels of study factors with adjustment for age, sex, proxy response , severity of stroke at admission and 
disability at three months 
  DHP perceived health   DHP pain   DHP disability  
  Adjusted*    Adjusted also 
for disability 
at 3 months  
  Adjusted*   Adjusted also 
for disability 
at 3 months 
  Adjusted*   Adjusted also 
for disability 
at 3 months 
 
 Mean (95% CI) Mean (95% CI) Mean (95% CI) Mean (95% CI) Mean (95% CI) Mean (95% CI) 
Age       
< 45 years 38.3 (26.7, 50.0) 31.3 (19.8, 42.8) 72.9. (61.6, 84.2) 67.1 (55.8, 78.4) 89.5 (76.2, 102.7) 73.2 (61.8, 84.5) 
45-54 years -6.0 (-19.8, 7.7) -1.1 (-14.5, 12.2) -8.0 (-21.4, 5.3) -4.1 (-17.2, 9.0) -13.4 (-29.0, 2.3) -2.3 (-15.5, 10.8) 
55-64 years -8.4 (-22.2, 5.4) -2.7 (-16.1, 10.7) -3.3 (-16.6, 10.1) 1.6 (-11.6, 14.7) -17.6 (-33.2, -2.0) -4.2 (-17.4, 8.9) 
65-74 years -11.6 (-26.0, 2.8) -0.6 (-15.0, 13.8) -16.2 (-30.1, -2.3) -7.3 (-21.4, 6.9) -27.7 (-44.0, -11.5) -2.4 (-16.6, 11.8) 
75+ years -17.0 (-31.7, -2.4) -6.0 (-20.6, 8.7) -16.1 (-30.3, -1.9) -7.0 (-21.4, 7.4) -31.6 (-48.3, -15.0) -6.0 (-20.4, 8.5) 
Trend -3.8 (-6.8, -0.8) -1.2 (-4.2, 1.9) -3.8 (-6.8, -0.9) -1.6 (-4.6, 1.4) -7.4 (-10.8, -3.9) -1.1 (-4.1, 1.9) 
Sex 
      
Male 30.8 (25.7, 35.8) 29.8 (24.9, 34.6) 68.5 (63.6, 73.4) 67.7 (62.9, 72.5) 67.2 (61.5, 73.0) 65.0 (60.3, 69.8) 
Female -3.9 (-11.5, 3.7) -1.7 (-9.0, 5.6) -10.6 (-18.0, -3.2) -8.8 (-16.0, -1.6) 5.7 (-2.9, 14.3) 10.5 (3.3, 17.6) 
Marital status 
        
Married 28.6 (24.3, 32.7) 28.6 (24.5, 32.7) 64.1  (59.9, 68.2) 63.9 (59.9, 67.9) 68.0 (63.1, 72.8) 67.7 (63.6, 71.6) 
Single 14.9 (-3.0, 32.8) 14.7 (-2.5, 31.9) 16.1 (-1.7, 33.9) 16.4 (-0.9, 33.8) 11.6 (-8.6, 31.8) 11.2 (-5.6, 28.0) 
Divorced -7.5 (-36.1, 21.1) -6.1 (-33.6, 21.5) 16.4 (-11.3, 44.1) 17.5 (-9.4, 44.5) -25.0 (-57.4, 7.3) -21.8 (-48.7, 5.0) 
Widowhood -0.9 (-12.8, 10.9) -0.8 (-12.2, 10.6) -8.4 (-19.7, 3.0) -7.7 (-18.8, 3.3) 11.2 (-2.0, 24.5) 13.0 (2.1, 24.0) 
Wealth index †       
1st quarter (richest) 36.6 (29.2, 44.1) 33.6 (26.3, 40.9) 64.8 (57.6, 72.0) 62.3 (55.2, 69.4) 77.0 (68.6, 85.3) 70.0 (63.0, 77.0) 
2nd quarter -6.3 (-17.3, 4.7) -1.8 (-12.6, 8.9) -1.9 (-12.5, 8.8) 2.0 (-8.5, 12.5) -15.1 (-27.5, -2.7) -4.1 (-14.5, 6.3) 
3rd quarter -11.4 (-21.8, -1.1) -7.2 (-17.4, 2.9) -2.4 (-12.4, 7.7) 0.9 (-9.0, 10.8) -4.4 (-16.0, 7.3) 5.0 (-4.8, 14.9) 
4th quarter (poorest) -11.9 (-22.2, -1.5) -8.3 (-18.4, 1.8) -0.5 (-10.6, 9.6) 2.3 (-7.6, 12.2) -11.0 (-22.7, 0.7) -3.0 (-12.8, 6.8) 
Trend -4.1 (-7.4, -0.8) -3.0 (-6.2, 0.2) -0.2 (-3.4, 3.0) 0.6 (-2.5, 3.7) -2.3 (-6.0, 1.4) 0 (-3.2, 3.1) 
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  DHP perceived health   DHP pain   DHP disability  
  Adjusted*    Adjusted also 
for disability 
at 3 months  
  Adjusted*   Adjusted also 
for disability 
at 3 months 
  Adjusted*   Adjusted also 
for disability 
at 3 months 
 
 Mean (95% CI) Mean (95% CI) Mean (95% CI) Mean (95% CI) Mean (95% CI) Mean (95% CI) 
Type of stroke 
      
ICH 30.8 (22.6, 39.0) 31.5 (23.6, 39.4) 59.9 (51.8, 67.9) 60.4 (52.6, 68.2) 67.0 (57.7, 76.4) 68.2  (60.4, 76.0) 
IS -2.3 (-11.8, 7.1) -3.2 (-12.3, 5.9) 4.8 (-4.4, 14.1) 4.2 (-4.8, 13.2) 3.6 (-7.1, 14.3) 2.1 (-6.8, 11.1) 
Severity of impairment  
      
NIHSS ≤ 7 33.9 (29.1, 38.7) 30.2 (25.3, 35.0) 68.5 (63.9, 73.2) 65.0 (60.3, 69.8) 76.4 (70.9, 81.9) 66.8 (62.1, 71.5) 
NIHSS > 7 -12.0 (-19.5, -4.5) -2.8 (-11.0, 5.3) -12.1 (-19.5, -4.7) -3.4 (-11.4, 4.6) -16.2 (-24.9, -7.5) 7.5 (-0.5, 15.4) 
Disability 
      
Least severe (mRS=0/1) 35.8 (24.6, 47.0) 31.8 (20.9, 42.7) 71.9 (61.2, 82.6) 71.2 (60.5, 82.0) 79.2 (66.7, 91.7) 70.3 (59.7, 80.8) 
Intermediate (mRS=2/3) -3.1 (-15.1, 8.9) 0.5 (-11.1, 12.2) -9.6 (-21.1, 1.9) -8.9 (-20.4, 2.7) -8.7 (-22.2, 4.7) -0.5 (-11.9, 10.8) 
More severe (mRS=4/5) -12.4 (-26.2, 1.3) -7.0 (-20.4, 6.5) -8.5 (-21.7, 4.8) -7.6 (-20.9, 5.7) -11.6 (-27.1, 3.8) 0.5 (-12.6, 13.6) 
Trend -6.9 (-13.5, -0.2) -4.3 (-10.8, 2.2) -3.1 (-9.6, 3.3) -2.8 (-9.2, 3.7) -5.2 (-12.7, 2.3) 0.4 (-5.9, 6.8) 
Disability at 3 months 
      
Least severe (mRS=0/1) 43.8 (37.2, 50.5) n.n. 73.0 (66.4, 79.6) n.n. 94.8 (88.3, 101.3) n.n. 
Intermediate (mRS=2/3) -22.7 (-31.5, -13.9)  -8.4 (-17.1, 0.3)  -16.6 (-25.1, -8.0)  
More severe (mRS=4/5) -22.5 (-33.8, -11.3)  -22.2 (-33.2, -11.1)  -67.6 (-78.5, -56.7)  
Trend -12.2 (-17.8, -6.5)  -10.9 (-16.4, -5.4)  -32.5 (-38.1, -26.9)  
* Adjusted for age, sex, proxy response and severity of impairment at admission 
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Chapter 8: Summary and Conclusions 
 
8.1. Introduction 
Stroke is the second most common cause of death [308], and a major contributor to morbidity 
and disability worldwide [308,309]. Up until the last decade or so, most of the data on the 
epidemiology of stroke had arisen from studies conducted in the developed world. There had 
been very little investigation of stroke in developing countries, likely due to a lack of 
resources and a shortage of adequately trained people to undertake the research. As outlined 
in Chapter 1, the evidence in respect of the burden of stroke in LMICs is limited with research 
largely confined to counts of events and acute outcomes, and with very limited examination of 
post-acute outcomes, particularly patient-centred ones such as HRQoL or costs. There is now 
some evidence [2] that the populations of LMICs are experiencing greater incidence of stroke 
than the populations of HICs. Recent reductions in communicable diseases in LMICs have 
resulted in greater longevity [64,65] and increased numbers of people surviving to the ages at 
which stroke is more common. It has been reported that rates of stroke among patients aged < 
75 years in LMICs is more than three-fold those in HICs [2], translating to a greater burden at 
younger ages.  
In response to this critical lack of information, this thesis has explored stroke in Viet Nam, a 
LMIC in south eastern Asia. This country shows the hallmarks of a country undergoing an 
‘epidemiological transition’ with the percentage of the population aged ≥ 60 years (the ageing 
index in the context of a LMIC) having risen from 24.3% in 1999 to 35.5% in 2009 [66]. 
Concurrently, the cardiovascular risk factor profile of the population has worsened with 
reductions in physical activity and increases in intake of fat, salt and sugar [310] and in 
prevalence of smoking [311]. It is therefore likely that stroke, along with other chronic 
diseases, is becoming more common in Viet Nam.  
The purpose of this thesis was to understand the current burden of stroke in Viet Nam. The 
approach was to look across different aspects of the burden of stroke including from the 
perspectives of the community, healthcare system and the patients. Investigation is made of 
the frequency of events, clinical manifestations, costs, case-fatality, functional outcomes and 
HRQoL. Unlike many studies of stroke in LMICs, this thesis explored the burden of stroke 
not only in acute phase, but also three months after discharge from hospital when functional 
status has somewhat stabilised [107,108,150,380]. 
The specific aims of this thesis were: 
1. To determine the frequency of admissions over a 12 month period to a tertiary hospital 
including by stroke type and assess stroke severity and 28-day case-fatality, and to 
estimate the incidence of hospital-admitted first-ever stroke in Ho Chi Minh City; 
2. To investigate case-fatality and functional outcomes three months after stroke; 
3. To estimate the societal costs of stroke, including direct medical costs of treatment and 
the associated direct non-medical and indirect costs incurred during hospitalisation; 
4. To assess the reliability and validity of assessments of health-related quality of life 
(HRQoL) from patient and proxy responses to the Duke Health Profile (DHP); 
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5. To assess the HRQoL of stroke survivors and to identify factors related to poor 
HRQoL three months post stroke. 
 
8.2. Major findings and implications 
 
Surveillance of stroke presentations over 12 months (Chapter 3) 
Significance 
It has been reported that the age-standardised incidence of stroke in LMICs is up to 23% 
greater than in HICs [2]. For the reasons outlined in the previous section, it is likely that 
stroke is becoming more common in Viet Nam, but there have been only two studies of stroke 
in the country [108,107] and one of those was conducted over 20 years ago [108]. This study 
is the first systematic surveillance of stroke admissions in Ho Chi Minh City, Viet Nam’s 
largest city. It was conducted to determine the frequency of admission of different types of 
stroke, as well as the profile of stroke severity and 28 day case-fatality. A secondary aim was 
to attempt to estimate the incidence of hospital-admitted first-ever stroke across Ho Chi Minh 
City using population data and geospatial analysis. 
Findings 
The principal findings of this study were that among 5,017 (54.3% male, 75.6% first-ever 
stroke) patients with stroke, the mean age of stroke onset was 61.8 (SD 13.1) years for males 
and 67.5 (SD 13.2) years for females with more males (58.6%) than females (39.1%) aged 
<65 years at onset. Ischaemic stroke was the dominant type, and 77.5% of patients had 
moderate-to-severe disability (mRS=3/4/5) including 51.7% with severe disability (mRS=4/5) 
assessed on the modified Rankin Scale (mRS). Slurred speech, limb weakness and face 
weakness were the most common symptoms and signs of stroke. Age standardised to the new 
world standard population, the estimated incidence density of hospital-admitted stroke was 
124.1 (95% confidence interval 99.7, 148.5) per 100,000 for males and 101.6 (95% 
confidence interval 74.8, 128.4) per 100,000 for females. The confirmed case-fatality at 28 
days among patients with known vital status was 12.2% (males 11.8%, females 12.8%), with 
another 18% of patients having unknown vital status due to loss to follow-up. 
Implications 
The findings on stroke occurrence in respect of mean age at diagnosis and type of stroke are 
similar to those of studies conducted in other LMICs. The mean age of stroke onset was much 
lower than that found in HICs, however. This lower age of onset has potential implications for 
the ongoing economic development of Viet Nam. Although the country is rapidly becoming 
‘westernised’, men are still largely responsible for providing the main income of Vietnamese 
families. Occurrence of stroke at young ages in the male population could lead to reductions 
in the labour workforce and economic hardship for the families of patients. 
The proportion of cases with moderate-to-severe disability at admission was larger than that 
reported for other LMICs. This may be due, at least in part, to the data collection being from a 
tertiary referral hospital that receives more severe cases than smaller provincial hospitals. 
Verifying this would require stroke surveillance in provincial general hospitals and district 
hospitals. Further investigation of early management of stroke, with monitoring of the time 
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from the onset of stroke to the time of admission to a hospital, and of the management of 
major risk factors for stroke in the community (such as high blood pressure, atrial fibrillation 
and diabetes), would assist in determining why patients admitted to this hospital include 
greater proportions of those with more severe stroke than is usual in LMICs. Moreover, 
further research to understand the level of stroke care in hospitals that do not have specialised 
stroke treatment should be undertaken. 
The similarity in clinical presentation of stroke patients in Viet Nam as elsewhere suggests 
that campaigns inform HICs, to raise awareness of the early signs and symptoms of stroke 
that would prompt an early hospital admission, can be considered for adoption in Viet Nam.  
The incidence density and 28-day case-fatality were lower than expected. This is possibly due 
to under-ascertainment of mild cases at one end of the severity spectrum and of severe cases 
at the other. A factor contributing to under-ascertainment of severe cases is that Vietnamese 
cultural beliefs favour palliation at home, with the result that hospital-based studies may never 
completely ascertain all cases of stroke in this country. While there is no routine death 
registration and the lack of medically-certified cause-of-death data in Viet Nam remains, 
verbal autopsy can and has been used to provide reliable diagnoses of stroke and more 
complete ascertainments of death due to stroke in rural communities in Viet Nam [381]. There 
should be efforts made to investigate the practicability of implementing ‘Step 2’ and ‘Step 3’ 
of the WHO STEPS-Stroke methodology within Ho Chi Minh City in order to ascertain the 
population-wide incidence of stroke. 
 
Case-fatality and functional status at three months after stroke onset (Chapter 4) 
Significance 
Observations about case-fatality and functional outcomes after stroke have come largely from 
studies conducted in HICs. Those studies show that reduced functional status or disability is 
common among survivors. It has been reported that approximately 30-40% of patients will 
have reduced function three months after stroke. Prior to this study, information about stroke 
patients after discharge from hospital was scarce in Viet Nam. This type of information is 
critical for planning the response to the growing burden of stroke in Viet Nam. Responding to 
this paucity of information, the author followed a cohort of first-ever stroke patients admitted 
to a stroke unit in a tertiary teaching hospital for three months after stroke and assessed case-
fatality and functional outcomes at three months post stroke. 
Findings 
Among 450 consecutive patients recruited at baseline and followed with a low proportion 
(6.1%) of loss to follow-up, in-hospital case-fatality was 3.3%, 28-day case-fatality was 6.7%, 
and three-month case-fatality was 10.4% among patients with known vital status. One-third of 
patients had ‘least severe disability’ (mRS=0/1), one-third had ‘intermediate disability’ 
(mRS=2/3) and another one-third had ‘most severe disability’ (mRS=4/5). Over the three 
months following discharge, one-half of patients had improvements in their functional status, 
while one-quarter had worsened functional status. Men were found to have greater 
improvement in function than women.  
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Implications 
As found in the surveillance study, and possibly for the same reasons, case-fatality was lower 
than that reported for other LMICs. The 28-day case-fatality in this study was much lower 
than that in a stroke registry study conducted at Da Nang Hospital, which is a provincial 
general hospital lacking a stroke unit and servicing a population in which the prevalence of 
untreated hypertension is high [107]. Furthermore, a national survey of risk factors for non-
communicable disease conducted in provinces representative of the eight ecological areas of 
Viet Nam has provided evidence that the proportion of Ho Chi Minh City residents who are 
under treatment for high blood pressure is higher than that of other provinces. This suggests 
that better management of high blood pressure in the community, and providing more 
specialist stroke units in provincial hospitals, should be considered to prevent strokes and 
improve outcomes following stroke in Viet Nam. 
The proportion of patients with severe functional limitations three months after stroke, and the 
proportion that had reductions in function over the three months, were similar to the findings 
of studies conducted in other LIMICs. However, it should be kept in mind that these 
outcomes were from a study conducted from a study of patients treated in one of the three 
major public hospitals with a specialist stroke unit, and with advanced imaging equipment and 
well-trained staff, in the largest city of Viet Nam. The proportion of patients with functional 
dependence following treatment for stroke in a provincial general hospital without a 
specialised stroke unit, or in a community hospital, would be higher.  
Although the dependency of stroke survivors in Viet Nam is high, facilities required for 
support of people with such severe disability are not available. Even basic amenities such as 
sealed footpaths and public transport are lacking. There are no social support programs to 
identify the needs of patients in their homes and provide necessary home modifications. 
Stroke survivors, particularly those with more severe disability after stroke, are likely to be 
isolated in their homes and totally dependent on the care provided by their families. It is 
recommended that public health professionals and health policy makers should address the 
needs of this vulnerable group of people. 
 
Costs of stroke in hospital (Chapter 5) 
Significance 
The economic burden of stroke including direct (medical and non-medical) and indirect (lost 
productivity or loss of income and caregiver burden) costs are likely to differ between 
countries due to differences in the presentation of stroke, its management and the costs 
assigned to resource use [326,327]. A limitation of existing work in this area is that most 
studies of the costs of stroke, particularly studies conducted in LMICs, have focused on direct 
costs without estimation of indirect costs. There has not been a previous report of the costs 
associated with the treatment of stroke in Viet Nam. This study provides the first estimates of 
the societal costs of stroke, including direct medical costs of treatment and the associated 
direct non-medical and indirect costs. Predictors of these costs of stroke during hospitalisation 
are identified. 
Findings 
From a societal perspective, the mean (SD) total costs per stroke admission were USD 963 
(SD 968), comprising of USD 560 (SD 562) for direct medical costs, USD 171 (SD 486) for 
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direct non-medical costs, and USD 240 (SD 392) for indirect costs. The mean (SD) length of 
stay was 6.6 days (SD 4.2). Diagnostic imaging, medications and bed-day fees were the 
largest contributors to direct medical costs and overall costs were greater for patients with 
comorbidity. Health insurance reduced out-of-pocket direct medical costs by 56%. Severity of 
stroke, length of stay and household wealth were the major predictors of treatment cost of 
stroke.  
Implications 
Despite relatively short average length of stay and possibly under-estimated indirect costs, the 
total costs of treatment were two-to-three times the median monthly income of patients, 
suggesting that stroke incurs substantial costs for both society and the patients’ families. Most 
stroke patients must rely on the support of relatives for payment of the hospital costs. Health 
insurance co-payments significantly reduce the out-of-pocket expenses for the families of 
insured patients. Viet Nam is moving towards universal healthcare with increased health 
insurance coverage of the population. This will help to reduce the burden of direct medical 
costs on patients.  
The stroke unit in this hospital is one of the leading stroke units in public hospitals in Ho Chi 
Minh City, with a high standard of diagnostic imaging techniques and treatment in accordance 
with guidelines. The direct medical costs of stroke treatment as measured in this study would 
be broadly similar to treatment costs in other hospitals with stroke units, but higher than the 
treatment costs in general departments of provincial or community hospitals without a 
specialised stroke unit. With this caveat, our estimates of treatment costs of stroke should 
provide reliable, evidence-based guidance for public health practitioners and health policy-
makers in Viet Nam. 
It should borne in mind that the estimates of direct non-medical costs presented in this study 
were derived from information provided by a cohort of patients who were Ho Chi Minh City 
residents at the time of stroke onset. However, another 40% of stroke patients admitted to this 
stroke unit were residents of other provinces at some distance from Ho Chi Minh City. The 
direct non-medical costs for food, transportation and other sundry expenses for those patients 
and their caregivers would be higher. Furthermore, the estimates of indirect costs made in this 
study were based on loss of income and took no account of loss of productivity not reflected 
by loss of income, and no allowance was made for loss of leisure time. If these other sources 
of loss were taken into account, the estimated burden of indirect costs for patients and their 
family would be much greater.  
 
Reliability and validity of health-related quality of life instruments (Chapter 6) 
Significance 
Because a major objective of this thesis was to explore patient-centred outcomes by 
measuring HRQoL, there was a requirement to select a dependable instrument with which to 
measure this construct. Review of the literature and discussions with local colleagues 
confirmed that there were no instruments available for which the validity of measurements of 
the HRQoL of stroke patients in Viet Nam, or anywhere else for that matter, had been 
assessed. One instrument – the Duke Health Profile (DHP) – had been translated and 
culturally adapted for use in the adolescent and general adult populations of Ho Chi Minh 
City, Viet Nam. This generic instrument provides assessments of dimensions of HRQoL that 
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are not captured by other HRQoL instruments such as the EuroQol EQ-5D. These other 
dimensions are social and mental health, which are potentially important after stroke. 
Therefore, the aim of this study was to assess the reliability and validity of measurements of 
HRQoL for stroke patients in Viet Nam made with the DHP, including when completed by a 
proxy on behalf of the patient.  
Findings 
Overall, the DHP was found to have moderate reliability when completed by patients or when 
completed by a proxy on behalf of the patient. For example, the intra-class correlations (ICCs) 
ranged from 0.60 to 0.86 for patient test-retest and from 0.55 to 0.98 for patient-proxy 
agreement. The ICCs were greatest for physical functioning components (patient test-retest 
0.63–0.86, patient-proxy: 0.69–0.98). The mean differences between test and retest 
assessments of HRQoL by patients were small and not clinically meaningful, and were not 
consistently associated with sex, age, type of stroke, or severity of impairment or disability. 
Direct assessments by the patient were on average greater than those obtained from the proxy. 
The correlations between the DHP dimensions and EQ-5D components were generally 
stronger when they measured similar constructs (r=0.53–0.66), and were lower for less related 
constructs (r=0.11–0.43). 
Implications 
The DHP may be used to measure the HRQoL of stroke patients, and possibly of people with 
other chronic diseases, and of patients with severe health conditions who cannot response 
directly to the DHP and require caregivers to provide information on their behalf. 
 
Health-related to quality of life of stroke survivors three months after stroke (Chapter 
7) 
Significance 
To fully understand the burden of stroke in LMICs such as Viet Nam, the HRQoL of stroke 
survivors should be assessed. This is because HRQoL is an important patient-centred 
outcome. To date, there has not been a study of HRQoL of stroke survivors in Viet Nam. To 
correct this deficiency, a study providing assessment of HRQoL of stroke survivors was 
conducted. The aims were to assess the HRQoL of survivors three months following a first-
ever stroke in Viet Nam, and to identify factors related to poor HRQoL. 
Findings 
The mean DHP general health score was 58.7 (SD 17.8). The mean EQ-5D utility score was 
0.67 (SD 0.33) and the mean VAS score was 61.3 (SD 20.4). For those with the least severity 
of disability (mRS=0/1) at admission, the mean DHP overall score was 66.9 (SD 14.7) and 
similar to that of a general population sample of Ho Chi Minh City [62.7(SD 18.2)]. The 
mean DHP overall score of patients with intermediate severity (mRS=2/3) and of those with 
most severe disability (mRS=4/5) at admission were 5.2 and 12.9 points lower respectively. 
The study factors associated with poorer HRQoL were increasing age, female sex, greater 
severity stroke at admission and greater severity of disability at three months. Only female sex 
and severity of disability at three months were independently associated with poorer HRQoL. 
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Implications 
Suggesting that severe strokes reduce well-being, measurements of HRQoL made with the 
DHP were substantially lower on average for patients with most severe disability (mRS=4/5) 
than the mean value for the general population from which they were drawn. For patients with 
less severe disability, their HRQoL was similar on average to that of members of the general 
population. 
Self-reported HRQoL was lower for female patients than for male patients, with the greatest 
deficits in the physical health, pain and depression dimensions. The study of functional 
outcomes at three months (Chapter 4) produced key findings that female patients had 
relatively greater severity of disability at three month than male patients and fewer had 
recovered during the intervening period, but the female deficits in general health and 
depression, and greater awareness of pain, remained after adjustment for severity of disability. 
A contributing factor may be the central role that the older woman plays in family life in Viet 
Nam. A disabling stroke would leave her unable to perform that role, and reverse family 
dependence relationships with a possible detriment to her social and mental health.  
It was important to confirm that the factors associated with poorer outcomes including 
HRQoL are similar to those found in other populations, suggesting application in Viet Nam of 
strategies for management of stroke primarily to reduce stroke severity and improve recovery 
that have been developed in HICs and are known to be effective. 
In Viet Nam, caregivers play an important role in caring for patients following a stroke, 
including by providing care in hospital and later at home. They typically have a close 
relationship with patients, being their spouse, parent or offspring in most cases. After being 
discharged from the hospital, the majority of participants in this study needed to receive care 
and around 40% were dependent on that care for activities of daily living (mRS ≥ 3). In the 
absence of residential aged care facilities such as nursing homes and rehabilitation centres, 
and without social support programs being available for patients following stroke, a 
substantial burden of care falls on caregivers in Viet Nam.  
 
8.3. Recommendations for future research 
The research reported in this thesis has provided important findings in relation to the 
occurrence, clinical presentation and treatment costs of stroke in Viet Nam and on outcomes 
three months following stroke in Viet Nam.  
It has also brought to light some gaps in information that need to be addressed in future 
research. These gaps are listed below: 
1. The extent of under-ascertainment of mild cases at one end of the severity spectrum, 
and particularly of severe cases at the other end of the spectrum, is unknown. Under-
ascertainment is to be expected in a hospital-based study, and well-designed 
community-based studies are needed to provide a more complete account of stroke 
occurrence and of the overall burden of stroke in Viet Nam. The success of the 
hospital-based surveillance at 115 People’s Hospital is a first step towards 
comprehensive stroke surveillance in Viet Nam; 
 
2. This study has not provided information on stroke patients treated in a provincial 
general hospital or a community hospital without a stroke unit. Further studies 
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investigating stroke care across a range of hospital are required to complete the 
description of the clinical pathways and outcomes for stroke patients in Viet Nam. 
Ultimately, quality standards for the hospitals management of acute stroke should be 
developed in Viet Nam; 
 
3. The contribution of delayed hospital admission to poor outcomes after stroke has not 
yet been investigated in Viet Nam. There is no centrally managed ambulance service 
in Viet Nam. In addition, the precursors of delayed admission – such as lack of 
awareness of stroke signs and symptoms by patients and caregivers, slow initial 
reaction to stroke and ineffective treatment-seeking behaviours at the time of onset – 
should be investigated; 
 
4. The information collected on costs of treatment for stroke included neither the losses 
of productivity not reflected by loss of income nor the larger indirect costs incurred by 
patients who travel great distances to receive treatment. More information on the costs 
of stroke during and after hospitalisation for an acute intensive treatment should be 
collected to describe more fully the burden of cost on patients and their families. It is 
also important to examine the extent of hardship on patients’ families following a 
stroke, including assessment of whether total health expenditure is so high as to be 
deemed catastrophic for a family;  
 
5. The longer-term outcomes of stroke survivors in Viet Nam have not been investigated. 
The success of the three-month follow-up of this cohort suggests that it should be 
feasible to follow a cohort of stroke patients for longer periods of time to investigate 
case-fatality, disability and HRQoL of stroke survivors after one or more years; 
 
6. Assessment of HRQoL of stroke survivors with stroke-specific instruments has not 
been attempted in Viet Nam. In this study, measurements were made using two 
generic instruments (the DHP and EQ-5D). A stroke-specific instrument – such as the 
Stroke Specific Quality of Life Scale or the Stroke and Aphasia Quality of Life Scale 
– should be translated, culturally adapted and used to assess HRQoL of stroke 
survivors in Viet Nam; 
 
7. There is a lack of information on population norms for the instruments that can be 
used to measure HRQoL of Vietnamese people. These data would be important for 
comparisons of outcomes across a range of conditions, and also for use in evaluation 
of programs to prevent and manage those conditions; 
 
8. This study has provided the first information on the impact on Vietnamese caregivers 
of caring for a person with stroke, but the picture is far from complete. The burden of 
stroke on caregivers seems to be substantial in Viet Nam. Further studies should be 
conducted to explore the level of physical function and health-related quality of life of 
caregivers of stroke patients, and of patients with other conditions. The specific 
influence of caregiver characteristics and well-being on patient outcomes should be 
investigated.  
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8.4. Conclusion 
The thesis provides original findings in respect of the epidemiology of stroke in urban Viet 
Nam and the burden of stroke on patients, their families, the healthcare system and society. A 
particularly novel aspect was the assessment of the outcomes at three months after stroke 
onset. Stroke in Viet Nam occurs at lesser mean age of onset and with three-quarters of 
patients having moderate-to-severe disability at admission. Three months following stroke, 
one-third of patients still had significant levels of disability and substantially lower 
psychological well-being. Stroke also imposes a huge cost on society and on the patient’s 
families. The true burden may be much larger, because the information analysed in this study 
was collected from patients who were treated at a major teaching public hospital with a stroke 
unit in the largest city of Viet Nam. Effective plans to diminish the burden of stroke in Viet 
Nam are required. 
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